MiRNA Name | p-value | p-value | Fold-Change (Day 5 vs. Day 0) | Fold-Change (Day 9 vs. Day 0) |
(Day 5 vs. Day 0) | (Day 9 vs. Day 0) | |||
hsa-miR-1224-5p | 0.025 | 0.004 | 3 | 5.1 |
hsa-miR-1225-5p | 0.014 | 0.003 | 4.6 | 7.7 |
hsa-miR-1226 | 0.017 | 0.011 | 1.7 | 1.8 |
hsa-miR-1231 | 0.015 | 0.003 | 9 | 24.4 |
hsa-miR-1254 | 0.01 | 0.005 | 3.4 | 4.2 |
hsa-miR-125b-1* | 0.011 | 0.001 | 4.7 | 14.1 |
hsa-miR-1270 | 0.012 | 0 | 1.5 | 2.1 |
hsa-miR-1275 | 0.013 | 0 | 2.8 | 9 |
hsa-miR-1287 | 0.023 | 0.045 | 1.6 | 1.5 |
hsa-miR-1292 | 0.026 | 0.008 | 2.5 | 3.5 |
hsa-miR-1304 | 0.046 | 0 | 1.6 | 3.6 |
hsa-miR-1469 | 0.042 | 0.009 | 3.5 | 6.5 |
hsa-miR-149* | 0.034 | 0.004 | 3.6 | 8.2 |
hsa-miR-150* | 0.039 | 0.001 | 3.1 | 13 |
hsa-miR-1538 | 0.034 | 0.009 | 1.5 | 1.8 |
hsa-miR-188-3p | 0.008 | 0.006 | -1.5 | -1.5 |
hsa-miR-1909* | 0.019 | 0.001 | 2.2 | 4.2 |
hsa-miR-193a-5p | 0.051 | 0.011 | 3.3 | 6 |
hsa-miR-197 | 0.015 | 0.002 | 1.5 | 1.9 |
hsa-miR-202* | 0.022 | 0.001 | -1.7 | -2.8 |
hsa-miR-2276 | 0.045 | 0.012 | 2 | 2.8 |
hsa-miR-23a* | 0.009 | 0.001 | 1.6 | 2.2 |
hsa-miR-3064-5p | 0.019 | 0.001 | 1.9 | 3.1 |
hsa-miR-31 | 0.028 | 0.034 | -1.9 | -1.8 |
hsa-miR-3162-5p | 0.006 | 0.001 | 2.6 | 3.7 |
hsa-miR-3163 | 0.033 | 0.003 | -1.6 | -2.2 |
hsa-miR-3177-3p | 0.028 | 0.01 | 2 | 2.5 |
hsa-miR-3185 | 0.034 | 0.007 | 4.6 | 9.5 |
hsa-miR-3187-3p | 0.046 | 0.004 | 3.3 | 8.6 |
hsa-miR-3195 | 0.043 | 0.002 | 2.8 | 9 |
hsa-miR-3605-5p | 0.023 | 0 | 1.6 | 3 |
hsa-miR-3646 | 0.005 | 0.002 | 1.5 | 1.7 |
hsa-miR-3663-3p | 0.024 | 0.003 | 6.4 | 18.1 |
hsa-miR-3679-5p | 0.029 | 0.003 | 2.6 | 5.1 |
hsa-miR-377* | 0.026 | 0.02 | 1.6 | 1.7 |
hsa-miR-3927 | 0.041 | 0.001 | -1.6 | -2.8 |
hsa-miR-3940-5p | 0.048 | 0.008 | 3 | 5.7 |
hsa-miR-432* | 0.018 | 0.015 | 1.6 | 1.6 |
hsa-miR-4462 | 0.053 | 0.011 | 2.5 | 3.9 |
hsa-miR-4463 | 0.039 | 0.005 | 3 | 5.8 |
hsa-miR-4486 | 0.026 | 0.003 | 5 | 14.8 |
hsa-miR-4516 | 0.034 | 0.014 | 3.6 | 4.9 |
hsa-miR-4523 | 0.001 | 0 | 1.6 | 2.2 |
hsa-miR-4530 | 0.029 | 0.009 | 3.3 | 5 |
hsa-miR-4532 | 0.007 | 0.001 | 6.8 | 24.9 |
hsa-miR-4651 | 0.03 | 0.01 | 3.7 | 5.7 |
hsa-miR-4674 | 0.026 | 0.003 | 4.2 | 10.2 |
hsa-miR-4689 | 0.026 | 0.014 | 5 | 6.5 |
hsa-miR-4695-5p | 0.02 | 0.003 | 3.4 | 6.3 |
hsa-miR-4707-5p | 0.025 | 0.006 | 4.1 | 7 |
hsa-miR-4734 | 0.03 | 0.009 | 4.2 | 6.9 |
hsa-miR-4741 | 0.016 | 0.005 | 5.4 | 8.8 |
hsa-miR-4745-5p | 0.023 | 0.006 | 4 | 6.8 |
hsa-miR-4791 | 0.01 | 0.003 | -2.6 | -3.4 |
hsa-miR-509-3-5p | 0.045 | 0.001 | -1.5 | -2.3 |
hsa-miR-510 | 0.022 | 0.006 | -1.8 | -2.2 |
hsa-miR-542-3p | 0.039 | 0.022 | -2.1 | -2.4 |
hsa-miR-548a-3p | 0.001 | 0 | -1.5 | -2.6 |
hsa-miR-548aa | 0.016 | 0 | -1.6 | -2.6 |
hsa-miR-548ac | 0.042 | 0.001 | -1.6 | -3.1 |
hsa-miR-548ae | 0.052 | 0.009 | -1.8 | -2.5 |
hsa-miR-548al | 0.043 | 0.042 | -2.1 | -2.1 |
hsa-miR-602 | 0.054 | 0.003 | 3.3 | 10.3 |
hsa-miR-603 | 0.036 | 0.004 | -1.8 | -2.7 |
hsa-miR-635 | 0.033 | 0.014 | -2.1 | -2.4 |
hsa-miR-642b | 0.004 | 0.001 | 4.4 | 6 |
hsa-miR-650 | 0.049 | 0.044 | 1.5 | 1.5 |
hsa-miR-943 | 0.03 | 0.001 | 1.6 | 2.5 |
Pathway | Adj p-value | Number of Genes |
Actin Cytoskeleton Signaling | <0.05 | 29 |
Integrin Signaling | <0.05 | 28 |
Molecular Mechanisms of Cancer | <0.05 | 36 |
Ephrin Receptor Signaling | <0.05 | 23 |
VEGF Signaling | <0.05 | 17 |
Top Network Functions | Adj p-value | Number of Genes |
Cell Morphology | <0.05 | 239 |
Cellular Movement | <0.05 | 184 |
Cellular Assembly and Organization | <0.05 | 187 |
Cellular Growth and Proliferation | <0.05 | 282 |
Cellular Function and Maintenance | <0.05 | 244 |
Symbol | Fold Change (Day 5 vs. Day 0) | Symbol | Fold Change (Day 9 vs. Day 0) |
ACTRT1 | 2.3 | COL8A2 | 2.9 |
COL8A2 | 2.2 | AKAP7 | 2.9 |
CSNK2A1 | 2.2 | LOC645932 | 2.9 |
LOC100130769 | 2.2 | USP33 | 2.8 |
OR2A42 | 1.9 | RN7SK | 2.8 |
FKBP3 | 1.8 | LOC645931 | 2.7 |
ROCK1 | 1.8 | MYL12A | 2.7 |
FNIP2 | 1.7 | CSNK2A1 | 2.7 |
YIPF1 | 1.7 | SIPA1L3 | 2.5 |
IL7 | 1.7 | ACTRT1 | 2.5 |
LOC100133939 | 1.7 | C9orf62 | 2.5 |
MAK10 | 1.7 | FZD7 | 2.4 |
SLC25A45 | 1.6 | LOC100130769 | 2.4 |
DNA2 | 1.6 | TTK | 2.4 |
MED31 | 1.6 | IL7 | 2.4 |
LCLAT1 | 1.6 | OR2A42 | 2.4 |
IGSF11 | 1.6 | LOC100133747 | 2.4 |
LYPD3 | 1.6 | SNORD13 | 2.3 |
TERF1 | 1.6 | LCLAT1 | 2.3 |
FAM13A | 1.6 | ROCK1 | 2.3 |
TTK | 1.6 | RNASEH2B | 2.3 |
LOC644632 | 1.6 | SDCCAG1 | 2.3 |
LOC646548 | 1.6 | LARP1B | 2.2 |
TRIO | 1.6 | FBXO2 | 2.2 |
DLEU1 | 1.5 | DNHD2 | 2.1 |
LRRCC1 | 1.5 | FKBP3 | 2.1 |
CISD2 | 1.5 | LARP7 | 2.0 |
TMEM55A | 1.5 | ITGA7 | 2.0 |
MGC3196 | 1.5 | FGF18 | 2.0 |
PRKACB | 1.5 | MAK10 | 2.0 |
ZSWIM4 | 1.5 | YIPF1 | 2.0 |
HGD | 1.5 | PTMS | 2.0 |
LOC100129195 | 1.5 | ZSWIM4 | 2.0 |
LOC100132918 | 1.5 | LOC402538 | 2.0 |
POLR2J2 | 1.5 | RASA4P | 2.0 |
LOC641814 | -1.5 | PTPN7 | 1.9 |
CIRBP | -1.5 | ATP5I | 1.9 |
LOC100133551 | -1.5 | C12orf24 | 1.9 |
ARPC4 | -1.6 | C11orf10 | 1.9 |
CIB1 | -1.6 | COX7B | 1.9 |
LOC284821 | -1.6 | FLJ44054 | 1.9 |
RPL14L | -1.6 | CCDC53 | 1.9 |
UBE2M | -1.6 | RRM1 | 1.9 |
LOC100129553 | -1.6 | LOC644914 | 1.9 |
UIMC1 | -1.6 | KIAA1967 | 1.9 |
LOC390345 | -1.7 | LOC729776 | 1.8 |
LOC650152 | -1.8 | SNHG9 | 1.8 |
PSAP | -1.9 | LRRCC1 | 1.8 |
LOC100130477 | -2.0 | DUSP15 | 1.8 |
LOC441013 | -2.0 | THOC2 | 1.8 |
NFE2 | -2.0 | FEZ1 | 1.7 |
ODC1 | -2.0 | PSMA6 | 1.7 |
LOC440589 | -2.2 | SNORD3A | 1.7 |
DIMT1L | -3.4 | C1orf50 | 1.7 |
GNG8 | 1.7 | ||
FXYD1 | 1.7 | ||
LOC100133477 | 1.7 | ||
ATP5L | 1.6 | ||
NOP10 | 1.6 | ||
DLEU1 | 1.6 | ||
NDUFA3 | 1.5 | ||
LOC729009 | 1.5 | ||
ZFAND1 | 1.5 | ||
EIF1AY | 1.5 | ||
LSM1 | 1.5 | ||
CIC | -1.5 | ||
CLEC2L | -1.5 | ||
DYRK1A | -1.5 | ||
HIST1H2BD | -1.5 | ||
MYO1C | -1.5 | ||
PLOD1 | -1.5 | ||
RHD | -1.5 | ||
TTC15 | -1.5 | ||
UQCRH | -1.5 | ||
DNAJA2 | -1.5 | ||
TMSB10 | -1.5 | ||
C17orf90 | -1.5 | ||
C5orf15 | -1.5 | ||
DSTN | -1.5 | ||
GTF3C5 | -1.5 | ||
LOC728139 | -1.5 | ||
SEC16A | -1.5 | ||
ARID3B | -1.5 | ||
ATP2A2 | -1.5 | ||
C9orf78 | -1.5 | ||
CDV3 | -1.5 | ||
LOC390466 | -1.5 | ||
LOC730990 | -1.5 | ||
NEURL1B | -1.5 | ||
PAFAH1B1 | -1.5 | ||
PPP2CB | -1.5 | ||
SCFD2 | -1.5 | ||
SLCO3A1 | -1.5 | ||
AP1M2 | -1.5 | ||
ARHGAP1 | -1.5 | ||
COPE | -1.5 | ||
DDX41 | -1.5 | ||
FAM100B | -1.5 | ||
FAM13B | -1.5 | ||
IRS1 | -1.5 | ||
LOC647340 | -1.5 | ||
POL3S | -1.5 | ||
SELT | -1.5 | ||
UPF1 | -1.5 | ||
AKAP13 | -1.5 | ||
BEST2 | -1.5 | ||
DNAH2 | -1.5 | ||
ITFG1 | -1.5 | ||
LOC100133649 | -1.5 | ||
LPIN2 | -1.5 | ||
MAP2K1 | -1.5 | ||
MAPK8IP3 | -1.5 | ||
MTHFD2 | -1.5 | ||
PARK7 | -1.5 | ||
RBM4 | -1.5 | ||
CNPY3 | -1.5 | ||
KLHDC3 | -1.5 | ||
LOC728368 | -1.5 | ||
NCOA6 | -1.5 | ||
PAPSS2 | -1.5 | ||
PLOD2 | -1.5 | ||
RNF10 | -1.5 | ||
SHCBP1 | -1.5 | ||
SRPR | -1.5 | ||
AHCTF1 | -1.5 | ||
AP3M2 | -1.5 | ||
KLF13 | -1.5 | ||
RNF44 | -1.5 | ||
BCL7B | -1.5 | ||
C19orf31 | -1.5 | ||
CS | -1.5 | ||
FNBP1 | -1.5 | ||
LGALS8 | -1.5 | ||
LOC649679 | -1.5 | ||
MTCH1 | -1.5 | ||
NCOA3 | -1.5 | ||
N-PAC | -1.5 | ||
PDLIM1 | -1.5 | ||
PRRT3 | -1.5 | ||
RAF1 | -1.5 | ||
RNF14 | -1.5 | ||
SAPS3 | -1.5 | ||
SHKBP1 | -1.5 | ||
STK40 | -1.5 | ||
UBQLN3 | -1.5 | ||
ARID1A | -1.5 | ||
DENND3 | -1.5 | ||
LOC100132394 | -1.5 | ||
LOC100132593 | -1.5 | ||
LOC203547 | -1.5 | ||
LOC339970 | -1.5 | ||
MID1IP1 | -1.5 | ||
ORAI3 | -1.5 | ||
TXNDC12 | -1.5 | ||
UBB | -1.5 | ||
ANXA2P2 | -1.6 | ||
LOC552889 | -1.6 | ||
MAP2K3 | -1.6 | ||
NAG18 | -1.6 | ||
SCYL1 | -1.6 | ||
TTC7B | -1.6 | ||
XPO6 | -1.6 | ||
ATF4 | -1.6 | ||
ATP5A1 | -1.6 | ||
C15orf39 | -1.6 | ||
C20orf11 | -1.6 | ||
CCR6 | -1.6 | ||
CUGBP2 | -1.6 | ||
RGS10 | -1.6 | ||
TMEM183B | -1.6 | ||
TNIP1 | -1.6 | ||
ETS1 | -1.6 | ||
GTDC1 | -1.6 | ||
KBTBD2 | -1.6 | ||
VIL2 | -1.6 | ||
ZMIZ2 | -1.6 | ||
MTMR14 | -1.6 | ||
RGS6 | -1.6 | ||
TBC1D14 | -1.6 | ||
YY1 | -1.6 | ||
LOC100133465 | -1.6 | ||
MAP2K2 | -1.6 | ||
SYT11 | -1.6 | ||
TRIP12 | -1.6 | ||
BCL2L1 | -1.6 | ||
COBRA1 | -1.6 | ||
ELMO2 | -1.6 | ||
GABARAPL2 | -1.6 | ||
ITIH5 | -1.6 | ||
LOC400446 | -1.6 | ||
LOC401052 | -1.6 | ||
LOC646723 | -1.6 | ||
LOC728553 | -1.6 | ||
CCNJL | -1.6 | ||
ORC6L | -1.6 | ||
PANK2 | -1.6 | ||
UHRF1BP1 | -1.6 | ||
ARAP1 | -1.6 | ||
LOC643738 | -1.6 | ||
LOC648210 | -1.6 | ||
MRPL18 | -1.6 | ||
PUM2 | -1.6 | ||
SPG3A | -1.6 | ||
TMEM183A | -1.6 | ||
VTI1B | -1.6 | ||
DIABLO | -1.6 | ||
GATA2 | -1.6 | ||
LOC649049 | -1.6 | ||
MPRIP | -1.6 | ||
SCAND1 | -1.6 | ||
SERF2 | -1.6 | ||
TBC1D20 | -1.6 | ||
C16orf7 | -1.6 | ||
CARD8 | -1.6 | ||
CASP6 | -1.6 | ||
IP6K1 | -1.6 | ||
CHFR | -1.7 | ||
CORO1A | -1.7 | ||
NCOR2 | -1.7 | ||
ARHGEF3 | -1.7 | ||
LOC650029 | -1.7 | ||
NECAP2 | -1.7 | ||
PCSK7 | -1.7 | ||
RP11-529I10.4 | -1.7 | ||
TMEM189 | -1.7 | ||
VIL1 | -1.7 | ||
YWHAB | -1.7 | ||
LOC650034 | -1.7 | ||
MSRA | -1.7 | ||
VASP | -1.7 | ||
ZC3H7A | -1.7 | ||
HLA-DRA | -1.7 | ||
SNRPB | -1.7 | ||
CHST12 | -1.7 | ||
LOC644739 | -1.7 | ||
NLRX1 | -1.7 | ||
PSMF1 | -1.7 | ||
VASH1 | -1.7 | ||
CHMP4B | -1.7 | ||
FBXW11 | -1.7 | ||
FOXO1 | -1.7 | ||
LOC728787 | -1.7 | ||
SRGN | -1.7 | ||
WIPI2 | -1.7 | ||
CABC1 | -1.7 | ||
CHSY1 | -1.7 | ||
COASY | -1.7 | ||
N4BP2L1 | -1.7 | ||
SH3KBP1 | -1.7 | ||
SPIRE1 | -1.7 | ||
ARHGDIA | -1.7 | ||
CBL | -1.7 | ||
DULLARD | -1.7 | ||
EIF3G | -1.7 | ||
EZR | -1.7 | ||
HCLS1 | -1.7 | ||
LOC399942 | -1.7 | ||
SMG7 | -1.7 | ||
MLEC | -1.7 | ||
CD44 | -1.8 | ||
FADD | -1.8 | ||
FASTKD5 | -1.8 | ||
INPP5A | -1.8 | ||
QSOX1 | -1.8 | ||
C6orf106 | -1.8 | ||
LTB | -1.8 | ||
MTHFR | -1.8 | ||
RBM14 | -1.8 | ||
SFRS9 | -1.8 | ||
SNX6 | -1.8 | ||
WNK1 | -1.8 | ||
SRF | -1.8 | ||
UBE2G1 | -1.8 | ||
HYAL3 | -1.8 | ||
NR1H2 | -1.8 | ||
VAMP3 | -1.8 | ||
ATG9A | -1.8 | ||
B4GALT1 | -1.8 | ||
GLG1 | -1.8 | ||
KIF1B | -1.8 | ||
YPEL2 | -1.8 | ||
ZFP91 | -1.8 | ||
ANKRD10 | -1.8 | ||
C16orf63 | -1.8 | ||
RAP2A | -1.8 | ||
SEPX1 | -1.8 | ||
SYF2 | -1.8 | ||
TMEM50A | -1.8 | ||
FGR | -1.8 | ||
BRD2 | -1.8 | ||
IVNS1ABP | -1.8 | ||
LOC148430 | -1.8 | ||
CHMP1B | -1.8 | ||
PRTFDC1 | -1.8 | ||
CMTM2 | -1.8 | ||
GUCY1B3 | -1.8 | ||
MTHFD2L | -1.8 | ||
SMCR7L | -1.8 | ||
VPS26B | -1.8 | ||
IGF2BP3 | -1.9 | ||
ITGA2 | -1.9 | ||
NUMB | -1.9 | ||
REPS2 | -1.9 | ||
ARMC7 | -1.9 | ||
CAV2 | -1.9 | ||
CLDN15 | -1.9 | ||
AKT1 | -1.9 | ||
PPP4C | -1.9 | ||
PTP4A3 | -1.9 | ||
RPRC1 | -1.9 | ||
TTC39B | -1.9 | ||
LOC493754 | -1.9 | ||
GP6 | -1.9 | ||
INPPL1 | -1.9 | ||
LOC441455 | -1.9 | ||
UBE2M | -1.9 | ||
ANKRD28 | -1.9 | ||
C17orf62 | -1.9 | ||
CDS2 | -1.9 | ||
EPOR | -1.9 | ||
PDGFC | -1.9 | ||
RALBP1 | -1.9 | ||
SLA2 | -1.9 | ||
C14orf147 | -1.9 | ||
OXTR | -1.9 | ||
PHTF1 | -1.9 | ||
SLC2A8 | -1.9 | ||
XPO7 | -1.9 | ||
KLHL6 | -1.9 | ||
LRMP | -1.9 | ||
WDR40A | -1.9 | ||
VIM | -1.9 | ||
ATP5D | -1.9 | ||
CABLES1 | -1.9 | ||
CHMP1A | -1.9 | ||
VISA | -1.9 | ||
ANTXR2 | -2.0 | ||
CLEC16A | -2.0 | ||
MPST | -2.0 | ||
RCOR3 | -2.0 | ||
SNAP29 | -2.0 | ||
TMEM14C | -2.0 | ||
POLR2A | -2.0 | ||
BNIP3L | -2.0 | ||
C6orf85 | -2.0 | ||
CDKL1 | -2.0 | ||
CEBPB | -2.0 | ||
LOC645173 | -2.0 | ||
NHP2L1 | -2.0 | ||
MFSD6 | -2.0 | ||
SLC35D3 | -2.0 | ||
BTG1 | -2.0 | ||
CTNNBIP1 | -2.0 | ||
HERC1 | -2.0 | ||
KATNB1 | -2.0 | ||
LOC441506 | -2.0 | ||
NKG7 | -2.0 | ||
PAM | -2.0 | ||
11-Sep | -2.0 | ||
FAM108A3 | -2.0 | ||
HIST1H3F | -2.0 | ||
PPM1G | -2.0 | ||
TCF25 | -2.0 | ||
FNBP1L | -2.0 | ||
SSBP2 | -2.0 | ||
EEF1G | -2.0 | ||
EHBP1 | -2.0 | ||
LOC642755 | -2.0 | ||
LOC648249 | -2.0 | ||
PTGIR | -2.0 | ||
VPS37C | -2.0 | ||
ACSS2 | -2.0 | ||
CYFIP1 | -2.0 | ||
DLG4 | -2.0 | ||
KIAA1545 | -2.0 | ||
KIF3C | -2.0 | ||
WWC3 | -2.0 | ||
DDA1 | -2.0 | ||
PACSIN2 | -2.0 | ||
UBE1 | -2.0 | ||
ZNF364 | -2.0 | ||
C7orf49 | -2.1 | ||
CD36 | -2.1 | ||
XRCC6 | -2.1 | ||
C12orf51 | -2.1 | ||
DSCR3 | -2.1 | ||
LOC440927 | -2.1 | ||
NCK2 | -2.1 | ||
ABHD4 | -2.1 | ||
CBARA1 | -2.1 | ||
LOC390345 | -2.1 | ||
NCOA7 | -2.1 | ||
P2RY12 | -2.1 | ||
STRN4 | -2.1 | ||
TGFBR2 | -2.1 | ||
UBAC1 | -2.1 | ||
CTBP1 | -2.1 | ||
PCTP | -2.1 | ||
SVIL | -2.1 | ||
GTF2IP1 | -2.1 | ||
ATP6V1B2 | -2.1 | ||
CD47 | -2.1 | ||
CLPTM1L | -2.1 | ||
MCM7 | -2.1 | ||
PKP4 | -2.1 | ||
TJP2 | -2.1 | ||
ACTN4 | -2.1 | ||
TMEM63A | -2.1 | ||
VPS8 | -2.1 | ||
ENKUR | -2.1 | ||
C16orf35 | -2.1 | ||
CLTA | -2.1 | ||
EIF4E3 | -2.1 | ||
EIF4H | -2.1 | ||
LTA | -2.1 | ||
NKIRAS2 | -2.1 | ||
RPL13A | -2.1 | ||
VHL | -2.1 | ||
DNAJC8 | -2.2 | ||
HIST1H3H | -2.2 | ||
LOC401537 | -2.2 | ||
PRPF8 | -2.2 | ||
RASA3 | -2.2 | ||
SLC25A3 | -2.2 | ||
CD37 | -2.2 | ||
LOC644330 | -2.2 | ||
ARHGEF12 | -2.2 | ||
KIAA0427 | -2.2 | ||
LOC728069 | -2.2 | ||
RNF38 | -2.2 | ||
SET | -2.2 | ||
TM2D2 | -2.2 | ||
PBX3 | -2.2 | ||
RICS | -2.2 | ||
RPLP0 | -2.2 | ||
SORT1 | -2.2 | ||
TXNRD1 | -2.2 | ||
ADRBK1 | -2.2 | ||
ARHGEF18 | -2.2 | ||
DNAJC9 | -2.2 | ||
ECGF1 | -2.2 | ||
ERICH1 | -2.2 | ||
TSC22D4 | -2.2 | ||
IRF9 | -2.2 | ||
PFDN6 | -2.2 | ||
PSMD2 | -2.2 | ||
RILPL2 | -2.2 | ||
EGF | -2.2 | ||
ZC3H11B | -2.2 | ||
C10orf26 | -2.3 | ||
HNRPUL1 | -2.3 | ||
PRKCA | -2.3 | ||
ATP6V0B | -2.3 | ||
MEF2D | -2.3 | ||
POLR1D | -2.3 | ||
CLCN7 | -2.3 | ||
PGK1 | -2.3 | ||
NIN | -2.3 | ||
LOC286444 | -2.3 | ||
MGEA5 | -2.3 | ||
RPS2 | -2.3 | ||
TMEM60 | -2.3 | ||
TUBB1 | -2.3 | ||
SLBP | -2.3 | ||
KIFAP3 | -2.3 | ||
PRKCQ | -2.3 | ||
PTPN6 | -2.3 | ||
PPP1CA | -2.3 | ||
HERC6 | -2.3 | ||
ARL8B | -2.3 | ||
ISCA1 | -2.3 | ||
LAMC1 | -2.3 | ||
RALB | -2.3 | ||
GFOD1 | -2.3 | ||
KIAA1147 | -2.3 | ||
MAN2A2 | -2.3 | ||
TBC1D13 | -2.3 | ||
MRFAP1 | -2.3 | ||
RPS6KB2 | -2.3 | ||
FLOT2 | -2.4 | ||
TERF2IP | -2.4 | ||
UBE2D3 | -2.4 | ||
FAM65B | -2.4 | ||
LOC388654 | -2.4 | ||
P4HB | -2.4 | ||
ATP6V0A1 | -2.4 | ||
ELMO1 | -2.4 | ||
SSH1 | -2.4 | ||
CMTM3 | -2.4 | ||
ETV6 | -2.4 | ||
FLI1 | -2.4 | ||
JUND | -2.4 | ||
NBEAL2 | -2.4 | ||
BCR | -2.4 | ||
GNA12 | -2.4 | ||
LOC100130291 | -2.4 | ||
LOC387867 | -2.4 | ||
RAB6B | -2.4 | ||
LOC728661 | -2.4 | ||
AP1B1 | -2.4 | ||
TXNIP | -2.4 | ||
C5orf21 | -2.4 | ||
CLIC1 | -2.4 | ||
FAM120A | -2.4 | ||
HDAC1 | -2.4 | ||
SYNM | -2.4 | ||
TXNL4B | -2.4 | ||
VCP | -2.4 | ||
LOC286157 | -2.4 | ||
ACADVL | -2.4 | ||
C16orf30 | -2.4 | ||
LOC642031 | -2.4 | ||
TWSG1 | -2.5 | ||
LOC100133591 | -2.5 | ||
SHC1 | -2.5 | ||
AXIN1 | -2.5 | ||
XYLT2 | -2.5 | ||
F11R | -2.5 | ||
UBE3B | -2.5 | ||
C22orf13 | -2.5 | ||
RPL3 | -2.5 | ||
EFHD2 | -2.5 | ||
GRB2 | -2.5 | ||
SECISBP2 | -2.5 | ||
SMARCA2 | -2.5 | ||
PIP5K1C | -2.5 | ||
C2orf88 | -2.5 | ||
COPA | -2.5 | ||
LHFPL2 | -2.5 | ||
MAPKAPK2 | -2.5 | ||
TNS1 | -2.5 | ||
C10orf47 | -2.5 | ||
ADD1 | -2.5 | ||
CHES1 | -2.5 | ||
PHGDH | -2.5 | ||
LASS2 | -2.6 | ||
EIF2C2 | -2.6 | ||
PIP5K2A | -2.6 | ||
C11orf21 | -2.6 | ||
RHEB | -2.6 | ||
SERPINE2 | -2.6 | ||
TGOLN2 | -2.6 | ||
TMEM189-UBE2V1 | -2.6 | ||
S100A4 | -2.6 | ||
ANKRD9 | -2.6 | ||
FHOD1 | -2.6 | ||
HMGN1 | -2.6 | ||
ROCK2 | -2.6 | ||
ZSWIM7 | -2.6 | ||
F2RL3 | -2.6 | ||
KIAA1191 | -2.6 | ||
LIMS1 | -2.6 | ||
C9orf69 | -2.6 | ||
GDE1 | -2.6 | ||
TUBB4Q | -2.6 | ||
MSRB3 | -2.6 | ||
C21orf63 | -2.6 | ||
PELI2 | -2.6 | ||
GNB5 | -2.6 | ||
MTSS1 | -2.6 | ||
STX1A | -2.6 | ||
ADD3 | -2.7 | ||
SLC37A1 | -2.7 | ||
STK38 | -2.7 | ||
ANAPC1 | -2.7 | ||
BAT5 | -2.7 | ||
VPS41 | -2.7 | ||
TADA3 | -2.7 | ||
CBX6 | -2.7 | ||
FSTL1 | -2.7 | ||
MAPRE2 | -2.7 | ||
TRIM8 | -2.7 | ||
TTYH3 | -2.7 | ||
SDHA | -2.7 | ||
CALD1 | -2.7 | ||
HCFC1 | -2.7 | ||
RAB10 | -2.7 | ||
DAG1 | -2.7 | ||
LOC440359 | -2.7 | ||
STAU1 | -2.7 | ||
ATXN7L3 | -2.7 | ||
LOC647000 | -2.7 | ||
SEPN1 | -2.7 | ||
PTPRA | -2.7 | ||
MAGED2 | -2.7 | ||
LOC642891 | -2.7 | ||
MTMR12 | -2.7 | ||
SLC39A3 | -2.7 | ||
STARD8 | -2.7 | ||
SPSB3 | -2.7 | ||
CHD4 | -2.8 | ||
TMEM9B | -2.8 | ||
ANK1 | -2.8 | ||
BCL2L2 | -2.8 | ||
SLMAP | -2.8 | ||
ZBED1 | -2.8 | ||
UBE2L3 | -2.8 | ||
PIK4CA | -2.8 | ||
NCOA1 | -2.8 | ||
TAPBP | -2.8 | ||
ACP1 | -2.8 | ||
BTN3A2 | -2.8 | ||
KIAA0430 | -2.8 | ||
STIM1 | -2.8 | ||
LAPTM4B | -2.8 | ||
ZBTB34 | -2.9 | ||
CCPG1 | -2.9 | ||
LOC285074 | -2.9 | ||
LOC732425 | -2.9 | ||
KIAA0174 | -2.9 | ||
DNMT1 | -2.9 | ||
AFAP1L2 | -2.9 | ||
PTPN1 | -2.9 | ||
ATP6V0D1 | -2.9 | ||
RALGDS | -2.9 | ||
KIAA1539 | -2.9 | ||
MYOM1 | -2.9 | ||
SDC4 | -2.9 | ||
CTNNA1 | -2.9 | ||
ZZEF1 | -3.0 | ||
CLIP1 | -3.0 | ||
THBS1 | -3.0 | ||
TMEM204 | -3.0 | ||
EFTUD2 | -3.0 | ||
TLK1 | -3.0 | ||
TPM3 | -3.0 | ||
FLII | -3.0 | ||
ADAR | -3.0 | ||
ABLIM1 | -3.0 | ||
FYN | -3.1 | ||
PECAM1 | -3.1 | ||
SMAP2 | -3.1 | ||
FNTB | -3.1 | ||
PFKFB3 | -3.1 | ||
SEC14L1 | -3.1 | ||
C1orf116 | -3.1 | ||
KIAA0494 | -3.1 | ||
JARID2 | -3.1 | ||
UBA1 | -3.1 | ||
LOC644132 | -3.2 | ||
LOC389286 | -3.2 | ||
RAB1B | -3.2 | ||
PGAM4 | -3.2 | ||
AMFR | -3.2 | ||
PSME4 | -3.2 | ||
NDST1 | -3.2 | ||
TNK2 | -3.2 | ||
LOC400890 | -3.2 | ||
LOC440589 | -3.2 | ||
UNC45A | -3.2 | ||
HDGF | -3.2 | ||
UBE2O | -3.2 | ||
NT5C2 | -3.3 | ||
P704P | -3.3 | ||
ADORA2A | -3.3 | ||
DIMT1L | -3.3 | ||
PROS1 | -3.3 | ||
SLC35E1 | -3.3 | ||
ZBTB4 | -3.3 | ||
ADIPOR2 | -3.3 | ||
CLCN3 | -3.3 | ||
EPN1 | -3.3 | ||
STS-1 | -3.3 | ||
SYTL4 | -3.3 | ||
UBXN2A | -3.3 | ||
TMCC2 | -3.3 | ||
RTN3 | -3.3 | ||
FURIN | -3.3 | ||
SLC16A5 | -3.3 | ||
TMEM39B | -3.3 | ||
ST3GAL1 | -3.4 | ||
KCNK6 | -3.4 | ||
ORMDL3 | -3.4 | ||
FOXO3 | -3.4 | ||
TNFRSF14 | -3.4 | ||
XK | -3.4 | ||
CTNS | -3.4 | ||
C22orf25 | -3.4 | ||
ARRB1 | -3.4 | ||
CENPT | -3.5 | ||
PPP2R2D | -3.5 | ||
PLEK | -3.5 | ||
SLC35D2 | -3.5 | ||
FAM62B | -3.5 | ||
LOC652624 | -3.5 | ||
ARPP19 | -3.5 | ||
KIF2A | -3.5 | ||
LOC100133163 | -3.6 | ||
ACTR3B | -3.6 | ||
DGKD | -3.6 | ||
TPM4 | -3.6 | ||
MAPRE1 | -3.6 | ||
HSBP1 | -3.6 | ||
C16orf56 | -3.7 | ||
GPD1L | -3.8 | ||
KLF9 | -3.8 | ||
HADH | -3.8 | ||
C20orf55 | -3.8 | ||
STX16 | -3.8 | ||
TUBA1B | -3.8 | ||
WIPI1 | -3.8 | ||
WASF2 | -3.9 | ||
FAM104A | -3.9 | ||
LMNA | -3.9 | ||
SH3PXD2A | -3.9 | ||
CDR2L | -3.9 | ||
DBNL | -3.9 | ||
WWP1 | -3.9 | ||
KLF11 | -3.9 | ||
PPP3R1 | -3.9 | ||
PNMA1 | -4.0 | ||
HEATR1 | -4.0 | ||
TUBB | -4.0 | ||
LSM14A | -4.0 | ||
P2RX1 | -4.0 | ||
ASAP2 | -4.0 | ||
LOC728533 | -4.0 | ||
FRMD8 | -4.0 | ||
GP1BA | -4.0 | ||
FAM20B | -4.1 | ||
UCP2 | -4.1 | ||
CD97 | -4.1 | ||
PGAM1 | -4.1 | ||
G3BP2 | -4.1 | ||
KIAA1949 | -4.2 | ||
ARF3 | -4.2 | ||
DSE | -4.2 | ||
LOC100130919 | -4.2 | ||
C5orf13 | -4.2 | ||
H3F3B | -4.2 | ||
ZDHHC7 | -4.2 | ||
CPNE5 | -4.2 | ||
CSNK1G2 | -4.2 | ||
MTPN | -4.2 | ||
RCC2 | -4.2 | ||
PDGFA | -4.3 | ||
DPY19L1 | -4.3 | ||
PLEKHA9 | -4.3 | ||
CASP2 | -4.3 | ||
SLC9A1 | -4.3 | ||
FYB | -4.3 | ||
INSIG1 | -4.3 | ||
RAB7A | -4.3 | ||
LOC648980 | -4.4 | ||
SPHK1 | -4.4 | ||
SYK | -4.4 | ||
IPO11 | -4.4 | ||
PTPRF | -4.4 | ||
CHMP6 | -4.4 | ||
NAP1L4 | -4.4 | ||
STX11 | -4.4 | ||
CCM2 | -4.4 | ||
CLIP2 | -4.4 | ||
ADCY3 | -4.5 | ||
ILK | -4.5 | ||
RAC1 | -4.5 | ||
GNB1 | -4.5 | ||
TSPAN18 | -4.6 | ||
ASAP1 | -4.6 | ||
EHD3 | -4.6 | ||
ULK1 | -4.6 | ||
SLC44A1 | -4.7 | ||
AZIN1 | -4.7 | ||
TUBA1A | -4.7 | ||
EGLN2 | -4.8 | ||
PPP2R5A | -4.8 | ||
DUSP3 | -4.8 | ||
MGLL | -4.9 | ||
NFE2 | -4.9 | ||
RHOBTB1 | -4.9 | ||
LRBA | -4.9 | ||
ARF1 | -5.0 | ||
DNM3 | -5.0 | ||
AFAP1 | -5.0 | ||
TPP1 | -5.0 | ||
LPAR5 | -5.0 | ||
RSU1 | -5.0 | ||
AMD1 | -5.0 | ||
LASP1 | -5.1 | ||
TACC1 | -5.1 | ||
TAL1 | -5.2 | ||
WASF3 | -5.2 | ||
NAP1L1 | -5.2 | ||
MADD | -5.2 | ||
GSN | -5.2 | ||
SH2B3 | -5.2 | ||
ALOX12 | -5.3 | ||
MAP1A | -5.3 | ||
RBM38 | -5.3 | ||
ACVR1 | -5.4 | ||
VPS37B | -5.4 | ||
ODC1 | -5.4 | ||
UBN1 | -5.4 | ||
BTBD12 | -5.4 | ||
LOC728431 | -5.5 | ||
IL8RBP | -5.5 | ||
CD9 | -5.5 | ||
FLNA | -5.6 | ||
CORO1C | -5.6 | ||
STK4 | -5.7 | ||
LOC650152 | -5.7 | ||
SELP | -5.7 | ||
ARHGAP21 | -5.7 | ||
PTK2 | -5.8 | ||
DDEF2 | -5.9 | ||
BRD3 | -6.0 | ||
CDC42SE2 | -6.0 | ||
NPTN | -6.1 | ||
CTDSP1 | -6.1 | ||
TNFSF4 | -6.1 | ||
CXorf20 | -6.2 | ||
TUBA1C | -6.2 | ||
CDC2L6 | -6.4 | ||
YWHAZ | -6.4 | ||
ITGB3 | -6.4 | ||
CRKL | -6.6 | ||
LOC440043 | -6.6 | ||
LDLRAP1 | -6.7 | ||
MOBKL2C | -6.7 | ||
BTBD11 | -6.9 | ||
MTMR10 | -7.0 | ||
PDE5A | -7.0 | ||
CAB39 | -7.1 | ||
KIAA0513 | -7.1 | ||
CSK | -7.1 | ||
LOC100130886 | -7.1 | ||
BICD2 | -7.2 | ||
ABCC4 | -7.3 | ||
SUSD3 | -7.3 | ||
STK24 | -7.3 | ||
VGLL4 | -7.4 | ||
C1orf198 | -7.4 | ||
CASP3 | -7.4 | ||
LOC644799 | -7.4 | ||
SRC | -7.5 | ||
CTDSP2 | -7.6 | ||
PGD | -7.6 | ||
INF2 | -7.7 | ||
MYH9 | -7.8 | ||
RAB11FIP3 | -7.9 | ||
GNAZ | -8.1 | ||
CDC14B | -8.1 | ||
PTBP1 | -8.4 | ||
TNS3 | -8.5 | ||
PNKD | -8.9 | ||
LOC402221 | -8.9 | ||
TST | -9.3 | ||
ARPC5 | -9.4 | ||
RIOK3 | -9.4 | ||
PIP4K2A | -9.6 | ||
SLC2A3 | -9.9 | ||
LOC151162 | -10.0 | ||
DIAPH1 | -10.1 | ||
CDKN1A | -10.6 | ||
JAM3 | -11.1 | ||
SEC14L5 | -11.2 | ||
SH3BGRL2 | -12.6 | ||
MBP | -12.6 | ||
MBNL1 | -12.9 | ||
SNN | -13.9 | ||
ANO6 | -15.1 | ||
CALM1 | -15.7 | ||
CTDSPL | -16.4 | ||
ENDOD1 | -16.8 |
miRNA name | p-value | Fold Change | Source | Confidence | Symbol | False Discovery Rate (q-value) | Fold Change | Pathway |
hsa-miR-3679-5p | 0.003 | 5.100 | TargetScan Human | Moderate (predicted) | AFAP1 | 0.000 | -4.990 | |
hsa-miR-3679-5p | 0.003 | 5.100 | TargetScan Human | Moderate (predicted) | ANKRD28 | 0.001 | -1.900 | |
hsa-miR-3679-5p | 0.003 | 5.100 | TargetScan Human | Moderate (predicted) | BTBD11 | 0.000 | -6.920 | |
hsa-miR-3679-5p | 0.003 | 5.100 | TargetScan Human | High (predicted), Moderate (predicted) | CARD8 | 0.000 | -1.640 | |
hsa-miR-3679-5p | 0.003 | 5.100 | TargetScan Human | Moderate (predicted) | DSTN | 0.037 | -1.470 | |
hsa-miR-3679-5p | 0.003 | 5.100 | TargetScan Human | Moderate (predicted) | GATA2 | 0.008 | -1.630 | Thrombin Signaling |
hsa-miR-3679-5p | 0.003 | 5.100 | TargetScan Human | Moderate (predicted) | MAP2K3 | 0.047 | -1.550 | Acute Myeloid Leukemia Signaling, Acute Phase Response Signaling, AMPK Signaling, B Cell Receptor Signaling, Cardiac Hypertrophy Signaling, CD27 Signaling in Lymphocytes, CD40 Signaling, Cholecystokinin/Gastrin-mediated Signaling, ErbB Signaling, Fc Epsilon RI Signaling, FGF Signaling, Germ Cell-Sertoli Cell Junction Signaling, GNRH Signaling, HMGB1 Signaling, IL-1 Signaling, IL-10 Signaling, IL-17 Signaling, IL-6 Signaling, LPS-stimulated MAPK Signaling, Melatonin Signaling, Molecular Mechanisms of Cancer, Neurotrophin/TRK Signaling, NRF2-mediated Oxidative Stress Response, p38 MAPK Signaling, PPARα/RXRα Activation, Pyridoxal 5'-phosphate Salvage Pathway, Regulation of the Epithelial-Mesenchymal Transition Pathway, Role of IL-17A in Arthritis, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of MAPK Signaling in the Pathogenesis of Influenza, Role of NFAT in Cardiac Hypertrophy, Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis, Role of PKR in Interferon Induction and Antiviral Response, Salvage Pathways of Pyrimidine Ribonucleotides, Sertoli Cell-Sertoli Cell Junction Signaling, TGF-β Signaling, Toll-like Receptor Signaling, Type I Diabetes Mellitus Signaling, Xenobiotic Metabolism Signaling |
hsa-miR-3679-5p | 0.003 | 5.100 | TargetScan Human | Moderate (predicted) | PROSER2 | 0.000 | -2.530 | |
hsa-miR-3679-5p | 0.003 | 5.100 | TargetScan Human | Moderate (predicted) | RGS6 | 0.000 | -1.580 | |
hsa-miR-3679-5p | 0.003 | 5.100 | TargetScan Human | Moderate (predicted) | SLC2A3 | 0.002 | -9.910 | Antioxidant Action of Vitamin C, HIF1α Signaling, Vitamin-C Transport |
hsa-miR-3679-5p | 0.003 | 5.100 | TargetScan Human | Moderate (predicted) | STK4 | 0.000 | -5.670 | HIPPO signaling, Non-Small Cell Lung Cancer Signaling |
hsa-miR-3679-5p | 0.003 | 5.100 | TargetScan Human | Moderate (predicted) | TMCC2 | 0.000 | -3.300 | |
hsa-miR-3679-5p | 0.003 | 5.100 | TargetScan Human | Moderate (predicted) | VPS41 | 0.010 | -2.660 | autophagy, phagosome maturation |
hsa-miR-1224-5p | 0.004 | 5.100 | TargetScan Human | Moderate (predicted) | BICD2 | 0.027 | -7.190 | |
hsa-miR-1224-5p | 0.004 | 5.100 | TargetScan Human | Moderate (predicted) | C1orf198 | 0.001 | -7.420 | |
hsa-miR-1224-5p | 0.004 | 5.100 | TargetScan Human | Moderate (predicted) | CBL | 0.000 | -1.740 | 14-3-3-mediated Signaling, Clathrin-mediated Endocytosis Signaling, Ephrin B Signaling, Erythropoietin Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, FLT3 Signaling in Hematopoietic Progenitor Cells, Insulin Receptor Signaling, Molecular Mechanisms of Cancer, PI3K Signaling in B Lymphocytes, Protein Ubiquitination Pathway, PTEN Signaling, RANK Signaling in Osteoclasts, Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis, Systemic Lupus Erythematosus Signaling, T Cell Receptor Signaling |
hsa-miR-1224-5p | 0.004 | 5.100 | TargetScan Human | Moderate (predicted) | DENND3 | 0.000 | -1.540 | |
hsa-miR-1224-5p | 0.004 | 5.100 | TargetScan Human | Moderate (predicted) | DYRK1A | 0.000 | -1.450 | Pyridoxal 5'-phosphate Salvage Pathway, Salvage Pathways of Pyrimidine Ribonucleotides, Sonic Hedgehog Signaling |
hsa-miR-1224-5p | 0.004 | 5.100 | TargetScan Human | Moderate (predicted) | FNBP1 | 0.000 | -1.530 | Actin Nucleation by ARP-WASP Complex, Cardiac Hypertrophy Signaling, Cholecystokinin/Gastrin-mediated Signaling, Colorectal Cancer Metastasis Signaling, CXCR4 Signaling, Germ Cell-Sertoli Cell Junction Signaling, Glioblastoma Multiforme Signaling, Glioma Invasiveness Signaling, Gαq Signaling, HMGB1 Signaling, IL-8 Signaling, ILK Signaling, Integrin Signaling, Molecular Mechanisms of Cancer, mTOR Signaling, phagosome formation, Phospholipase C Signaling, Production of Nitric Oxide and Reactive Oxygen Species in Macrophages, Regulation of Actin-based Motility by Rho, RhoGDI Signaling, Semaphorin Signaling in Neurons, Signaling by Rho Family GTPases, Sphingosine-1-phosphate Signaling, Tec Kinase Signaling, Thrombin Signaling |
hsa-miR-1224-5p | 0.004 | 5.100 | TargetScan Human | Moderate (predicted) | GDE1 | 0.018 | -2.620 | |
hsa-miR-1224-5p | 0.004 | 5.100 | TargetScan Human | Moderate (predicted) | GTDC1 | 0.000 | -1.570 | |
hsa-miR-1224-5p | 0.004 | 5.100 | TargetScan Human | Moderate (predicted) | H3F3A/H3F3B | 0.000 | -4.180 | ERK/MAPK Signaling, Estrogen Receptor Signaling, p38 MAPK Signaling, Protein Kinase A Signaling, UVB-Induced MAPK Signaling |
hsa-miR-1224-5p | 0.004 | 5.100 | TargetScan Human | Moderate (predicted) | HECTD4 | 0.000 | -2.070 | |
hsa-miR-1224-5p | 0.004 | 5.100 | TargetScan Human | High (predicted) | MADD | 0.000 | -5.195 | TNFR1 Signaling |
hsa-miR-1224-5p | 0.004 | 5.100 | TargetScan Human | Moderate (predicted) | MAPK8IP3 | 0.000 | -1.500 | Reelin Signaling in Neurons, SAPK/JNK Signaling |
hsa-miR-1224-5p | 0.004 | 5.100 | TargetScan Human | Moderate (predicted) | MBP | 0.000 | -12.630 | |
hsa-miR-1224-5p | 0.004 | 5.100 | TargetScan Human | Moderate (predicted) | MID1IP1 | 0.000 | -1.540 | |
hsa-miR-1224-5p | 0.004 | 5.100 | TargetScan Human | Moderate (predicted) | PNKD | 0.000 | -8.870 | |
hsa-miR-1224-5p | 0.004 | 5.100 | TargetScan Human | Moderate (predicted) | POLR1D | 0.029 | -2.260 | Assembly of RNA Polymerase I Complex |
hsa-miR-1224-5p | 0.004 | 5.100 | TargetScan Human | Moderate (predicted) | RAP2A | 0.000 | -1.800 | B Cell Receptor Signaling, Calcium Signaling, Integrin Signaling, Molecular Mechanisms of Cancer |
hsa-miR-1224-5p | 0.004 | 5.100 | TargetScan Human | Moderate (predicted) | SEC14L1 | 0.044 | -3.080 | |
hsa-miR-1224-5p | 0.004 | 5.100 | TargetScan Human | Moderate (predicted) | SHKBP1 | 0.000 | -1.530 | |
hsa-miR-1224-5p | 0.004 | 5.100 | TargetScan Human | Moderate (predicted) | SLA2 | 0.030 | -1.900 | |
hsa-miR-1224-5p | 0.004 | 5.100 | TargetScan Human | Moderate (predicted) | SLC39A3 | 0.000 | -2.730 | |
hsa-miR-1224-5p | 0.004 | 5.100 | TargetScan Human | Moderate (predicted) | TLK1 | 0.024 | -3.010 | ATM Signaling, Role of CHK Proteins in Cell Cycle Checkpoint Control |
hsa-miR-1224-5p | 0.004 | 5.100 | TargetScan Human | High (predicted) | TNS1 | 0.000 | -2.530 | FAK Signaling |
hsa-miR-1224-5p | 0.004 | 5.100 | TargetScan Human | Moderate (predicted) | TPP1 | 0.013 | -5.000 | Telomerase Signaling |
hsa-miR-1224-5p | 0.004 | 5.100 | TargetScan Human | Moderate (predicted) | TTC7B | 0.000 | -1.550 | |
hsa-miR-1225-5p | 0.003 | 7.700 | TargetScan Human | Moderate (predicted) | ARHGAP21 | 0.006 | -5.740 | |
hsa-miR-1225-5p | 0.003 | 7.700 | TargetScan Human | Moderate (predicted) | BCL2L2 | 0.000 | -2.780 | |
hsa-miR-1225-5p | 0.003 | 7.700 | TargetScan Human | Moderate (predicted) | BCL7B | 0.053 | -1.530 | |
hsa-miR-1225-5p | 0.003 | 7.700 | TargetScan Human | Moderate (predicted) | CD47 | 0.003 | -2.120 | Inhibition of Angiogenesis by TSP1 |
hsa-miR-1225-5p | 0.003 | 7.700 | TargetScan Human | High (predicted) | CDC14B | 0.000 | -8.130 | Protein Kinase A Signaling |
hsa-miR-1225-5p | 0.003 | 7.700 | TargetScan Human | Moderate (predicted) | CSK | 0.000 | -7.130 | Actin Cytoskeleton Signaling, B Cell Receptor Signaling, CD28 Signaling in T Helper Cells, FAK Signaling, Gαq Signaling, iCOS-iCOSL Signaling in T Helper Cells, Paxillin Signaling, RAR Activation, T Cell Receptor Signaling |
hsa-miR-1225-5p | 0.003 | 7.700 | TargetScan Human | Moderate (predicted) | EIF4H | 0.000 | -2.140 | |
hsa-miR-1225-5p | 0.003 | 7.700 | TargetScan Human | Moderate (predicted) | ELMO2 | 0.000 | -1.600 | CXCR4 Signaling |
hsa-miR-1225-5p | 0.003 | 7.700 | TargetScan Human | Moderate (predicted) | GLG1 | 0.000 | -1.790 | Agranulocyte Adhesion and Diapedesis, Atherosclerosis Signaling, Granulocyte Adhesion and Diapedesis |
hsa-miR-1225-5p | 0.003 | 7.700 | TargetScan Human | Moderate (predicted) | GTDC1 | 0.000 | -1.570 | |
hsa-miR-1225-5p | 0.003 | 7.700 | TargetScan Human | Moderate (predicted) | IRS1 | 0.007 | -1.490 | 14-3-3-mediated Signaling, 3-phosphoinositide Biosynthesis, Actin Cytoskeleton Signaling, Acute Myeloid Leukemia Signaling, Aldosterone Signaling in Epithelial Cells, AMPK Signaling, Amyotrophic Lateral Sclerosis Signaling, Angiopoietin Signaling, Antiproliferative Role of Somatostatin Receptor 2, Axonal Guidance Signaling, B Cell Receptor Signaling, Breast Cancer Regulation by Stathmin1, Cardiac Hypertrophy Signaling, CCR3 Signaling in Eosinophils, CD28 Signaling in T Helper Cells, CD40 Signaling, Ceramide Signaling, Chronic Myeloid Leukemia Signaling, Clathrin-mediated Endocytosis Signaling, CNTF Signaling, Colorectal Cancer Metastasis Signaling, CREB Signaling in Neurons, CTLA4 Signaling in Cytotoxic T Lymphocytes, CXCR4 Signaling, Dendritic Cell Maturation, Docosahexaenoic Acid (DHA) Signaling, EGF Signaling, EIF2 Signaling, Endometrial Cancer Signaling, Endothelin-1 Signaling, eNOS Signaling, Ephrin A Signaling, ErbB Signaling, ErbB2-ErbB3 Signaling, ErbB4 Signaling, ERK/MAPK Signaling, Erythropoietin Signaling, Estrogen-Dependent Breast Cancer Signaling, FAK Signaling, Fc Epsilon RI Signaling, FcγRIIB Signaling in B Lymphocytes, FGF Signaling, FLT3 Signaling in Hematopoietic Progenitor Cells, fMLP Signaling in Neutrophils, G-Protein Coupled Receptor Signaling, Gap Junction Signaling, GDNF Family Ligand-Receptor Interactions, Germ Cell-Sertoli Cell Junction Signaling, Glioblastoma Multiforme Signaling, Glioma Invasiveness Signaling, Glioma Signaling, Glucocorticoid Receptor Signaling, GM-CSF Signaling, Growth Hormone Signaling, Gα12/13 Signaling, Gαq Signaling, HER-2 Signaling in Breast Cancer, Hereditary Breast Cancer Signaling, HGF Signaling, HIF1α Signaling, HMGB1 Signaling, Human Embryonic Stem Cell Pluripotency, Huntington's Disease Signaling, iCOS-iCOSL Signaling in T Helper Cells, IGF-1 Signaling, IL-12 Signaling and Production in Macrophages, IL-15 Signaling, IL-17 Signaling, IL-17A Signaling in Airway Cells, IL-2 Signaling, IL-3 Signaling, IL-4 Signaling, IL-6 Signaling, IL-8 Signaling, IL-9 Signaling, ILK Signaling, Insulin Receptor Signaling, Integrin Signaling, JAK/Stat Signaling, Leptin Signaling in Obesity, Leukocyte Extravasation Signaling, LPS-stimulated MAPK Signaling, Lymphotoxin β Receptor Signaling, Macropinocytosis Signaling, Melanocyte Development and Pigmentation Signaling, Melanoma Signaling, Molecular Mechanisms of Cancer, Mouse Embryonic Stem Cell Pluripotency, MSP-RON Signaling Pathway, mTOR Signaling, Myc Mediated Apoptosis Signaling, Natural Killer Cell Signaling, Neuropathic Pain Signaling In Dorsal Horn Neurons, Neurotrophin/TRK Signaling, NF-κB Activation by Viruses, NF-κB Signaling, NGF Signaling, Nitric Oxide Signaling in the Cardiovascular System, Non-Small Cell Lung Cancer Signaling, NRF2-mediated Oxidative Stress Response, Ovarian Cancer Signaling, P2Y Purigenic Receptor Signaling Pathway, p53 Signaling, p70S6K Signaling, PAK Signaling, Pancreatic Adenocarcinoma Signaling, Paxillin Signaling, PDGF Signaling, PEDF Signaling, phagosome formation, PI3K Signaling in B Lymphocytes, PKCθ Signaling in T Lymphocytes, PPARα/RXRα Activation, Production of Nitric Oxide and Reactive Oxygen Species in Macrophages, Prolactin Signaling, Prostate Cancer Signaling, Rac Signaling, RANK Signaling in Osteoclasts, Reelin Signaling in Neurons, Regulation of eIF4 and p70S6K Signaling, Regulation of the Epithelial-Mesenchymal Transition Pathway, Relaxin Signaling, Renal Cell Carcinoma Signaling, Renin-Angiotensin Signaling, Role of IL-17A in Arthritis, Role of JAK1 and JAK3 in γc Cytokine Signaling, Role of JAK2 in Hormone-like Cytokine Signaling, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of NANOG in Mammalian Embryonic Stem Cell Pluripotency, Role of NFAT in Cardiac Hypertrophy, Role of NFAT in Regulation of the Immune Response, Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis, Role of p14/p19ARF in Tumor Suppression, Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses, Role of PI3K/AKT Signaling in the Pathogenesis of Influenza, Role of Tissue Factor in Cancer, SAPK/JNK Signaling, Signaling by Rho Family GTPases, Small Cell Lung Cancer Signaling, Sphingosine-1-phosphate Signaling, Superpathway of Inositol Phosphate Compounds, Systemic Lupus Erythematosus Signaling, T Cell Receptor Signaling, Tec Kinase Signaling, Telomerase Signaling, Thrombin Signaling, Thrombopoietin Signaling, TR/RXR Activation, Type II Diabetes Mellitus Signaling, UVA-Induced MAPK Signaling, UVB-Induced MAPK Signaling, VEGF Family Ligand-Receptor Interactions, VEGF Signaling, Virus Entry via Endocytic Pathways, Xenobiotic Metabolism Signaling |
hsa-miR-1225-5p | 0.003 | 7.700 | TargetScan Human | High (predicted) | NREP | 0.001 | -4.180 | |
hsa-miR-1225-5p | 0.003 | 7.700 | TargetScan Human | Moderate (predicted) | PSME4 | 0.001 | -3.180 | Huntington's Disease Signaling, Polyamine Regulation in Colon Cancer |
hsa-miR-1225-5p | 0.003 | 7.700 | TargetScan Human | Moderate (predicted) | SEC16A | 0.003 | -1.470 | 1D-myo-inositol Hexakisphosphate Biosynthesis II (Mammalian), D-myo-inositol (1, 3, 4)-trisphosphate Biosynthesis, D-myo-inositol (1, 4, 5)-trisphosphate Degradation, Superpathway of D-myo-inositol (1, 4, 5)-trisphosphate Metabolism, Superpathway of Inositol Phosphate Compounds |
hsa-miR-1225-5p | 0.003 | 7.700 | TargetScan Human | Moderate (predicted) | SLMAP | 0.052 | -2.780 | |
hsa-miR-1225-5p | 0.003 | 7.700 | TargetScan Human | Moderate (predicted) | SYK | 0.003 | -4.360 | B Cell Receptor Signaling, CD28 Signaling in T Helper Cells, CTLA4 Signaling in Cytotoxic T Lymphocytes, Fc Epsilon RI Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, FcγRIIB Signaling in B Lymphocytes, IL-15 Signaling, IL-2 Signaling, Natural Killer Cell Signaling, p70S6K Signaling, phagosome formation, Phospholipase C Signaling, PI3K Signaling in B Lymphocytes, Role of JAK1 and JAK3 in γc Cytokine Signaling, Role of NFAT in Regulation of the Immune Response, Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses |
hsa-miR-1225-5p | 0.003 | 7.700 | TargetScan Human | High (predicted) | TAL1 | 0.000 | -5.160 | |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | Moderate (predicted) | ADIPOR2 | 0.000 | -3.280 | PPARα/RXRα Activation, Type II Diabetes Mellitus Signaling |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | High (predicted) | ATP2A2 | 0.002 | -1.480 | Calcium Signaling, Calcium Transport I, Calcium-induced T Lymphocyte Apoptosis, Cardiac β-adrenergic Signaling, Dopamine-DARPP32 Feedback in cAMP Signaling, Nitric Oxide Signaling in the Cardiovascular System |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | Moderate (predicted) | ATXN7L3 | 0.025 | -2.710 | |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | High (predicted) | B4GALT1 | 0.000 | -1.790 | |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | Moderate (predicted) | BCR | 0.000 | -2.390 | |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | Moderate (predicted) | C9orf69 | 0.010 | -2.620 | |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | Moderate (predicted) | CD47 | 0.003 | -2.120 | Inhibition of Angiogenesis by TSP1 |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | Moderate (predicted) | CDR2L | 0.000 | -3.870 | |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | Moderate (predicted) | CDS2 | 0.007 | -1.900 | CDP-diacylglycerol Biosynthesis I, Phosphatidylglycerol Biosynthesis II (Non-plastidic) |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | Moderate (predicted) | CHMP6 | 0.047 | -4.410 | Mechanisms of Viral Exit from Host Cells |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | Moderate (predicted) | CLCN3 | 0.001 | -3.280 | |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | Moderate (predicted) | CTDSPL | 0.000 | -16.420 | |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | High (predicted) | DAG1 | 0.000 | -2.700 | Agrin Interactions at Neuromuscular Junction, nNOS Signaling in Skeletal Muscle Cells |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | Moderate (predicted) | DSCR3 | 0.000 | -2.070 | |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | Moderate (predicted) | GFOD1 | 0.000 | -2.330 | |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | Moderate (predicted) | GRB2 | 0.000 | -2.500 | 14-3-3-mediated Signaling, 3-phosphoinositide Biosynthesis, Actin Cytoskeleton Signaling, Actin Nucleation by ARP-WASP Complex, Acute Myeloid Leukemia Signaling, Acute Phase Response Signaling, Aldosterone Signaling in Epithelial Cells, AMPK Signaling, Amyotrophic Lateral Sclerosis Signaling, Angiopoietin Signaling, Antiproliferative Role of Somatostatin Receptor 2, Axonal Guidance Signaling, B Cell Receptor Signaling, BMP signaling pathway, Breast Cancer Regulation by Stathmin1, Cardiac Hypertrophy Signaling, CCR3 Signaling in Eosinophils, CD28 Signaling in T Helper Cells, CD40 Signaling, Ceramide Signaling, Cholecystokinin/Gastrin-mediated Signaling, Chronic Myeloid Leukemia Signaling, Clathrin-mediated Endocytosis Signaling, CNTF Signaling, Colorectal Cancer Metastasis Signaling, CREB Signaling in Neurons, CTLA4 Signaling in Cytotoxic T Lymphocytes, CXCR4 Signaling, Dendritic Cell Maturation, Docosahexaenoic Acid (DHA) Signaling, EGF Signaling, EIF2 Signaling, Endometrial Cancer Signaling, Endothelin-1 Signaling, eNOS Signaling, Ephrin A Signaling, Ephrin Receptor Signaling, ErbB Signaling, ErbB2-ErbB3 Signaling, ErbB4 Signaling, ERK/MAPK Signaling, Erythropoietin Signaling, Estrogen Receptor Signaling, Estrogen-Dependent Breast Cancer Signaling, FAK Signaling, Fc Epsilon RI Signaling, FcγRIIB Signaling in B Lymphocytes, FGF Signaling, FLT3 Signaling in Hematopoietic Progenitor Cells, fMLP Signaling in Neutrophils, G Beta Gamma Signaling, G-Protein Coupled Receptor Signaling, Gap Junction Signaling, GDNF Family Ligand-Receptor Interactions, Germ Cell-Sertoli Cell Junction Signaling, Glioblastoma Multiforme Signaling, Glioma Invasiveness Signaling, Glioma Signaling, Glucocorticoid Receptor Signaling, GM-CSF Signaling, GNRH Signaling, Growth Hormone Signaling, Gα12/13 Signaling, Gαi Signaling, Gαq Signaling, HER-2 Signaling in Breast Cancer, Hereditary Breast Cancer Signaling, HGF Signaling, HIF1α Signaling, HMGB1 Signaling, Human Embryonic Stem Cell Pluripotency, Huntington's Disease Signaling, iCOS-iCOSL Signaling in T Helper Cells, IGF-1 Signaling, IL-12 Signaling and Production in Macrophages, IL-15 Signaling, IL-17 Signaling, IL-17A Signaling in Airway Cells, IL-2 Signaling, IL-3 Signaling, IL-4 Signaling, IL-6 Signaling, IL-8 Signaling, IL-9 Signaling, ILK Signaling, Insulin Receptor Signaling, Integrin Signaling, JAK/Stat Signaling, Leptin Signaling in Obesity, Leukocyte Extravasation Signaling, LPS-stimulated MAPK Signaling, Lymphotoxin β Receptor Signaling, Macropinocytosis Signaling, Melanocyte Development and Pigmentation Signaling, Melanoma Signaling, Molecular Mechanisms of Cancer, Mouse Embryonic Stem Cell Pluripotency, MSP-RON Signaling Pathway, mTOR Signaling, Myc Mediated Apoptosis Signaling, Natural Killer Cell Signaling, Neuregulin Signaling, Neuropathic Pain Signaling In Dorsal Horn Neurons, Neurotrophin/TRK Signaling, NF-κB Activation by Viruses, NF-κB Signaling, NGF Signaling, Nitric Oxide Signaling in the Cardiovascular System, Non-Small Cell Lung Cancer Signaling, NRF2-mediated Oxidative Stress Response, Oncostatin M Signaling, Ovarian Cancer Signaling, P2Y Purigenic Receptor Signaling Pathway, p53 Signaling, p70S6K Signaling, PAK Signaling, Pancreatic Adenocarcinoma Signaling, Paxillin Signaling, PDGF Signaling, PEDF Signaling, phagosome formation, Phospholipase C Signaling, PI3K/AKT Signaling, PKCθ Signaling in T Lymphocytes, PPAR Signaling, PPARα/RXRα Activation, Production of Nitric Oxide and Reactive Oxygen Species in Macrophages, Prolactin Signaling, Prostate Cancer Signaling, PTEN Signaling, Rac Signaling, RANK Signaling in Osteoclasts, Reelin Signaling in Neurons, Regulation of Cellular Mechanics by Calpain Protease, Regulation of eIF4 and p70S6K Signaling, Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes, Regulation of the Epithelial-Mesenchymal Transition Pathway, Relaxin Signaling, Renal Cell Carcinoma Signaling, Renin-Angiotensin Signaling, Role of IL-17A in Arthritis, Role of JAK1 and JAK3 in γc Cytokine Signaling, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of NANOG in Mammalian Embryonic Stem Cell Pluripotency, Role of NFAT in Cardiac Hypertrophy, Role of NFAT in Regulation of the Immune Response, Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis, Role of p14/p19ARF in Tumor Suppression, Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses, Role of PI3K/AKT Signaling in the Pathogenesis of Influenza, Role of Tissue Factor in Cancer, SAPK/JNK Signaling, Signaling by Rho Family GTPases, Small Cell Lung Cancer Signaling, Sphingosine-1-phosphate Signaling, Superpathway of Inositol Phosphate Compounds, Systemic Lupus Erythematosus Signaling, T Cell Receptor Signaling, Tec Kinase Signaling, Telomerase Signaling, TGF-β Signaling, Thrombin Signaling, Thrombopoietin Signaling, TR/RXR Activation, TREM1 Signaling, Type II Diabetes Mellitus Signaling, UVA-Induced MAPK Signaling, UVB-Induced MAPK Signaling, VEGF Family Ligand-Receptor Interactions, VEGF Signaling, Virus Entry via Endocytic Pathways, Xenobiotic Metabolism Signaling |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | Moderate (predicted) | IGF2BP3 | 0.041 | -1.850 | |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | Moderate (predicted) | IRF9 | 0.018 | -2.200 | Activation of IRF by Cytosolic Pattern Recognition Receptors, Interferon Signaling |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | Moderate (predicted) | KIF1B | 0.000 | -1.790 | |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | Moderate (predicted) | LASP1 | 0.000 | -5.070 | IL-8 Signaling |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | Moderate (predicted) | MAP2K2 | 0.000 | -1.590 | 14-3-3-mediated Signaling, 4-1BB Signaling in T Lymphocytes, Actin Cytoskeleton Signaling, Acute Myeloid Leukemia Signaling, Acute Phase Response Signaling, Aldosterone Signaling in Epithelial Cells, Antiproliferative Role of Somatostatin Receptor 2, Apoptosis Signaling, Axonal Guidance Signaling, B Cell Receptor Signaling, Bladder Cancer Signaling, BMP signaling pathway, Breast Cancer Regulation by Stathmin1, cAMP-mediated signaling, Cancer Drug Resistance By Drug Efflux, Cardiac Hypertrophy Signaling, CCR3 Signaling in Eosinophils, CD27 Signaling in Lymphocytes, CD28 Signaling in T Helper Cells, CD40 Signaling, CDK5 Signaling, Chemokine Signaling, Cholecystokinin/Gastrin-mediated Signaling, Chronic Myeloid Leukemia Signaling, CNTF Signaling, Colorectal Cancer Metastasis Signaling, Corticotropin Releasing Hormone Signaling, CREB Signaling in Neurons, CXCR4 Signaling, EIF2 Signaling, Endometrial Cancer Signaling, Ephrin Receptor Signaling, ErbB Signaling, ErbB2-ErbB3 Signaling, ErbB4 Signaling, ERK/MAPK Signaling, Erythropoietin Signaling, Estrogen Receptor Signaling, FAK Signaling, Fc Epsilon RI Signaling, FLT3 Signaling in Hematopoietic Progenitor Cells, fMLP Signaling in Neutrophils, G-Protein Coupled Receptor Signaling, Gap Junction Signaling, GDNF Family Ligand-Receptor Interactions, Germ Cell-Sertoli Cell Junction Signaling, Glioblastoma Multiforme Signaling, Glioma Signaling, Glucocorticoid Receptor Signaling, GM-CSF Signaling, GNRH Signaling, Gα12/13 Signaling, Gαq Signaling, Gαs Signaling, HGF Signaling, HMGB1 Signaling, IGF-1 Signaling, IL-12 Signaling and Production in Macrophages, IL-15 Signaling, IL-17 Signaling, IL-17A Signaling in Airway Cells, IL-2 Signaling, IL-3 Signaling, IL-6 Signaling, IL-8 Signaling, Insulin Receptor Signaling, Integrin Signaling, JAK/Stat Signaling, Leptin Signaling in Obesity, Leukocyte Extravasation Signaling, LPS-stimulated MAPK Signaling, Melanocyte Development and Pigmentation Signaling, Melanoma Signaling, Melatonin Signaling, Molecular Mechanisms of Cancer, Mouse Embryonic Stem Cell Pluripotency, Natural Killer Cell Signaling, Neuregulin Signaling, Neurotrophin/TRK Signaling, NGF Signaling, Nitric Oxide Signaling in the Cardiovascular System, Non-Small Cell Lung Cancer Signaling, NRF2-mediated Oxidative Stress Response, Oncostatin M Signaling, Ovarian Cancer Signaling, P2Y Purigenic Receptor Signaling Pathway, p70S6K Signaling, PAK Signaling, Pancreatic Adenocarcinoma Signaling, PDGF Signaling, Phospholipase C Signaling, PI3K Signaling in B Lymphocytes, PI3K/AKT Signaling, PPAR Signaling, PPARα/RXRα Activation, Prolactin Signaling, Prostate Cancer Signaling, Protein Kinase A Signaling, PTEN Signaling, Pyridoxal 5'-phosphate Salvage Pathway, Rac Signaling, RANK Signaling in Osteoclasts, Regulation of eIF4 and p70S6K Signaling, Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes, Regulation of the Epithelial-Mesenchymal Transition Pathway, Renal Cell Carcinoma Signaling, Renin-Angiotensin Signaling, Role of IL-17A in Arthritis, Role of IL-17F in Allergic Inflammatory Airway Diseases, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of MAPK Signaling in the Pathogenesis of Influenza, Role of NANOG in Mammalian Embryonic Stem Cell Pluripotency, Role of NFAT in Cardiac Hypertrophy, Role of NFAT in Regulation of the Immune Response, Role of PI3K/AKT Signaling in the Pathogenesis of Influenza, Salvage Pathways of Pyrimidine Ribonucleotides, Sertoli Cell-Sertoli Cell Junction Signaling, Signaling by Rho Family GTPases, STAT3 Pathway, Synaptic Long Term Depression, Synaptic Long Term Potentiation, T Cell Receptor Signaling, Telomerase Signaling, TGF-β Signaling, Thrombin Signaling, Thrombopoietin Signaling, Thyroid Cancer Signaling, UVC-Induced MAPK Signaling, VEGF Family Ligand-Receptor Interactions, VEGF Signaling, Xenobiotic Metabolism Signaling, α-Adrenergic Signaling |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | Moderate (predicted) | MAPKAPK2 | 0.000 | -2.530 | Cardiac Hypertrophy Signaling, CD40 Signaling, FGF Signaling, IL-17 Signaling, IL-6 Signaling, p38 MAPK Signaling, RAR Activation, Role of IL-17A in Arthritis, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | Moderate (predicted) | MICU1 | 0.009 | -2.080 | Calcium Signaling |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | Moderate (predicted) | MPRIP | 0.000 | -1.630 | Actin Cytoskeleton Signaling, CCR3 Signaling in Eosinophils, Cdc42 Signaling, Cellular Effects of Sildenafil (Viagra), Chemokine Signaling, Integrin Signaling, Phospholipase C Signaling, Regulation of Actin-based Motility by Rho, RhoA Signaling, Thrombin Signaling |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | High (predicted) | MTPN | 0.010 | -4.220 | |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | Moderate (predicted) | NAP1L1 | 0.000 | -5.190 | |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | Moderate (predicted) | NPRL3 | 0.001 | -2.140 | |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | Moderate (predicted) | PLEK | 0.000 | -3.490 | |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | Moderate (predicted) | PPP1R18 | 0.033 | -4.160 | |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | Moderate (predicted) | PSAP | 0.000 | -1.860 | Lipid Antigen Presentation by CD1 |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | Moderate (predicted) | RAB11FIP3 | 0.000 | -7.870 | |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | Moderate (predicted) | SECISBP2 | 0.000 | -2.500 | |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | Moderate (predicted) | SH3BGRL2 | 0.000 | -12.590 | |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | Moderate (predicted) | SLC35E1 | 0.000 | -3.270 | |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | Moderate (predicted) | SLC9A1 | 0.006 | -4.300 | Actin Cytoskeleton Signaling, Aldosterone Signaling in Epithelial Cells, Signaling by Rho Family GTPases |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | Moderate (predicted) | TGOLN2 | 0.000 | -2.570 | |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | Moderate (predicted) | TJP2 | 0.005 | -2.120 | Hepatic Cholestasis, HIPPO signaling, Sertoli Cell-Sertoli Cell Junction Signaling, Tight Junction Signaling |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | Moderate (predicted) | TWSG1 | 0.000 | -2.450 | Antiproliferative Role of TOB in T Cell Signaling |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | Moderate (predicted) | UCP2 | 0.049 | -4.070 | Mitochondrial Dysfunction, TR/RXR Activation |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | Moderate (predicted) | ULK1 | 0.000 | -4.635 | AMPK Signaling, autophagy, mTOR Signaling |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | Moderate (predicted) | VAMP3 | 0.000 | -1.780 | Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, Huntington's Disease Signaling, phagosome maturation, Tight Junction Signaling |
hsa-miR-1226 | 0.011 | 1.800 | TargetScan Human | High (predicted) | VASH1 | 0.007 | -1.690 | |
hsa-miR-1231 | 0.003 | 24.400 | TargetScan Human | High (predicted) | AZIN1 | 0.015 | -4.670 | Polyamine Regulation in Colon Cancer |
hsa-miR-1231 | 0.003 | 24.400 | TargetScan Human | Moderate (predicted) | BTG1 | 0.000 | -1.990 | Cell Cycle Regulation by BTG Family Proteins |
hsa-miR-1231 | 0.003 | 24.400 | TargetScan Human | High (predicted), Moderate (predicted) | BTN3A2 | 0.003 | -2.840 | |
hsa-miR-1231 | 0.003 | 24.400 | TargetScan Human | Moderate (predicted) | CABLES1 | 0.000 | -1.940 | CDK5 Signaling |
hsa-miR-1231 | 0.003 | 24.400 | TargetScan Human | Moderate (predicted) | CARD8 | 0.000 | -1.640 | |
hsa-miR-1231 | 0.003 | 24.400 | TargetScan Human | Moderate (predicted) | CTDSPL | 0.000 | -16.420 | |
hsa-miR-1231 | 0.003 | 24.400 | TargetScan Human | Moderate (predicted) | DNAJC9 | 0.000 | -2.180 | Aldosterone Signaling in Epithelial Cells, NRF2-mediated Oxidative Stress Response, Protein Ubiquitination Pathway |
hsa-miR-1231 | 0.003 | 24.400 | TargetScan Human | Moderate (predicted) | EGF | 0.000 | -2.220 | Actin Cytoskeleton Signaling, Axonal Guidance Signaling, Bladder Cancer Signaling, Caveolar-mediated Endocytosis Signaling, Clathrin-mediated Endocytosis Signaling, Colorectal Cancer Metastasis Signaling, EGF Signaling, Ephrin Receptor Signaling, Epithelial Adherens Junction Signaling, ErbB Signaling, ERK5 Signaling, FAK Signaling, Gap Junction Signaling, Glioblastoma Multiforme Signaling, Glioma Signaling, GNRH Signaling, Hepatic Fibrosis / Hepatic Stellate Cell Activation, HER-2 Signaling in Breast Cancer, Huntington's Disease Signaling, IL-8 Signaling, Macropinocytosis Signaling, Neuregulin Signaling, NF-κB Signaling, Non-Small Cell Lung Cancer Signaling, Ovarian Cancer Signaling, Pancreatic Adenocarcinoma Signaling, Regulation of Cellular Mechanics by Calpain Protease, Regulation of the Epithelial-Mesenchymal Transition Pathway, Telomerase Signaling, Thrombin Signaling |
hsa-miR-1231 | 0.003 | 24.400 | TargetScan Human | High (predicted) | GLG1 | 0.000 | -1.790 | Agranulocyte Adhesion and Diapedesis, Atherosclerosis Signaling, Granulocyte Adhesion and Diapedesis |
hsa-miR-1231 | 0.003 | 24.400 | TargetScan Human | High (predicted) | HECTD4 | 0.000 | -2.070 | |
hsa-miR-1231 | 0.003 | 24.400 | TargetScan Human | High (predicted) | KIAA0513 | 0.000 | -7.100 | |
hsa-miR-1231 | 0.003 | 24.400 | TargetScan Human | Moderate (predicted) | MAPKAPK2 | 0.000 | -2.530 | Cardiac Hypertrophy Signaling, CD40 Signaling, FGF Signaling, IL-17 Signaling, IL-6 Signaling, p38 MAPK Signaling, RAR Activation, Role of IL-17A in Arthritis, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis |
hsa-miR-1231 | 0.003 | 24.400 | TargetScan Human | Moderate (predicted) | MBP | 0.000 | -12.630 | |
hsa-miR-1231 | 0.003 | 24.400 | TargetScan Human | Moderate (predicted) | MSRB3 | 0.020 | -2.625 | |
hsa-miR-1231 | 0.003 | 24.400 | TargetScan Human | Moderate (predicted) | NUMB | 0.019 | -1.850 | Clathrin-mediated Endocytosis Signaling, Notch Signaling |
hsa-miR-1231 | 0.003 | 24.400 | TargetScan Human | Moderate (predicted) | PAPSS2 | 0.020 | -1.510 | LPS/IL-1 Mediated Inhibition of RXR Function, PXR/RXR Activation, Sulfate Activation for Sulfonation |
hsa-miR-1231 | 0.003 | 24.400 | TargetScan Human | Moderate (predicted) | RBM4 | 0.000 | -1.500 | |
hsa-miR-1231 | 0.003 | 24.400 | TargetScan Human | Moderate (predicted) | REPS2 | 0.015 | -1.855 | |
hsa-miR-1231 | 0.003 | 24.400 | TargetScan Human | Moderate (predicted) | SLC39A3 | 0.000 | -2.730 | |
hsa-miR-1231 | 0.003 | 24.400 | TargetScan Human | Moderate (predicted) | SMARCA2 | 0.002 | -2.510 | AMPK Signaling, Glucocorticoid Receptor Signaling, Hereditary Breast Cancer Signaling, RAR Activation, Role of BRCA1 in DNA Damage Response |
hsa-miR-1292 | 0.008 | 3.500 | TargetScan Human | Moderate (predicted) | ABHD4 | 0.000 | -2.080 | |
hsa-miR-1292 | 0.008 | 3.500 | TargetScan Human | Moderate (predicted) | ADAR | 0.000 | -3.030 | Activation of IRF by Cytosolic Pattern Recognition Receptors |
hsa-miR-1292 | 0.008 | 3.500 | TargetScan Human | Moderate (predicted) | AFAP1 | 0.000 | -4.990 | |
hsa-miR-1292 | 0.008 | 3.500 | TargetScan Human | Moderate (predicted) | BTN3A2 | 0.003 | -2.840 | |
hsa-miR-1292 | 0.008 | 3.500 | TargetScan Human | Moderate (predicted) | CPNE5 | 0.019 | -4.210 | |
hsa-miR-1292 | 0.008 | 3.500 | TargetScan Human | Moderate (predicted) | IP6K1 | 0.000 | -1.647 | Inositol Pyrophosphates Biosynthesis, Superpathway of Inositol Phosphate Compounds |
hsa-miR-1292 | 0.008 | 3.500 | TargetScan Human | Moderate (predicted) | MAPRE2 | 0.050 | -2.680 | Remodeling of Epithelial Adherens Junctions |
hsa-miR-1292 | 0.008 | 3.500 | TargetScan Human | High (predicted) | NDST1 | 0.000 | -3.200 | Chondroitin Sulfate Biosynthesis, Chondroitin Sulfate Biosynthesis (Late Stages), Dermatan Sulfate Biosynthesis, Dermatan Sulfate Biosynthesis (Late Stages), Heparan Sulfate Biosynthesis, Heparan Sulfate Biosynthesis (Late Stages), LPS/IL-1 Mediated Inhibition of RXR Function, Triacylglycerol Degradation, Xenobiotic Metabolism Signaling |
hsa-miR-1292 | 0.008 | 3.500 | TargetScan Human | Moderate (predicted) | PRKCA | 0.000 | -2.250 | 14-3-3-mediated Signaling, Aldosterone Signaling in Epithelial Cells, Androgen Signaling, Apoptosis Signaling, Axonal Guidance Signaling, Breast Cancer Regulation by Stathmin1, Calcium-induced T Lymphocyte Apoptosis, Caveolar-mediated Endocytosis Signaling, CCR3 Signaling in Eosinophils, CCR5 Signaling in Macrophages, Chemokine Signaling, Cholecystokinin/Gastrin-mediated Signaling, Corticotropin Releasing Hormone Signaling, CREB Signaling in Neurons, CXCR4 Signaling, Dopamine-DARPP32 Feedback in cAMP Signaling, EGF Signaling, Endothelin-1 Signaling, eNOS Signaling, ErbB Signaling, ErbB4 Signaling, ERK/MAPK Signaling, Erythropoietin Signaling, Factors Promoting Cardiogenesis in Vertebrates, Fc Epsilon RI Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, FGF Signaling, fMLP Signaling in Neutrophils, G Beta Gamma Signaling, G-Protein Coupled Receptor Signaling, Gap Junction Signaling, Glioma Signaling, GNRH Signaling, GPCR-Mediated Nutrient Sensing in Enteroendocrine Cells, Growth Hormone Signaling, Gαq Signaling, Hepatic Cholestasis, HER-2 Signaling in Breast Cancer, HGF Signaling, Huntington's Disease Signaling, IL-12 Signaling and Production in Macrophages, IL-3 Signaling, IL-8 Signaling, Leukocyte Extravasation Signaling, LPS-stimulated MAPK Signaling, Macropinocytosis Signaling, Mechanisms of Viral Exit from Host Cells, Melatonin Signaling, Molecular Mechanisms of Cancer, mTOR Signaling, Natural Killer Cell Signaling, Neuregulin Signaling, Neuropathic Pain Signaling In Dorsal Horn Neurons, NF-κB Activation by Viruses, Nitric Oxide Signaling in the Cardiovascular System, nNOS Signaling in Neurons, Non-Small Cell Lung Cancer Signaling, NRF2-mediated Oxidative Stress Response, P2Y Purigenic Receptor Signaling Pathway, p70S6K Signaling, PDGF Signaling, phagosome formation, Phospholipase C Signaling, PPARα/RXRα Activation, Production of Nitric Oxide and Reactive Oxygen Species in Macrophages, Prolactin Signaling, Protein Kinase A Signaling, RAR Activation, Renin-Angiotensin Signaling, RhoGDI Signaling, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of MAPK Signaling in the Pathogenesis of Influenza, Role of NFAT in Cardiac Hypertrophy, Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses, Role of Tissue Factor in Cancer, Sperm Motility, Synaptic Long Term Depression, Synaptic Long Term Potentiation, Tec Kinase Signaling, Thrombin Signaling, Thrombopoietin Signaling, Type II Diabetes Mellitus Signaling, UVA-Induced MAPK Signaling, UVB-Induced MAPK Signaling, UVC-Induced MAPK Signaling, VDR/RXR Activation, VEGF Family Ligand-Receptor Interactions, VEGF Signaling, Virus Entry via Endocytic Pathways, Wnt/Ca+ pathway, Xenobiotic Metabolism Signaling, α-Adrenergic Signaling |
hsa-miR-1292 | 0.008 | 3.500 | TargetScan Human | Moderate (predicted) | RSU1 | 0.000 | -5.020 | ILK Signaling |
hsa-miR-1292 | 0.008 | 3.500 | TargetScan Human | Moderate (predicted) | SMAP2 | 0.005 | -3.070 | |
hsa-miR-1292 | 0.008 | 3.500 | TargetScan Human | Moderate (predicted) | STX16 | 0.000 | -3.840 | Huntington's Disease Signaling, phagosome maturation, Tight Junction Signaling |
hsa-miR-1292 | 0.008 | 3.500 | TargetScan Human | High (predicted) | VASP | 0.001 | -1.680 | Actin Nucleation by ARP-WASP Complex, Axonal Guidance Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, IL-8 Signaling, Integrin Signaling, Leukocyte Extravasation Signaling, Protein Kinase A Signaling, Tight Junction Signaling |
hsa-miR-1292 | 0.008 | 3.500 | TargetScan Human | Moderate (predicted) | ZBED1 | 0.031 | -2.780 | |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | ACTN4 | 0.005 | -2.130 | Actin Cytoskeleton Signaling, Epithelial Adherens Junction Signaling, Germ Cell-Sertoli Cell Junction Signaling, ILK Signaling, Integrin Signaling, Leukocyte Extravasation Signaling, Macropinocytosis Signaling, Paxillin Signaling, Regulation of Cellular Mechanics by Calpain Protease, Remodeling of Epithelial Adherens Junctions, Sertoli Cell-Sertoli Cell Junction Signaling, VEGF Signaling |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | AGO2 | 0.047 | -2.560 | EIF2 Signaling, Regulation of eIF4 and p70S6K Signaling |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | High (predicted) | AHCTF1 | 0.024 | -1.520 | |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | ANK1 | 0.000 | -2.780 | Rac Signaling |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | AP1B1 | 0.000 | -2.400 | Clathrin-mediated Endocytosis Signaling, CTLA4 Signaling in Cytotoxic T Lymphocytes, GABA Receptor Signaling, Lipid Antigen Presentation by CD1, Virus Entry via Endocytic Pathways |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | ARHGAP1 | 0.003 | -1.490 | Leukocyte Extravasation Signaling, RhoA Signaling, RhoGDI Signaling, Semaphorin Signaling in Neurons |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | ARID3B | 0.000 | -1.480 | |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | ARRB1 | 0.002 | -3.440 | Clathrin-mediated Endocytosis Signaling, Colorectal Cancer Metastasis Signaling, Ovarian Cancer Signaling, Role of Tissue Factor in Cancer |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | BCL7B | 0.053 | -1.530 | |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | BTBD11 | 0.000 | -6.920 | |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | BTN3A2 | 0.003 | -2.840 | |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | CAV2 | 0.000 | -1.860 | G Beta Gamma Signaling |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | High (predicted) | CBL | 0.000 | -1.740 | 14-3-3-mediated Signaling, Clathrin-mediated Endocytosis Signaling, Ephrin B Signaling, Erythropoietin Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, FLT3 Signaling in Hematopoietic Progenitor Cells, Insulin Receptor Signaling, Molecular Mechanisms of Cancer, PI3K Signaling in B Lymphocytes, Protein Ubiquitination Pathway, PTEN Signaling, RANK Signaling in Osteoclasts, Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis, Systemic Lupus Erythematosus Signaling, T Cell Receptor Signaling |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | CBX6 | 0.018 | -2.680 | |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | CLIP1 | 0.000 | -2.970 | Cdc42 Signaling, Epithelial Adherens Junction Signaling, Remodeling of Epithelial Adherens Junctions, Signaling by Rho Family GTPases |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | High (predicted) | CLIP2 | 0.000 | -4.440 | |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | CTDSP2 | 0.000 | -7.600 | |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | High (predicted) | DUSP3 | 0.031 | -4.840 | Protein Kinase A Signaling |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | High (predicted) | EFCAB14 | 0.000 | -3.100 | |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | EGF | 0.000 | -2.220 | Actin Cytoskeleton Signaling, Axonal Guidance Signaling, Bladder Cancer Signaling, Caveolar-mediated Endocytosis Signaling, Clathrin-mediated Endocytosis Signaling, Colorectal Cancer Metastasis Signaling, EGF Signaling, Ephrin Receptor Signaling, Epithelial Adherens Junction Signaling, ErbB Signaling, ERK5 Signaling, FAK Signaling, Gap Junction Signaling, Glioblastoma Multiforme Signaling, Glioma Signaling, GNRH Signaling, Hepatic Fibrosis / Hepatic Stellate Cell Activation, HER-2 Signaling in Breast Cancer, Huntington's Disease Signaling, IL-8 Signaling, Macropinocytosis Signaling, Neuregulin Signaling, NF-κB Signaling, Non-Small Cell Lung Cancer Signaling, Ovarian Cancer Signaling, Pancreatic Adenocarcinoma Signaling, Regulation of Cellular Mechanics by Calpain Protease, Regulation of the Epithelial-Mesenchymal Transition Pathway, Telomerase Signaling, Thrombin Signaling |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | ENKUR | 0.000 | -2.140 | |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | High (predicted) | FRMD8 | 0.007 | -4.010 | |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | FURIN | 0.007 | -3.340 | Mitochondrial Dysfunction, Notch Signaling |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | GDE1 | 0.018 | -2.620 | |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | GFOD1 | 0.000 | -2.330 | |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | GLG1 | 0.000 | -1.790 | Agranulocyte Adhesion and Diapedesis, Atherosclerosis Signaling, Granulocyte Adhesion and Diapedesis |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | HDGF | 0.000 | -3.240 | |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | IP6K1 | 0.000 | -1.647 | Inositol Pyrophosphates Biosynthesis, Superpathway of Inositol Phosphate Compounds |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | IST1 | 0.000 | -2.880 | |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | ITIH5 | 0.000 | -1.600 | |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | LSM14A | 0.000 | -3.980 | Systemic Lupus Erythematosus Signaling |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | MADD | 0.000 | -5.195 | TNFR1 Signaling |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | MAPK8IP3 | 0.000 | -1.500 | Reelin Signaling in Neurons, SAPK/JNK Signaling |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | High (predicted) | MLEC | 0.000 | -1.745 | |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | High (predicted) | MOB3C | 0.010 | -6.740 | |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | MTHFD2 | 0.000 | -1.500 | Folate Transformations I, Histidine Degradation III, Tetrahydrofolate Salvage from 5, 10-methenyltetrahydrofolate |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | MTHFR | 0.000 | -1.760 | Folate Transformations I |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | High (predicted) | N4BP2L1 | 0.018 | -1.720 | |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | High (predicted) | NCOA3 | 0.000 | -1.530 | Aryl Hydrocarbon Receptor Signaling, Estrogen Receptor Signaling, Glucocorticoid Receptor Signaling, PPARα/RXRα Activation, Role of Wnt/GSK-3β Signaling in the Pathogenesis of Influenza, TR/RXR Activation, VDR/RXR Activation |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | NDST1 | 0.000 | -3.200 | Chondroitin Sulfate Biosynthesis, Chondroitin Sulfate Biosynthesis (Late Stages), Dermatan Sulfate Biosynthesis, Dermatan Sulfate Biosynthesis (Late Stages), Heparan Sulfate Biosynthesis, Heparan Sulfate Biosynthesis (Late Stages), LPS/IL-1 Mediated Inhibition of RXR Function, Triacylglycerol Degradation, Xenobiotic Metabolism Signaling |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | NT5C2 | 0.000 | -3.250 | Adenosine Nucleotides Degradation II, Guanosine Nucleotides Degradation III, NAD Salvage Pathway II, Purine Nucleotides Degradation II (Aerobic), Urate Biosynthesis/Inosine 5'-phosphate Degradation |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | P4HB | 0.026 | -2.360 | Hypoxia Signaling in the Cardiovascular System, Role of Tissue Factor in Cancer, Unfolded protein response |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | PANK2 | 0.037 | -1.610 | |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | PNKD | 0.000 | -8.870 | |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | PPP2R5A | 0.000 | -4.830 | 3-phosphoinositide Biosynthesis, 3-phosphoinositide Degradation, AMPK Signaling, Breast Cancer Regulation by Stathmin1, Cardiac β-adrenergic Signaling, CDK5 Signaling, Cell Cycle Regulation by BTG Family Proteins, Ceramide Signaling, CTLA4 Signaling in Cytotoxic T Lymphocytes, Cyclins and Cell Cycle Regulation, D-myo-inositol (1, 4, 5, 6)-Tetrakisphosphate Biosynthesis, D-myo-inositol (3, 4, 5, 6)-tetrakisphosphate Biosynthesis, D-myo-inositol-5-phosphate Metabolism, Dopamine Receptor Signaling, Dopamine-DARPP32 Feedback in cAMP Signaling, ERK/MAPK Signaling, HIPPO signaling, ILK Signaling, Mitotic Roles of Polo-Like Kinase, mTOR Signaling, p70S6K Signaling, PI3K/AKT Signaling, Production of Nitric Oxide and Reactive Oxygen Species in Macrophages, Regulation of eIF4 and p70S6K Signaling, Role of CHK Proteins in Cell Cycle Checkpoint Control, Superpathway of Inositol Phosphate Compounds, Synaptic Long Term Depression, Telomerase Signaling, Tight Junction Signaling, Wnt/β-catenin Signaling, Xenobiotic Metabolism Signaling |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | PTBP1 | 0.000 | -8.430 | |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | RAF1 | 0.000 | -1.530 | 14-3-3-mediated Signaling, Actin Cytoskeleton Signaling, Acute Myeloid Leukemia Signaling, Acute Phase Response Signaling, Aldosterone Signaling in Epithelial Cells, Apoptosis Signaling, Axonal Guidance Signaling, B Cell Receptor Signaling, Bladder Cancer Signaling, BMP signaling pathway, Breast Cancer Regulation by Stathmin1, cAMP-mediated signaling, Cancer Drug Resistance By Drug Efflux, Cardiac Hypertrophy Signaling, CCR3 Signaling in Eosinophils, Cdc42 Signaling, CDK5 Signaling, Ceramide Signaling, Chemokine Signaling, Cholecystokinin/Gastrin-mediated Signaling, Chronic Myeloid Leukemia Signaling, CNTF Signaling, Corticotropin Releasing Hormone Signaling, CREB Signaling in Neurons, CXCR4 Signaling, Cyclins and Cell Cycle Regulation, EGF Signaling, EIF2 Signaling, Endometrial Cancer Signaling, Endothelin-1 Signaling, Ephrin Receptor Signaling, ErbB Signaling, ErbB2-ErbB3 Signaling, ErbB4 Signaling, ERK/MAPK Signaling, Erythropoietin Signaling, Estrogen Receptor Signaling, FAK Signaling, Fc Epsilon RI Signaling, FGF Signaling, FLT3 Signaling in Hematopoietic Progenitor Cells, fMLP Signaling in Neutrophils, G Beta Gamma Signaling, G-Protein Coupled Receptor Signaling, Gap Junction Signaling, GDNF Family Ligand-Receptor Interactions, Glioblastoma Multiforme Signaling, Glioma Signaling, Glucocorticoid Receptor Signaling, GM-CSF Signaling, GNRH Signaling, Gα12/13 Signaling, Gαi Signaling, Gαq Signaling, HGF Signaling, IGF-1 Signaling, IL-15 Signaling, IL-2 Signaling, IL-3 Signaling, IL-6 Signaling, IL-8 Signaling, Insulin Receptor Signaling, Integrin Signaling, JAK/Stat Signaling, LPS-stimulated MAPK Signaling, Melanocyte Development and Pigmentation Signaling, Melanoma Signaling, Melatonin Signaling, Molecular Mechanisms of Cancer, Mouse Embryonic Stem Cell Pluripotency, Natural Killer Cell Signaling, Neuregulin Signaling, Neurotrophin/TRK Signaling, NF-κB Activation by Viruses, NF-κB Signaling, NGF Signaling, Non-Small Cell Lung Cancer Signaling, NRF2-mediated Oxidative Stress Response, Oncostatin M Signaling, Ovarian Cancer Signaling, P2Y Purigenic Receptor Signaling Pathway, p70S6K Signaling, PAK Signaling, Pancreatic Adenocarcinoma Signaling, PDGF Signaling, PEDF Signaling, Phospholipase C Signaling, PI3K Signaling in B Lymphocytes, PI3K/AKT Signaling, PPAR Signaling, PPARα/RXRα Activation, Prolactin Signaling, Prostate Cancer Signaling, Protein Kinase A Signaling, PTEN Signaling, Rac Signaling, RANK Signaling in Osteoclasts, Regulation of eIF4 and p70S6K Signaling, Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes, Regulation of the Epithelial-Mesenchymal Transition Pathway, Renal Cell Carcinoma Signaling, Renin-Angiotensin Signaling, Role of IL-17F in Allergic Inflammatory Airway Diseases, Role of JAK1, JAK2 and TYK2 in Interferon Signaling, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of MAPK Signaling in the Pathogenesis of Influenza, Role of NANOG in Mammalian Embryonic Stem Cell Pluripotency, Role of NFAT in Cardiac Hypertrophy, Role of NFAT in Regulation of the Immune Response, Sertoli Cell-Sertoli Cell Junction Signaling, Signaling by Rho Family GTPases, STAT3 Pathway, Synaptic Long Term Depression, Synaptic Long Term Potentiation, T Cell Receptor Signaling, Telomerase Signaling, TGF-β Signaling, Thrombin Signaling, Thrombopoietin Signaling, UVC-Induced MAPK Signaling, VEGF Family Ligand-Receptor Interactions, VEGF Signaling, Xenobiotic Metabolism Signaling, α-Adrenergic Signaling |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | High (predicted) | RASA3 | 0.038 | -2.150 | |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | RBM14 | 0.000 | -1.760 | |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | High (predicted) | SEC14L5 | 0.000 | -11.160 | |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | SLA2 | 0.030 | -1.900 | |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | SLC9A1 | 0.006 | -4.300 | Actin Cytoskeleton Signaling, Aldosterone Signaling in Epithelial Cells, Signaling by Rho Family GTPases |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | SRGN | 0.025 | -1.700 | Tumoricidal Function of Hepatic Natural Killer Cells |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | STK24 | 0.000 | -7.300 | |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | High (predicted) | STK40 | 0.000 | -1.530 | |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | STX1A | 0.023 | -2.640 | Huntington's Disease Signaling |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | TACC1 | 0.000 | -5.110 | |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | High (predicted) | TMEM63A | 0.007 | -2.130 | |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | TNFSF4 | 0.001 | -6.110 | OX40 Signaling Pathway |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | High (predicted) | TNS3 | 0.000 | -8.510 | 3-phosphoinositide Biosynthesis, 3-phosphoinositide Degradation, D-myo-inositol (1, 4, 5, 6)-Tetrakisphosphate Biosynthesis, D-myo-inositol (3, 4, 5, 6)-tetrakisphosphate Biosynthesis, D-myo-inositol-5-phosphate Metabolism, Superpathway of Inositol Phosphate Compounds |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | TRIP12 | 0.000 | -1.590 | Cell Cycle: G2/M DNA Damage Checkpoint Regulation |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | TSPAN18 | 0.000 | -4.570 | |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | TUBB | 0.000 | -3.970 | 14-3-3-mediated Signaling, Axonal Guidance Signaling, Breast Cancer Regulation by Stathmin1, Epithelial Adherens Junction Signaling, Gap Junction Signaling, Germ Cell-Sertoli Cell Junction Signaling, phagosome maturation, Remodeling of Epithelial Adherens Junctions, Sertoli Cell-Sertoli Cell Junction Signaling |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | UBN1 | 0.000 | -5.410 | |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | VASP | 0.001 | -1.680 | Actin Nucleation by ARP-WASP Complex, Axonal Guidance Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, IL-8 Signaling, Integrin Signaling, Leukocyte Extravasation Signaling, Protein Kinase A Signaling, Tight Junction Signaling |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | WIPI1 | 0.000 | -3.840 | autophagy |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | ZBED1 | 0.031 | -2.780 | |
hsa-miR-1254 | 0.005 | 4.200 | TargetScan Human | Moderate (predicted) | ZZEF1 | 0.000 | -2.950 | |
hsa-miR-1270 | 0.000 | 2.100 | TargetScan Human | Moderate (predicted) | ABCC4 | 0.013 | -7.280 | LPS/IL-1 Mediated Inhibition of RXR Function, NRF2-mediated Oxidative Stress Response |
hsa-miR-1270 | 0.000 | 2.100 | TargetScan Human | Moderate (predicted) | CHSY1 | 0.000 | -1.710 | Chondroitin and Dermatan Biosynthesis, Chondroitin Sulfate Biosynthesis, Chondroitin Sulfate Biosynthesis (Late Stages), Dermatan Sulfate Biosynthesis |
hsa-miR-1270 | 0.000 | 2.100 | TargetScan Human | Moderate (predicted) | CTNS | 0.027 | -3.420 | |
hsa-miR-1270 | 0.000 | 2.100 | TargetScan Human | Moderate (predicted) | FAM104A | 0.000 | -3.860 | |
hsa-miR-1270 | 0.000 | 2.100 | TargetScan Human | Moderate (predicted) | FOXO1 | 0.000 | -1.700 | 14-3-3-mediated Signaling, Adipogenesis pathway, AMPK Signaling, Angiopoietin Signaling, B Cell Receptor Signaling, Cancer Drug Resistance By Drug Efflux, Cell Cycle: G1/S Checkpoint Regulation, Docosahexaenoic Acid (DHA) Signaling, ErbB Signaling, ErbB2-ErbB3 Signaling, FXR/RXR Activation, Glioblastoma Multiforme Signaling, HER-2 Signaling in Breast Cancer, Human Embryonic Stem Cell Pluripotency, IGF-1 Signaling, IL-3 Signaling, Insulin Receptor Signaling, Leptin Signaling in Obesity, Molecular Mechanisms of Cancer, PI3K/AKT Signaling, Prostate Cancer Signaling, PTEN Signaling, PXR/RXR Activation, Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis, VDR/RXR Activation, VEGF Signaling |
hsa-miR-1270 | 0.000 | 2.100 | TargetScan Human | Moderate (predicted) | FYB | 0.000 | -4.310 | Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes |
hsa-miR-1270 | 0.000 | 2.100 | TargetScan Human | High (predicted) | GTDC1 | 0.000 | -1.570 | |
hsa-miR-1270 | 0.000 | 2.100 | TargetScan Human | Moderate (predicted) | IST1 | 0.000 | -2.880 | |
hsa-miR-1270 | 0.000 | 2.100 | TargetScan Human | High (predicted) | KIF1B | 0.000 | -1.790 | |
hsa-miR-1270 | 0.000 | 2.100 | TargetScan Human | Moderate (predicted) | KLF11 | 0.000 | -3.920 | |
hsa-miR-1270 | 0.000 | 2.100 | TargetScan Human | High (predicted) | KLHDC3 | 0.000 | -1.510 | |
hsa-miR-1270 | 0.000 | 2.100 | TargetScan Human | High (predicted), Moderate (predicted) | N4BP2L1 | 0.018 | -1.720 | |
hsa-miR-1270 | 0.000 | 2.100 | TargetScan Human | Moderate (predicted) | NLRX1 | 0.000 | -1.690 | |
hsa-miR-1270 | 0.000 | 2.100 | TargetScan Human | Moderate (predicted) | PDGFC | 0.006 | -1.900 | Actin Cytoskeleton Signaling, Amyotrophic Lateral Sclerosis Signaling, Atherosclerosis Signaling, Axonal Guidance Signaling, Bladder Cancer Signaling, Clathrin-mediated Endocytosis Signaling, Colorectal Cancer Metastasis Signaling, eNOS Signaling, Ephrin Receptor Signaling, Glioblastoma Multiforme Signaling, Glioma Signaling, Hepatic Fibrosis / Hepatic Stellate Cell Activation, HIF1α Signaling, Human Embryonic Stem Cell Pluripotency, IL-8 Signaling, ILK Signaling, Macropinocytosis Signaling, mTOR Signaling, Nitric Oxide Signaling in the Cardiovascular System, Ovarian Cancer Signaling, PAK Signaling, Pancreatic Adenocarcinoma Signaling, PDGF Signaling, PPAR Signaling, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Sphingosine-1-phosphate Signaling, VEGF Signaling |
hsa-miR-1270 | 0.000 | 2.100 | TargetScan Human | Moderate (predicted) | REPS2 | 0.015 | -1.855 | |
hsa-miR-1270 | 0.000 | 2.100 | TargetScan Human | Moderate (predicted) | RNF38 | 0.016 | -2.160 | |
hsa-miR-1270 | 0.000 | 2.100 | TargetScan Human | High (predicted) | SET | 0.023 | -2.160 | 3-phosphoinositide Biosynthesis, 3-phosphoinositide Degradation, D-myo-inositol (1, 4, 5, 6)-Tetrakisphosphate Biosynthesis, D-myo-inositol (3, 4, 5, 6)-tetrakisphosphate Biosynthesis, D-myo-inositol-5-phosphate Metabolism, Granzyme A Signaling, Superpathway of Inositol Phosphate Compounds, Transcriptional Regulatory Network in Embryonic Stem Cells |
hsa-miR-1270 | 0.000 | 2.100 | TargetScan Human | Moderate (predicted) | SH3BGRL2 | 0.000 | -12.590 | |
hsa-miR-1270 | 0.000 | 2.100 | TargetScan Human | Moderate (predicted) | SH3PXD2A | 0.000 | -3.860 | |
hsa-miR-1270 | 0.000 | 2.100 | TargetScan Human | Moderate (predicted) | STAU1 | 0.000 | -2.700 | |
hsa-miR-1270 | 0.000 | 2.100 | TargetScan Human | Moderate (predicted) | STK4 | 0.000 | -5.670 | HIPPO signaling, Non-Small Cell Lung Cancer Signaling |
hsa-miR-1270 | 0.000 | 2.100 | TargetScan Human | Moderate (predicted) | STX11 | 0.042 | -4.430 | |
hsa-miR-1270 | 0.000 | 2.100 | TargetScan Human | Moderate (predicted) | TMEM183A | 0.018 | -1.620 | |
hsa-miR-1270 | 0.000 | 2.100 | TargetScan Human | High (predicted) | TMEM183B | 0.033 | -1.560 | |
hsa-miR-1270 | 0.000 | 2.100 | TargetScan Human | High (predicted) | TUBB | 0.000 | -3.970 | 14-3-3-mediated Signaling, Axonal Guidance Signaling, Breast Cancer Regulation by Stathmin1, Epithelial Adherens Junction Signaling, Gap Junction Signaling, Germ Cell-Sertoli Cell Junction Signaling, phagosome maturation, Remodeling of Epithelial Adherens Junctions, Sertoli Cell-Sertoli Cell Junction Signaling |
hsa-miR-1270 | 0.000 | 2.100 | TargetScan Human | Moderate (predicted) | UBE2G1 | 0.000 | -1.770 | Hypoxia Signaling in the Cardiovascular System, Protein Ubiquitination Pathway |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | ABCC4 | 0.013 | -7.280 | LPS/IL-1 Mediated Inhibition of RXR Function, NRF2-mediated Oxidative Stress Response |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | High (predicted) | ADAR | 0.000 | -3.030 | Activation of IRF by Cytosolic Pattern Recognition Receptors |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | High (predicted) | AFAP1 | 0.000 | -4.990 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | ALOX12 | 0.008 | -5.290 | Atherosclerosis Signaling, Eicosanoid Signaling, IL-12 Signaling and Production in Macrophages |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | AMD1 | 0.000 | -5.040 | Spermidine Biosynthesis I, Spermine Biosynthesis |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | ANKRD28 | 0.001 | -1.900 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | ARHGAP1 | 0.003 | -1.490 | Leukocyte Extravasation Signaling, RhoA Signaling, RhoGDI Signaling, Semaphorin Signaling in Neurons |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | ARHGDIA | 0.042 | -1.740 | Regulation of Actin-based Motility by Rho, RhoGDI Signaling |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | ARID1A | 0.000 | -1.540 | AMPK Signaling, Glucocorticoid Receptor Signaling, Hereditary Breast Cancer Signaling, RAR Activation, Role of BRCA1 in DNA Damage Response |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | ARPP19 | 0.000 | -3.540 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | High (predicted) | ARRB1 | 0.002 | -3.440 | Clathrin-mediated Endocytosis Signaling, Colorectal Cancer Metastasis Signaling, Ovarian Cancer Signaling, Role of Tissue Factor in Cancer |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | ASAP1 | 0.051 | -4.590 | FAK Signaling, Integrin Signaling |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | BCL2L1 | 0.009 | -1.600 | Amyotrophic Lateral Sclerosis Signaling, Apoptosis Signaling, B Cell Receptor Signaling, CD27 Signaling in Lymphocytes, Chronic Myeloid Leukemia Signaling, Colorectal Cancer Metastasis Signaling, Docosahexaenoic Acid (DHA) Signaling, Glucocorticoid Receptor Signaling, GM-CSF Signaling, Huntington's Disease Signaling, IL-15 Signaling, IL-8 Signaling, Induction of Apoptosis by HIV1, JAK/Stat Signaling, Lymphotoxin β Receptor Signaling, Molecular Mechanisms of Cancer, OX40 Signaling Pathway, p53 Signaling, Pancreatic Adenocarcinoma Signaling, PEDF Signaling, PI3K/AKT Signaling, PTEN Signaling, Role of Tissue Factor in Cancer, Small Cell Lung Cancer Signaling, UVA-Induced MAPK Signaling, VEGF Signaling |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | BCL7B | 0.053 | -1.530 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | High (predicted) | BNIP3L | 0.002 | -1.965 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | High (predicted) | C1orf198 | 0.001 | -7.420 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | C5orf15 | 0.008 | -1.470 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | C6orf106 | 0.000 | -1.760 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | CALD1 | 0.037 | -2.690 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | CD44 | 0.001 | -1.750 | Chondroitin Sulfate Degradation (Metazoa), Dermatan Sulfate Degradation (Metazoa), Glioma Invasiveness Signaling, HIPPO signaling, Leukocyte Extravasation Signaling, Ovarian Cancer Signaling, Rac Signaling, RhoGDI Signaling, Wnt/β-catenin Signaling |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | CDR2L | 0.000 | -3.870 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | High (predicted) | CLIP2 | 0.000 | -4.440 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | CTDSP1 | 0.000 | -6.090 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | High (predicted) | CTDSPL | 0.000 | -16.420 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | CTIF | 0.000 | -2.160 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | High (predicted) | DDA1 | 0.024 | -2.040 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | High (predicted) | DENND3 | 0.000 | -1.540 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | DLG4 | 0.021 | -2.030 | Glutamate Receptor Signaling, HIPPO signaling, Huntington's Disease Signaling, Neuregulin Signaling, nNOS Signaling in Neurons |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | DYRK1A | 0.000 | -1.450 | Pyridoxal 5'-phosphate Salvage Pathway, Salvage Pathways of Pyrimidine Ribonucleotides, Sonic Hedgehog Signaling |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | EFHD2 | 0.000 | -2.500 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | EFTUD2 | 0.000 | -2.990 | Systemic Lupus Erythematosus Signaling |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | EHBP1 | 0.049 | -2.020 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | ELMO2 | 0.000 | -1.600 | CXCR4 Signaling |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | ENKUR | 0.000 | -2.140 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | F2RL3 | 0.000 | -2.600 | Gα12/13 Signaling, p70S6K Signaling, Thrombin Signaling |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | FAM110A | 0.007 | -3.840 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | FBXW11 | 0.009 | -1.700 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | FLOT2 | 0.000 | -2.350 | Caveolar-mediated Endocytosis Signaling |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | FRMD8 | 0.007 | -4.010 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | High (predicted) | FSTL1 | 0.001 | -2.680 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | FURIN | 0.007 | -3.340 | Mitochondrial Dysfunction, Notch Signaling |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | High (predicted) | G3BP2 | 0.000 | -4.125 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | HCFC1 | 0.000 | -2.690 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | IGF2BP3 | 0.041 | -1.850 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | KIAA0513 | 0.000 | -7.100 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | KLF13 | 0.000 | -1.520 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | High (predicted) | LAPTM4B | 0.000 | -2.845 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | LHFPL2 | 0.000 | -2.530 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | LIMS1 | 0.016 | -2.617 | ILK Signaling, Integrin Signaling, PI3K/AKT Signaling |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | High (predicted) | MAP1A | 0.000 | -5.290 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | MAP7D1 | 0.000 | -1.870 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | MAPK8IP3 | 0.000 | -1.500 | Reelin Signaling in Neurons, SAPK/JNK Signaling |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | MEF2D | 0.000 | -2.260 | Calcium Signaling, Calcium-induced T Lymphocyte Apoptosis, Cardiac Hypertrophy Signaling, Cholecystokinin/Gastrin-mediated Signaling, Corticotropin Releasing Hormone Signaling, ERK5 Signaling, Gα12/13 Signaling, Nur77 Signaling in T Lymphocytes, p38 MAPK Signaling, Phospholipase C Signaling, Role of NFAT in Cardiac Hypertrophy, Role of NFAT in Regulation of the Immune Response |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | High (predicted) | MTHFD2L | 0.032 | -1.840 | Folate Transformations I, Histidine Degradation III, Tetrahydrofolate Salvage from 5, 10-methenyltetrahydrofolate |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | MTHFR | 0.000 | -1.760 | Folate Transformations I |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | MTMR14 | 0.000 | -1.580 | 3-phosphoinositide Degradation |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | NCOA7 | 0.000 | -2.080 | Aryl Hydrocarbon Receptor Signaling |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | NCOR2 | 0.000 | -1.650 | Aryl Hydrocarbon Receptor Signaling, Estrogen Receptor Signaling, Glucocorticoid Receptor Signaling, Huntington's Disease Signaling, LXR/RXR Activation, PPAR Signaling, PPARα/RXRα Activation, RAR Activation, TR/RXR Activation, VDR/RXR Activation, Xenobiotic Metabolism Signaling |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | NEURL1B | 0.006 | -1.480 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | High (predicted) | NUMB | 0.019 | -1.850 | Clathrin-mediated Endocytosis Signaling, Notch Signaling |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | ORAI3 | 0.000 | -1.540 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | ORMDL3 | 0.019 | -3.370 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | PACSIN2 | 0.001 | -2.040 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | High (predicted) | PCSK7 | 0.009 | -1.660 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | PELI2 | 0.044 | -2.630 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | PHGDH | 0.033 | -2.540 | Serine Biosynthesis, Superpathway of Serine and Glycine Biosynthesis I |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | PNMA1 | 0.005 | -3.950 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | POLR1D | 0.029 | -2.260 | Assembly of RNA Polymerase I Complex |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | PPP4C | 0.000 | -1.870 | 3-phosphoinositide Biosynthesis, 3-phosphoinositide Degradation, D-myo-inositol (1, 4, 5, 6)-Tetrakisphosphate Biosynthesis, D-myo-inositol (3, 4, 5, 6)-tetrakisphosphate Biosynthesis, D-myo-inositol-5-phosphate Metabolism, Superpathway of Inositol Phosphate Compounds |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | High (predicted) | PRKCA | 0.000 | -2.250 | 14-3-3-mediated Signaling, Aldosterone Signaling in Epithelial Cells, Androgen Signaling, Apoptosis Signaling, Axonal Guidance Signaling, Breast Cancer Regulation by Stathmin1, Calcium-induced T Lymphocyte Apoptosis, Caveolar-mediated Endocytosis Signaling, CCR3 Signaling in Eosinophils, CCR5 Signaling in Macrophages, Chemokine Signaling, Cholecystokinin/Gastrin-mediated Signaling, Corticotropin Releasing Hormone Signaling, CREB Signaling in Neurons, CXCR4 Signaling, Dopamine-DARPP32 Feedback in cAMP Signaling, EGF Signaling, Endothelin-1 Signaling, eNOS Signaling, ErbB Signaling, ErbB4 Signaling, ERK/MAPK Signaling, Erythropoietin Signaling, Factors Promoting Cardiogenesis in Vertebrates, Fc Epsilon RI Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, FGF Signaling, fMLP Signaling in Neutrophils, G Beta Gamma Signaling, G-Protein Coupled Receptor Signaling, Gap Junction Signaling, Glioma Signaling, GNRH Signaling, GPCR-Mediated Nutrient Sensing in Enteroendocrine Cells, Growth Hormone Signaling, Gαq Signaling, Hepatic Cholestasis, HER-2 Signaling in Breast Cancer, HGF Signaling, Huntington's Disease Signaling, IL-12 Signaling and Production in Macrophages, IL-3 Signaling, IL-8 Signaling, Leukocyte Extravasation Signaling, LPS-stimulated MAPK Signaling, Macropinocytosis Signaling, Mechanisms of Viral Exit from Host Cells, Melatonin Signaling, Molecular Mechanisms of Cancer, mTOR Signaling, Natural Killer Cell Signaling, Neuregulin Signaling, Neuropathic Pain Signaling In Dorsal Horn Neurons, NF-κB Activation by Viruses, Nitric Oxide Signaling in the Cardiovascular System, nNOS Signaling in Neurons, Non-Small Cell Lung Cancer Signaling, NRF2-mediated Oxidative Stress Response, P2Y Purigenic Receptor Signaling Pathway, p70S6K Signaling, PDGF Signaling, phagosome formation, Phospholipase C Signaling, PPARα/RXRα Activation, Production of Nitric Oxide and Reactive Oxygen Species in Macrophages, Prolactin Signaling, Protein Kinase A Signaling, RAR Activation, Renin-Angiotensin Signaling, RhoGDI Signaling, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of MAPK Signaling in the Pathogenesis of Influenza, Role of NFAT in Cardiac Hypertrophy, Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses, Role of Tissue Factor in Cancer, Sperm Motility, Synaptic Long Term Depression, Synaptic Long Term Potentiation, Tec Kinase Signaling, Thrombin Signaling, Thrombopoietin Signaling, Type II Diabetes Mellitus Signaling, UVA-Induced MAPK Signaling, UVB-Induced MAPK Signaling, UVC-Induced MAPK Signaling, VDR/RXR Activation, VEGF Family Ligand-Receptor Interactions, VEGF Signaling, Virus Entry via Endocytic Pathways, Wnt/Ca+ pathway, Xenobiotic Metabolism Signaling, α-Adrenergic Signaling |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | High (predicted) | PSAP | 0.000 | -1.860 | Lipid Antigen Presentation by CD1 |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | PTGIR | 0.038 | -2.020 | cAMP-mediated signaling, Eicosanoid Signaling, G-Protein Coupled Receptor Signaling, Gαs Signaling |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | RNF10 | 0.025 | -1.510 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | RSU1 | 0.000 | -5.020 | ILK Signaling |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | SEC14L1 | 0.044 | -3.080 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | SEPN1 | 0.003 | -2.715 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | SERF2 | 0.005 | -1.630 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | SERPINE2 | 0.011 | -2.570 | p53 Signaling |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | SLA2 | 0.030 | -1.900 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | SLC2A3 | 0.002 | -9.910 | Antioxidant Action of Vitamin C, HIF1α Signaling, Vitamin-C Transport |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | High (predicted), Moderate (predicted) | SLC39A3 | 0.000 | -2.730 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | SLC9A1 | 0.006 | -4.300 | Actin Cytoskeleton Signaling, Aldosterone Signaling in Epithelial Cells, Signaling by Rho Family GTPases |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | SPTSSA | 0.000 | -1.910 | Ceramide Biosynthesis |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | SRC | 0.000 | -7.470 | 14-3-3-mediated Signaling, Agrin Interactions at Neuromuscular Junction, AMPK Signaling, Androgen Signaling, Antiproliferative Role of Somatostatin Receptor 2, Aryl Hydrocarbon Receptor Signaling, cAMP-mediated signaling, Caveolar-mediated Endocytosis Signaling, Cdc42 Signaling, Chemokine Signaling, Cholecystokinin/Gastrin-mediated Signaling, Clathrin-mediated Endocytosis Signaling, Colorectal Cancer Metastasis Signaling, CXCR4 Signaling, EGF Signaling, Endothelin-1 Signaling, Ephrin Receptor Signaling, Epithelial Adherens Junction Signaling, ERK/MAPK Signaling, ERK5 Signaling, Erythropoietin Signaling, Estrogen Receptor Signaling, Estrogen-Dependent Breast Cancer Signaling, FAK Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, G Beta Gamma Signaling, G-Protein Coupled Receptor Signaling, Gap Junction Signaling, Germ Cell-Sertoli Cell Junction Signaling, Glioblastoma Multiforme Signaling, GNRH Signaling, Gα12/13 Signaling, Gαi Signaling, Gαs Signaling, IL-8 Signaling, Integrin Signaling, Leukocyte Extravasation Signaling, Macropinocytosis Signaling, Melanocyte Development and Pigmentation Signaling, Molecular Mechanisms of Cancer, Neuregulin Signaling, Neuropathic Pain Signaling In Dorsal Horn Neurons, Ovarian Cancer Signaling, p70S6K Signaling, Paxillin Signaling, PDGF Signaling, Phospholipase C Signaling, RANK Signaling in Osteoclasts, RAR Activation, Reelin Signaling in Neurons, Regulation of Cellular Mechanics by Calpain Protease, Remodeling of Epithelial Adherens Junctions, RhoGDI Signaling, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of NFAT in Cardiac Hypertrophy, Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis, Role of Tissue Factor in Cancer, Sertoli Cell-Sertoli Cell Junction Signaling, STAT3 Pathway, Tec Kinase Signaling, Thrombin Signaling, UVC-Induced MAPK Signaling, VEGF Signaling, Virus Entry via Endocytic Pathways, Wnt/β-catenin Signaling |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | STIM1 | 0.000 | -2.840 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | STRN4 | 0.000 | -2.090 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | SYK | 0.003 | -4.360 | B Cell Receptor Signaling, CD28 Signaling in T Helper Cells, CTLA4 Signaling in Cytotoxic T Lymphocytes, Fc Epsilon RI Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, FcγRIIB Signaling in B Lymphocytes, IL-15 Signaling, IL-2 Signaling, Natural Killer Cell Signaling, p70S6K Signaling, phagosome formation, Phospholipase C Signaling, PI3K Signaling in B Lymphocytes, Role of JAK1 and JAK3 in γc Cytokine Signaling, Role of NFAT in Regulation of the Immune Response, Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | TADA3 | 0.053 | -2.670 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | TERF2IP | 0.000 | -2.350 | Telomerase Signaling, Telomere Extension by Telomerase |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | High (predicted) | TM2D2 | 0.006 | -2.160 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | High (predicted) | TMEM189 | 0.000 | -1.660 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | TMEM189-UBE2V1 | 0.007 | -2.570 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | TNK2 | 0.001 | -3.200 | Cdc42 Signaling, Integrin Signaling |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | TNS3 | 0.000 | -8.510 | 3-phosphoinositide Biosynthesis, 3-phosphoinositide Degradation, D-myo-inositol (1, 4, 5, 6)-Tetrakisphosphate Biosynthesis, D-myo-inositol (3, 4, 5, 6)-tetrakisphosphate Biosynthesis, D-myo-inositol-5-phosphate Metabolism, Superpathway of Inositol Phosphate Compounds |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | TSPAN18 | 0.000 | -4.570 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | High (predicted) | TTC39B | 0.003 | -1.870 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | TTYH3 | 0.000 | -2.680 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | TWSG1 | 0.000 | -2.450 | Antiproliferative Role of TOB in T Cell Signaling |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | UHRF1BP1 | 0.000 | -1.610 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | VASH1 | 0.007 | -1.690 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | High (predicted) | VPS37B | 0.000 | -5.390 | phagosome maturation |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | WBP1L | 0.000 | -2.250 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | ZBTB4 | 0.000 | -3.270 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | ZMIZ2 | 0.025 | -1.570 | |
hsa-miR-1275 | 0.000 | 9.000 | TargetScan Human | Moderate (predicted) | ZSWIM7 | 0.000 | -2.590 | |
hsa-miR-1287 | 0.045 | 1.500 | TargetScan Human | Moderate (predicted) | ADIPOR2 | 0.000 | -3.280 | PPARα/RXRα Activation, Type II Diabetes Mellitus Signaling |
hsa-miR-1287 | 0.045 | 1.500 | TargetScan Human | Moderate (predicted) | C1orf116 | 0.000 | -3.090 | |
hsa-miR-1287 | 0.045 | 1.500 | TargetScan Human | Moderate (predicted) | CARD8 | 0.000 | -1.640 | |
hsa-miR-1287 | 0.045 | 1.500 | TargetScan Human | Moderate (predicted) | CCR6 | 0.024 | -1.560 | |
hsa-miR-1287 | 0.045 | 1.500 | TargetScan Human | High (predicted) | CTDSPL | 0.000 | -16.420 | |
hsa-miR-1287 | 0.045 | 1.500 | TargetScan Human | Moderate (predicted) | CTNS | 0.027 | -3.420 | |
hsa-miR-1287 | 0.045 | 1.500 | TargetScan Human | Moderate (predicted) | DNAJA2 | 0.005 | -1.460 | NRF2-mediated Oxidative Stress Response, Unfolded protein response |
hsa-miR-1287 | 0.045 | 1.500 | TargetScan Human | Moderate (predicted) | DPY19L1 | 0.000 | -4.270 | |
hsa-miR-1287 | 0.045 | 1.500 | TargetScan Human | Moderate (predicted) | DSCR3 | 0.000 | -2.070 | |
hsa-miR-1287 | 0.045 | 1.500 | TargetScan Human | Moderate (predicted) | GFOD1 | 0.000 | -2.330 | |
hsa-miR-1287 | 0.045 | 1.500 | TargetScan Human | Moderate (predicted) | IPO11 | 0.008 | -4.380 | |
hsa-miR-1287 | 0.045 | 1.500 | TargetScan Human | Moderate (predicted) | ITIH5 | 0.000 | -1.600 | |
hsa-miR-1287 | 0.045 | 1.500 | TargetScan Human | Moderate (predicted) | KIF1B | 0.000 | -1.790 | |
hsa-miR-1287 | 0.045 | 1.500 | TargetScan Human | Moderate (predicted) | LPAR5 | 0.006 | -5.010 | eNOS Signaling, GPCR-Mediated Nutrient Sensing in Enteroendocrine Cells, Gα12/13 Signaling, RhoA Signaling |
hsa-miR-1287 | 0.045 | 1.500 | TargetScan Human | Moderate (predicted) | MBNL1 | 0.000 | -12.940 | |
hsa-miR-1287 | 0.045 | 1.500 | TargetScan Human | Moderate (predicted) | MPRIP | 0.000 | -1.630 | Actin Cytoskeleton Signaling, CCR3 Signaling in Eosinophils, Cdc42 Signaling, Cellular Effects of Sildenafil (Viagra), Chemokine Signaling, Integrin Signaling, Phospholipase C Signaling, Regulation of Actin-based Motility by Rho, RhoA Signaling, Thrombin Signaling |
hsa-miR-1287 | 0.045 | 1.500 | TargetScan Human | Moderate (predicted) | NT5C2 | 0.000 | -3.250 | Adenosine Nucleotides Degradation II, Guanosine Nucleotides Degradation III, NAD Salvage Pathway II, Purine Nucleotides Degradation II (Aerobic), Urate Biosynthesis/Inosine 5'-phosphate Degradation |
hsa-miR-1287 | 0.045 | 1.500 | TargetScan Human | Moderate (predicted) | RAB7A | 0.000 | -4.340 | Clathrin-mediated Endocytosis Signaling, IL-12 Signaling and Production in Macrophages, phagosome maturation, Remodeling of Epithelial Adherens Junctions |
hsa-miR-1287 | 0.045 | 1.500 | TargetScan Human | Moderate (predicted) | RGS6 | 0.000 | -1.580 | |
hsa-miR-1287 | 0.045 | 1.500 | TargetScan Human | Moderate (predicted) | SHC1 | 0.005 | -2.460 | Actin Cytoskeleton Signaling, Acute Phase Response Signaling, Androgen Signaling, Axonal Guidance Signaling, B Cell Receptor Signaling, Breast Cancer Regulation by Stathmin1, Cholecystokinin/Gastrin-mediated Signaling, CREB Signaling in Neurons, EGF Signaling, EIF2 Signaling, Endothelin-1 Signaling, Ephrin Receptor Signaling, ErbB Signaling, ErbB2-ErbB3 Signaling, ErbB4 Signaling, ERK/MAPK Signaling, Erythropoietin Signaling, Estrogen Receptor Signaling, FcγRIIB Signaling in B Lymphocytes, FLT3 Signaling in Hematopoietic Progenitor Cells, G Beta Gamma Signaling, G-Protein Coupled Receptor Signaling, GDNF Family Ligand-Receptor Interactions, Glioblastoma Multiforme Signaling, Glioma Signaling, Glucocorticoid Receptor Signaling, GM-CSF Signaling, Gαi Signaling, Huntington's Disease Signaling, iCOS-iCOSL Signaling in T Helper Cells, IGF-1 Signaling, IL-15 Signaling, IL-2 Signaling, IL-3 Signaling, IL-4 Signaling, IL-6 Signaling, Insulin Receptor Signaling, Integrin Signaling, JAK/Stat Signaling, Melanocyte Development and Pigmentation Signaling, Molecular Mechanisms of Cancer, Myc Mediated Apoptosis Signaling, Natural Killer Cell Signaling, Neuregulin Signaling, Neurotrophin/TRK Signaling, NGF Signaling, Oncostatin M Signaling, p70S6K Signaling, PAK Signaling, PDGF Signaling, Phospholipase C Signaling, PI3K/AKT Signaling, PPAR Signaling, PPARα/RXRα Activation, Prolactin Signaling, PTEN Signaling, Regulation of eIF4 and p70S6K Signaling, Renin-Angiotensin Signaling, Role of JAK1 and JAK3 in γc Cytokine Signaling, Role of JAK2 in Hormone-like Cytokine Signaling, Role of NANOG in Mammalian Embryonic Stem Cell Pluripotency, Role of NFAT in Cardiac Hypertrophy, SAPK/JNK Signaling, Telomerase Signaling, Thrombin Signaling, Thrombopoietin Signaling, Thyroid Cancer Signaling, VEGF Family Ligand-Receptor Interactions, VEGF Signaling |
hsa-miR-1287 | 0.045 | 1.500 | TargetScan Human | Moderate (predicted) | SLA2 | 0.030 | -1.900 | |
hsa-miR-1287 | 0.045 | 1.500 | TargetScan Human | Moderate (predicted) | TAL1 | 0.000 | -5.160 | |
hsa-miR-1287 | 0.045 | 1.500 | TargetScan Human | Moderate (predicted) | TXNL4B | 0.000 | -2.420 | |
hsa-miR-1287 | 0.045 | 1.500 | TargetScan Human | Moderate (predicted) | VIM | 0.000 | -1.925 | 14-3-3-mediated Signaling, ILK Signaling, Signaling by Rho Family GTPases |
hsa-miR-1304 | 0.000 | 3.600 | TargetScan Human | High (predicted) | CALM1 (includes others) | 0.000 | -15.670 | 1D-myo-inositol Hexakisphosphate Biosynthesis II (Mammalian), Androgen Signaling, B Cell Receptor Signaling, Breast Cancer Regulation by Stathmin1, Calcium Signaling, Calcium-induced T Lymphocyte Apoptosis, cAMP-mediated signaling, Cardiac Hypertrophy Signaling, CCR3 Signaling in Eosinophils, CCR5 Signaling in Macrophages, CD28 Signaling in T Helper Cells, Cellular Effects of Sildenafil (Viagra), Chemokine Signaling, Corticotropin Releasing Hormone Signaling, CREB Signaling in Neurons, D-myo-inositol (1, 3, 4)-trisphosphate Biosynthesis, Dopamine-DARPP32 Feedback in cAMP Signaling, eNOS Signaling, fMLP Signaling in Neutrophils, Glioma Signaling, Glutamate Receptor Signaling, Gαq Signaling, iCOS-iCOSL Signaling in T Helper Cells, iNOS Signaling, Melatonin Signaling, Nitric Oxide Signaling in the Cardiovascular System, nNOS Signaling in Neurons, nNOS Signaling in Skeletal Muscle Cells, Nur77 Signaling in T Lymphocytes, Phospholipase C Signaling, PI3K Signaling in B Lymphocytes, Protein Kinase A Signaling, RANK Signaling in Osteoclasts, Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of NFAT in Cardiac Hypertrophy, Role of NFAT in Regulation of the Immune Response, Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis, Sperm Motility, Superpathway of D-myo-inositol (1, 4, 5)-trisphosphate Metabolism, Superpathway of Inositol Phosphate Compounds, Synaptic Long Term Potentiation, T Cell Receptor Signaling, α-Adrenergic Signaling |
hsa-miR-1304 | 0.000 | 3.600 | TargetScan Human | Moderate (predicted) | CDKN1A | 0.006 | -10.640 | AMPK Signaling, Antiproliferative Role of Somatostatin Receptor 2, Aryl Hydrocarbon Receptor Signaling, ATM Signaling, Bladder Cancer Signaling, Breast Cancer Regulation by Stathmin1, Cell Cycle: G1/S Checkpoint Regulation, Cell Cycle: G2/M DNA Damage Checkpoint Regulation, Chronic Myeloid Leukemia Signaling, Cyclins and Cell Cycle Regulation, Estrogen-mediated S-phase Entry, GADD45 Signaling, Glioblastoma Multiforme Signaling, Glioma Signaling, Glucocorticoid Receptor Signaling, HER-2 Signaling in Breast Cancer, Hereditary Breast Cancer Signaling, HGF Signaling, JAK/Stat Signaling, Melanoma Signaling, Molecular Mechanisms of Cancer, p53 Signaling, Pancreatic Adenocarcinoma Signaling, PI3K/AKT Signaling, Prostate Cancer Signaling, PTEN Signaling, Role of BRCA1 in DNA Damage Response, Role of CHK Proteins in Cell Cycle Checkpoint Control, STAT3 Pathway, Telomerase Signaling, VDR/RXR Activation |
hsa-miR-1304 | 0.000 | 3.600 | TargetScan Human | Moderate (predicted) | DAG1 | 0.000 | -2.700 | Agrin Interactions at Neuromuscular Junction, nNOS Signaling in Skeletal Muscle Cells |
hsa-miR-1304 | 0.000 | 3.600 | TargetScan Human | Moderate (predicted) | DSCR3 | 0.000 | -2.070 | |
hsa-miR-1304 | 0.000 | 3.600 | TargetScan Human | Moderate (predicted) | DSTN | 0.037 | -1.470 | |
hsa-miR-1304 | 0.000 | 3.600 | TargetScan Human | Moderate (predicted) | EGF | 0.000 | -2.220 | Actin Cytoskeleton Signaling, Axonal Guidance Signaling, Bladder Cancer Signaling, Caveolar-mediated Endocytosis Signaling, Clathrin-mediated Endocytosis Signaling, Colorectal Cancer Metastasis Signaling, EGF Signaling, Ephrin Receptor Signaling, Epithelial Adherens Junction Signaling, ErbB Signaling, ERK5 Signaling, FAK Signaling, Gap Junction Signaling, Glioblastoma Multiforme Signaling, Glioma Signaling, GNRH Signaling, Hepatic Fibrosis / Hepatic Stellate Cell Activation, HER-2 Signaling in Breast Cancer, Huntington's Disease Signaling, IL-8 Signaling, Macropinocytosis Signaling, Neuregulin Signaling, NF-κB Signaling, Non-Small Cell Lung Cancer Signaling, Ovarian Cancer Signaling, Pancreatic Adenocarcinoma Signaling, Regulation of Cellular Mechanics by Calpain Protease, Regulation of the Epithelial-Mesenchymal Transition Pathway, Telomerase Signaling, Thrombin Signaling |
hsa-miR-1304 | 0.000 | 3.600 | TargetScan Human | Moderate (predicted) | GNA12 | 0.000 | -2.390 | Actin Cytoskeleton Signaling, Actin Nucleation by ARP-WASP Complex, Androgen Signaling, Axonal Guidance Signaling, Cardiac Hypertrophy Signaling, Cholecystokinin/Gastrin-mediated Signaling, CREB Signaling in Neurons, CXCR4 Signaling, Endothelin-1 Signaling, Ephrin B Signaling, Ephrin Receptor Signaling, ERK5 Signaling, G Beta Gamma Signaling, Gα12/13 Signaling, IL-1 Signaling, IL-8 Signaling, Molecular Mechanisms of Cancer, Relaxin Signaling, RhoA Signaling, RhoGDI Signaling, Role of NFAT in Regulation of the Immune Response, Role of Tissue Factor in Cancer, SAPK/JNK Signaling, Signaling by Rho Family GTPases, Sphingosine-1-phosphate Signaling, Synaptic Long Term Depression, Tec Kinase Signaling, Thrombin Signaling |
hsa-miR-1304 | 0.000 | 3.600 | TargetScan Human | Moderate (predicted) | GNB5 | 0.005 | -2.640 | Androgen Signaling, Antiproliferative Role of Somatostatin Receptor 2, Axonal Guidance Signaling, Breast Cancer Regulation by Stathmin1, Cardiac Hypertrophy Signaling, Cardiac β-adrenergic Signaling, CCR3 Signaling in Eosinophils, CCR5 Signaling in Macrophages, Colorectal Cancer Metastasis Signaling, CREB Signaling in Neurons, CXCR4 Signaling, Ephrin B Signaling, Ephrin Receptor Signaling, fMLP Signaling in Neutrophils, G Beta Gamma Signaling, G Protein Signaling Mediated by Tubby, Gαi Signaling, Gαq Signaling, Gαs Signaling, Huntington's Disease Signaling, IL-1 Signaling, IL-8 Signaling, P2Y Purigenic Receptor Signaling Pathway, Phospholipase C Signaling, Phototransduction Pathway, Protein Kinase A Signaling, Relaxin Signaling, RhoGDI Signaling, Role of NFAT in Cardiac Hypertrophy, Role of NFAT in Regulation of the Immune Response, Signaling by Rho Family GTPases, Tec Kinase Signaling, Thrombin Signaling, α-Adrenergic Signaling |
hsa-miR-1304 | 0.000 | 3.600 | TargetScan Human | Moderate (predicted) | IPO11 | 0.008 | -4.380 | |
hsa-miR-1304 | 0.000 | 3.600 | TargetScan Human | Moderate (predicted) | JUND | 0.000 | -2.380 | Corticotropin Releasing Hormone Signaling, NRF2-mediated Oxidative Stress Response, PCP pathway |
hsa-miR-1304 | 0.000 | 3.600 | TargetScan Human | Moderate (predicted) | NT5C2 | 0.000 | -3.250 | Adenosine Nucleotides Degradation II, Guanosine Nucleotides Degradation III, NAD Salvage Pathway II, Purine Nucleotides Degradation II (Aerobic), Urate Biosynthesis/Inosine 5'-phosphate Degradation |
hsa-miR-1304 | 0.000 | 3.600 | TargetScan Human | Moderate (predicted) | PNKD | 0.000 | -8.870 | |
hsa-miR-1304 | 0.000 | 3.600 | TargetScan Human | Moderate (predicted) | RGS6 | 0.000 | -1.580 | |
hsa-miR-1304 | 0.000 | 3.600 | TargetScan Human | Moderate (predicted) | ROCK2 | 0.038 | -2.590 | Actin Cytoskeleton Signaling, Actin Nucleation by ARP-WASP Complex, Axonal Guidance Signaling, Breast Cancer Regulation by Stathmin1, Cardiac Hypertrophy Signaling, CCR3 Signaling in Eosinophils, Chemokine Signaling, Cholecystokinin/Gastrin-mediated Signaling, CXCR4 Signaling, Ephrin A Signaling, Ephrin B Signaling, Ephrin Receptor Signaling, Gα12/13 Signaling, Gαq Signaling, IL-8 Signaling, Leukocyte Extravasation Signaling, NGF Signaling, PCP pathway, PEDF Signaling, Protein Kinase A Signaling, RhoA Signaling, RhoGDI Signaling, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Semaphorin Signaling in Neurons, Signaling by Rho Family GTPases, Thrombin Signaling, VEGF Signaling |
hsa-miR-1304 | 0.000 | 3.600 | TargetScan Human | High (predicted) | SH3KBP1 | 0.001 | -1.720 | Clathrin-mediated Endocytosis Signaling |
hsa-miR-1304 | 0.000 | 3.600 | TargetScan Human | Moderate (predicted) | SMARCA2 | 0.002 | -2.510 | AMPK Signaling, Glucocorticoid Receptor Signaling, Hereditary Breast Cancer Signaling, RAR Activation, Role of BRCA1 in DNA Damage Response |
hsa-miR-1304 | 0.000 | 3.600 | TargetScan Human | Moderate (predicted) | UBE3B | 0.000 | -2.480 | Protein Ubiquitination Pathway |
hsa-miR-1304 | 0.000 | 3.600 | TargetScan Human | Moderate (predicted) | YPEL2 | 0.000 | -1.790 | |
hsa-miR-1469 | 0.009 | 6.500 | TargetScan Human | Moderate (predicted) | ARHGEF18 | 0.000 | -2.180 | Breast Cancer Regulation by Stathmin1, Molecular Mechanisms of Cancer, Phospholipase C Signaling, RhoGDI Signaling, Signaling by Rho Family GTPases |
hsa-miR-1469 | 0.009 | 6.500 | TargetScan Human | Moderate (predicted) | PIP5K1C | 0.000 | -2.520 | 3-phosphoinositide Biosynthesis, Actin Cytoskeleton Signaling, Aldosterone Signaling in Epithelial Cells, Clathrin-mediated Endocytosis Signaling, D-myo-inositol (1, 4, 5)-Trisphosphate Biosynthesis, Rac Signaling, Regulation of Actin-based Motility by Rho, RhoA Signaling, RhoGDI Signaling, Signaling by Rho Family GTPases, Superpathway of Inositol Phosphate Compounds |
hsa-miR-1469 | 0.009 | 6.500 | TargetScan Human | Moderate (predicted) | RSU1 | 0.000 | -5.020 | ILK Signaling |
hsa-miR-1469 | 0.009 | 6.500 | TargetScan Human | Moderate (predicted) | TMSB10/TMSB4X | 0.002 | -1.460 | Actin Cytoskeleton Signaling, ILK Signaling |
hsa-miR-1469 | 0.009 | 6.500 | TargetScan Human | Moderate (predicted) | UPF1 | 0.016 | -1.490 | |
hsa-miR-1469 | 0.009 | 6.500 | TargetScan Human | High (predicted) | WASF2 | 0.003 | -3.850 | Actin Cytoskeleton Signaling, PEDF Signaling, RhoGDI Signaling |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | ABLIM1 | 0.001 | -3.045 | Axonal Guidance Signaling, Netrin Signaling |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | ACSS2 | 0.003 | -2.025 | Acetate Conversion to Acetyl-CoA, Ethanol Degradation II, Ethanol Degradation IV, Oxidative Ethanol Degradation III |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | ACVR1 | 0.004 | -5.360 | Epithelial Adherens Junction Signaling, Factors Promoting Cardiogenesis in Vertebrates, Human Embryonic Stem Cell Pluripotency, PPARα/RXRα Activation, TGF-β Signaling, Wnt/β-catenin Signaling |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | ADAR | 0.000 | -3.030 | Activation of IRF by Cytosolic Pattern Recognition Receptors |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | ADRBK1 | 0.004 | -2.180 | cAMP-mediated signaling, Cardiac β-adrenergic Signaling, Colorectal Cancer Metastasis Signaling, G-Protein Coupled Receptor Signaling, Gαq Signaling, Sonic Hedgehog Signaling |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | AKT1 | 0.003 | -1.870 | 14-3-3-mediated Signaling, Acute Myeloid Leukemia Signaling, Acute Phase Response Signaling, Adipogenesis pathway, AMPK Signaling, Amyloid Processing, Angiopoietin Signaling, Axonal Guidance Signaling, B Cell Receptor Signaling, Cancer Drug Resistance By Drug Efflux, Cardiac Hypertrophy Signaling, CD28 Signaling in T Helper Cells, Ceramide Signaling, Chronic Myeloid Leukemia Signaling, CNTF Signaling, Colorectal Cancer Metastasis Signaling, CREB Signaling in Neurons, CTLA4 Signaling in Cytotoxic T Lymphocytes, CXCR4 Signaling, Dendritic Cell Maturation, DNA damage-induced 14-3-3σ Signaling, Docosahexaenoic Acid (DHA) Signaling, EGF Signaling, EIF2 Signaling, Endometrial Cancer Signaling, eNOS Signaling, Ephrin Receptor Signaling, Epithelial Adherens Junction Signaling, ErbB Signaling, ErbB2-ErbB3 Signaling, ErbB4 Signaling, ERK5 Signaling, Erythropoietin Signaling, Estrogen-Dependent Breast Cancer Signaling, FAK Signaling, Fc Epsilon RI Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, FcγRIIB Signaling in B Lymphocytes, FGF Signaling, FLT3 Signaling in Hematopoietic Progenitor Cells, FXR/RXR Activation, G Beta Gamma Signaling, G-Protein Coupled Receptor Signaling, Gap Junction Signaling, Germ Cell-Sertoli Cell Junction Signaling, Glioblastoma Multiforme Signaling, Glioma Signaling, Glucocorticoid Receptor Signaling, GM-CSF Signaling, Gα12/13 Signaling, Gαq Signaling, HER-2 Signaling in Breast Cancer, Hereditary Breast Cancer Signaling, HGF Signaling, HIF1α Signaling, HMGB1 Signaling, Human Embryonic Stem Cell Pluripotency, Huntington's Disease Signaling, Hypoxia Signaling in the Cardiovascular System, iCOS-iCOSL Signaling in T Helper Cells, IGF-1 Signaling, IL-12 Signaling and Production in Macrophages, IL-15 Signaling, IL-17 Signaling, IL-17A Signaling in Airway Cells, IL-2 Signaling, IL-22 Signaling, IL-3 Signaling, IL-4 Signaling, IL-6 Signaling, IL-8 Signaling, ILK Signaling, Inhibition of Angiogenesis by TSP1, Insulin Receptor Signaling, Integrin Signaling, JAK/Stat Signaling, Leptin Signaling in Obesity, Lymphotoxin β Receptor Signaling, Melanoma Signaling, Molecular Mechanisms of Cancer, Mouse Embryonic Stem Cell Pluripotency, mTOR Signaling, Myc Mediated Apoptosis Signaling, Natural Killer Cell Signaling, Neuregulin Signaling, Neurotrophin/TRK Signaling, NF-κB Activation by Viruses, NF-κB Signaling, NGF Signaling, Nitric Oxide Signaling in the Cardiovascular System, Non-Small Cell Lung Cancer Signaling, NRF2-mediated Oxidative Stress Response, Ovarian Cancer Signaling, P2Y Purigenic Receptor Signaling Pathway, p53 Signaling, p70S6K Signaling, Pancreatic Adenocarcinoma Signaling, PEDF Signaling, PI3K Signaling in B Lymphocytes, PI3K/AKT Signaling, Production of Nitric Oxide and Reactive Oxygen Species in Macrophages, Prostate Cancer Signaling, PTEN Signaling, PXR/RXR Activation, RANK Signaling in Osteoclasts, RAR Activation, Reelin Signaling in Neurons, Regulation of eIF4 and p70S6K Signaling, Regulation of the Epithelial-Mesenchymal Transition Pathway, Relaxin Signaling, Renal Cell Carcinoma Signaling, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of MAPK Signaling in the Pathogenesis of Influenza, Role of NANOG in Mammalian Embryonic Stem Cell Pluripotency, Role of NFAT in Cardiac Hypertrophy, Role of NFAT in Regulation of the Immune Response, Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis, Role of PI3K/AKT Signaling in the Pathogenesis of Influenza, Role of PKR in Interferon Induction and Antiviral Response, Role of Tissue Factor in Cancer, Sertoli Cell-Sertoli Cell Junction Signaling, Small Cell Lung Cancer Signaling, Sphingosine-1-phosphate Signaling, Systemic Lupus Erythematosus Signaling, Telomerase Signaling, Thrombin Signaling, Tight Junction Signaling, TR/RXR Activation, TREM1 Signaling, Type II Diabetes Mellitus Signaling, UVB-Induced MAPK Signaling, VEGF Family Ligand-Receptor Interactions, VEGF Signaling, Wnt/β-catenin Signaling |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | ANK1 | 0.000 | -2.780 | Rac Signaling |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | ANO6 | 0.000 | -15.080 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | ARHGDIA | 0.042 | -1.740 | Regulation of Actin-based Motility by Rho, RhoGDI Signaling |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | ARID1A | 0.000 | -1.540 | AMPK Signaling, Glucocorticoid Receptor Signaling, Hereditary Breast Cancer Signaling, RAR Activation, Role of BRCA1 in DNA Damage Response |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | ARID3B | 0.000 | -1.480 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | ARPC4 | 0.015 | -1.570 | Actin Cytoskeleton Signaling, Actin Nucleation by ARP-WASP Complex, Axonal Guidance Signaling, CD28 Signaling in T Helper Cells, Cdc42 Signaling, Clathrin-mediated Endocytosis Signaling, Ephrin Receptor Signaling, Epithelial Adherens Junction Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, fMLP Signaling in Neutrophils, Integrin Signaling, Rac Signaling, Regulation of Actin-based Motility by Rho, Remodeling of Epithelial Adherens Junctions, RhoA Signaling, RhoGDI Signaling, Signaling by Rho Family GTPases |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | ATP6V0D1 | 0.000 | -2.910 | phagosome maturation |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | BCL2L1 | 0.009 | -1.600 | Amyotrophic Lateral Sclerosis Signaling, Apoptosis Signaling, B Cell Receptor Signaling, CD27 Signaling in Lymphocytes, Chronic Myeloid Leukemia Signaling, Colorectal Cancer Metastasis Signaling, Docosahexaenoic Acid (DHA) Signaling, Glucocorticoid Receptor Signaling, GM-CSF Signaling, Huntington's Disease Signaling, IL-15 Signaling, IL-8 Signaling, Induction of Apoptosis by HIV1, JAK/Stat Signaling, Lymphotoxin β Receptor Signaling, Molecular Mechanisms of Cancer, OX40 Signaling Pathway, p53 Signaling, Pancreatic Adenocarcinoma Signaling, PEDF Signaling, PI3K/AKT Signaling, PTEN Signaling, Role of Tissue Factor in Cancer, Small Cell Lung Cancer Signaling, UVA-Induced MAPK Signaling, VEGF Signaling |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | BCR | 0.000 | -2.390 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | C1orf198 | 0.001 | -7.420 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | C9orf78 | 0.003 | -1.480 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | CALM1 (includes others) | 0.000 | -15.670 | 1D-myo-inositol Hexakisphosphate Biosynthesis II (Mammalian), Androgen Signaling, B Cell Receptor Signaling, Breast Cancer Regulation by Stathmin1, Calcium Signaling, Calcium-induced T Lymphocyte Apoptosis, cAMP-mediated signaling, Cardiac Hypertrophy Signaling, CCR3 Signaling in Eosinophils, CCR5 Signaling in Macrophages, CD28 Signaling in T Helper Cells, Cellular Effects of Sildenafil (Viagra), Chemokine Signaling, Corticotropin Releasing Hormone Signaling, CREB Signaling in Neurons, D-myo-inositol (1, 3, 4)-trisphosphate Biosynthesis, Dopamine-DARPP32 Feedback in cAMP Signaling, eNOS Signaling, fMLP Signaling in Neutrophils, Glioma Signaling, Glutamate Receptor Signaling, Gαq Signaling, iCOS-iCOSL Signaling in T Helper Cells, iNOS Signaling, Melatonin Signaling, Nitric Oxide Signaling in the Cardiovascular System, nNOS Signaling in Neurons, nNOS Signaling in Skeletal Muscle Cells, Nur77 Signaling in T Lymphocytes, Phospholipase C Signaling, PI3K Signaling in B Lymphocytes, Protein Kinase A Signaling, RANK Signaling in Osteoclasts, Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of NFAT in Cardiac Hypertrophy, Role of NFAT in Regulation of the Immune Response, Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis, Sperm Motility, Superpathway of D-myo-inositol (1, 4, 5)-trisphosphate Metabolism, Superpathway of Inositol Phosphate Compounds, Synaptic Long Term Potentiation, T Cell Receptor Signaling, α-Adrenergic Signaling |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | CBL | 0.000 | -1.740 | 14-3-3-mediated Signaling, Clathrin-mediated Endocytosis Signaling, Ephrin B Signaling, Erythropoietin Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, FLT3 Signaling in Hematopoietic Progenitor Cells, Insulin Receptor Signaling, Molecular Mechanisms of Cancer, PI3K Signaling in B Lymphocytes, Protein Ubiquitination Pathway, PTEN Signaling, RANK Signaling in Osteoclasts, Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis, Systemic Lupus Erythematosus Signaling, T Cell Receptor Signaling |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | CBX6 | 0.018 | -2.680 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | CDKN1A | 0.006 | -10.640 | AMPK Signaling, Antiproliferative Role of Somatostatin Receptor 2, Aryl Hydrocarbon Receptor Signaling, ATM Signaling, Bladder Cancer Signaling, Breast Cancer Regulation by Stathmin1, Cell Cycle: G1/S Checkpoint Regulation, Cell Cycle: G2/M DNA Damage Checkpoint Regulation, Chronic Myeloid Leukemia Signaling, Cyclins and Cell Cycle Regulation, Estrogen-mediated S-phase Entry, GADD45 Signaling, Glioblastoma Multiforme Signaling, Glioma Signaling, Glucocorticoid Receptor Signaling, HER-2 Signaling in Breast Cancer, Hereditary Breast Cancer Signaling, HGF Signaling, JAK/Stat Signaling, Melanoma Signaling, Molecular Mechanisms of Cancer, p53 Signaling, Pancreatic Adenocarcinoma Signaling, PI3K/AKT Signaling, Prostate Cancer Signaling, PTEN Signaling, Role of BRCA1 in DNA Damage Response, Role of CHK Proteins in Cell Cycle Checkpoint Control, STAT3 Pathway, Telomerase Signaling, VDR/RXR Activation |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | CDR2L | 0.000 | -3.870 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | CDS2 | 0.007 | -1.900 | CDP-diacylglycerol Biosynthesis I, Phosphatidylglycerol Biosynthesis II (Non-plastidic) |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | CERS2 | 0.002 | -2.555 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | CIC | 0.000 | -1.450 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | CLCN7 | 0.013 | -2.270 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | CLIP2 | 0.000 | -4.440 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | CPNE5 | 0.019 | -4.210 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | CTDNEP1 | 0.014 | -1.740 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | CTDSP1 | 0.000 | -6.090 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | CTDSP2 | 0.000 | -7.600 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | CTIF | 0.000 | -2.160 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | CTNS | 0.027 | -3.420 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | DBNL | 0.046 | -3.870 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | DLG4 | 0.021 | -2.030 | Glutamate Receptor Signaling, HIPPO signaling, Huntington's Disease Signaling, Neuregulin Signaling, nNOS Signaling in Neurons |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | DSCR3 | 0.000 | -2.070 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | DUSP3 | 0.031 | -4.840 | Protein Kinase A Signaling |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | EFHD2 | 0.000 | -2.500 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | ETV6 | 0.000 | -2.380 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | F11R | 0.002 | -2.480 | Leukocyte Extravasation Signaling, Sertoli Cell-Sertoli Cell Junction Signaling, Tight Junction Signaling |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | FAM110A | 0.007 | -3.840 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | FAM214B | 0.000 | -2.930 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | FNBP1 | 0.000 | -1.530 | Actin Nucleation by ARP-WASP Complex, Cardiac Hypertrophy Signaling, Cholecystokinin/Gastrin-mediated Signaling, Colorectal Cancer Metastasis Signaling, CXCR4 Signaling, Germ Cell-Sertoli Cell Junction Signaling, Glioblastoma Multiforme Signaling, Glioma Invasiveness Signaling, Gαq Signaling, HMGB1 Signaling, IL-8 Signaling, ILK Signaling, Integrin Signaling, Molecular Mechanisms of Cancer, mTOR Signaling, phagosome formation, Phospholipase C Signaling, Production of Nitric Oxide and Reactive Oxygen Species in Macrophages, Regulation of Actin-based Motility by Rho, RhoGDI Signaling, Semaphorin Signaling in Neurons, Signaling by Rho Family GTPases, Sphingosine-1-phosphate Signaling, Tec Kinase Signaling, Thrombin Signaling |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | FNBP1L | 0.004 | -2.010 | Cdc42 Signaling |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | FOPNL | 0.035 | -1.800 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | FRMD8 | 0.007 | -4.010 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | FURIN | 0.007 | -3.340 | Mitochondrial Dysfunction, Notch Signaling |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | FYN | 0.000 | -3.053 | 3-phosphoinositide Biosynthesis, Axonal Guidance Signaling, Caveolar-mediated Endocytosis Signaling, CD28 Signaling in T Helper Cells, CTLA4 Signaling in Cytotoxic T Lymphocytes, Ephrin A Signaling, Ephrin Receptor Signaling, ERK/MAPK Signaling, FAK Signaling, Fc Epsilon RI Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, G-Protein Coupled Receptor Signaling, Inhibition of Angiogenesis by TSP1, Insulin Receptor Signaling, Integrin Signaling, Molecular Mechanisms of Cancer, Natural Killer Cell Signaling, Phospholipase C Signaling, PI3K Signaling in B Lymphocytes, PKCθ Signaling in T Lymphocytes, Prolactin Signaling, Reelin Signaling in Neurons, Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes, Role of NFAT in Regulation of the Immune Response, Role of Tissue Factor in Cancer, Semaphorin Signaling in Neurons, Superpathway of Inositol Phosphate Compounds, T Cell Receptor Signaling, Tec Kinase Signaling, Virus Entry via Endocytic Pathways |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | GFOD1 | 0.000 | -2.330 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | GLG1 | 0.000 | -1.790 | Agranulocyte Adhesion and Diapedesis, Atherosclerosis Signaling, Granulocyte Adhesion and Diapedesis |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | GNAZ | 0.000 | -8.090 | Androgen Signaling, Axonal Guidance Signaling, Cardiac Hypertrophy Signaling, CREB Signaling in Neurons, CXCR4 Signaling, Endothelin-1 Signaling, Ephrin B Signaling, Ephrin Receptor Signaling, G Beta Gamma Signaling, IL-1 Signaling, Molecular Mechanisms of Cancer, Relaxin Signaling, RhoGDI Signaling, Role of NFAT in Regulation of the Immune Response, Signaling by Rho Family GTPases, Synaptic Long Term Depression, Tec Kinase Signaling, Thrombin Signaling |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | HCFC1 | 0.000 | -2.690 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | HCLS1 | 0.001 | -1.740 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | HEATR1 | 0.022 | -3.960 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | HECTD4 | 0.000 | -2.070 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | HERC1 | 0.000 | -1.990 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | HYAL3 | 0.008 | -1.780 | Chondroitin Sulfate Degradation (Metazoa), Dermatan Sulfate Degradation (Metazoa) |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | INF2 | 0.004 | -7.710 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | INPPL1 | 0.028 | -1.890 | 1D-myo-inositol Hexakisphosphate Biosynthesis II (Mammalian), 3-phosphoinositide Degradation, B Cell Receptor Signaling, D-myo-inositol (1, 3, 4)-trisphosphate Biosynthesis, D-myo-inositol (1, 4, 5)-trisphosphate Degradation, Fc Epsilon RI Signaling, IL-4 Signaling, Insulin Receptor Signaling, Natural Killer Cell Signaling, PDGF Signaling, phagosome formation, PI3K/AKT Signaling, PTEN Signaling, Superpathway of D-myo-inositol (1, 4, 5)-trisphosphate Metabolism, Superpathway of Inositol Phosphate Compounds |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | IP6K1 | 0.000 | -1.647 | Inositol Pyrophosphates Biosynthesis, Superpathway of Inositol Phosphate Compounds |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | ITIH5 | 0.000 | -1.600 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | JARID2 | 0.000 | -3.110 | Role of Oct4 in Mammalian Embryonic Stem Cell Pluripotency |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | JUND | 0.000 | -2.380 | Corticotropin Releasing Hormone Signaling, NRF2-mediated Oxidative Stress Response, PCP pathway |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | KLHDC3 | 0.000 | -1.510 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | LAMC1 | 0.000 | -2.320 | Agrin Interactions at Neuromuscular Junction, CDK5 Signaling |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | LASP1 | 0.000 | -5.070 | IL-8 Signaling |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | LHFPL2 | 0.000 | -2.530 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | LOC401052 | 0.024 | -1.600 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | MAP1A | 0.000 | -5.290 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | MAPK8IP3 | 0.000 | -1.500 | Reelin Signaling in Neurons, SAPK/JNK Signaling |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | MBP | 0.000 | -12.630 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | MEF2D | 0.000 | -2.260 | Calcium Signaling, Calcium-induced T Lymphocyte Apoptosis, Cardiac Hypertrophy Signaling, Cholecystokinin/Gastrin-mediated Signaling, Corticotropin Releasing Hormone Signaling, ERK5 Signaling, Gα12/13 Signaling, Nur77 Signaling in T Lymphocytes, p38 MAPK Signaling, Phospholipase C Signaling, Role of NFAT in Cardiac Hypertrophy, Role of NFAT in Regulation of the Immune Response |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | MGLL | 0.014 | -4.850 | Triacylglycerol Degradation |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | MOB3C | 0.010 | -6.740 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | MTMR12 | 0.000 | -2.730 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | MYH9 | 0.052 | -7.770 | Actin Cytoskeleton Signaling, Agranulocyte Adhesion and Diapedesis, Calcium Signaling, Cellular Effects of Sildenafil (Viagra), Epithelial Adherens Junction Signaling, Hepatic Fibrosis / Hepatic Stellate Cell Activation, ILK Signaling, Tight Junction Signaling |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | MYO1C | 0.053 | -1.450 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | NCOR2 | 0.000 | -1.650 | Aryl Hydrocarbon Receptor Signaling, Estrogen Receptor Signaling, Glucocorticoid Receptor Signaling, Huntington's Disease Signaling, LXR/RXR Activation, PPAR Signaling, PPARα/RXRα Activation, RAR Activation, TR/RXR Activation, VDR/RXR Activation, Xenobiotic Metabolism Signaling |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | NDST1 | 0.000 | -3.200 | Chondroitin Sulfate Biosynthesis, Chondroitin Sulfate Biosynthesis (Late Stages), Dermatan Sulfate Biosynthesis, Dermatan Sulfate Biosynthesis (Late Stages), Heparan Sulfate Biosynthesis, Heparan Sulfate Biosynthesis (Late Stages), LPS/IL-1 Mediated Inhibition of RXR Function, Triacylglycerol Degradation, Xenobiotic Metabolism Signaling |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | NKIRAS2 | 0.014 | -2.140 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | NR1H2 | 0.001 | -1.780 | LPS/IL-1 Mediated Inhibition of RXR Function, LXR/RXR Activation |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | OXTR | 0.023 | -1.910 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | P2RX1 | 0.034 | -3.990 | Gustation Pathway |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | PGAM1 | 0.002 | -4.110 | Gluconeogenesis I, Glycolysis I, Rapoport-Luebering Glycolytic Shunt |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | PGAM4 | 0.000 | -3.175 | 3-phosphoinositide Biosynthesis, 3-phosphoinositide Degradation, D-myo-inositol (1, 4, 5, 6)-Tetrakisphosphate Biosynthesis, D-myo-inositol (3, 4, 5, 6)-tetrakisphosphate Biosynthesis, D-myo-inositol-5-phosphate Metabolism, Gluconeogenesis I, Glycolysis I, Superpathway of Inositol Phosphate Compounds |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | PIP5K1C | 0.000 | -2.520 | 3-phosphoinositide Biosynthesis, Actin Cytoskeleton Signaling, Aldosterone Signaling in Epithelial Cells, Clathrin-mediated Endocytosis Signaling, D-myo-inositol (1, 4, 5)-Trisphosphate Biosynthesis, Rac Signaling, Regulation of Actin-based Motility by Rho, RhoA Signaling, RhoGDI Signaling, Signaling by Rho Family GTPases, Superpathway of Inositol Phosphate Compounds |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | PLEK | 0.000 | -3.490 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | PPP2R5A | 0.000 | -4.830 | 3-phosphoinositide Biosynthesis, 3-phosphoinositide Degradation, AMPK Signaling, Breast Cancer Regulation by Stathmin1, Cardiac β-adrenergic Signaling, CDK5 Signaling, Cell Cycle Regulation by BTG Family Proteins, Ceramide Signaling, CTLA4 Signaling in Cytotoxic T Lymphocytes, Cyclins and Cell Cycle Regulation, D-myo-inositol (1, 4, 5, 6)-Tetrakisphosphate Biosynthesis, D-myo-inositol (3, 4, 5, 6)-tetrakisphosphate Biosynthesis, D-myo-inositol-5-phosphate Metabolism, Dopamine Receptor Signaling, Dopamine-DARPP32 Feedback in cAMP Signaling, ERK/MAPK Signaling, HIPPO signaling, ILK Signaling, Mitotic Roles of Polo-Like Kinase, mTOR Signaling, p70S6K Signaling, PI3K/AKT Signaling, Production of Nitric Oxide and Reactive Oxygen Species in Macrophages, Regulation of eIF4 and p70S6K Signaling, Role of CHK Proteins in Cell Cycle Checkpoint Control, Superpathway of Inositol Phosphate Compounds, Synaptic Long Term Depression, Telomerase Signaling, Tight Junction Signaling, Wnt/β-catenin Signaling, Xenobiotic Metabolism Signaling |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | PRKCA | 0.000 | -2.250 | 14-3-3-mediated Signaling, Aldosterone Signaling in Epithelial Cells, Androgen Signaling, Apoptosis Signaling, Axonal Guidance Signaling, Breast Cancer Regulation by Stathmin1, Calcium-induced T Lymphocyte Apoptosis, Caveolar-mediated Endocytosis Signaling, CCR3 Signaling in Eosinophils, CCR5 Signaling in Macrophages, Chemokine Signaling, Cholecystokinin/Gastrin-mediated Signaling, Corticotropin Releasing Hormone Signaling, CREB Signaling in Neurons, CXCR4 Signaling, Dopamine-DARPP32 Feedback in cAMP Signaling, EGF Signaling, Endothelin-1 Signaling, eNOS Signaling, ErbB Signaling, ErbB4 Signaling, ERK/MAPK Signaling, Erythropoietin Signaling, Factors Promoting Cardiogenesis in Vertebrates, Fc Epsilon RI Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, FGF Signaling, fMLP Signaling in Neutrophils, G Beta Gamma Signaling, G-Protein Coupled Receptor Signaling, Gap Junction Signaling, Glioma Signaling, GNRH Signaling, GPCR-Mediated Nutrient Sensing in Enteroendocrine Cells, Growth Hormone Signaling, Gαq Signaling, Hepatic Cholestasis, HER-2 Signaling in Breast Cancer, HGF Signaling, Huntington's Disease Signaling, IL-12 Signaling and Production in Macrophages, IL-3 Signaling, IL-8 Signaling, Leukocyte Extravasation Signaling, LPS-stimulated MAPK Signaling, Macropinocytosis Signaling, Mechanisms of Viral Exit from Host Cells, Melatonin Signaling, Molecular Mechanisms of Cancer, mTOR Signaling, Natural Killer Cell Signaling, Neuregulin Signaling, Neuropathic Pain Signaling In Dorsal Horn Neurons, NF-κB Activation by Viruses, Nitric Oxide Signaling in the Cardiovascular System, nNOS Signaling in Neurons, Non-Small Cell Lung Cancer Signaling, NRF2-mediated Oxidative Stress Response, P2Y Purigenic Receptor Signaling Pathway, p70S6K Signaling, PDGF Signaling, phagosome formation, Phospholipase C Signaling, PPARα/RXRα Activation, Production of Nitric Oxide and Reactive Oxygen Species in Macrophages, Prolactin Signaling, Protein Kinase A Signaling, RAR Activation, Renin-Angiotensin Signaling, RhoGDI Signaling, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of MAPK Signaling in the Pathogenesis of Influenza, Role of NFAT in Cardiac Hypertrophy, Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses, Role of Tissue Factor in Cancer, Sperm Motility, Synaptic Long Term Depression, Synaptic Long Term Potentiation, Tec Kinase Signaling, Thrombin Signaling, Thrombopoietin Signaling, Type II Diabetes Mellitus Signaling, UVA-Induced MAPK Signaling, UVB-Induced MAPK Signaling, UVC-Induced MAPK Signaling, VDR/RXR Activation, VEGF Family Ligand-Receptor Interactions, VEGF Signaling, Virus Entry via Endocytic Pathways, Wnt/Ca+ pathway, Xenobiotic Metabolism Signaling, α-Adrenergic Signaling |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | PSAP | 0.000 | -1.860 | Lipid Antigen Presentation by CD1 |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | PTK2 | 0.000 | -5.750 | Actin Cytoskeleton Signaling, Agrin Interactions at Neuromuscular Junction, Angiopoietin Signaling, Axonal Guidance Signaling, B Cell Receptor Signaling, Chemokine Signaling, Cholecystokinin/Gastrin-mediated Signaling, CXCR4 Signaling, Ephrin A Signaling, Ephrin B Signaling, Ephrin Receptor Signaling, ERK/MAPK Signaling, FAK Signaling, Germ Cell-Sertoli Cell Junction Signaling, Glioma Invasiveness Signaling, GNRH Signaling, Gα12/13 Signaling, HGF Signaling, IGF-1 Signaling, IL-15 Production, IL-15 Signaling, IL-8 Signaling, ILK Signaling, Integrin Signaling, Leukocyte Extravasation Signaling, Molecular Mechanisms of Cancer, PAK Signaling, Paxillin Signaling, Protein Kinase A Signaling, PTEN Signaling, Rac Signaling, Regulation of Cellular Mechanics by Calpain Protease, Renin-Angiotensin Signaling, RhoA Signaling, Semaphorin Signaling in Neurons, Signaling by Rho Family GTPases, Small Cell Lung Cancer Signaling, Sperm Motility, Sphingosine-1-phosphate Signaling, Tec Kinase Signaling, Thrombin Signaling, VEGF Signaling |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | PTP4A3 | 0.001 | -1.870 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | PTPRA | 0.001 | -2.720 | Protein Kinase A Signaling |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | QSOX1 | 0.006 | -1.750 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | RAB1B | 0.000 | -3.170 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | RALB | 0.007 | -2.320 | Gαi Signaling, Integrin Signaling, Molecular Mechanisms of Cancer, Phospholipase C Signaling |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | RALGDS | 0.038 | -2.910 | Colorectal Cancer Metastasis Signaling, Gαi Signaling, Molecular Mechanisms of Cancer, Pancreatic Adenocarcinoma Signaling, Phospholipase C Signaling |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | RHCE/RHD | 0.003 | -1.450 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | RHEB | 0.014 | -2.570 | mTOR Signaling, PI3K/AKT Signaling |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | RNF38 | 0.016 | -2.160 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | RNF44 | 0.000 | -1.520 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | RTN3 | 0.030 | -3.330 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | SDC4 | 0.000 | -2.930 | Agranulocyte Adhesion and Diapedesis, Granulocyte Adhesion and Diapedesis, PCP pathway |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | SEC14L1 | 0.044 | -3.080 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | SEC14L5 | 0.000 | -11.160 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | SEPN1 | 0.003 | -2.715 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | SH3PXD2A | 0.000 | -3.860 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | SHC1 | 0.005 | -2.460 | Actin Cytoskeleton Signaling, Acute Phase Response Signaling, Androgen Signaling, Axonal Guidance Signaling, B Cell Receptor Signaling, Breast Cancer Regulation by Stathmin1, Cholecystokinin/Gastrin-mediated Signaling, CREB Signaling in Neurons, EGF Signaling, EIF2 Signaling, Endothelin-1 Signaling, Ephrin Receptor Signaling, ErbB Signaling, ErbB2-ErbB3 Signaling, ErbB4 Signaling, ERK/MAPK Signaling, Erythropoietin Signaling, Estrogen Receptor Signaling, FcγRIIB Signaling in B Lymphocytes, FLT3 Signaling in Hematopoietic Progenitor Cells, G Beta Gamma Signaling, G-Protein Coupled Receptor Signaling, GDNF Family Ligand-Receptor Interactions, Glioblastoma Multiforme Signaling, Glioma Signaling, Glucocorticoid Receptor Signaling, GM-CSF Signaling, Gαi Signaling, Huntington's Disease Signaling, iCOS-iCOSL Signaling in T Helper Cells, IGF-1 Signaling, IL-15 Signaling, IL-2 Signaling, IL-3 Signaling, IL-4 Signaling, IL-6 Signaling, Insulin Receptor Signaling, Integrin Signaling, JAK/Stat Signaling, Melanocyte Development and Pigmentation Signaling, Molecular Mechanisms of Cancer, Myc Mediated Apoptosis Signaling, Natural Killer Cell Signaling, Neuregulin Signaling, Neurotrophin/TRK Signaling, NGF Signaling, Oncostatin M Signaling, p70S6K Signaling, PAK Signaling, PDGF Signaling, Phospholipase C Signaling, PI3K/AKT Signaling, PPAR Signaling, PPARα/RXRα Activation, Prolactin Signaling, PTEN Signaling, Regulation of eIF4 and p70S6K Signaling, Renin-Angiotensin Signaling, Role of JAK1 and JAK3 in γc Cytokine Signaling, Role of JAK2 in Hormone-like Cytokine Signaling, Role of NANOG in Mammalian Embryonic Stem Cell Pluripotency, Role of NFAT in Cardiac Hypertrophy, SAPK/JNK Signaling, Telomerase Signaling, Thrombin Signaling, Thrombopoietin Signaling, Thyroid Cancer Signaling, VEGF Family Ligand-Receptor Interactions, VEGF Signaling |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | SHKBP1 | 0.000 | -1.530 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | SLC22A23 | 0.000 | -1.970 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | SLC39A3 | 0.000 | -2.730 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | SLC9A1 | 0.006 | -4.300 | Actin Cytoskeleton Signaling, Aldosterone Signaling in Epithelial Cells, Signaling by Rho Family GTPases |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | SNU13 | 0.018 | -1.970 | Systemic Lupus Erythematosus Signaling |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | SRF | 0.000 | -1.770 | Cardiac Hypertrophy Signaling, Cholecystokinin/Gastrin-mediated Signaling, EGF Signaling, ERK/MAPK Signaling, Growth Hormone Signaling, IGF-1 Signaling, IL-6 Signaling, LPS-stimulated MAPK Signaling, p38 MAPK Signaling, PDGF Signaling, PEDF Signaling |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | SRPRA | 0.000 | -1.510 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | SSBP2 | 0.047 | -2.010 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | SSH1 | 0.038 | -2.370 | Actin Cytoskeleton Signaling |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | ST3GAL1 | 0.002 | -3.350 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | STAU1 | 0.000 | -2.700 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | STIM1 | 0.000 | -2.840 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | STRN4 | 0.000 | -2.090 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | STX1A | 0.023 | -2.640 | Huntington's Disease Signaling |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | SYT11 | 0.000 | -1.590 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | TAL1 | 0.000 | -5.160 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | TANGO2 | 0.018 | -3.430 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | TAPBP | 0.002 | -2.820 | Antigen Presentation Pathway |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | TGOLN2 | 0.000 | -2.570 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | THBS1 | 0.003 | -2.980 | Bladder Cancer Signaling, Inhibition of Angiogenesis by TSP1, p53 Signaling |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | TMEM189-UBE2V1 | 0.007 | -2.570 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | TMEM63A | 0.007 | -2.130 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | TNFSF4 | 0.001 | -6.110 | OX40 Signaling Pathway |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | TNS1 | 0.000 | -2.530 | FAK Signaling |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | TSPAN18 | 0.000 | -4.570 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | TTYH3 | 0.000 | -2.680 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | TXNL4B | 0.000 | -2.420 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | UBE3B | 0.000 | -2.480 | Protein Ubiquitination Pathway |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | ULK1 | 0.000 | -4.635 | AMPK Signaling, autophagy, mTOR Signaling |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | VASP | 0.001 | -1.680 | Actin Nucleation by ARP-WASP Complex, Axonal Guidance Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, IL-8 Signaling, Integrin Signaling, Leukocyte Extravasation Signaling, Protein Kinase A Signaling, Tight Junction Signaling |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | VPS37C | 0.000 | -2.020 | Mechanisms of Viral Exit from Host Cells, phagosome maturation |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | WASF2 | 0.003 | -3.850 | Actin Cytoskeleton Signaling, PEDF Signaling, RhoGDI Signaling |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | XRCC6 | 0.000 | -2.050 | DNA Double-Strand Break Repair by Non-Homologous End Joining, Telomere Extension by Telomerase |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | XYLT2 | 0.000 | -2.470 | Chondroitin Sulfate Biosynthesis, Dermatan Sulfate Biosynthesis, Glycoaminoglycan-protein Linkage Region Biosynthesis, Heparan Sulfate Biosynthesis |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | ZBTB34 | 0.000 | -2.860 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | High (predicted) | ZBTB4 | 0.000 | -3.270 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | ZFP91 | 0.000 | -1.790 | |
hsa-miR-149* | 0.004 | 8.200 | TargetScan Human | Moderate (predicted) | ZZEF1 | 0.000 | -2.950 | |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | Moderate (predicted) | ABLIM1 | 0.001 | -3.045 | Axonal Guidance Signaling, Netrin Signaling |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | High (predicted) | ACTN4 | 0.005 | -2.130 | Actin Cytoskeleton Signaling, Epithelial Adherens Junction Signaling, Germ Cell-Sertoli Cell Junction Signaling, ILK Signaling, Integrin Signaling, Leukocyte Extravasation Signaling, Macropinocytosis Signaling, Paxillin Signaling, Regulation of Cellular Mechanics by Calpain Protease, Remodeling of Epithelial Adherens Junctions, Sertoli Cell-Sertoli Cell Junction Signaling, VEGF Signaling |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | Moderate (predicted) | ANK1 | 0.000 | -2.780 | Rac Signaling |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | Moderate (predicted) | ARPC4 | 0.015 | -1.570 | Actin Cytoskeleton Signaling, Actin Nucleation by ARP-WASP Complex, Axonal Guidance Signaling, CD28 Signaling in T Helper Cells, Cdc42 Signaling, Clathrin-mediated Endocytosis Signaling, Ephrin Receptor Signaling, Epithelial Adherens Junction Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, fMLP Signaling in Neutrophils, Integrin Signaling, Rac Signaling, Regulation of Actin-based Motility by Rho, Remodeling of Epithelial Adherens Junctions, RhoA Signaling, RhoGDI Signaling, Signaling by Rho Family GTPases |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | Moderate (predicted) | BCR | 0.000 | -2.390 | |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | Moderate (predicted) | C17orf62 | 0.001 | -1.900 | |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | Moderate (predicted) | C7orf49 | 0.000 | -2.050 | |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | Moderate (predicted) | CASP2 | 0.000 | -4.300 | Apoptosis Signaling, Death Receptor Signaling, Endothelin-1 Signaling, Huntington's Disease Signaling, Sphingosine-1-phosphate Signaling, TNFR1 Signaling |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | Moderate (predicted) | CEBPB | 0.042 | -1.970 | Acute Phase Response Signaling, Adipogenesis pathway, Glucocorticoid Receptor Signaling, IL-12 Signaling and Production in Macrophages, IL-17 Signaling, IL-17A Signaling in Fibroblasts, IL-6 Signaling, JAK/Stat Signaling, Prolactin Signaling, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Type II Diabetes Mellitus Signaling, Unfolded protein response, VDR/RXR Activation |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | Moderate (predicted) | CHFR | 0.000 | -1.650 | |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | Moderate (predicted) | CHMP6 | 0.047 | -4.410 | Mechanisms of Viral Exit from Host Cells |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | Moderate (predicted) | CIB1 | 0.000 | -1.570 | |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | Moderate (predicted) | CLCN7 | 0.013 | -2.270 | |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | High (predicted) | CLEC2L | 0.011 | -1.450 | |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | Moderate (predicted) | CPNE5 | 0.019 | -4.210 | |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | Moderate (predicted) | CSK | 0.000 | -7.130 | Actin Cytoskeleton Signaling, B Cell Receptor Signaling, CD28 Signaling in T Helper Cells, FAK Signaling, Gαq Signaling, iCOS-iCOSL Signaling in T Helper Cells, Paxillin Signaling, RAR Activation, T Cell Receptor Signaling |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | Moderate (predicted) | CTDSP2 | 0.000 | -7.600 | |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | Moderate (predicted) | CTNS | 0.027 | -3.420 | |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | Moderate (predicted) | DDA1 | 0.024 | -2.040 | |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | Moderate (predicted) | ETV6 | 0.000 | -2.380 | |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | High (predicted) | FNBP1 | 0.000 | -1.530 | Actin Nucleation by ARP-WASP Complex, Cardiac Hypertrophy Signaling, Cholecystokinin/Gastrin-mediated Signaling, Colorectal Cancer Metastasis Signaling, CXCR4 Signaling, Germ Cell-Sertoli Cell Junction Signaling, Glioblastoma Multiforme Signaling, Glioma Invasiveness Signaling, Gαq Signaling, HMGB1 Signaling, IL-8 Signaling, ILK Signaling, Integrin Signaling, Molecular Mechanisms of Cancer, mTOR Signaling, phagosome formation, Phospholipase C Signaling, Production of Nitric Oxide and Reactive Oxygen Species in Macrophages, Regulation of Actin-based Motility by Rho, RhoGDI Signaling, Semaphorin Signaling in Neurons, Signaling by Rho Family GTPases, Sphingosine-1-phosphate Signaling, Tec Kinase Signaling, Thrombin Signaling |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | Moderate (predicted) | GUCD1 | 0.000 | -2.490 | |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | Moderate (predicted) | HDGF | 0.000 | -3.240 | |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | High (predicted) | INF2 | 0.004 | -7.710 | |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | Moderate (predicted) | INPPL1 | 0.028 | -1.890 | 1D-myo-inositol Hexakisphosphate Biosynthesis II (Mammalian), 3-phosphoinositide Degradation, B Cell Receptor Signaling, D-myo-inositol (1, 3, 4)-trisphosphate Biosynthesis, D-myo-inositol (1, 4, 5)-trisphosphate Degradation, Fc Epsilon RI Signaling, IL-4 Signaling, Insulin Receptor Signaling, Natural Killer Cell Signaling, PDGF Signaling, phagosome formation, PI3K/AKT Signaling, PTEN Signaling, Superpathway of D-myo-inositol (1, 4, 5)-trisphosphate Metabolism, Superpathway of Inositol Phosphate Compounds |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | Moderate (predicted) | KIAA0513 | 0.000 | -7.100 | |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | Moderate (predicted) | LMNA | 0.018 | -3.860 | Apoptosis Signaling, Death Receptor Signaling |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | High (predicted) | LSM14A | 0.000 | -3.980 | Systemic Lupus Erythematosus Signaling |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | Moderate (predicted) | MTMR10 | 0.000 | -6.990 | |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | Moderate (predicted) | MYH9 | 0.052 | -7.770 | Actin Cytoskeleton Signaling, Agranulocyte Adhesion and Diapedesis, Calcium Signaling, Cellular Effects of Sildenafil (Viagra), Epithelial Adherens Junction Signaling, Hepatic Fibrosis / Hepatic Stellate Cell Activation, ILK Signaling, Tight Junction Signaling |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | High (predicted) | MYO1C | 0.053 | -1.450 | |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | Moderate (predicted) | NCK2 | 0.028 | -2.070 | Actin Nucleation by ARP-WASP Complex, Axonal Guidance Signaling, Ephrin B Signaling, Ephrin Receptor Signaling, ErbB Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, ILK Signaling, Integrin Signaling, Netrin Signaling, PAK Signaling, Paxillin Signaling |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | Moderate (predicted) | NDST1 | 0.000 | -3.200 | Chondroitin Sulfate Biosynthesis, Chondroitin Sulfate Biosynthesis (Late Stages), Dermatan Sulfate Biosynthesis, Dermatan Sulfate Biosynthesis (Late Stages), Heparan Sulfate Biosynthesis, Heparan Sulfate Biosynthesis (Late Stages), LPS/IL-1 Mediated Inhibition of RXR Function, Triacylglycerol Degradation, Xenobiotic Metabolism Signaling |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | Moderate (predicted) | NPRL3 | 0.001 | -2.140 | |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | High (predicted) | PIP5K1C | 0.000 | -2.520 | 3-phosphoinositide Biosynthesis, Actin Cytoskeleton Signaling, Aldosterone Signaling in Epithelial Cells, Clathrin-mediated Endocytosis Signaling, D-myo-inositol (1, 4, 5)-Trisphosphate Biosynthesis, Rac Signaling, Regulation of Actin-based Motility by Rho, RhoA Signaling, RhoGDI Signaling, Signaling by Rho Family GTPases, Superpathway of Inositol Phosphate Compounds |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | Moderate (predicted) | PTBP1 | 0.000 | -8.430 | |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | Moderate (predicted) | PTPN1 | 0.000 | -2.900 | 3-phosphoinositide Biosynthesis, 3-phosphoinositide Degradation, Caveolar-mediated Endocytosis Signaling, D-myo-inositol (1, 4, 5, 6)-Tetrakisphosphate Biosynthesis, D-myo-inositol (3, 4, 5, 6)-tetrakisphosphate Biosynthesis, D-myo-inositol-5-phosphate Metabolism, Insulin Receptor Signaling, JAK/Stat Signaling, Protein Kinase A Signaling, Role of JAK2 in Hormone-like Cytokine Signaling, Superpathway of Inositol Phosphate Compounds |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | Moderate (predicted) | QSOX1 | 0.006 | -1.750 | |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | Moderate (predicted) | RBM38 | 0.000 | -5.310 | |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | High (predicted) | RGS6 | 0.000 | -1.580 | |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | Moderate (predicted) | SHCBP1 | 0.041 | -1.510 | |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | Moderate (predicted) | SLC39A3 | 0.000 | -2.730 | |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | Moderate (predicted) | SLX4 | 0.012 | -5.420 | |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | Moderate (predicted) | SRC | 0.000 | -7.470 | 14-3-3-mediated Signaling, Agrin Interactions at Neuromuscular Junction, AMPK Signaling, Androgen Signaling, Antiproliferative Role of Somatostatin Receptor 2, Aryl Hydrocarbon Receptor Signaling, cAMP-mediated signaling, Caveolar-mediated Endocytosis Signaling, Cdc42 Signaling, Chemokine Signaling, Cholecystokinin/Gastrin-mediated Signaling, Clathrin-mediated Endocytosis Signaling, Colorectal Cancer Metastasis Signaling, CXCR4 Signaling, EGF Signaling, Endothelin-1 Signaling, Ephrin Receptor Signaling, Epithelial Adherens Junction Signaling, ERK/MAPK Signaling, ERK5 Signaling, Erythropoietin Signaling, Estrogen Receptor Signaling, Estrogen-Dependent Breast Cancer Signaling, FAK Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, G Beta Gamma Signaling, G-Protein Coupled Receptor Signaling, Gap Junction Signaling, Germ Cell-Sertoli Cell Junction Signaling, Glioblastoma Multiforme Signaling, GNRH Signaling, Gα12/13 Signaling, Gαi Signaling, Gαs Signaling, IL-8 Signaling, Integrin Signaling, Leukocyte Extravasation Signaling, Macropinocytosis Signaling, Melanocyte Development and Pigmentation Signaling, Molecular Mechanisms of Cancer, Neuregulin Signaling, Neuropathic Pain Signaling In Dorsal Horn Neurons, Ovarian Cancer Signaling, p70S6K Signaling, Paxillin Signaling, PDGF Signaling, Phospholipase C Signaling, RANK Signaling in Osteoclasts, RAR Activation, Reelin Signaling in Neurons, Regulation of Cellular Mechanics by Calpain Protease, Remodeling of Epithelial Adherens Junctions, RhoGDI Signaling, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of NFAT in Cardiac Hypertrophy, Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis, Role of Tissue Factor in Cancer, Sertoli Cell-Sertoli Cell Junction Signaling, STAT3 Pathway, Tec Kinase Signaling, Thrombin Signaling, UVC-Induced MAPK Signaling, VEGF Signaling, Virus Entry via Endocytic Pathways, Wnt/β-catenin Signaling |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | High (predicted) | STK40 | 0.000 | -1.530 | |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | Moderate (predicted) | SYF2 | 0.000 | -1.800 | |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | Moderate (predicted) | UBN1 | 0.000 | -5.410 | |
hsa-miR-1538 | 0.009 | 1.800 | TargetScan Human | High (predicted) | UCP2 | 0.049 | -4.070 | Mitochondrial Dysfunction, TR/RXR Activation |
hsa-miR-3927 | 0.001 | -2.800 | TargetScan Human | Moderate (predicted) | DNA2 | 0.000 | 1.630 | |
hsa-miR-3927 | 0.001 | -2.800 | TargetScan Human | Moderate (predicted) | MED31 | 0.051 | 1.620 | Estrogen Receptor Signaling |
hsa-miR-188-3p | 0.006 | -1.500 | TargetScan Human | Moderate (predicted) | CCAR2 | 0.006 | 1.850 | |
hsa-miR-188-3p | 0.006 | -1.500 | TargetScan Human | High (predicted) | CSNK2A1 | 0.008 | 2.650 | Amyloid Processing, Clathrin-mediated Endocytosis Signaling, EGF Signaling, IGF-1 Signaling, IL-2 Signaling, IL-6 Signaling, NF-κB Signaling, PDGF Signaling, PTEN Signaling, RAR Activation, VDR/RXR Activation, Wnt/β-catenin Signaling |
hsa-miR-188-3p | 0.006 | -1.500 | TargetScan Human | High (predicted) | LCLAT1 | 0.000 | 2.280 | CDP-diacylglycerol Biosynthesis I, Phosphatidylglycerol Biosynthesis II (Non-plastidic), Triacylglycerol Biosynthesis |
hsa-miR-188-3p | 0.006 | -1.500 | TargetScan Human | Moderate (predicted) | PRKACB | 0.000 | 1.510 | AMPK Signaling, Amyloid Processing, Androgen Signaling, Axonal Guidance Signaling, BMP signaling pathway, Breast Cancer Regulation by Stathmin1, Calcium Signaling, cAMP-mediated signaling, Cardiac Hypertrophy Signaling, Cardiac β-adrenergic Signaling, CDK5 Signaling, Cellular Effects of Sildenafil (Viagra), Colorectal Cancer Metastasis Signaling, Corticotropin Releasing Hormone Signaling, CREB Signaling in Neurons, Dopamine Receptor Signaling, Dopamine-DARPP32 Feedback in cAMP Signaling, eNOS Signaling, ERK/MAPK Signaling, G Beta Gamma Signaling, G-Protein Coupled Receptor Signaling, Gap Junction Signaling, Glucocorticoid Receptor Signaling, GNRH Signaling, GPCR-Mediated Integration of Enteroendocrine Signaling Exemplified by an L Cell, GPCR-Mediated Nutrient Sensing in Enteroendocrine Cells, Gustation Pathway, Gαi Signaling, Gαs Signaling, Hepatic Cholestasis, IGF-1 Signaling, IL-1 Signaling, Insulin Receptor Signaling, Leptin Signaling in Obesity, Melanocyte Development and Pigmentation Signaling, Melatonin Signaling, Molecular Mechanisms of Cancer, Netrin Signaling, Neuropathic Pain Signaling In Dorsal Horn Neurons, Neuroprotective Role of THOP1 in Alzheimer's Disease, NF-κB Signaling, Nitric Oxide Signaling in the Cardiovascular System, Ovarian Cancer Signaling, P2Y Purigenic Receptor Signaling Pathway, Phototransduction Pathway, PPARα/RXRα Activation, Protein Kinase A Signaling, PXR/RXR Activation, RAR Activation, Relaxin Signaling, Renin-Angiotensin Signaling, Role of NFAT in Cardiac Hypertrophy, Sertoli Cell-Sertoli Cell Junction Signaling, Sonic Hedgehog Signaling, Sperm Motility, Synaptic Long Term Potentiation, Tight Junction Signaling, α-Adrenergic Signaling |
hsa-miR-193a-5p | 0.011 | 6.000 | TargetScan Human | Moderate (predicted) | ACVR1 | 0.004 | -5.360 | Epithelial Adherens Junction Signaling, Factors Promoting Cardiogenesis in Vertebrates, Human Embryonic Stem Cell Pluripotency, PPARα/RXRα Activation, TGF-β Signaling, Wnt/β-catenin Signaling |
hsa-miR-193a-5p | 0.011 | 6.000 | TargetScan Human | Moderate (predicted) | AMD1 | 0.000 | -5.040 | Spermidine Biosynthesis I, Spermine Biosynthesis |
hsa-miR-193a-5p | 0.011 | 6.000 | TargetScan Human | Moderate (predicted) | ATP5D | 0.021 | -1.940 | Mitochondrial Dysfunction, Oxidative Phosphorylation |
hsa-miR-193a-5p | 0.011 | 6.000 | TargetScan Human | Moderate (predicted) | BICD2 | 0.027 | -7.190 | |
hsa-miR-193a-5p | 0.011 | 6.000 | TargetScan Human | Moderate (predicted) | BTG1 | 0.000 | -1.990 | Cell Cycle Regulation by BTG Family Proteins |
hsa-miR-193a-5p | 0.011 | 6.000 | TargetScan Human | Moderate (predicted) | BTN3A2 | 0.003 | -2.840 | |
hsa-miR-193a-5p | 0.011 | 6.000 | TargetScan Human | Moderate (predicted) | CARD8 | 0.000 | -1.640 | |
hsa-miR-193a-5p | 0.011 | 6.000 | TargetScan Human | Moderate (predicted) | CHMP1B | 0.055 | -1.830 | |
hsa-miR-193a-5p | 0.011 | 6.000 | TargetScan Human | High (predicted) | DDA1 | 0.024 | -2.040 | |
hsa-miR-193a-5p | 0.011 | 6.000 | TargetScan Human | Moderate (predicted) | DSE | 0.000 | -4.170 | Dermatan Sulfate Biosynthesis, Dermatan Sulfate Biosynthesis (Late Stages) |
hsa-miR-193a-5p | 0.011 | 6.000 | TargetScan Human | Moderate (predicted) | FADD | 0.000 | -1.750 | Activation of IRF by Cytosolic Pattern Recognition Receptors, Cytotoxic T Lymphocyte-mediated Apoptosis of Target Cells, Death Receptor Signaling, Induction of Apoptosis by HIV1, Molecular Mechanisms of Cancer, Myc Mediated Apoptosis Signaling, NF-κB Signaling, p38 MAPK Signaling, Retinoic acid Mediated Apoptosis Signaling, Role of PKR in Interferon Induction and Antiviral Response, Role of RIG1-like Receptors in Antiviral Innate Immunity, SAPK/JNK Signaling, Tec Kinase Signaling, TNFR1 Signaling, Tumoricidal Function of Hepatic Natural Killer Cells, TWEAK Signaling, Type I Diabetes Mellitus Signaling |
hsa-miR-193a-5p | 0.011 | 6.000 | TargetScan Human | Moderate (predicted) | HDGF | 0.000 | -3.240 | |
hsa-miR-193a-5p | 0.011 | 6.000 | TargetScan Human | Moderate (predicted) | MTMR14 | 0.000 | -1.580 | 3-phosphoinositide Degradation |
hsa-miR-193a-5p | 0.011 | 6.000 | TargetScan Human | Moderate (predicted) | PIP4K2A | 0.000 | -9.600 | 3-phosphoinositide Biosynthesis, Actin Cytoskeleton Signaling, Aldosterone Signaling in Epithelial Cells, D-myo-inositol (1, 4, 5)-Trisphosphate Biosynthesis, D-myo-inositol-5-phosphate Metabolism, Rac Signaling, Regulation of Actin-based Motility by Rho, RhoA Signaling, RhoGDI Signaling, Signaling by Rho Family GTPases, Superpathway of Inositol Phosphate Compounds |
hsa-miR-193a-5p | 0.011 | 6.000 | TargetScan Human | Moderate (predicted) | RAP2A | 0.000 | -1.800 | B Cell Receptor Signaling, Calcium Signaling, Integrin Signaling, Molecular Mechanisms of Cancer |
hsa-miR-193a-5p | 0.011 | 6.000 | TargetScan Human | Moderate (predicted) | RHOBTB1 | 0.000 | -4.930 | |
hsa-miR-193a-5p | 0.011 | 6.000 | TargetScan Human | Moderate (predicted) | SPTSSA | 0.000 | -1.910 | Ceramide Biosynthesis |
hsa-miR-193a-5p | 0.011 | 6.000 | TargetScan Human | Moderate (predicted) | TMEM14C | 0.038 | -1.950 | |
hsa-miR-193a-5p | 0.011 | 6.000 | TargetScan Human | Moderate (predicted) | TNS1 | 0.000 | -2.530 | FAK Signaling |
hsa-miR-193a-5p | 0.011 | 6.000 | TargetScan Human | Moderate (predicted) | TUBA1A | 0.000 | -4.720 | 14-3-3-mediated Signaling, Axonal Guidance Signaling, Breast Cancer Regulation by Stathmin1, Epithelial Adherens Junction Signaling, Gap Junction Signaling, Germ Cell-Sertoli Cell Junction Signaling, phagosome maturation, Remodeling of Epithelial Adherens Junctions, Sertoli Cell-Sertoli Cell Junction Signaling |
hsa-miR-193a-5p | 0.011 | 6.000 | TargetScan Human | Moderate (predicted) | XK | 0.000 | -3.400 | |
hsa-miR-197 | 0.002 | 1.900 | Ingenuity Expert Findings, TargetScan Human | Experimentally Observed, Moderate (predicted) | ACVR1 | 0.004 | -5.360 | Epithelial Adherens Junction Signaling, Factors Promoting Cardiogenesis in Vertebrates, Human Embryonic Stem Cell Pluripotency, PPARα/RXRα Activation, TGF-β Signaling, Wnt/β-catenin Signaling |
hsa-miR-197 | 0.002 | 1.900 | TargetScan Human | High (predicted) | AFAP1L2 | 0.000 | -2.900 | |
hsa-miR-197 | 0.002 | 1.900 | TargetScan Human | High (predicted) | AGO2 | 0.047 | -2.560 | EIF2 Signaling, Regulation of eIF4 and p70S6K Signaling |
hsa-miR-197 | 0.002 | 1.900 | TargetScan Human | Moderate (predicted) | AHCTF1 | 0.024 | -1.520 | |
hsa-miR-197 | 0.002 | 1.900 | TargetScan Human | Moderate (predicted) | ARHGEF12 | 0.000 | -2.160 | Actin Cytoskeleton Signaling, Axonal Guidance Signaling, Breast Cancer Regulation by Stathmin1, Molecular Mechanisms of Cancer, Phospholipase C Signaling, Reelin Signaling in Neurons, RhoA Signaling, RhoGDI Signaling, Semaphorin Signaling in Neurons, Signaling by Rho Family GTPases, Thrombin Signaling |
hsa-miR-197 | 0.002 | 1.900 | TargetScan Human | Moderate (predicted) | ARMC7 | 0.000 | -1.860 | |
hsa-miR-197 | 0.002 | 1.900 | TargetScan Human | Moderate (predicted) | ARRB1 | 0.002 | -3.440 | Clathrin-mediated Endocytosis Signaling, Colorectal Cancer Metastasis Signaling, Ovarian Cancer Signaling, Role of Tissue Factor in Cancer |
hsa-miR-197 | 0.002 | 1.900 | TargetScan Human | Moderate (predicted) | ATG9A | 0.000 | -1.785 | autophagy |
hsa-miR-197 | 0.002 | 1.900 | TargetScan Human | Moderate (predicted) | CALD1 | 0.037 | -2.690 | |
hsa-miR-197 | 0.002 | 1.900 | TargetScan Human | High (predicted) | CBL | 0.000 | -1.740 | 14-3-3-mediated Signaling, Clathrin-mediated Endocytosis Signaling, Ephrin B Signaling, Erythropoietin Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, FLT3 Signaling in Hematopoietic Progenitor Cells, Insulin Receptor Signaling, Molecular Mechanisms of Cancer, PI3K Signaling in B Lymphocytes, Protein Ubiquitination Pathway, PTEN Signaling, RANK Signaling in Osteoclasts, Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis, Systemic Lupus Erythematosus Signaling, T Cell Receptor Signaling |
hsa-miR-197 | 0.002 | 1.900 | TargetScan Human | Moderate (predicted) | CCNJL | 0.000 | -1.610 | |
hsa-miR-197 | 0.002 | 1.900 | TargetScan Human | High (predicted) | CORO1C | 0.000 | -5.630 | |
hsa-miR-197 | 0.002 | 1.900 | TargetScan Human | High (predicted) | CTNNA1 | 0.003 | -2.945 | Endometrial Cancer Signaling, Epithelial Adherens Junction Signaling, Germ Cell-Sertoli Cell Junction Signaling, Leukocyte Extravasation Signaling, Molecular Mechanisms of Cancer, Remodeling of Epithelial Adherens Junctions, Sertoli Cell-Sertoli Cell Junction Signaling, Tight Junction Signaling |
hsa-miR-197 | 0.002 | 1.900 | TargetScan Human | Moderate (predicted) | DYRK1A | 0.000 | -1.450 | Pyridoxal 5'-phosphate Salvage Pathway, Salvage Pathways of Pyrimidine Ribonucleotides, Sonic Hedgehog Signaling |
hsa-miR-197 | 0.002 | 1.900 | TargetScan Human | High (predicted) | GLG1 | 0.000 | -1.790 | Agranulocyte Adhesion and Diapedesis, Atherosclerosis Signaling, Granulocyte Adhesion and Diapedesis |
hsa-miR-197 | 0.002 | 1.900 | TargetScan Human | Moderate (predicted) | INPP5A | 0.000 | -1.750 | 1D-myo-inositol Hexakisphosphate Biosynthesis II (Mammalian), D-myo-inositol (1, 3, 4)-trisphosphate Biosynthesis, D-myo-inositol (1, 4, 5)-trisphosphate Degradation, Superpathway of D-myo-inositol (1, 4, 5)-trisphosphate Metabolism, Superpathway of Inositol Phosphate Compounds |
hsa-miR-197 | 0.002 | 1.900 | TargetScan Human | Moderate (predicted) | ITIH5 | 0.000 | -1.600 | |
hsa-miR-197 | 0.002 | 1.900 | TargetScan Human | Moderate (predicted) | LASP1 | 0.000 | -5.070 | IL-8 Signaling |
hsa-miR-197 | 0.002 | 1.900 | TargetScan Human | High (predicted) | LHFPL2 | 0.000 | -2.530 | |
hsa-miR-197 | 0.002 | 1.900 | TargetScan Human | Moderate (predicted) | MAP2K1 | 0.013 | -1.500 | 14-3-3-mediated Signaling, 4-1BB Signaling in T Lymphocytes, Actin Cytoskeleton Signaling, Acute Myeloid Leukemia Signaling, Acute Phase Response Signaling, Aldosterone Signaling in Epithelial Cells, Antiproliferative Role of Somatostatin Receptor 2, Apoptosis Signaling, Axonal Guidance Signaling, B Cell Receptor Signaling, Bladder Cancer Signaling, BMP signaling pathway, Breast Cancer Regulation by Stathmin1, cAMP-mediated signaling, Cancer Drug Resistance By Drug Efflux, Cardiac Hypertrophy Signaling, CCR3 Signaling in Eosinophils, CD27 Signaling in Lymphocytes, CD28 Signaling in T Helper Cells, CD40 Signaling, CDK5 Signaling, Ceramide Signaling, Chemokine Signaling, Cholecystokinin/Gastrin-mediated Signaling, Chronic Myeloid Leukemia Signaling, CNTF Signaling, Colorectal Cancer Metastasis Signaling, Corticotropin Releasing Hormone Signaling, CREB Signaling in Neurons, CXCR4 Signaling, EGF Signaling, EIF2 Signaling, Endometrial Cancer Signaling, Ephrin Receptor Signaling, ErbB Signaling, ErbB2-ErbB3 Signaling, ErbB4 Signaling, ERK/MAPK Signaling, Erythropoietin Signaling, Estrogen Receptor Signaling, FAK Signaling, Fc Epsilon RI Signaling, FGF Signaling, FLT3 Signaling in Hematopoietic Progenitor Cells, fMLP Signaling in Neutrophils, G-Protein Coupled Receptor Signaling, Gap Junction Signaling, GDNF Family Ligand-Receptor Interactions, Germ Cell-Sertoli Cell Junction Signaling, Glioblastoma Multiforme Signaling, Glioma Signaling, Glucocorticoid Receptor Signaling, GM-CSF Signaling, GNRH Signaling, Gα12/13 Signaling, Gαq Signaling, Gαs Signaling, HGF Signaling, HMGB1 Signaling, IGF-1 Signaling, IL-12 Signaling and Production in Macrophages, IL-15 Signaling, IL-17 Signaling, IL-17A Signaling in Airway Cells, IL-2 Signaling, IL-3 Signaling, IL-6 Signaling, IL-8 Signaling, Insulin Receptor Signaling, Integrin Signaling, JAK/Stat Signaling, Leptin Signaling in Obesity, LPS-stimulated MAPK Signaling, Melanocyte Development and Pigmentation Signaling, Melanoma Signaling, Melatonin Signaling, Molecular Mechanisms of Cancer, Mouse Embryonic Stem Cell Pluripotency, Natural Killer Cell Signaling, Neuregulin Signaling, Neurotrophin/TRK Signaling, NGF Signaling, Nitric Oxide Signaling in the Cardiovascular System, Non-Small Cell Lung Cancer Signaling, NRF2-mediated Oxidative Stress Response, Oncostatin M Signaling, Ovarian Cancer Signaling, P2Y Purigenic Receptor Signaling Pathway, p70S6K Signaling, PAK Signaling, Pancreatic Adenocarcinoma Signaling, PDGF Signaling, Phospholipase C Signaling, PI3K Signaling in B Lymphocytes, PI3K/AKT Signaling, PPAR Signaling, PPARα/RXRα Activation, Production of Nitric Oxide and Reactive Oxygen Species in Macrophages, Prolactin Signaling, Prostate Cancer Signaling, Protein Kinase A Signaling, PTEN Signaling, Pyridoxal 5'-phosphate Salvage Pathway, Rac Signaling, RANK Signaling in Osteoclasts, RAR Activation, Regulation of eIF4 and p70S6K Signaling, Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes, Regulation of the Epithelial-Mesenchymal Transition Pathway, Relaxin Signaling, Renal Cell Carcinoma Signaling, Renin-Angiotensin Signaling, Role of IL-17A in Arthritis, Role of IL-17F in Allergic Inflammatory Airway Diseases, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of MAPK Signaling in the Pathogenesis of Influenza, Role of NANOG in Mammalian Embryonic Stem Cell Pluripotency, Role of NFAT in Cardiac Hypertrophy, Role of NFAT in Regulation of the Immune Response, Role of PI3K/AKT Signaling in the Pathogenesis of Influenza, Salvage Pathways of Pyrimidine Ribonucleotides, Sertoli Cell-Sertoli Cell Junction Signaling, Signaling by Rho Family GTPases, STAT3 Pathway, Synaptic Long Term Depression, Synaptic Long Term Potentiation, T Cell Receptor Signaling, Telomerase Signaling, TGF-β Signaling, Thrombin Signaling, Thrombopoietin Signaling, Thyroid Cancer Signaling, UVB-Induced MAPK Signaling, UVC-Induced MAPK Signaling, VEGF Family Ligand-Receptor Interactions, VEGF Signaling, Xenobiotic Metabolism Signaling, α-Adrenergic Signaling |
hsa-miR-197 | 0.002 | 1.900 | TargetScan Human | Moderate (predicted) | NAP1L1 | 0.000 | -5.190 | |
hsa-miR-197 | 0.002 | 1.900 | TargetScan Human | High (predicted) | NAP1L4 | 0.000 | -4.430 | |
hsa-miR-197 | 0.002 | 1.900 | TargetScan Human | Moderate (predicted) | NT5C2 | 0.000 | -3.250 | Adenosine Nucleotides Degradation II, Guanosine Nucleotides Degradation III, NAD Salvage Pathway II, Purine Nucleotides Degradation II (Aerobic), Urate Biosynthesis/Inosine 5'-phosphate Degradation |
hsa-miR-197 | 0.002 | 1.900 | TargetScan Human | Moderate (predicted) | OXTR | 0.023 | -1.910 | |
hsa-miR-197 | 0.002 | 1.900 | TargetScan Human | High (predicted) | PAFAH1B1 | 0.011 | -1.480 | Antioxidant Action of Vitamin C, Atherosclerosis Signaling, Eicosanoid Signaling, Endothelin-1 Signaling, Phospholipases, Reelin Signaling in Neurons, Role of MAPK Signaling in the Pathogenesis of Influenza, Sperm Motility, Synaptic Long Term Depression |
hsa-miR-197 | 0.002 | 1.900 | TargetScan Human | Moderate (predicted) | PDGFC | 0.006 | -1.900 | Actin Cytoskeleton Signaling, Amyotrophic Lateral Sclerosis Signaling, Atherosclerosis Signaling, Axonal Guidance Signaling, Bladder Cancer Signaling, Clathrin-mediated Endocytosis Signaling, Colorectal Cancer Metastasis Signaling, eNOS Signaling, Ephrin Receptor Signaling, Glioblastoma Multiforme Signaling, Glioma Signaling, Hepatic Fibrosis / Hepatic Stellate Cell Activation, HIF1α Signaling, Human Embryonic Stem Cell Pluripotency, IL-8 Signaling, ILK Signaling, Macropinocytosis Signaling, mTOR Signaling, Nitric Oxide Signaling in the Cardiovascular System, Ovarian Cancer Signaling, PAK Signaling, Pancreatic Adenocarcinoma Signaling, PDGF Signaling, PPAR Signaling, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Sphingosine-1-phosphate Signaling, VEGF Signaling |
hsa-miR-197 | 0.002 | 1.900 | TargetScan Human | Moderate (predicted) | PSME4 | 0.001 | -3.180 | Huntington's Disease Signaling, Polyamine Regulation in Colon Cancer |
hsa-miR-197 | 0.002 | 1.900 | TargetScan Human | Moderate (predicted) | RALB | 0.007 | -2.320 | Gαi Signaling, Integrin Signaling, Molecular Mechanisms of Cancer, Phospholipase C Signaling |
hsa-miR-197 | 0.002 | 1.900 | TargetScan Human | Moderate (predicted) | RILPL2 | 0.001 | -2.210 | |
hsa-miR-197 | 0.002 | 1.900 | TargetScan Human | High (predicted) | SYK | 0.003 | -4.360 | B Cell Receptor Signaling, CD28 Signaling in T Helper Cells, CTLA4 Signaling in Cytotoxic T Lymphocytes, Fc Epsilon RI Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, FcγRIIB Signaling in B Lymphocytes, IL-15 Signaling, IL-2 Signaling, Natural Killer Cell Signaling, p70S6K Signaling, phagosome formation, Phospholipase C Signaling, PI3K Signaling in B Lymphocytes, Role of JAK1 and JAK3 in γc Cytokine Signaling, Role of NFAT in Regulation of the Immune Response, Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses |
hsa-miR-197 | 0.002 | 1.900 | TargetScan Human | High (predicted) | TAL1 | 0.000 | -5.160 | |
hsa-miR-197 | 0.002 | 1.900 | TargetScan Human | Moderate (predicted) | TMEM189 | 0.000 | -1.660 | |
hsa-miR-197 | 0.002 | 1.900 | TargetScan Human | Moderate (predicted) | TXNDC12 | 0.000 | -1.540 | Glutathione Redox Reactions II |
hsa-miR-197 | 0.002 | 1.900 | TargetScan Human | High (predicted) | WIPI2 | 0.000 | -1.700 | |
hsa-miR-2276 | 0.012 | 2.800 | TargetScan Human | Moderate (predicted) | BCL2L1 | 0.009 | -1.600 | Amyotrophic Lateral Sclerosis Signaling, Apoptosis Signaling, B Cell Receptor Signaling, CD27 Signaling in Lymphocytes, Chronic Myeloid Leukemia Signaling, Colorectal Cancer Metastasis Signaling, Docosahexaenoic Acid (DHA) Signaling, Glucocorticoid Receptor Signaling, GM-CSF Signaling, Huntington's Disease Signaling, IL-15 Signaling, IL-8 Signaling, Induction of Apoptosis by HIV1, JAK/Stat Signaling, Lymphotoxin β Receptor Signaling, Molecular Mechanisms of Cancer, OX40 Signaling Pathway, p53 Signaling, Pancreatic Adenocarcinoma Signaling, PEDF Signaling, PI3K/AKT Signaling, PTEN Signaling, Role of Tissue Factor in Cancer, Small Cell Lung Cancer Signaling, UVA-Induced MAPK Signaling, VEGF Signaling |
hsa-miR-2276 | 0.012 | 2.800 | TargetScan Human | Moderate (predicted) | EFHD2 | 0.000 | -2.500 | |
hsa-miR-2276 | 0.012 | 2.800 | TargetScan Human | Moderate (predicted) | EGF | 0.000 | -2.220 | Actin Cytoskeleton Signaling, Axonal Guidance Signaling, Bladder Cancer Signaling, Caveolar-mediated Endocytosis Signaling, Clathrin-mediated Endocytosis Signaling, Colorectal Cancer Metastasis Signaling, EGF Signaling, Ephrin Receptor Signaling, Epithelial Adherens Junction Signaling, ErbB Signaling, ERK5 Signaling, FAK Signaling, Gap Junction Signaling, Glioblastoma Multiforme Signaling, Glioma Signaling, GNRH Signaling, Hepatic Fibrosis / Hepatic Stellate Cell Activation, HER-2 Signaling in Breast Cancer, Huntington's Disease Signaling, IL-8 Signaling, Macropinocytosis Signaling, Neuregulin Signaling, NF-κB Signaling, Non-Small Cell Lung Cancer Signaling, Ovarian Cancer Signaling, Pancreatic Adenocarcinoma Signaling, Regulation of Cellular Mechanics by Calpain Protease, Regulation of the Epithelial-Mesenchymal Transition Pathway, Telomerase Signaling, Thrombin Signaling |
hsa-miR-2276 | 0.012 | 2.800 | TargetScan Human | Moderate (predicted) | EIF4E3 | 0.000 | -2.140 | |
hsa-miR-2276 | 0.012 | 2.800 | TargetScan Human | High (predicted) | ENDOD1 | 0.000 | -16.800 | |
hsa-miR-2276 | 0.012 | 2.800 | TargetScan Human | Moderate (predicted) | EPOR | 0.013 | -1.900 | Erythropoietin Signaling, Role of JAK2 in Hormone-like Cytokine Signaling |
hsa-miR-2276 | 0.012 | 2.800 | TargetScan Human | High (predicted) | ETV6 | 0.000 | -2.380 | |
hsa-miR-2276 | 0.012 | 2.800 | TargetScan Human | Moderate (predicted) | GDE1 | 0.018 | -2.620 | |
hsa-miR-2276 | 0.012 | 2.800 | TargetScan Human | Moderate (predicted) | GNA12 | 0.000 | -2.390 | Actin Cytoskeleton Signaling, Actin Nucleation by ARP-WASP Complex, Androgen Signaling, Axonal Guidance Signaling, Cardiac Hypertrophy Signaling, Cholecystokinin/Gastrin-mediated Signaling, CREB Signaling in Neurons, CXCR4 Signaling, Endothelin-1 Signaling, Ephrin B Signaling, Ephrin Receptor Signaling, ERK5 Signaling, G Beta Gamma Signaling, Gα12/13 Signaling, IL-1 Signaling, IL-8 Signaling, Molecular Mechanisms of Cancer, Relaxin Signaling, RhoA Signaling, RhoGDI Signaling, Role of NFAT in Regulation of the Immune Response, Role of Tissue Factor in Cancer, SAPK/JNK Signaling, Signaling by Rho Family GTPases, Sphingosine-1-phosphate Signaling, Synaptic Long Term Depression, Tec Kinase Signaling, Thrombin Signaling |
hsa-miR-2276 | 0.012 | 2.800 | TargetScan Human | Moderate (predicted) | HSBP1 | 0.001 | -3.640 | |
hsa-miR-2276 | 0.012 | 2.800 | TargetScan Human | Moderate (predicted) | LOC401052 | 0.024 | -1.600 | |
hsa-miR-2276 | 0.012 | 2.800 | TargetScan Human | Moderate (predicted) | LSM14A | 0.000 | -3.980 | Systemic Lupus Erythematosus Signaling |
hsa-miR-2276 | 0.012 | 2.800 | TargetScan Human | Moderate (predicted) | MGLL | 0.014 | -4.850 | Triacylglycerol Degradation |
hsa-miR-2276 | 0.012 | 2.800 | TargetScan Human | Moderate (predicted) | MPRIP | 0.000 | -1.630 | Actin Cytoskeleton Signaling, CCR3 Signaling in Eosinophils, Cdc42 Signaling, Cellular Effects of Sildenafil (Viagra), Chemokine Signaling, Integrin Signaling, Phospholipase C Signaling, Regulation of Actin-based Motility by Rho, RhoA Signaling, Thrombin Signaling |
hsa-miR-2276 | 0.012 | 2.800 | TargetScan Human | Moderate (predicted) | NREP | 0.001 | -4.180 | |
hsa-miR-2276 | 0.012 | 2.800 | TargetScan Human | Moderate (predicted) | ORAI3 | 0.000 | -1.540 | |
hsa-miR-2276 | 0.012 | 2.800 | TargetScan Human | Moderate (predicted) | PIP4K2A | 0.000 | -9.600 | 3-phosphoinositide Biosynthesis, Actin Cytoskeleton Signaling, Aldosterone Signaling in Epithelial Cells, D-myo-inositol (1, 4, 5)-Trisphosphate Biosynthesis, D-myo-inositol-5-phosphate Metabolism, Rac Signaling, Regulation of Actin-based Motility by Rho, RhoA Signaling, RhoGDI Signaling, Signaling by Rho Family GTPases, Superpathway of Inositol Phosphate Compounds |
hsa-miR-2276 | 0.012 | 2.800 | TargetScan Human | Moderate (predicted) | PPP2R5A | 0.000 | -4.830 | 3-phosphoinositide Biosynthesis, 3-phosphoinositide Degradation, AMPK Signaling, Breast Cancer Regulation by Stathmin1, Cardiac β-adrenergic Signaling, CDK5 Signaling, Cell Cycle Regulation by BTG Family Proteins, Ceramide Signaling, CTLA4 Signaling in Cytotoxic T Lymphocytes, Cyclins and Cell Cycle Regulation, D-myo-inositol (1, 4, 5, 6)-Tetrakisphosphate Biosynthesis, D-myo-inositol (3, 4, 5, 6)-tetrakisphosphate Biosynthesis, D-myo-inositol-5-phosphate Metabolism, Dopamine Receptor Signaling, Dopamine-DARPP32 Feedback in cAMP Signaling, ERK/MAPK Signaling, HIPPO signaling, ILK Signaling, Mitotic Roles of Polo-Like Kinase, mTOR Signaling, p70S6K Signaling, PI3K/AKT Signaling, Production of Nitric Oxide and Reactive Oxygen Species in Macrophages, Regulation of eIF4 and p70S6K Signaling, Role of CHK Proteins in Cell Cycle Checkpoint Control, Superpathway of Inositol Phosphate Compounds, Synaptic Long Term Depression, Telomerase Signaling, Tight Junction Signaling, Wnt/β-catenin Signaling, Xenobiotic Metabolism Signaling |
hsa-miR-2276 | 0.012 | 2.800 | TargetScan Human | Moderate (predicted) | PTGIR | 0.038 | -2.020 | cAMP-mediated signaling, Eicosanoid Signaling, G-Protein Coupled Receptor Signaling, Gαs Signaling |
hsa-miR-2276 | 0.012 | 2.800 | TargetScan Human | Moderate (predicted) | RAP2A | 0.000 | -1.800 | B Cell Receptor Signaling, Calcium Signaling, Integrin Signaling, Molecular Mechanisms of Cancer |
hsa-miR-2276 | 0.012 | 2.800 | TargetScan Human | Moderate (predicted) | RCC2 | 0.000 | -4.220 | |
hsa-miR-2276 | 0.012 | 2.800 | TargetScan Human | Moderate (predicted) | SNAP29 | 0.002 | -1.950 | |
hsa-miR-2276 | 0.012 | 2.800 | TargetScan Human | Moderate (predicted) | SYK | 0.003 | -4.360 | B Cell Receptor Signaling, CD28 Signaling in T Helper Cells, CTLA4 Signaling in Cytotoxic T Lymphocytes, Fc Epsilon RI Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, FcγRIIB Signaling in B Lymphocytes, IL-15 Signaling, IL-2 Signaling, Natural Killer Cell Signaling, p70S6K Signaling, phagosome formation, Phospholipase C Signaling, PI3K Signaling in B Lymphocytes, Role of JAK1 and JAK3 in γc Cytokine Signaling, Role of NFAT in Regulation of the Immune Response, Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses |
hsa-miR-2276 | 0.012 | 2.800 | TargetScan Human | Moderate (predicted) | TM2D2 | 0.006 | -2.160 | |
hsa-miR-2276 | 0.012 | 2.800 | TargetScan Human | Moderate (predicted) | TNIP1 | 0.007 | -1.560 | Angiopoietin Signaling, NF-κB Signaling, RAR Activation |
hsa-miR-2276 | 0.012 | 2.800 | TargetScan Human | Moderate (predicted) | TRIP12 | 0.000 | -1.590 | Cell Cycle: G2/M DNA Damage Checkpoint Regulation |
hsa-miR-2276 | 0.012 | 2.800 | TargetScan Human | Moderate (predicted) | TTC39B | 0.003 | -1.870 | |
hsa-miR-2276 | 0.012 | 2.800 | TargetScan Human | Moderate (predicted) | VCP | 0.001 | -2.420 | NRF2-mediated Oxidative Stress Response, Unfolded protein response |
hsa-miR-2276 | 0.012 | 2.800 | TargetScan Human | Moderate (predicted) | WASF3 | 0.000 | -5.160 | Signaling by Rho Family GTPases |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | ABHD4 | 0.000 | -2.080 | |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | ADD1 | 0.002 | -2.540 | Gαs Signaling, Protein Kinase A Signaling |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | High (predicted) | ARHGAP21 | 0.006 | -5.740 | |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | ARHGDIA | 0.042 | -1.740 | Regulation of Actin-based Motility by Rho, RhoGDI Signaling |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | ARHGEF18 | 0.000 | -2.180 | Breast Cancer Regulation by Stathmin1, Molecular Mechanisms of Cancer, Phospholipase C Signaling, RhoGDI Signaling, Signaling by Rho Family GTPases |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | ARHGEF3 | 0.000 | -1.660 | Breast Cancer Regulation by Stathmin1, Molecular Mechanisms of Cancer, Phospholipase C Signaling, Reelin Signaling in Neurons, RhoGDI Signaling, Signaling by Rho Family GTPases, Thrombin Signaling |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | BTN3A2 | 0.003 | -2.840 | |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | C15orf39 | 0.016 | -1.560 | |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | C7orf49 | 0.000 | -2.050 | |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | CDV3 | 0.000 | -1.480 | |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | CHMP1A | 0.026 | -1.940 | Axonal Guidance Signaling |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | High (predicted) | CLIP2 | 0.000 | -4.440 | |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | CMTM3 | 0.021 | -2.380 | |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | CTDSP2 | 0.000 | -7.600 | |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | DNAJC9 | 0.000 | -2.180 | Aldosterone Signaling in Epithelial Cells, NRF2-mediated Oxidative Stress Response, Protein Ubiquitination Pathway |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | ELMO2 | 0.000 | -1.600 | CXCR4 Signaling |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | FURIN | 0.007 | -3.340 | Mitochondrial Dysfunction, Notch Signaling |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | GNB5 | 0.005 | -2.640 | Androgen Signaling, Antiproliferative Role of Somatostatin Receptor 2, Axonal Guidance Signaling, Breast Cancer Regulation by Stathmin1, Cardiac Hypertrophy Signaling, Cardiac β-adrenergic Signaling, CCR3 Signaling in Eosinophils, CCR5 Signaling in Macrophages, Colorectal Cancer Metastasis Signaling, CREB Signaling in Neurons, CXCR4 Signaling, Ephrin B Signaling, Ephrin Receptor Signaling, fMLP Signaling in Neutrophils, G Beta Gamma Signaling, G Protein Signaling Mediated by Tubby, Gαi Signaling, Gαq Signaling, Gαs Signaling, Huntington's Disease Signaling, IL-1 Signaling, IL-8 Signaling, P2Y Purigenic Receptor Signaling Pathway, Phospholipase C Signaling, Phototransduction Pathway, Protein Kinase A Signaling, Relaxin Signaling, RhoGDI Signaling, Role of NFAT in Cardiac Hypertrophy, Role of NFAT in Regulation of the Immune Response, Signaling by Rho Family GTPases, Tec Kinase Signaling, Thrombin Signaling, α-Adrenergic Signaling |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | GTF3C5 | 0.003 | -1.470 | Assembly of RNA Polymerase III Complex |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | GUCD1 | 0.000 | -2.490 | |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | INF2 | 0.004 | -7.710 | |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | KIF1B | 0.000 | -1.790 | |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | KLHDC3 | 0.000 | -1.510 | |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | High (predicted) | MFSD6 | 0.001 | -1.980 | |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | MLEC | 0.000 | -1.745 | |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | MOB3C | 0.010 | -6.740 | |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | MRPL18 | 0.002 | -1.620 | |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | MSRB1 | 0.000 | -1.800 | |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | MYH9 | 0.052 | -7.770 | Actin Cytoskeleton Signaling, Agranulocyte Adhesion and Diapedesis, Calcium Signaling, Cellular Effects of Sildenafil (Viagra), Epithelial Adherens Junction Signaling, Hepatic Fibrosis / Hepatic Stellate Cell Activation, ILK Signaling, Tight Junction Signaling |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | N4BP2L1 | 0.018 | -1.720 | |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | NKIRAS2 | 0.014 | -2.140 | |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | P2RX1 | 0.034 | -3.990 | Gustation Pathway |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | PACSIN2 | 0.001 | -2.040 | |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | PCTP | 0.000 | -2.100 | |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | RALB | 0.007 | -2.320 | Gαi Signaling, Integrin Signaling, Molecular Mechanisms of Cancer, Phospholipase C Signaling |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | High (predicted) | REPS2 | 0.015 | -1.855 | |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | SEPN1 | 0.003 | -2.715 | |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | SLC35D3 | 0.000 | -1.980 | |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | STK24 | 0.000 | -7.300 | |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | STK38 | 0.000 | -2.650 | |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | SYK | 0.003 | -4.360 | B Cell Receptor Signaling, CD28 Signaling in T Helper Cells, CTLA4 Signaling in Cytotoxic T Lymphocytes, Fc Epsilon RI Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, FcγRIIB Signaling in B Lymphocytes, IL-15 Signaling, IL-2 Signaling, Natural Killer Cell Signaling, p70S6K Signaling, phagosome formation, Phospholipase C Signaling, PI3K Signaling in B Lymphocytes, Role of JAK1 and JAK3 in γc Cytokine Signaling, Role of NFAT in Regulation of the Immune Response, Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | TAL1 | 0.000 | -5.160 | |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | TJP2 | 0.005 | -2.120 | Hepatic Cholestasis, HIPPO signaling, Sertoli Cell-Sertoli Cell Junction Signaling, Tight Junction Signaling |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | TSPAN18 | 0.000 | -4.570 | |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | High (predicted) | TXNIP | 0.042 | -2.400 | Adipogenesis pathway |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | UBE2L3 | 0.000 | -2.790 | Hypoxia Signaling in the Cardiovascular System, Protein Ubiquitination Pathway |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | High (predicted) | UCP2 | 0.049 | -4.070 | Mitochondrial Dysfunction, TR/RXR Activation |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | VPS37B | 0.000 | -5.390 | phagosome maturation |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | High (predicted) | WASF3 | 0.000 | -5.160 | Signaling by Rho Family GTPases |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | WBP1L | 0.000 | -2.250 | |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | XRCC6 | 0.000 | -2.050 | DNA Double-Strand Break Repair by Non-Homologous End Joining, Telomere Extension by Telomerase |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | ZDHHC7 | 0.000 | -4.190 | |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | ZMIZ2 | 0.025 | -1.570 | |
hsa-miR-3064-5p | 0.001 | 3.100 | TargetScan Human | Moderate (predicted) | ZSWIM7 | 0.000 | -2.590 | |
hsa-miR-31 | 0.034 | -1.800 | TargetScan Human | High (predicted) | AKAP7 | 0.000 | 2.860 | cAMP-mediated signaling, Cardiac β-adrenergic Signaling, Protein Kinase A Signaling |
hsa-miR-31 | 0.034 | -1.800 | TargetScan Human | High (predicted) | CCAR2 | 0.006 | 1.850 | |
hsa-miR-31 | 0.034 | -1.800 | TargetScan Human | Moderate (predicted) | IGSF11 | 0.044 | 1.590 | |
hsa-miR-3162-5p | 0.001 | 3.700 | TargetScan Human | Moderate (predicted) | ATP6V0D1 | 0.000 | -2.910 | phagosome maturation |
hsa-miR-3162-5p | 0.001 | 3.700 | TargetScan Human | Moderate (predicted) | C15orf39 | 0.016 | -1.560 | |
hsa-miR-3162-5p | 0.001 | 3.700 | TargetScan Human | Moderate (predicted) | C9orf78 | 0.003 | -1.480 | |
hsa-miR-3162-5p | 0.001 | 3.700 | TargetScan Human | Moderate (predicted) | CALM1 (includes others) | 0.000 | -15.670 | 1D-myo-inositol Hexakisphosphate Biosynthesis II (Mammalian), Androgen Signaling, B Cell Receptor Signaling, Breast Cancer Regulation by Stathmin1, Calcium Signaling, Calcium-induced T Lymphocyte Apoptosis, cAMP-mediated signaling, Cardiac Hypertrophy Signaling, CCR3 Signaling in Eosinophils, CCR5 Signaling in Macrophages, CD28 Signaling in T Helper Cells, Cellular Effects of Sildenafil (Viagra), Chemokine Signaling, Corticotropin Releasing Hormone Signaling, CREB Signaling in Neurons, D-myo-inositol (1, 3, 4)-trisphosphate Biosynthesis, Dopamine-DARPP32 Feedback in cAMP Signaling, eNOS Signaling, fMLP Signaling in Neutrophils, Glioma Signaling, Glutamate Receptor Signaling, Gαq Signaling, iCOS-iCOSL Signaling in T Helper Cells, iNOS Signaling, Melatonin Signaling, Nitric Oxide Signaling in the Cardiovascular System, nNOS Signaling in Neurons, nNOS Signaling in Skeletal Muscle Cells, Nur77 Signaling in T Lymphocytes, Phospholipase C Signaling, PI3K Signaling in B Lymphocytes, Protein Kinase A Signaling, RANK Signaling in Osteoclasts, Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of NFAT in Cardiac Hypertrophy, Role of NFAT in Regulation of the Immune Response, Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis, Sperm Motility, Superpathway of D-myo-inositol (1, 4, 5)-trisphosphate Metabolism, Superpathway of Inositol Phosphate Compounds, Synaptic Long Term Potentiation, T Cell Receptor Signaling, α-Adrenergic Signaling |
hsa-miR-3162-5p | 0.001 | 3.700 | TargetScan Human | High (predicted) | CERS2 | 0.002 | -2.555 | |
hsa-miR-3162-5p | 0.001 | 3.700 | TargetScan Human | Moderate (predicted) | EIF4E3 | 0.000 | -2.140 | |
hsa-miR-3162-5p | 0.001 | 3.700 | TargetScan Human | Moderate (predicted) | ELMO1 | 0.014 | -2.370 | CXCR4 Signaling |
hsa-miR-3162-5p | 0.001 | 3.700 | TargetScan Human | Moderate (predicted) | ETV6 | 0.000 | -2.380 | |
hsa-miR-3162-5p | 0.001 | 3.700 | TargetScan Human | Moderate (predicted) | FAM104A | 0.000 | -3.860 | |
hsa-miR-3162-5p | 0.001 | 3.700 | TargetScan Human | Moderate (predicted) | G3BP2 | 0.000 | -4.125 | |
hsa-miR-3162-5p | 0.001 | 3.700 | TargetScan Human | Moderate (predicted) | HECTD4 | 0.000 | -2.070 | |
hsa-miR-3162-5p | 0.001 | 3.700 | TargetScan Human | Moderate (predicted) | MBP | 0.000 | -12.630 | |
hsa-miR-3162-5p | 0.001 | 3.700 | TargetScan Human | Moderate (predicted) | MICU1 | 0.009 | -2.080 | Calcium Signaling |
hsa-miR-3162-5p | 0.001 | 3.700 | TargetScan Human | Moderate (predicted) | MTPN | 0.010 | -4.220 | |
hsa-miR-3162-5p | 0.001 | 3.700 | TargetScan Human | Moderate (predicted) | MYOM1 | 0.000 | -2.930 | |
hsa-miR-3162-5p | 0.001 | 3.700 | TargetScan Human | Moderate (predicted) | PIP4K2A | 0.000 | -9.600 | 3-phosphoinositide Biosynthesis, Actin Cytoskeleton Signaling, Aldosterone Signaling in Epithelial Cells, D-myo-inositol (1, 4, 5)-Trisphosphate Biosynthesis, D-myo-inositol-5-phosphate Metabolism, Rac Signaling, Regulation of Actin-based Motility by Rho, RhoA Signaling, RhoGDI Signaling, Signaling by Rho Family GTPases, Superpathway of Inositol Phosphate Compounds |
hsa-miR-3162-5p | 0.001 | 3.700 | TargetScan Human | Moderate (predicted) | RAB10 | 0.046 | -2.690 | |
hsa-miR-3162-5p | 0.001 | 3.700 | TargetScan Human | High (predicted) | SMARCA2 | 0.002 | -2.510 | AMPK Signaling, Glucocorticoid Receptor Signaling, Hereditary Breast Cancer Signaling, RAR Activation, Role of BRCA1 in DNA Damage Response |
hsa-miR-3162-5p | 0.001 | 3.700 | TargetScan Human | Moderate (predicted) | SYK | 0.003 | -4.360 | B Cell Receptor Signaling, CD28 Signaling in T Helper Cells, CTLA4 Signaling in Cytotoxic T Lymphocytes, Fc Epsilon RI Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, FcγRIIB Signaling in B Lymphocytes, IL-15 Signaling, IL-2 Signaling, Natural Killer Cell Signaling, p70S6K Signaling, phagosome formation, Phospholipase C Signaling, PI3K Signaling in B Lymphocytes, Role of JAK1 and JAK3 in γc Cytokine Signaling, Role of NFAT in Regulation of the Immune Response, Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses |
hsa-miR-3162-5p | 0.001 | 3.700 | TargetScan Human | Moderate (predicted) | TADA3 | 0.053 | -2.670 | |
hsa-miR-3162-5p | 0.001 | 3.700 | TargetScan Human | High (predicted) | TAPBP | 0.002 | -2.820 | Antigen Presentation Pathway |
hsa-miR-3162-5p | 0.001 | 3.700 | TargetScan Human | Moderate (predicted) | TNS1 | 0.000 | -2.530 | FAK Signaling |
hsa-miR-3162-5p | 0.001 | 3.700 | TargetScan Human | High (predicted) | TPP1 | 0.013 | -5.000 | Telomerase Signaling |
hsa-miR-3177-3p | 0.010 | 2.500 | TargetScan Human | Moderate (predicted) | ABLIM1 | 0.001 | -3.045 | Axonal Guidance Signaling, Netrin Signaling |
hsa-miR-3177-3p | 0.010 | 2.500 | TargetScan Human | Moderate (predicted) | AFAP1 | 0.000 | -4.990 | |
hsa-miR-3177-3p | 0.010 | 2.500 | TargetScan Human | High (predicted) | ATP6V0A1 | 0.000 | -2.370 | phagosome maturation |
hsa-miR-3177-3p | 0.010 | 2.500 | TargetScan Human | Moderate (predicted) | ATP6V0B | 0.000 | -2.260 | phagosome maturation |
hsa-miR-3177-3p | 0.010 | 2.500 | TargetScan Human | Moderate (predicted) | ATP6V1B2 | 0.011 | -2.120 | phagosome maturation |
hsa-miR-3177-3p | 0.010 | 2.500 | TargetScan Human | Moderate (predicted) | B4GALT1 | 0.000 | -1.790 | |
hsa-miR-3177-3p | 0.010 | 2.500 | TargetScan Human | Moderate (predicted) | C11orf21 | 0.000 | -2.570 | |
hsa-miR-3177-3p | 0.010 | 2.500 | TargetScan Human | High (predicted) | C17orf62 | 0.001 | -1.900 | |
hsa-miR-3177-3p | 0.010 | 2.500 | TargetScan Human | High (predicted) | CSNK1G2 | 0.027 | -4.220 | Dopamine-DARPP32 Feedback in cAMP Signaling, Gap Junction Signaling, Role of NFAT in Regulation of the Immune Response, Role of Wnt/GSK-3β Signaling in the Pathogenesis of Influenza, Wnt/β-catenin Signaling |
hsa-miR-3177-3p | 0.010 | 2.500 | TargetScan Human | Moderate (predicted) | FLNA | 0.004 | -5.600 | Actin Cytoskeleton Signaling, Caveolar-mediated Endocytosis Signaling, ILK Signaling, Protein Kinase A Signaling, Virus Entry via Endocytic Pathways |
hsa-miR-3177-3p | 0.010 | 2.500 | TargetScan Human | High (predicted) | GNA12 | 0.000 | -2.390 | Actin Cytoskeleton Signaling, Actin Nucleation by ARP-WASP Complex, Androgen Signaling, Axonal Guidance Signaling, Cardiac Hypertrophy Signaling, Cholecystokinin/Gastrin-mediated Signaling, CREB Signaling in Neurons, CXCR4 Signaling, Endothelin-1 Signaling, Ephrin B Signaling, Ephrin Receptor Signaling, ERK5 Signaling, G Beta Gamma Signaling, Gα12/13 Signaling, IL-1 Signaling, IL-8 Signaling, Molecular Mechanisms of Cancer, Relaxin Signaling, RhoA Signaling, RhoGDI Signaling, Role of NFAT in Regulation of the Immune Response, Role of Tissue Factor in Cancer, SAPK/JNK Signaling, Signaling by Rho Family GTPases, Sphingosine-1-phosphate Signaling, Synaptic Long Term Depression, Tec Kinase Signaling, Thrombin Signaling |
hsa-miR-3177-3p | 0.010 | 2.500 | TargetScan Human | Moderate (predicted) | GNAZ | 0.000 | -8.090 | Androgen Signaling, Axonal Guidance Signaling, Cardiac Hypertrophy Signaling, CREB Signaling in Neurons, CXCR4 Signaling, Endothelin-1 Signaling, Ephrin B Signaling, Ephrin Receptor Signaling, G Beta Gamma Signaling, IL-1 Signaling, Molecular Mechanisms of Cancer, Relaxin Signaling, RhoGDI Signaling, Role of NFAT in Regulation of the Immune Response, Signaling by Rho Family GTPases, Synaptic Long Term Depression, Tec Kinase Signaling, Thrombin Signaling |
hsa-miR-3177-3p | 0.010 | 2.500 | TargetScan Human | High (predicted) | HYAL3 | 0.008 | -1.780 | Chondroitin Sulfate Degradation (Metazoa), Dermatan Sulfate Degradation (Metazoa) |
hsa-miR-3177-3p | 0.010 | 2.500 | TargetScan Human | Moderate (predicted) | JAM3 | 0.004 | -11.080 | Agranulocyte Adhesion and Diapedesis, Granulocyte Adhesion and Diapedesis, Leukocyte Extravasation Signaling, Sertoli Cell-Sertoli Cell Junction Signaling, Tight Junction Signaling |
hsa-miR-3177-3p | 0.010 | 2.500 | TargetScan Human | Moderate (predicted) | KIAA1147 | 0.000 | -2.330 | |
hsa-miR-3177-3p | 0.010 | 2.500 | TargetScan Human | Moderate (predicted) | MAPKAPK2 | 0.000 | -2.530 | Cardiac Hypertrophy Signaling, CD40 Signaling, FGF Signaling, IL-17 Signaling, IL-6 Signaling, p38 MAPK Signaling, RAR Activation, Role of IL-17A in Arthritis, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis |
hsa-miR-3177-3p | 0.010 | 2.500 | TargetScan Human | Moderate (predicted) | PPP1CA | 0.000 | -2.300 | 3-phosphoinositide Biosynthesis, 3-phosphoinositide Degradation, Breast Cancer Regulation by Stathmin1, Cardiac β-adrenergic Signaling, CDK5 Signaling, D-myo-inositol (1, 4, 5, 6)-Tetrakisphosphate Biosynthesis, D-myo-inositol (3, 4, 5, 6)-tetrakisphosphate Biosynthesis, D-myo-inositol-5-phosphate Metabolism, Dopamine Receptor Signaling, Dopamine-DARPP32 Feedback in cAMP Signaling, EIF2 Signaling, ERK/MAPK Signaling, HIPPO signaling, Insulin Receptor Signaling, Production of Nitric Oxide and Reactive Oxygen Species in Macrophages, Protein Kinase A Signaling, Superpathway of Inositol Phosphate Compounds, Synaptic Long Term Potentiation |
hsa-miR-3177-3p | 0.010 | 2.500 | TargetScan Human | Moderate (predicted) | PTP4A3 | 0.001 | -1.870 | |
hsa-miR-3177-3p | 0.010 | 2.500 | TargetScan Human | Moderate (predicted) | RALBP1 | 0.010 | -1.900 | Molecular Mechanisms of Cancer, Pancreatic Adenocarcinoma Signaling |
hsa-miR-3177-3p | 0.010 | 2.500 | TargetScan Human | Moderate (predicted) | SLC39A3 | 0.000 | -2.730 | |
hsa-miR-3177-3p | 0.010 | 2.500 | TargetScan Human | Moderate (predicted) | SLX4 | 0.012 | -5.420 | |
hsa-miR-3177-3p | 0.010 | 2.500 | TargetScan Human | Moderate (predicted) | TBC1D13 | 0.000 | -2.330 | |
hsa-miR-3177-3p | 0.010 | 2.500 | TargetScan Human | Moderate (predicted) | THBS1 | 0.003 | -2.980 | Bladder Cancer Signaling, Inhibition of Angiogenesis by TSP1, p53 Signaling |
hsa-miR-3177-3p | 0.010 | 2.500 | TargetScan Human | Moderate (predicted) | TTYH3 | 0.000 | -2.680 | |
hsa-miR-3177-3p | 0.010 | 2.500 | TargetScan Human | Moderate (predicted) | UBE2L3 | 0.000 | -2.790 | Hypoxia Signaling in the Cardiovascular System, Protein Ubiquitination Pathway |
hsa-miR-3177-3p | 0.010 | 2.500 | TargetScan Human | Moderate (predicted) | VPS9D1 | 0.002 | -1.640 | Mitochondrial Dysfunction, Oxidative Phosphorylation |
hsa-miR-3185 | 0.007 | 9.500 | TargetScan Human | Moderate (predicted) | BRD2 | 0.019 | -1.820 | |
hsa-miR-3185 | 0.007 | 9.500 | TargetScan Human | Moderate (predicted) | BRD3 | 0.047 | -5.970 | |
hsa-miR-3185 | 0.007 | 9.500 | TargetScan Human | Moderate (predicted) | DSE | 0.000 | -4.170 | Dermatan Sulfate Biosynthesis, Dermatan Sulfate Biosynthesis (Late Stages) |
hsa-miR-3185 | 0.007 | 9.500 | TargetScan Human | Moderate (predicted) | EFHD2 | 0.000 | -2.500 | |
hsa-miR-3185 | 0.007 | 9.500 | TargetScan Human | Moderate (predicted) | MSRB3 | 0.020 | -2.625 | |
hsa-miR-3185 | 0.007 | 9.500 | TargetScan Human | Moderate (predicted) | OXTR | 0.023 | -1.910 | |
hsa-miR-3185 | 0.007 | 9.500 | TargetScan Human | Moderate (predicted) | PGK1 | 0.030 | -2.270 | Gluconeogenesis I, Glycolysis I |
hsa-miR-3185 | 0.007 | 9.500 | TargetScan Human | Moderate (predicted) | RCOR3 | 0.005 | -1.950 | Huntington's Disease Signaling |
hsa-miR-3185 | 0.007 | 9.500 | TargetScan Human | Moderate (predicted) | SNN | 0.000 | -13.920 | |
hsa-miR-3185 | 0.007 | 9.500 | TargetScan Human | Moderate (predicted) | STK24 | 0.000 | -7.300 | |
hsa-miR-3185 | 0.007 | 9.500 | TargetScan Human | Moderate (predicted) | TNFSF4 | 0.001 | -6.110 | OX40 Signaling Pathway |
hsa-miR-3187-3p | 0.004 | 8.600 | TargetScan Human | Moderate (predicted) | ABLIM1 | 0.001 | -3.045 | Axonal Guidance Signaling, Netrin Signaling |
hsa-miR-3187-3p | 0.004 | 8.600 | TargetScan Human | Moderate (predicted) | BTN3A2 | 0.003 | -2.840 | |
hsa-miR-3187-3p | 0.004 | 8.600 | TargetScan Human | High (predicted) | CCPG1 | 0.006 | -2.870 | |
hsa-miR-3187-3p | 0.004 | 8.600 | TargetScan Human | Moderate (predicted) | CCR6 | 0.024 | -1.560 | |
hsa-miR-3187-3p | 0.004 | 8.600 | TargetScan Human | Moderate (predicted) | CD36 | 0.000 | -2.050 | Atherosclerosis Signaling, Inhibition of Angiogenesis by TSP1, LXR/RXR Activation, PPARα/RXRα Activation, Type II Diabetes Mellitus Signaling |
hsa-miR-3187-3p | 0.004 | 8.600 | TargetScan Human | Moderate (predicted) | CLIP1 | 0.000 | -2.970 | Cdc42 Signaling, Epithelial Adherens Junction Signaling, Remodeling of Epithelial Adherens Junctions, Signaling by Rho Family GTPases |
hsa-miR-3187-3p | 0.004 | 8.600 | TargetScan Human | Moderate (predicted) | COASY | 0.000 | -1.710 | Coenzyme A Biosynthesis |
hsa-miR-3187-3p | 0.004 | 8.600 | TargetScan Human | Moderate (predicted) | DBNL | 0.046 | -3.870 | |
hsa-miR-3187-3p | 0.004 | 8.600 | TargetScan Human | Moderate (predicted) | DDA1 | 0.024 | -2.040 | |
hsa-miR-3187-3p | 0.004 | 8.600 | TargetScan Human | High (predicted) | EHD3 | 0.000 | -4.610 | |
hsa-miR-3187-3p | 0.004 | 8.600 | TargetScan Human | Moderate (predicted) | ESYT2 | 0.000 | -3.520 | |
hsa-miR-3187-3p | 0.004 | 8.600 | TargetScan Human | Moderate (predicted) | FAM65B | 0.011 | -2.360 | |
hsa-miR-3187-3p | 0.004 | 8.600 | TargetScan Human | Moderate (predicted) | GFOD1 | 0.000 | -2.330 | |
hsa-miR-3187-3p | 0.004 | 8.600 | TargetScan Human | Moderate (predicted) | HERC1 | 0.000 | -1.990 | |
hsa-miR-3187-3p | 0.004 | 8.600 | TargetScan Human | Moderate (predicted) | ITIH5 | 0.000 | -1.600 | |
hsa-miR-3187-3p | 0.004 | 8.600 | TargetScan Human | Moderate (predicted) | MBNL1 | 0.000 | -12.940 | |
hsa-miR-3187-3p | 0.004 | 8.600 | TargetScan Human | Moderate (predicted) | MTMR12 | 0.000 | -2.730 | |
hsa-miR-3187-3p | 0.004 | 8.600 | TargetScan Human | Moderate (predicted) | P4HB | 0.026 | -2.360 | Hypoxia Signaling in the Cardiovascular System, Role of Tissue Factor in Cancer, Unfolded protein response |
hsa-miR-3187-3p | 0.004 | 8.600 | TargetScan Human | Moderate (predicted) | PAPSS2 | 0.020 | -1.510 | LPS/IL-1 Mediated Inhibition of RXR Function, PXR/RXR Activation, Sulfate Activation for Sulfonation |
hsa-miR-3187-3p | 0.004 | 8.600 | TargetScan Human | High (predicted) | PIP5K1C | 0.000 | -2.520 | 3-phosphoinositide Biosynthesis, Actin Cytoskeleton Signaling, Aldosterone Signaling in Epithelial Cells, Clathrin-mediated Endocytosis Signaling, D-myo-inositol (1, 4, 5)-Trisphosphate Biosynthesis, Rac Signaling, Regulation of Actin-based Motility by Rho, RhoA Signaling, RhoGDI Signaling, Signaling by Rho Family GTPases, Superpathway of Inositol Phosphate Compounds |
hsa-miR-3187-3p | 0.004 | 8.600 | TargetScan Human | Moderate (predicted) | PPP2R5A | 0.000 | -4.830 | 3-phosphoinositide Biosynthesis, 3-phosphoinositide Degradation, AMPK Signaling, Breast Cancer Regulation by Stathmin1, Cardiac β-adrenergic Signaling, CDK5 Signaling, Cell Cycle Regulation by BTG Family Proteins, Ceramide Signaling, CTLA4 Signaling in Cytotoxic T Lymphocytes, Cyclins and Cell Cycle Regulation, D-myo-inositol (1, 4, 5, 6)-Tetrakisphosphate Biosynthesis, D-myo-inositol (3, 4, 5, 6)-tetrakisphosphate Biosynthesis, D-myo-inositol-5-phosphate Metabolism, Dopamine Receptor Signaling, Dopamine-DARPP32 Feedback in cAMP Signaling, ERK/MAPK Signaling, HIPPO signaling, ILK Signaling, Mitotic Roles of Polo-Like Kinase, mTOR Signaling, p70S6K Signaling, PI3K/AKT Signaling, Production of Nitric Oxide and Reactive Oxygen Species in Macrophages, Regulation of eIF4 and p70S6K Signaling, Role of CHK Proteins in Cell Cycle Checkpoint Control, Superpathway of Inositol Phosphate Compounds, Synaptic Long Term Depression, Telomerase Signaling, Tight Junction Signaling, Wnt/β-catenin Signaling, Xenobiotic Metabolism Signaling |
hsa-miR-3187-3p | 0.004 | 8.600 | TargetScan Human | Moderate (predicted) | PPP6R3 | 0.000 | -1.530 | |
hsa-miR-3187-3p | 0.004 | 8.600 | TargetScan Human | Moderate (predicted) | PTK2 | 0.000 | -5.750 | Actin Cytoskeleton Signaling, Agrin Interactions at Neuromuscular Junction, Angiopoietin Signaling, Axonal Guidance Signaling, B Cell Receptor Signaling, Chemokine Signaling, Cholecystokinin/Gastrin-mediated Signaling, CXCR4 Signaling, Ephrin A Signaling, Ephrin B Signaling, Ephrin Receptor Signaling, ERK/MAPK Signaling, FAK Signaling, Germ Cell-Sertoli Cell Junction Signaling, Glioma Invasiveness Signaling, GNRH Signaling, Gα12/13 Signaling, HGF Signaling, IGF-1 Signaling, IL-15 Production, IL-15 Signaling, IL-8 Signaling, ILK Signaling, Integrin Signaling, Leukocyte Extravasation Signaling, Molecular Mechanisms of Cancer, PAK Signaling, Paxillin Signaling, Protein Kinase A Signaling, PTEN Signaling, Rac Signaling, Regulation of Cellular Mechanics by Calpain Protease, Renin-Angiotensin Signaling, RhoA Signaling, Semaphorin Signaling in Neurons, Signaling by Rho Family GTPases, Small Cell Lung Cancer Signaling, Sperm Motility, Sphingosine-1-phosphate Signaling, Tec Kinase Signaling, Thrombin Signaling, VEGF Signaling |
hsa-miR-3187-3p | 0.004 | 8.600 | TargetScan Human | Moderate (predicted) | PTPN1 | 0.000 | -2.900 | 3-phosphoinositide Biosynthesis, 3-phosphoinositide Degradation, Caveolar-mediated Endocytosis Signaling, D-myo-inositol (1, 4, 5, 6)-Tetrakisphosphate Biosynthesis, D-myo-inositol (3, 4, 5, 6)-tetrakisphosphate Biosynthesis, D-myo-inositol-5-phosphate Metabolism, Insulin Receptor Signaling, JAK/Stat Signaling, Protein Kinase A Signaling, Role of JAK2 in Hormone-like Cytokine Signaling, Superpathway of Inositol Phosphate Compounds |
hsa-miR-3187-3p | 0.004 | 8.600 | TargetScan Human | Moderate (predicted) | RASA3 | 0.038 | -2.150 | |
hsa-miR-3187-3p | 0.004 | 8.600 | TargetScan Human | Moderate (predicted) | SRGN | 0.025 | -1.700 | Tumoricidal Function of Hepatic Natural Killer Cells |
hsa-miR-3187-3p | 0.004 | 8.600 | TargetScan Human | Moderate (predicted) | TM2D2 | 0.006 | -2.160 | |
hsa-miR-3187-3p | 0.004 | 8.600 | TargetScan Human | Moderate (predicted) | TPP1 | 0.013 | -5.000 | Telomerase Signaling |
hsa-miR-3187-3p | 0.004 | 8.600 | TargetScan Human | Moderate (predicted) | TUBB | 0.000 | -3.970 | 14-3-3-mediated Signaling, Axonal Guidance Signaling, Breast Cancer Regulation by Stathmin1, Epithelial Adherens Junction Signaling, Gap Junction Signaling, Germ Cell-Sertoli Cell Junction Signaling, phagosome maturation, Remodeling of Epithelial Adherens Junctions, Sertoli Cell-Sertoli Cell Junction Signaling |
hsa-miR-3187-3p | 0.004 | 8.600 | TargetScan Human | High (predicted) | UBQLN3 | 0.002 | -1.530 | |
hsa-miR-3195 | 0.002 | 9.000 | TargetScan Human | Moderate (predicted) | ADRBK1 | 0.004 | -2.180 | cAMP-mediated signaling, Cardiac β-adrenergic Signaling, Colorectal Cancer Metastasis Signaling, G-Protein Coupled Receptor Signaling, Gαq Signaling, Sonic Hedgehog Signaling |
hsa-miR-3195 | 0.002 | 9.000 | TargetScan Human | Moderate (predicted) | ASAP1 | 0.051 | -4.590 | FAK Signaling, Integrin Signaling |
hsa-miR-3195 | 0.002 | 9.000 | TargetScan Human | Moderate (predicted) | C17orf62 | 0.001 | -1.900 | |
hsa-miR-3195 | 0.002 | 9.000 | TargetScan Human | Moderate (predicted) | C9orf69 | 0.010 | -2.620 | |
hsa-miR-3195 | 0.002 | 9.000 | TargetScan Human | Moderate (predicted) | CASP6 | 0.002 | -1.640 | Apoptosis Signaling, Cytotoxic T Lymphocyte-mediated Apoptosis of Target Cells, Death Receptor Signaling, Endothelin-1 Signaling, Huntington's Disease Signaling, Molecular Mechanisms of Cancer, p53 Signaling, Role of Oct4 in Mammalian Embryonic Stem Cell Pluripotency, Sphingosine-1-phosphate Signaling, TNFR1 Signaling, Tumoricidal Function of Hepatic Natural Killer Cells, TWEAK Signaling |
hsa-miR-3195 | 0.002 | 9.000 | TargetScan Human | Moderate (predicted) | CELF2 | 0.000 | -1.560 | |
hsa-miR-3195 | 0.002 | 9.000 | TargetScan Human | High (predicted) | CHMP6 | 0.047 | -4.410 | Mechanisms of Viral Exit from Host Cells |
hsa-miR-3195 | 0.002 | 9.000 | TargetScan Human | Moderate (predicted) | CSNK1G2 | 0.027 | -4.220 | Dopamine-DARPP32 Feedback in cAMP Signaling, Gap Junction Signaling, Role of NFAT in Regulation of the Immune Response, Role of Wnt/GSK-3β Signaling in the Pathogenesis of Influenza, Wnt/β-catenin Signaling |
hsa-miR-3195 | 0.002 | 9.000 | TargetScan Human | Moderate (predicted) | DDA1 | 0.024 | -2.040 | |
hsa-miR-3195 | 0.002 | 9.000 | TargetScan Human | Moderate (predicted) | EFHD2 | 0.000 | -2.500 | |
hsa-miR-3195 | 0.002 | 9.000 | TargetScan Human | Moderate (predicted) | GID8 | 0.000 | -1.560 | |
hsa-miR-3195 | 0.002 | 9.000 | TargetScan Human | Moderate (predicted) | KIAA0513 | 0.000 | -7.100 | |
hsa-miR-3195 | 0.002 | 9.000 | TargetScan Human | Moderate (predicted) | MAN2A2 | 0.000 | -2.330 | |
hsa-miR-3195 | 0.002 | 9.000 | TargetScan Human | Moderate (predicted) | PTPN1 | 0.000 | -2.900 | 3-phosphoinositide Biosynthesis, 3-phosphoinositide Degradation, Caveolar-mediated Endocytosis Signaling, D-myo-inositol (1, 4, 5, 6)-Tetrakisphosphate Biosynthesis, D-myo-inositol (3, 4, 5, 6)-tetrakisphosphate Biosynthesis, D-myo-inositol-5-phosphate Metabolism, Insulin Receptor Signaling, JAK/Stat Signaling, Protein Kinase A Signaling, Role of JAK2 in Hormone-like Cytokine Signaling, Superpathway of Inositol Phosphate Compounds |
hsa-miR-3195 | 0.002 | 9.000 | TargetScan Human | Moderate (predicted) | RBM14 | 0.000 | -1.760 | |
hsa-miR-3195 | 0.002 | 9.000 | TargetScan Human | Moderate (predicted) | ST3GAL1 | 0.002 | -3.350 | |
hsa-miR-3195 | 0.002 | 9.000 | TargetScan Human | Moderate (predicted) | TAPBP | 0.002 | -2.820 | Antigen Presentation Pathway |
hsa-miR-3195 | 0.002 | 9.000 | TargetScan Human | Moderate (predicted) | ZZEF1 | 0.000 | -2.950 | |
hsa-miR-4791 | 0.003 | -3.400 | TargetScan Human | Moderate (predicted) | LSM1 | 0.000 | 1.450 | Systemic Lupus Erythematosus Signaling |
hsa-miR-3663-3p | 0.003 | 18.100 | TargetScan Human | Moderate (predicted) | ASAP1 | 0.051 | -4.590 | FAK Signaling, Integrin Signaling |
hsa-miR-3663-3p | 0.003 | 18.100 | TargetScan Human | High (predicted) | BEST2 | 0.051 | -1.500 | |
hsa-miR-3663-3p | 0.003 | 18.100 | TargetScan Human | High (predicted) | CASP2 | 0.000 | -4.300 | Apoptosis Signaling, Death Receptor Signaling, Endothelin-1 Signaling, Huntington's Disease Signaling, Sphingosine-1-phosphate Signaling, TNFR1 Signaling |
hsa-miR-3663-3p | 0.003 | 18.100 | TargetScan Human | Moderate (predicted) | CDC14B | 0.000 | -8.130 | Protein Kinase A Signaling |
hsa-miR-3663-3p | 0.003 | 18.100 | TargetScan Human | High (predicted) | CDKN1A | 0.006 | -10.640 | AMPK Signaling, Antiproliferative Role of Somatostatin Receptor 2, Aryl Hydrocarbon Receptor Signaling, ATM Signaling, Bladder Cancer Signaling, Breast Cancer Regulation by Stathmin1, Cell Cycle: G1/S Checkpoint Regulation, Cell Cycle: G2/M DNA Damage Checkpoint Regulation, Chronic Myeloid Leukemia Signaling, Cyclins and Cell Cycle Regulation, Estrogen-mediated S-phase Entry, GADD45 Signaling, Glioblastoma Multiforme Signaling, Glioma Signaling, Glucocorticoid Receptor Signaling, HER-2 Signaling in Breast Cancer, Hereditary Breast Cancer Signaling, HGF Signaling, JAK/Stat Signaling, Melanoma Signaling, Molecular Mechanisms of Cancer, p53 Signaling, Pancreatic Adenocarcinoma Signaling, PI3K/AKT Signaling, Prostate Cancer Signaling, PTEN Signaling, Role of BRCA1 in DNA Damage Response, Role of CHK Proteins in Cell Cycle Checkpoint Control, STAT3 Pathway, Telomerase Signaling, VDR/RXR Activation |
hsa-miR-3663-3p | 0.003 | 18.100 | TargetScan Human | Moderate (predicted) | CHFR | 0.000 | -1.650 | |
hsa-miR-3663-3p | 0.003 | 18.100 | TargetScan Human | High (predicted) | CHSY1 | 0.000 | -1.710 | Chondroitin and Dermatan Biosynthesis, Chondroitin Sulfate Biosynthesis, Chondroitin Sulfate Biosynthesis (Late Stages), Dermatan Sulfate Biosynthesis |
hsa-miR-3663-3p | 0.003 | 18.100 | TargetScan Human | Moderate (predicted) | DIABLO | 0.015 | -1.630 | Apoptosis Signaling, Ceramide Signaling, Death Receptor Signaling, Induction of Apoptosis by HIV1, Lymphotoxin β Receptor Signaling, Molecular Mechanisms of Cancer |
hsa-miR-3663-3p | 0.003 | 18.100 | TargetScan Human | Moderate (predicted) | EIF4E3 | 0.000 | -2.140 | |
hsa-miR-3663-3p | 0.003 | 18.100 | TargetScan Human | Moderate (predicted) | EZR | 0.000 | -1.740 | Actin Cytoskeleton Signaling, Agranulocyte Adhesion and Diapedesis, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, Granulocyte Adhesion and Diapedesis, Leukocyte Extravasation Signaling, Regulation of Cellular Mechanics by Calpain Protease, RhoA Signaling, RhoGDI Signaling, Signaling by Rho Family GTPases |
hsa-miR-3663-3p | 0.003 | 18.100 | TargetScan Human | Moderate (predicted) | FAM13B | 0.000 | -1.490 | |
hsa-miR-3663-3p | 0.003 | 18.100 | TargetScan Human | Moderate (predicted) | FSTL1 | 0.001 | -2.680 | |
hsa-miR-3663-3p | 0.003 | 18.100 | TargetScan Human | Moderate (predicted) | IP6K1 | 0.000 | -1.647 | Inositol Pyrophosphates Biosynthesis, Superpathway of Inositol Phosphate Compounds |
hsa-miR-3663-3p | 0.003 | 18.100 | TargetScan Human | Moderate (predicted) | KIAA0513 | 0.000 | -7.100 | |
hsa-miR-3663-3p | 0.003 | 18.100 | TargetScan Human | Moderate (predicted) | KIAA1191 | 0.044 | -2.600 | |
hsa-miR-3663-3p | 0.003 | 18.100 | TargetScan Human | High (predicted) | KLF11 | 0.000 | -3.920 | |
hsa-miR-3663-3p | 0.003 | 18.100 | TargetScan Human | Moderate (predicted) | KLHDC3 | 0.000 | -1.510 | |
hsa-miR-3663-3p | 0.003 | 18.100 | TargetScan Human | Moderate (predicted) | LHFPL2 | 0.000 | -2.530 | |
hsa-miR-3663-3p | 0.003 | 18.100 | TargetScan Human | High (predicted), Moderate (predicted) | MAPKAPK2 | 0.000 | -2.530 | Cardiac Hypertrophy Signaling, CD40 Signaling, FGF Signaling, IL-17 Signaling, IL-6 Signaling, p38 MAPK Signaling, RAR Activation, Role of IL-17A in Arthritis, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis |
hsa-miR-3663-3p | 0.003 | 18.100 | TargetScan Human | Moderate (predicted) | MEF2D | 0.000 | -2.260 | Calcium Signaling, Calcium-induced T Lymphocyte Apoptosis, Cardiac Hypertrophy Signaling, Cholecystokinin/Gastrin-mediated Signaling, Corticotropin Releasing Hormone Signaling, ERK5 Signaling, Gα12/13 Signaling, Nur77 Signaling in T Lymphocytes, p38 MAPK Signaling, Phospholipase C Signaling, Role of NFAT in Cardiac Hypertrophy, Role of NFAT in Regulation of the Immune Response |
hsa-miR-3663-3p | 0.003 | 18.100 | TargetScan Human | Moderate (predicted) | NKIRAS2 | 0.014 | -2.140 | |
hsa-miR-3663-3p | 0.003 | 18.100 | TargetScan Human | Moderate (predicted) | PHTF1 | 0.000 | -1.910 | |
hsa-miR-3663-3p | 0.003 | 18.100 | TargetScan Human | Moderate (predicted) | PTP4A3 | 0.001 | -1.870 | |
hsa-miR-3663-3p | 0.003 | 18.100 | TargetScan Human | Moderate (predicted) | PTPN1 | 0.000 | -2.900 | 3-phosphoinositide Biosynthesis, 3-phosphoinositide Degradation, Caveolar-mediated Endocytosis Signaling, D-myo-inositol (1, 4, 5, 6)-Tetrakisphosphate Biosynthesis, D-myo-inositol (3, 4, 5, 6)-tetrakisphosphate Biosynthesis, D-myo-inositol-5-phosphate Metabolism, Insulin Receptor Signaling, JAK/Stat Signaling, Protein Kinase A Signaling, Role of JAK2 in Hormone-like Cytokine Signaling, Superpathway of Inositol Phosphate Compounds |
hsa-miR-3663-3p | 0.003 | 18.100 | TargetScan Human | Moderate (predicted) | RAP2A | 0.000 | -1.800 | B Cell Receptor Signaling, Calcium Signaling, Integrin Signaling, Molecular Mechanisms of Cancer |
hsa-miR-3663-3p | 0.003 | 18.100 | TargetScan Human | Moderate (predicted) | SET | 0.023 | -2.160 | 3-phosphoinositide Biosynthesis, 3-phosphoinositide Degradation, D-myo-inositol (1, 4, 5, 6)-Tetrakisphosphate Biosynthesis, D-myo-inositol (3, 4, 5, 6)-tetrakisphosphate Biosynthesis, D-myo-inositol-5-phosphate Metabolism, Granzyme A Signaling, Superpathway of Inositol Phosphate Compounds, Transcriptional Regulatory Network in Embryonic Stem Cells |
hsa-miR-3663-3p | 0.003 | 18.100 | TargetScan Human | Moderate (predicted) | SMAP2 | 0.005 | -3.070 | |
hsa-miR-3663-3p | 0.003 | 18.100 | TargetScan Human | Moderate (predicted) | STX11 | 0.042 | -4.430 | |
hsa-miR-3663-3p | 0.003 | 18.100 | TargetScan Human | Moderate (predicted) | TJP2 | 0.005 | -2.120 | Hepatic Cholestasis, HIPPO signaling, Sertoli Cell-Sertoli Cell Junction Signaling, Tight Junction Signaling |
hsa-miR-3663-3p | 0.003 | 18.100 | TargetScan Human | Moderate (predicted) | TNFSF4 | 0.001 | -6.110 | OX40 Signaling Pathway |
hsa-miR-3663-3p | 0.003 | 18.100 | TargetScan Human | Moderate (predicted) | TSPAN18 | 0.000 | -4.570 | |
hsa-miR-3663-3p | 0.003 | 18.100 | TargetScan Human | Moderate (predicted) | UBN1 | 0.000 | -5.410 | |
hsa-miR-3663-3p | 0.003 | 18.100 | TargetScan Human | Moderate (predicted) | VPS37C | 0.000 | -2.020 | Mechanisms of Viral Exit from Host Cells, phagosome maturation |
hsa-miR-3663-3p | 0.003 | 18.100 | TargetScan Human | Moderate (predicted) | XYLT2 | 0.000 | -2.470 | Chondroitin Sulfate Biosynthesis, Dermatan Sulfate Biosynthesis, Glycoaminoglycan-protein Linkage Region Biosynthesis, Heparan Sulfate Biosynthesis |
hsa-miR-3663-3p | 0.003 | 18.100 | TargetScan Human | High (predicted) | YPEL2 | 0.000 | -1.790 | |
hsa-miR-3663-3p | 0.003 | 18.100 | TargetScan Human | Moderate (predicted) | YWHAB | 0.000 | -1.660 | 14-3-3-mediated Signaling, Cell Cycle: G2/M DNA Damage Checkpoint Regulation, ERK/MAPK Signaling, ERK5 Signaling, HIPPO signaling, IGF-1 Signaling, Myc Mediated Apoptosis Signaling, p70S6K Signaling, PI3K/AKT Signaling, Protein Kinase A Signaling |
hsa-miR-3663-3p | 0.003 | 18.100 | TargetScan Human | High (predicted) | YY1 | 0.025 | -1.580 | VDR/RXR Activation |
hsa-miR-3663-3p | 0.003 | 18.100 | TargetScan Human | Moderate (predicted) | ZFP91 | 0.000 | -1.790 | |
hsa-miR-603 | 0.004 | -2.700 | TargetScan Human | Moderate (predicted) | CSNK2A1 | 0.008 | 2.650 | Amyloid Processing, Clathrin-mediated Endocytosis Signaling, EGF Signaling, IGF-1 Signaling, IL-2 Signaling, IL-6 Signaling, NF-κB Signaling, PDGF Signaling, PTEN Signaling, RAR Activation, VDR/RXR Activation, Wnt/β-catenin Signaling |
hsa-miR-603 | 0.004 | -2.700 | TargetScan Human | Moderate (predicted) | EIF1AY | 0.000 | 1.470 | Regulation of eIF4 and p70S6K Signaling, VEGF Signaling |
hsa-miR-3605-5p | 0.000 | 3.000 | TargetScan Human | Moderate (predicted) | BTN3A2 | 0.003 | -2.840 | |
hsa-miR-3605-5p | 0.000 | 3.000 | TargetScan Human | Moderate (predicted) | C1orf116 | 0.000 | -3.090 | |
hsa-miR-3605-5p | 0.000 | 3.000 | TargetScan Human | Moderate (predicted) | CARD8 | 0.000 | -1.640 | |
hsa-miR-3605-5p | 0.000 | 3.000 | TargetScan Human | Moderate (predicted) | CD36 | 0.000 | -2.050 | Atherosclerosis Signaling, Inhibition of Angiogenesis by TSP1, LXR/RXR Activation, PPARα/RXRα Activation, Type II Diabetes Mellitus Signaling |
hsa-miR-3605-5p | 0.000 | 3.000 | TargetScan Human | High (predicted), Moderate (predicted) | CHMP1A | 0.026 | -1.940 | Axonal Guidance Signaling |
hsa-miR-3605-5p | 0.000 | 3.000 | TargetScan Human | Moderate (predicted) | ITIH5 | 0.000 | -1.600 | |
hsa-miR-3605-5p | 0.000 | 3.000 | TargetScan Human | Moderate (predicted) | KCNK6 | 0.000 | -3.360 | |
hsa-miR-3605-5p | 0.000 | 3.000 | TargetScan Human | Moderate (predicted) | KIF1B | 0.000 | -1.790 | |
hsa-miR-3605-5p | 0.000 | 3.000 | TargetScan Human | Moderate (predicted) | MAGED2 | 0.000 | -2.720 | |
hsa-miR-3605-5p | 0.000 | 3.000 | TargetScan Human | Moderate (predicted) | MLEC | 0.000 | -1.745 | |
hsa-miR-3605-5p | 0.000 | 3.000 | TargetScan Human | Moderate (predicted) | MRPL18 | 0.002 | -1.620 | |
hsa-miR-3605-5p | 0.000 | 3.000 | TargetScan Human | Moderate (predicted) | NCOA1 | 0.000 | -2.820 | Androgen Signaling, Estrogen Receptor Signaling, Glucocorticoid Receptor Signaling, HIF1α Signaling, IL-12 Signaling and Production in Macrophages, LPS/IL-1 Mediated Inhibition of RXR Function, PPAR Signaling, PXR/RXR Activation, RAR Activation, Role of Wnt/GSK-3β Signaling in the Pathogenesis of Influenza, TR/RXR Activation, VDR/RXR Activation, Xenobiotic Metabolism Signaling |
hsa-miR-3605-5p | 0.000 | 3.000 | TargetScan Human | Moderate (predicted) | NT5C2 | 0.000 | -3.250 | Adenosine Nucleotides Degradation II, Guanosine Nucleotides Degradation III, NAD Salvage Pathway II, Purine Nucleotides Degradation II (Aerobic), Urate Biosynthesis/Inosine 5'-phosphate Degradation |
hsa-miR-3605-5p | 0.000 | 3.000 | TargetScan Human | High (predicted) | PCSK7 | 0.009 | -1.660 | |
hsa-miR-3605-5p | 0.000 | 3.000 | TargetScan Human | Moderate (predicted) | RTN3 | 0.030 | -3.330 | |
hsa-miR-3605-5p | 0.000 | 3.000 | TargetScan Human | Moderate (predicted) | SLC2A3 | 0.002 | -9.910 | Antioxidant Action of Vitamin C, HIF1α Signaling, Vitamin-C Transport |
hsa-miR-3605-5p | 0.000 | 3.000 | TargetScan Human | Moderate (predicted) | SLC9A1 | 0.006 | -4.300 | Actin Cytoskeleton Signaling, Aldosterone Signaling in Epithelial Cells, Signaling by Rho Family GTPases |
hsa-miR-3605-5p | 0.000 | 3.000 | TargetScan Human | Moderate (predicted) | SMG7 | 0.000 | -1.740 | |
hsa-miR-3605-5p | 0.000 | 3.000 | TargetScan Human | Moderate (predicted) | STK24 | 0.000 | -7.300 | |
hsa-miR-3605-5p | 0.000 | 3.000 | TargetScan Human | Moderate (predicted) | SYTL4 | 0.009 | -3.290 | |
hsa-miR-3605-5p | 0.000 | 3.000 | TargetScan Human | Moderate (predicted) | TNS1 | 0.000 | -2.530 | FAK Signaling |
hsa-miR-3605-5p | 0.000 | 3.000 | TargetScan Human | Moderate (predicted) | TXNIP | 0.042 | -2.400 | Adipogenesis pathway |
hsa-miR-3605-5p | 0.000 | 3.000 | TargetScan Human | Moderate (predicted) | VPS41 | 0.010 | -2.660 | autophagy, phagosome maturation |
hsa-miR-3605-5p | 0.000 | 3.000 | TargetScan Human | Moderate (predicted) | WNK1 | 0.000 | -1.760 | ERK5 Signaling |
hsa-miR-3605-5p | 0.000 | 3.000 | TargetScan Human | Moderate (predicted) | XPO7 | 0.000 | -1.910 | |
hsa-miR-3605-5p | 0.000 | 3.000 | TargetScan Human | Moderate (predicted) | ZMIZ2 | 0.025 | -1.570 | |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | High (predicted) | ACSS2 | 0.003 | -2.025 | Acetate Conversion to Acetyl-CoA, Ethanol Degradation II, Ethanol Degradation IV, Oxidative Ethanol Degradation III |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | ADRBK1 | 0.004 | -2.180 | cAMP-mediated signaling, Cardiac β-adrenergic Signaling, Colorectal Cancer Metastasis Signaling, G-Protein Coupled Receptor Signaling, Gαq Signaling, Sonic Hedgehog Signaling |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | AMFR | 0.000 | -3.180 | Protein Ubiquitination Pathway, Unfolded protein response |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | ARF1 | 0.040 | -4.970 | Integrin Signaling, Paxillin Signaling |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | ARF3 | 0.007 | -4.170 | Integrin Signaling |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | ARHGAP1 | 0.003 | -1.490 | Leukocyte Extravasation Signaling, RhoA Signaling, RhoGDI Signaling, Semaphorin Signaling in Neurons |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | High (predicted) | ARHGDIA | 0.042 | -1.740 | Regulation of Actin-based Motility by Rho, RhoGDI Signaling |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | ARPC5 | 0.000 | -9.370 | Actin Cytoskeleton Signaling, Actin Nucleation by ARP-WASP Complex, Axonal Guidance Signaling, CD28 Signaling in T Helper Cells, Cdc42 Signaling, Clathrin-mediated Endocytosis Signaling, Corticotropin Releasing Hormone Signaling, Ephrin Receptor Signaling, Epithelial Adherens Junction Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, fMLP Signaling in Neutrophils, Integrin Signaling, Rac Signaling, Regulation of Actin-based Motility by Rho, Remodeling of Epithelial Adherens Junctions, RhoA Signaling, RhoGDI Signaling, Signaling by Rho Family GTPases |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | ATP2A2 | 0.002 | -1.480 | Calcium Signaling, Calcium Transport I, Calcium-induced T Lymphocyte Apoptosis, Cardiac β-adrenergic Signaling, Dopamine-DARPP32 Feedback in cAMP Signaling, Nitric Oxide Signaling in the Cardiovascular System |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | ATXN7L3 | 0.025 | -2.710 | |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | AXIN1 | 0.000 | -2.470 | Basal Cell Carcinoma Signaling, Colorectal Cancer Metastasis Signaling, Endometrial Cancer Signaling, Ephrin B Signaling, Ephrin Receptor Signaling, Factors Promoting Cardiogenesis in Vertebrates, Germ Cell-Sertoli Cell Junction Signaling, Glioblastoma Multiforme Signaling, Human Embryonic Stem Cell Pluripotency, Molecular Mechanisms of Cancer, Mouse Embryonic Stem Cell Pluripotency, Ovarian Cancer Signaling, Regulation of the Epithelial-Mesenchymal Transition Pathway, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of NANOG in Mammalian Embryonic Stem Cell Pluripotency, Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis, Role of Wnt/GSK-3β Signaling in the Pathogenesis of Influenza, Sertoli Cell-Sertoli Cell Junction Signaling, Wnt/Ca+ pathway, Wnt/β-catenin Signaling |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | C17orf62 | 0.001 | -1.900 | |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | CDS2 | 0.007 | -1.900 | CDP-diacylglycerol Biosynthesis I, Phosphatidylglycerol Biosynthesis II (Non-plastidic) |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | CDV3 | 0.000 | -1.480 | |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | CERS2 | 0.002 | -2.555 | |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | CHST12 | 0.000 | -1.690 | Chondroitin Sulfate Biosynthesis, Chondroitin Sulfate Biosynthesis (Late Stages), Dermatan Sulfate Biosynthesis, Dermatan Sulfate Biosynthesis (Late Stages), Heparan Sulfate Biosynthesis, Heparan Sulfate Biosynthesis (Late Stages), LPS/IL-1 Mediated Inhibition of RXR Function, Xenobiotic Metabolism Signaling |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | CLCN7 | 0.013 | -2.270 | |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | CS | 0.010 | -1.530 | TCA Cycle II (Eukaryotic) |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | CTDSPL | 0.000 | -16.420 | |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | DAG1 | 0.000 | -2.700 | Agrin Interactions at Neuromuscular Junction, nNOS Signaling in Skeletal Muscle Cells |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | High (predicted) | DDA1 | 0.024 | -2.040 | |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | DENND3 | 0.000 | -1.540 | |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | DLG4 | 0.021 | -2.030 | Glutamate Receptor Signaling, HIPPO signaling, Huntington's Disease Signaling, Neuregulin Signaling, nNOS Signaling in Neurons |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | High (predicted) | DNAJC9 | 0.000 | -2.180 | Aldosterone Signaling in Epithelial Cells, NRF2-mediated Oxidative Stress Response, Protein Ubiquitination Pathway |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | ESYT2 | 0.000 | -3.520 | |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | FAM214B | 0.000 | -2.930 | |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | High (predicted) | FLI1 | 0.002 | -2.380 | |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | FNBP1 | 0.000 | -1.530 | Actin Nucleation by ARP-WASP Complex, Cardiac Hypertrophy Signaling, Cholecystokinin/Gastrin-mediated Signaling, Colorectal Cancer Metastasis Signaling, CXCR4 Signaling, Germ Cell-Sertoli Cell Junction Signaling, Glioblastoma Multiforme Signaling, Glioma Invasiveness Signaling, Gαq Signaling, HMGB1 Signaling, IL-8 Signaling, ILK Signaling, Integrin Signaling, Molecular Mechanisms of Cancer, mTOR Signaling, phagosome formation, Phospholipase C Signaling, Production of Nitric Oxide and Reactive Oxygen Species in Macrophages, Regulation of Actin-based Motility by Rho, RhoGDI Signaling, Semaphorin Signaling in Neurons, Signaling by Rho Family GTPases, Sphingosine-1-phosphate Signaling, Tec Kinase Signaling, Thrombin Signaling |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | FOXO1 | 0.000 | -1.700 | 14-3-3-mediated Signaling, Adipogenesis pathway, AMPK Signaling, Angiopoietin Signaling, B Cell Receptor Signaling, Cancer Drug Resistance By Drug Efflux, Cell Cycle: G1/S Checkpoint Regulation, Docosahexaenoic Acid (DHA) Signaling, ErbB Signaling, ErbB2-ErbB3 Signaling, FXR/RXR Activation, Glioblastoma Multiforme Signaling, HER-2 Signaling in Breast Cancer, Human Embryonic Stem Cell Pluripotency, IGF-1 Signaling, IL-3 Signaling, Insulin Receptor Signaling, Leptin Signaling in Obesity, Molecular Mechanisms of Cancer, PI3K/AKT Signaling, Prostate Cancer Signaling, PTEN Signaling, PXR/RXR Activation, Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis, VDR/RXR Activation, VEGF Signaling |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | FURIN | 0.007 | -3.340 | Mitochondrial Dysfunction, Notch Signaling |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | High (predicted), Moderate (predicted) | GLG1 | 0.000 | -1.790 | Agranulocyte Adhesion and Diapedesis, Atherosclerosis Signaling, Granulocyte Adhesion and Diapedesis |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | GRB2 | 0.000 | -2.500 | 14-3-3-mediated Signaling, 3-phosphoinositide Biosynthesis, Actin Cytoskeleton Signaling, Actin Nucleation by ARP-WASP Complex, Acute Myeloid Leukemia Signaling, Acute Phase Response Signaling, Aldosterone Signaling in Epithelial Cells, AMPK Signaling, Amyotrophic Lateral Sclerosis Signaling, Angiopoietin Signaling, Antiproliferative Role of Somatostatin Receptor 2, Axonal Guidance Signaling, B Cell Receptor Signaling, BMP signaling pathway, Breast Cancer Regulation by Stathmin1, Cardiac Hypertrophy Signaling, CCR3 Signaling in Eosinophils, CD28 Signaling in T Helper Cells, CD40 Signaling, Ceramide Signaling, Cholecystokinin/Gastrin-mediated Signaling, Chronic Myeloid Leukemia Signaling, Clathrin-mediated Endocytosis Signaling, CNTF Signaling, Colorectal Cancer Metastasis Signaling, CREB Signaling in Neurons, CTLA4 Signaling in Cytotoxic T Lymphocytes, CXCR4 Signaling, Dendritic Cell Maturation, Docosahexaenoic Acid (DHA) Signaling, EGF Signaling, EIF2 Signaling, Endometrial Cancer Signaling, Endothelin-1 Signaling, eNOS Signaling, Ephrin A Signaling, Ephrin Receptor Signaling, ErbB Signaling, ErbB2-ErbB3 Signaling, ErbB4 Signaling, ERK/MAPK Signaling, Erythropoietin Signaling, Estrogen Receptor Signaling, Estrogen-Dependent Breast Cancer Signaling, FAK Signaling, Fc Epsilon RI Signaling, FcγRIIB Signaling in B Lymphocytes, FGF Signaling, FLT3 Signaling in Hematopoietic Progenitor Cells, fMLP Signaling in Neutrophils, G Beta Gamma Signaling, G-Protein Coupled Receptor Signaling, Gap Junction Signaling, GDNF Family Ligand-Receptor Interactions, Germ Cell-Sertoli Cell Junction Signaling, Glioblastoma Multiforme Signaling, Glioma Invasiveness Signaling, Glioma Signaling, Glucocorticoid Receptor Signaling, GM-CSF Signaling, GNRH Signaling, Growth Hormone Signaling, Gα12/13 Signaling, Gαi Signaling, Gαq Signaling, HER-2 Signaling in Breast Cancer, Hereditary Breast Cancer Signaling, HGF Signaling, HIF1α Signaling, HMGB1 Signaling, Human Embryonic Stem Cell Pluripotency, Huntington's Disease Signaling, iCOS-iCOSL Signaling in T Helper Cells, IGF-1 Signaling, IL-12 Signaling and Production in Macrophages, IL-15 Signaling, IL-17 Signaling, IL-17A Signaling in Airway Cells, IL-2 Signaling, IL-3 Signaling, IL-4 Signaling, IL-6 Signaling, IL-8 Signaling, IL-9 Signaling, ILK Signaling, Insulin Receptor Signaling, Integrin Signaling, JAK/Stat Signaling, Leptin Signaling in Obesity, Leukocyte Extravasation Signaling, LPS-stimulated MAPK Signaling, Lymphotoxin β Receptor Signaling, Macropinocytosis Signaling, Melanocyte Development and Pigmentation Signaling, Melanoma Signaling, Molecular Mechanisms of Cancer, Mouse Embryonic Stem Cell Pluripotency, MSP-RON Signaling Pathway, mTOR Signaling, Myc Mediated Apoptosis Signaling, Natural Killer Cell Signaling, Neuregulin Signaling, Neuropathic Pain Signaling In Dorsal Horn Neurons, Neurotrophin/TRK Signaling, NF-κB Activation by Viruses, NF-κB Signaling, NGF Signaling, Nitric Oxide Signaling in the Cardiovascular System, Non-Small Cell Lung Cancer Signaling, NRF2-mediated Oxidative Stress Response, Oncostatin M Signaling, Ovarian Cancer Signaling, P2Y Purigenic Receptor Signaling Pathway, p53 Signaling, p70S6K Signaling, PAK Signaling, Pancreatic Adenocarcinoma Signaling, Paxillin Signaling, PDGF Signaling, PEDF Signaling, phagosome formation, Phospholipase C Signaling, PI3K/AKT Signaling, PKCθ Signaling in T Lymphocytes, PPAR Signaling, PPARα/RXRα Activation, Production of Nitric Oxide and Reactive Oxygen Species in Macrophages, Prolactin Signaling, Prostate Cancer Signaling, PTEN Signaling, Rac Signaling, RANK Signaling in Osteoclasts, Reelin Signaling in Neurons, Regulation of Cellular Mechanics by Calpain Protease, Regulation of eIF4 and p70S6K Signaling, Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes, Regulation of the Epithelial-Mesenchymal Transition Pathway, Relaxin Signaling, Renal Cell Carcinoma Signaling, Renin-Angiotensin Signaling, Role of IL-17A in Arthritis, Role of JAK1 and JAK3 in γc Cytokine Signaling, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of NANOG in Mammalian Embryonic Stem Cell Pluripotency, Role of NFAT in Cardiac Hypertrophy, Role of NFAT in Regulation of the Immune Response, Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis, Role of p14/p19ARF in Tumor Suppression, Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses, Role of PI3K/AKT Signaling in the Pathogenesis of Influenza, Role of Tissue Factor in Cancer, SAPK/JNK Signaling, Signaling by Rho Family GTPases, Small Cell Lung Cancer Signaling, Sphingosine-1-phosphate Signaling, Superpathway of Inositol Phosphate Compounds, Systemic Lupus Erythematosus Signaling, T Cell Receptor Signaling, Tec Kinase Signaling, Telomerase Signaling, TGF-β Signaling, Thrombin Signaling, Thrombopoietin Signaling, TR/RXR Activation, TREM1 Signaling, Type II Diabetes Mellitus Signaling, UVA-Induced MAPK Signaling, UVB-Induced MAPK Signaling, VEGF Family Ligand-Receptor Interactions, VEGF Signaling, Virus Entry via Endocytic Pathways, Xenobiotic Metabolism Signaling |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | HCLS1 | 0.001 | -1.740 | |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | HECTD4 | 0.000 | -2.070 | |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | HNRNPUL1 | 0.000 | -2.250 | |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | ILK | 0.046 | -4.510 | Endometrial Cancer Signaling, Germ Cell-Sertoli Cell Junction Signaling, ILK Signaling, Integrin Signaling, PI3K/AKT Signaling, PTEN Signaling, Sertoli Cell-Sertoli Cell Junction Signaling, Wnt/β-catenin Signaling |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | ITGB3 | 0.007 | -6.420 | Agrin Interactions at Neuromuscular Junction, Caveolar-mediated Endocytosis Signaling, Clathrin-mediated Endocytosis Signaling, Glioma Invasiveness Signaling, Granulocyte Adhesion and Diapedesis, HER-2 Signaling in Breast Cancer, IL-8 Signaling, ILK Signaling, Integrin Signaling, Leukocyte Extravasation Signaling, Macropinocytosis Signaling, NF-κB Activation by Viruses, P2Y Purigenic Receptor Signaling Pathway, Paxillin Signaling, Reelin Signaling in Neurons, Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis, Role of Tissue Factor in Cancer, Virus Entry via Endocytic Pathways |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | KIF1B | 0.000 | -1.790 | |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | KIF3C | 0.001 | -2.030 | |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | KLF13 | 0.000 | -1.520 | |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | LASP1 | 0.000 | -5.070 | IL-8 Signaling |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | High (predicted) | LDLRAP1 | 0.000 | -6.690 | Clathrin-mediated Endocytosis Signaling |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | LGALS8 | 0.000 | -1.530 | |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | LMNA | 0.018 | -3.860 | Apoptosis Signaling, Death Receptor Signaling |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | High (predicted) | LTA | 0.011 | -2.140 | Activation of IRF by Cytosolic Pattern Recognition Receptors, Altered T Cell and B Cell Signaling in Rheumatoid Arthritis, CD40 Signaling, Crosstalk between Dendritic Cells and Natural Killer Cells, Dendritic Cell Maturation, Hepatic Cholestasis, HMGB1 Signaling, Lymphotoxin β Receptor Signaling, NF-κB Signaling, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses, TNFR2 Signaling, Type I Diabetes Mellitus Signaling |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | MAN2A2 | 0.000 | -2.330 | |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | High (predicted) | MOB3C | 0.010 | -6.740 | |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | MSRB1 | 0.000 | -1.800 | |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | MTHFR | 0.000 | -1.760 | Folate Transformations I |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | MTMR12 | 0.000 | -2.730 | |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | MYH9 | 0.052 | -7.770 | Actin Cytoskeleton Signaling, Agranulocyte Adhesion and Diapedesis, Calcium Signaling, Cellular Effects of Sildenafil (Viagra), Epithelial Adherens Junction Signaling, Hepatic Fibrosis / Hepatic Stellate Cell Activation, ILK Signaling, Tight Junction Signaling |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | High (predicted) | NCOA1 | 0.000 | -2.820 | Androgen Signaling, Estrogen Receptor Signaling, Glucocorticoid Receptor Signaling, HIF1α Signaling, IL-12 Signaling and Production in Macrophages, LPS/IL-1 Mediated Inhibition of RXR Function, PPAR Signaling, PXR/RXR Activation, RAR Activation, Role of Wnt/GSK-3β Signaling in the Pathogenesis of Influenza, TR/RXR Activation, VDR/RXR Activation, Xenobiotic Metabolism Signaling |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | NCOR2 | 0.000 | -1.650 | Aryl Hydrocarbon Receptor Signaling, Estrogen Receptor Signaling, Glucocorticoid Receptor Signaling, Huntington's Disease Signaling, LXR/RXR Activation, PPAR Signaling, PPARα/RXRα Activation, RAR Activation, TR/RXR Activation, VDR/RXR Activation, Xenobiotic Metabolism Signaling |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | NDST1 | 0.000 | -3.200 | Chondroitin Sulfate Biosynthesis, Chondroitin Sulfate Biosynthesis (Late Stages), Dermatan Sulfate Biosynthesis, Dermatan Sulfate Biosynthesis (Late Stages), Heparan Sulfate Biosynthesis, Heparan Sulfate Biosynthesis (Late Stages), LPS/IL-1 Mediated Inhibition of RXR Function, Triacylglycerol Degradation, Xenobiotic Metabolism Signaling |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | NLRX1 | 0.000 | -1.690 | |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | P2RX1 | 0.034 | -3.990 | Gustation Pathway |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | High (predicted) | PCSK7 | 0.009 | -1.660 | |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | PFKFB3 | 0.000 | -3.080 | AMPK Signaling |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | PIP5K1C | 0.000 | -2.520 | 3-phosphoinositide Biosynthesis, Actin Cytoskeleton Signaling, Aldosterone Signaling in Epithelial Cells, Clathrin-mediated Endocytosis Signaling, D-myo-inositol (1, 4, 5)-Trisphosphate Biosynthesis, Rac Signaling, Regulation of Actin-based Motility by Rho, RhoA Signaling, RhoGDI Signaling, Signaling by Rho Family GTPases, Superpathway of Inositol Phosphate Compounds |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | PLOD1 | 0.000 | -1.450 | |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | PRKCA | 0.000 | -2.250 | 14-3-3-mediated Signaling, Aldosterone Signaling in Epithelial Cells, Androgen Signaling, Apoptosis Signaling, Axonal Guidance Signaling, Breast Cancer Regulation by Stathmin1, Calcium-induced T Lymphocyte Apoptosis, Caveolar-mediated Endocytosis Signaling, CCR3 Signaling in Eosinophils, CCR5 Signaling in Macrophages, Chemokine Signaling, Cholecystokinin/Gastrin-mediated Signaling, Corticotropin Releasing Hormone Signaling, CREB Signaling in Neurons, CXCR4 Signaling, Dopamine-DARPP32 Feedback in cAMP Signaling, EGF Signaling, Endothelin-1 Signaling, eNOS Signaling, ErbB Signaling, ErbB4 Signaling, ERK/MAPK Signaling, Erythropoietin Signaling, Factors Promoting Cardiogenesis in Vertebrates, Fc Epsilon RI Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, FGF Signaling, fMLP Signaling in Neutrophils, G Beta Gamma Signaling, G-Protein Coupled Receptor Signaling, Gap Junction Signaling, Glioma Signaling, GNRH Signaling, GPCR-Mediated Nutrient Sensing in Enteroendocrine Cells, Growth Hormone Signaling, Gαq Signaling, Hepatic Cholestasis, HER-2 Signaling in Breast Cancer, HGF Signaling, Huntington's Disease Signaling, IL-12 Signaling and Production in Macrophages, IL-3 Signaling, IL-8 Signaling, Leukocyte Extravasation Signaling, LPS-stimulated MAPK Signaling, Macropinocytosis Signaling, Mechanisms of Viral Exit from Host Cells, Melatonin Signaling, Molecular Mechanisms of Cancer, mTOR Signaling, Natural Killer Cell Signaling, Neuregulin Signaling, Neuropathic Pain Signaling In Dorsal Horn Neurons, NF-κB Activation by Viruses, Nitric Oxide Signaling in the Cardiovascular System, nNOS Signaling in Neurons, Non-Small Cell Lung Cancer Signaling, NRF2-mediated Oxidative Stress Response, P2Y Purigenic Receptor Signaling Pathway, p70S6K Signaling, PDGF Signaling, phagosome formation, Phospholipase C Signaling, PPARα/RXRα Activation, Production of Nitric Oxide and Reactive Oxygen Species in Macrophages, Prolactin Signaling, Protein Kinase A Signaling, RAR Activation, Renin-Angiotensin Signaling, RhoGDI Signaling, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of MAPK Signaling in the Pathogenesis of Influenza, Role of NFAT in Cardiac Hypertrophy, Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses, Role of Tissue Factor in Cancer, Sperm Motility, Synaptic Long Term Depression, Synaptic Long Term Potentiation, Tec Kinase Signaling, Thrombin Signaling, Thrombopoietin Signaling, Type II Diabetes Mellitus Signaling, UVA-Induced MAPK Signaling, UVB-Induced MAPK Signaling, UVC-Induced MAPK Signaling, VDR/RXR Activation, VEGF Family Ligand-Receptor Interactions, VEGF Signaling, Virus Entry via Endocytic Pathways, Wnt/Ca+ pathway, Xenobiotic Metabolism Signaling, α-Adrenergic Signaling |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | High (predicted) | RAC1 | 0.000 | -4.510 | Actin Cytoskeleton Signaling, Actin Nucleation by ARP-WASP Complex, Agrin Interactions at Neuromuscular Junction, Amyotrophic Lateral Sclerosis Signaling, Axonal Guidance Signaling, B Cell Receptor Signaling, Breast Cancer Regulation by Stathmin1, CCR3 Signaling in Eosinophils, CD28 Signaling in T Helper Cells, Clathrin-mediated Endocytosis Signaling, Colorectal Cancer Metastasis Signaling, CXCR4 Signaling, Ephrin A Signaling, Ephrin B Signaling, Ephrin Receptor Signaling, Epithelial Adherens Junction Signaling, ERK/MAPK Signaling, FAK Signaling, Fc Epsilon RI Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, FGF Signaling, fMLP Signaling in Neutrophils, GDNF Family Ligand-Receptor Interactions, Germ Cell-Sertoli Cell Junction Signaling, Glioblastoma Multiforme Signaling, Glucocorticoid Receptor Signaling, GNRH Signaling, HGF Signaling, HMGB1 Signaling, iCOS-iCOSL Signaling in T Helper Cells, IL-3 Signaling, IL-8 Signaling, Integrin Signaling, Leukocyte Extravasation Signaling, LPS-stimulated MAPK Signaling, Macropinocytosis Signaling, Molecular Mechanisms of Cancer, mTOR Signaling, Natural Killer Cell Signaling, Netrin Signaling, NGF Signaling, PAK Signaling, Pancreatic Adenocarcinoma Signaling, Paxillin Signaling, PCP pathway, PEDF Signaling, Phospholipase C Signaling, PI3K Signaling in B Lymphocytes, PKCθ Signaling in T Lymphocytes, Production of Nitric Oxide and Reactive Oxygen Species in Macrophages, PTEN Signaling, Rac Signaling, RAR Activation, Regulation of Actin-based Motility by Rho, Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes, Renal Cell Carcinoma Signaling, Renin-Angiotensin Signaling, RhoGDI Signaling, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of p14/p19ARF in Tumor Suppression, Role of Tissue Factor in Cancer, SAPK/JNK Signaling, Semaphorin Signaling in Neurons, Sertoli Cell-Sertoli Cell Junction Signaling, Signaling by Rho Family GTPases, Sphingosine-1-phosphate Signaling, STAT3 Pathway, T Cell Receptor Signaling, Tight Junction Signaling, Virus Entry via Endocytic Pathways |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | RBM4 | 0.000 | -1.500 | |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | RCOR3 | 0.005 | -1.950 | Huntington's Disease Signaling |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | RIOK3 | 0.000 | -9.390 | |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | High (predicted) | SLA2 | 0.030 | -1.900 | |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | High (predicted) | SLX4 | 0.012 | -5.420 | |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | SRF | 0.000 | -1.770 | Cardiac Hypertrophy Signaling, Cholecystokinin/Gastrin-mediated Signaling, EGF Signaling, ERK/MAPK Signaling, Growth Hormone Signaling, IGF-1 Signaling, IL-6 Signaling, LPS-stimulated MAPK Signaling, p38 MAPK Signaling, PDGF Signaling, PEDF Signaling |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | STIM1 | 0.000 | -2.840 | |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | STX11 | 0.042 | -4.430 | |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | STX16 | 0.000 | -3.840 | Huntington's Disease Signaling, phagosome maturation, Tight Junction Signaling |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | High (predicted) | TACC1 | 0.000 | -5.110 | |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | TAL1 | 0.000 | -5.160 | |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | TBC1D13 | 0.000 | -2.330 | |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | TGFBR2 | 0.000 | -2.090 | Antiproliferative Role of TOB in T Cell Signaling, Cardiac Hypertrophy Signaling, Chronic Myeloid Leukemia Signaling, Colorectal Cancer Metastasis Signaling, Epithelial Adherens Junction Signaling, Factors Promoting Cardiogenesis in Vertebrates, Germ Cell-Sertoli Cell Junction Signaling, Glucocorticoid Receptor Signaling, Hepatic Fibrosis / Hepatic Stellate Cell Activation, Human Embryonic Stem Cell Pluripotency, Inhibition of Angiogenesis by TSP1, Molecular Mechanisms of Cancer, NF-κB Signaling, p38 MAPK Signaling, Pancreatic Adenocarcinoma Signaling, PPARα/RXRα Activation, Protein Kinase A Signaling, PTEN Signaling, Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes, Regulation of the Epithelial-Mesenchymal Transition Pathway, Role of NFAT in Cardiac Hypertrophy, STAT3 Pathway, T Helper Cell Differentiation, TGF-β Signaling, Tight Junction Signaling, Wnt/β-catenin Signaling |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | THBS1 | 0.003 | -2.980 | Bladder Cancer Signaling, Inhibition of Angiogenesis by TSP1, p53 Signaling |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | TMEM204 | 0.045 | -2.980 | |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | TMEM63A | 0.007 | -2.130 | |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | High (predicted) | TNS1 | 0.000 | -2.530 | FAK Signaling |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | TTC39B | 0.003 | -1.870 | |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | UBE2M | 0.000 | -1.890 | Hypoxia Signaling in the Cardiovascular System, Protein Ubiquitination Pathway |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | High (predicted) | UBE3B | 0.000 | -2.480 | Protein Ubiquitination Pathway |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | VHL | 0.000 | -2.145 | HIF1α Signaling, Hypoxia Signaling in the Cardiovascular System, Protein Ubiquitination Pathway, Renal Cell Carcinoma Signaling |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | VPS26B | 0.047 | -1.840 | |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | VPS41 | 0.010 | -2.660 | autophagy, phagosome maturation |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | High (predicted) | WASF2 | 0.003 | -3.850 | Actin Cytoskeleton Signaling, PEDF Signaling, RhoGDI Signaling |
hsa-miR-650 | 0.044 | 1.500 | TargetScan Human | Moderate (predicted) | ZFP91 | 0.000 | -1.790 | |
hsa-miR-3646 | 0.002 | 1.700 | TargetScan Human | Moderate (predicted) | ANO6 | 0.000 | -15.080 | |
hsa-miR-3646 | 0.002 | 1.700 | TargetScan Human | Moderate (predicted) | CBL | 0.000 | -1.740 | 14-3-3-mediated Signaling, Clathrin-mediated Endocytosis Signaling, Ephrin B Signaling, Erythropoietin Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, FLT3 Signaling in Hematopoietic Progenitor Cells, Insulin Receptor Signaling, Molecular Mechanisms of Cancer, PI3K Signaling in B Lymphocytes, Protein Ubiquitination Pathway, PTEN Signaling, RANK Signaling in Osteoclasts, Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis, Systemic Lupus Erythematosus Signaling, T Cell Receptor Signaling |
hsa-miR-3940-5p | 0.008 | 5.700 | TargetScan Human | Moderate (predicted) | ANO6 | 0.000 | -15.080 | |
hsa-miR-3940-5p | 0.008 | 5.700 | TargetScan Human | Moderate (predicted) | ATP6V0B | 0.000 | -2.260 | phagosome maturation |
hsa-miR-3940-5p | 0.008 | 5.700 | TargetScan Human | Moderate (predicted) | CDC14B | 0.000 | -8.130 | Protein Kinase A Signaling |
hsa-miR-3940-5p | 0.008 | 5.700 | TargetScan Human | High (predicted) | ENKUR | 0.000 | -2.140 | |
hsa-miR-3940-5p | 0.008 | 5.700 | TargetScan Human | Moderate (predicted) | FLOT2 | 0.000 | -2.350 | Caveolar-mediated Endocytosis Signaling |
hsa-miR-3940-5p | 0.008 | 5.700 | TargetScan Human | High (predicted) | H3F3A/H3F3B | 0.000 | -4.180 | ERK/MAPK Signaling, Estrogen Receptor Signaling, p38 MAPK Signaling, Protein Kinase A Signaling, UVB-Induced MAPK Signaling |
hsa-miR-3940-5p | 0.008 | 5.700 | TargetScan Human | Moderate (predicted) | JAM3 | 0.004 | -11.080 | Agranulocyte Adhesion and Diapedesis, Granulocyte Adhesion and Diapedesis, Leukocyte Extravasation Signaling, Sertoli Cell-Sertoli Cell Junction Signaling, Tight Junction Signaling |
hsa-miR-3940-5p | 0.008 | 5.700 | TargetScan Human | Moderate (predicted) | MAN2A2 | 0.000 | -2.330 | |
hsa-miR-3940-5p | 0.008 | 5.700 | TargetScan Human | Moderate (predicted) | MAPRE2 | 0.050 | -2.680 | Remodeling of Epithelial Adherens Junctions |
hsa-miR-3940-5p | 0.008 | 5.700 | TargetScan Human | Moderate (predicted) | MTCH1 | 0.000 | -1.530 | |
hsa-miR-3940-5p | 0.008 | 5.700 | TargetScan Human | Moderate (predicted) | OXTR | 0.023 | -1.910 | |
hsa-miR-3940-5p | 0.008 | 5.700 | TargetScan Human | Moderate (predicted) | PUM2 | 0.000 | -1.620 | |
hsa-miR-3940-5p | 0.008 | 5.700 | TargetScan Human | Moderate (predicted) | REPS2 | 0.015 | -1.855 | |
hsa-miR-3940-5p | 0.008 | 5.700 | TargetScan Human | High (predicted) | RNF10 | 0.025 | -1.510 | |
hsa-miR-3940-5p | 0.008 | 5.700 | TargetScan Human | Moderate (predicted) | SCFD2 | 0.028 | -1.480 | |
hsa-miR-3940-5p | 0.008 | 5.700 | TargetScan Human | Moderate (predicted) | SLC35E1 | 0.000 | -3.270 | |
hsa-miR-3940-5p | 0.008 | 5.700 | TargetScan Human | Moderate (predicted) | TM2D2 | 0.006 | -2.160 | |
hsa-miR-3940-5p | 0.008 | 5.700 | TargetScan Human | Moderate (predicted) | UBAC1 | 0.000 | -2.090 | |
hsa-miR-3940-5p | 0.008 | 5.700 | TargetScan Human | Moderate (predicted) | XK | 0.000 | -3.400 | |
hsa-miR-3940-5p | 0.008 | 5.700 | TargetScan Human | Moderate (predicted) | ZMIZ2 | 0.025 | -1.570 | |
hsa-miR-4516 | 0.014 | 4.900 | TargetScan Human | Moderate (predicted) | ABHD16A | 0.002 | -2.660 | |
hsa-miR-4516 | 0.014 | 4.900 | TargetScan Human | Moderate (predicted) | ADD3 | 0.017 | -2.650 | Gαs Signaling, Protein Kinase A Signaling |
hsa-miR-4516 | 0.014 | 4.900 | TargetScan Human | Moderate (predicted) | AKAP13 | 0.000 | -1.500 | cAMP-mediated signaling, Cardiac β-adrenergic Signaling, Protein Kinase A Signaling |
hsa-miR-4516 | 0.014 | 4.900 | TargetScan Human | Moderate (predicted) | BICD2 | 0.027 | -7.190 | |
hsa-miR-4516 | 0.014 | 4.900 | TargetScan Human | Moderate (predicted) | C1orf198 | 0.001 | -7.420 | |
hsa-miR-4516 | 0.014 | 4.900 | TargetScan Human | Moderate (predicted) | FLNA | 0.004 | -5.600 | Actin Cytoskeleton Signaling, Caveolar-mediated Endocytosis Signaling, ILK Signaling, Protein Kinase A Signaling, Virus Entry via Endocytic Pathways |
hsa-miR-4516 | 0.014 | 4.900 | TargetScan Human | Moderate (predicted) | FSTL1 | 0.001 | -2.680 | |
hsa-miR-4516 | 0.014 | 4.900 | TargetScan Human | Moderate (predicted) | GNB1 | 0.000 | -4.520 | Androgen Signaling, Antiproliferative Role of Somatostatin Receptor 2, Axonal Guidance Signaling, Breast Cancer Regulation by Stathmin1, Cardiac Hypertrophy Signaling, Cardiac β-adrenergic Signaling, CCR3 Signaling in Eosinophils, CCR5 Signaling in Macrophages, Colorectal Cancer Metastasis Signaling, CREB Signaling in Neurons, CXCR4 Signaling, Ephrin B Signaling, Ephrin Receptor Signaling, fMLP Signaling in Neutrophils, G Beta Gamma Signaling, G Protein Signaling Mediated by Tubby, Glutamate Receptor Signaling, Gustation Pathway, Gαi Signaling, Gαq Signaling, Gαs Signaling, Huntington's Disease Signaling, IL-1 Signaling, IL-8 Signaling, P2Y Purigenic Receptor Signaling Pathway, Phospholipase C Signaling, Phototransduction Pathway, Protein Kinase A Signaling, Relaxin Signaling, RhoGDI Signaling, Role of NFAT in Cardiac Hypertrophy, Role of NFAT in Regulation of the Immune Response, SAPK/JNK Signaling, Signaling by Rho Family GTPases, Tec Kinase Signaling, Thrombin Signaling, α-Adrenergic Signaling |
hsa-miR-4516 | 0.014 | 4.900 | TargetScan Human | Moderate (predicted) | H3F3A/H3F3B | 0.000 | -4.180 | ERK/MAPK Signaling, Estrogen Receptor Signaling, p38 MAPK Signaling, Protein Kinase A Signaling, UVB-Induced MAPK Signaling |
hsa-miR-4516 | 0.014 | 4.900 | TargetScan Human | Moderate (predicted) | HCFC1 | 0.000 | -2.690 | |
hsa-miR-4516 | 0.014 | 4.900 | TargetScan Human | Moderate (predicted) | LPAR5 | 0.006 | -5.010 | eNOS Signaling, GPCR-Mediated Nutrient Sensing in Enteroendocrine Cells, Gα12/13 Signaling, RhoA Signaling |
hsa-miR-4516 | 0.014 | 4.900 | TargetScan Human | Moderate (predicted) | MLEC | 0.000 | -1.745 | |
hsa-miR-4516 | 0.014 | 4.900 | TargetScan Human | Moderate (predicted) | MSRB3 | 0.020 | -2.625 | |
hsa-miR-4516 | 0.014 | 4.900 | TargetScan Human | High (predicted) | PLEK | 0.000 | -3.490 | |
hsa-miR-4516 | 0.014 | 4.900 | TargetScan Human | Moderate (predicted) | PPP3R1 | 0.000 | -3.920 | Axonal Guidance Signaling, B Cell Receptor Signaling, Calcium Signaling, Calcium-induced T Lymphocyte Apoptosis, cAMP-mediated signaling, Cardiac Hypertrophy Signaling, CD28 Signaling in T Helper Cells, Clathrin-mediated Endocytosis Signaling, Dopamine-DARPP32 Feedback in cAMP Signaling, fMLP Signaling in Neutrophils, Gap Junction Signaling, Glucocorticoid Receptor Signaling, GM-CSF Signaling, Gαq Signaling, iCOS-iCOSL Signaling in T Helper Cells, IL-3 Signaling, Netrin Signaling, nNOS Signaling in Neurons, Nur77 Signaling in T Lymphocytes, Phospholipase C Signaling, PI3K Signaling in B Lymphocytes, PKCθ Signaling in T Lymphocytes, Protein Kinase A Signaling, RANK Signaling in Osteoclasts, Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of NFAT in Cardiac Hypertrophy, Role of NFAT in Regulation of the Immune Response, Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis, Synaptic Long Term Potentiation, T Cell Receptor Signaling |
hsa-miR-4516 | 0.014 | 4.900 | TargetScan Human | Moderate (predicted) | PPP6R3 | 0.000 | -1.530 | |
hsa-miR-4516 | 0.014 | 4.900 | TargetScan Human | Moderate (predicted) | RAB1B | 0.000 | -3.170 | |
hsa-miR-4516 | 0.014 | 4.900 | TargetScan Human | Moderate (predicted) | RNF10 | 0.025 | -1.510 | |
hsa-miR-4516 | 0.014 | 4.900 | TargetScan Human | Moderate (predicted) | RNF115 | 0.000 | -2.040 | |
hsa-miR-4516 | 0.014 | 4.900 | TargetScan Human | Moderate (predicted) | SET | 0.023 | -2.160 | 3-phosphoinositide Biosynthesis, 3-phosphoinositide Degradation, D-myo-inositol (1, 4, 5, 6)-Tetrakisphosphate Biosynthesis, D-myo-inositol (3, 4, 5, 6)-tetrakisphosphate Biosynthesis, D-myo-inositol-5-phosphate Metabolism, Granzyme A Signaling, Superpathway of Inositol Phosphate Compounds, Transcriptional Regulatory Network in Embryonic Stem Cells |
hsa-miR-4516 | 0.014 | 4.900 | TargetScan Human | Moderate (predicted) | SMG7 | 0.000 | -1.740 | |
hsa-miR-4516 | 0.014 | 4.900 | TargetScan Human | Moderate (predicted) | STK4 | 0.000 | -5.670 | HIPPO signaling, Non-Small Cell Lung Cancer Signaling |
hsa-miR-4516 | 0.014 | 4.900 | TargetScan Human | Moderate (predicted) | TACC1 | 0.000 | -5.110 | |
hsa-miR-4516 | 0.014 | 4.900 | TargetScan Human | Moderate (predicted) | TBC1D13 | 0.000 | -2.330 | |
hsa-miR-4516 | 0.014 | 4.900 | TargetScan Human | Moderate (predicted) | THBS1 | 0.003 | -2.980 | Bladder Cancer Signaling, Inhibition of Angiogenesis by TSP1, p53 Signaling |
hsa-miR-4516 | 0.014 | 4.900 | TargetScan Human | Moderate (predicted) | TJP2 | 0.005 | -2.120 | Hepatic Cholestasis, HIPPO signaling, Sertoli Cell-Sertoli Cell Junction Signaling, Tight Junction Signaling |
hsa-miR-4516 | 0.014 | 4.900 | TargetScan Human | High (predicted) | TMCC2 | 0.000 | -3.300 | |
hsa-miR-4516 | 0.014 | 4.900 | TargetScan Human | Moderate (predicted) | TMEM183A | 0.018 | -1.620 | |
hsa-miR-4516 | 0.014 | 4.900 | TargetScan Human | High (predicted) | TMEM183B | 0.033 | -1.560 | |
hsa-miR-4516 | 0.014 | 4.900 | TargetScan Human | Moderate (predicted) | TXNDC12 | 0.000 | -1.540 | Glutathione Redox Reactions II |
hsa-miR-4516 | 0.014 | 4.900 | TargetScan Human | Moderate (predicted) | TXNRD1 | 0.000 | -2.170 | Antioxidant Action of Vitamin C, NRF2-mediated Oxidative Stress Response, Thioredoxin Pathway, Vitamin-C Transport |
hsa-miR-4516 | 0.014 | 4.900 | TargetScan Human | Moderate (predicted) | UHRF1BP1 | 0.000 | -1.610 | |
hsa-miR-4516 | 0.014 | 4.900 | TargetScan Human | Moderate (predicted) | VASP | 0.001 | -1.680 | Actin Nucleation by ARP-WASP Complex, Axonal Guidance Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, IL-8 Signaling, Integrin Signaling, Leukocyte Extravasation Signaling, Protein Kinase A Signaling, Tight Junction Signaling |
hsa-miR-4516 | 0.014 | 4.900 | TargetScan Human | Moderate (predicted) | VPS8 | 0.000 | -2.130 | |
hsa-miR-4516 | 0.014 | 4.900 | TargetScan Human | Moderate (predicted) | XPO7 | 0.000 | -1.910 | |
hsa-miR-4516 | 0.014 | 4.900 | TargetScan Human | Moderate (predicted) | ZDHHC7 | 0.000 | -4.190 | |
hsa-miR-548al | 0.042 | -2.100 | TargetScan Human | Moderate (predicted) | FEZ1 | 0.002 | 1.740 | |
hsa-miR-4462 | 0.011 | 3.900 | TargetScan Human | Moderate (predicted) | ADAR | 0.000 | -3.030 | Activation of IRF by Cytosolic Pattern Recognition Receptors |
hsa-miR-4462 | 0.011 | 3.900 | TargetScan Human | Moderate (predicted) | ARHGEF12 | 0.000 | -2.160 | Actin Cytoskeleton Signaling, Axonal Guidance Signaling, Breast Cancer Regulation by Stathmin1, Molecular Mechanisms of Cancer, Phospholipase C Signaling, Reelin Signaling in Neurons, RhoA Signaling, RhoGDI Signaling, Semaphorin Signaling in Neurons, Signaling by Rho Family GTPases, Thrombin Signaling |
hsa-miR-4462 | 0.011 | 3.900 | TargetScan Human | Moderate (predicted) | AXIN1 | 0.000 | -2.470 | Basal Cell Carcinoma Signaling, Colorectal Cancer Metastasis Signaling, Endometrial Cancer Signaling, Ephrin B Signaling, Ephrin Receptor Signaling, Factors Promoting Cardiogenesis in Vertebrates, Germ Cell-Sertoli Cell Junction Signaling, Glioblastoma Multiforme Signaling, Human Embryonic Stem Cell Pluripotency, Molecular Mechanisms of Cancer, Mouse Embryonic Stem Cell Pluripotency, Ovarian Cancer Signaling, Regulation of the Epithelial-Mesenchymal Transition Pathway, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of NANOG in Mammalian Embryonic Stem Cell Pluripotency, Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis, Role of Wnt/GSK-3β Signaling in the Pathogenesis of Influenza, Sertoli Cell-Sertoli Cell Junction Signaling, Wnt/Ca+ pathway, Wnt/β-catenin Signaling |
hsa-miR-4462 | 0.011 | 3.900 | TargetScan Human | Moderate (predicted) | CBX6 | 0.018 | -2.680 | |
hsa-miR-4462 | 0.011 | 3.900 | TargetScan Human | High (predicted) | CCNJL | 0.000 | -1.610 | |
hsa-miR-4462 | 0.011 | 3.900 | TargetScan Human | Moderate (predicted) | CLDN15 | 0.002 | -1.860 | Agranulocyte Adhesion and Diapedesis, Granulocyte Adhesion and Diapedesis, Leukocyte Extravasation Signaling, Sertoli Cell-Sertoli Cell Junction Signaling, Tight Junction Signaling |
hsa-miR-4462 | 0.011 | 3.900 | TargetScan Human | Moderate (predicted) | CLEC16A | 0.000 | -1.950 | |
hsa-miR-4462 | 0.011 | 3.900 | TargetScan Human | Moderate (predicted) | CSK | 0.000 | -7.130 | Actin Cytoskeleton Signaling, B Cell Receptor Signaling, CD28 Signaling in T Helper Cells, FAK Signaling, Gαq Signaling, iCOS-iCOSL Signaling in T Helper Cells, Paxillin Signaling, RAR Activation, T Cell Receptor Signaling |
hsa-miR-4462 | 0.011 | 3.900 | TargetScan Human | Moderate (predicted) | CTDSP1 | 0.000 | -6.090 | |
hsa-miR-4462 | 0.011 | 3.900 | TargetScan Human | Moderate (predicted) | DBNL | 0.046 | -3.870 | |
hsa-miR-4462 | 0.011 | 3.900 | TargetScan Human | Moderate (predicted) | DDA1 | 0.024 | -2.040 | |
hsa-miR-4462 | 0.011 | 3.900 | TargetScan Human | Moderate (predicted) | FADD | 0.000 | -1.750 | Activation of IRF by Cytosolic Pattern Recognition Receptors, Cytotoxic T Lymphocyte-mediated Apoptosis of Target Cells, Death Receptor Signaling, Induction of Apoptosis by HIV1, Molecular Mechanisms of Cancer, Myc Mediated Apoptosis Signaling, NF-κB Signaling, p38 MAPK Signaling, Retinoic acid Mediated Apoptosis Signaling, Role of PKR in Interferon Induction and Antiviral Response, Role of RIG1-like Receptors in Antiviral Innate Immunity, SAPK/JNK Signaling, Tec Kinase Signaling, TNFR1 Signaling, Tumoricidal Function of Hepatic Natural Killer Cells, TWEAK Signaling, Type I Diabetes Mellitus Signaling |
hsa-miR-4462 | 0.011 | 3.900 | TargetScan Human | High (predicted) | FAM110A | 0.007 | -3.840 | |
hsa-miR-4462 | 0.011 | 3.900 | TargetScan Human | Moderate (predicted) | FNBP1 | 0.000 | -1.530 | Actin Nucleation by ARP-WASP Complex, Cardiac Hypertrophy Signaling, Cholecystokinin/Gastrin-mediated Signaling, Colorectal Cancer Metastasis Signaling, CXCR4 Signaling, Germ Cell-Sertoli Cell Junction Signaling, Glioblastoma Multiforme Signaling, Glioma Invasiveness Signaling, Gαq Signaling, HMGB1 Signaling, IL-8 Signaling, ILK Signaling, Integrin Signaling, Molecular Mechanisms of Cancer, mTOR Signaling, phagosome formation, Phospholipase C Signaling, Production of Nitric Oxide and Reactive Oxygen Species in Macrophages, Regulation of Actin-based Motility by Rho, RhoGDI Signaling, Semaphorin Signaling in Neurons, Signaling by Rho Family GTPases, Sphingosine-1-phosphate Signaling, Tec Kinase Signaling, Thrombin Signaling |
hsa-miR-4462 | 0.011 | 3.900 | TargetScan Human | Moderate (predicted) | FOXO3 | 0.014 | -3.380 | AMPK Signaling, Cancer Drug Resistance By Drug Efflux, Endometrial Cancer Signaling, ERK5 Signaling, Glucocorticoid Receptor Signaling, IGF-1 Signaling, Insulin Receptor Signaling, Non-Small Cell Lung Cancer Signaling, PI3K Signaling in B Lymphocytes, PI3K/AKT Signaling, PTEN Signaling, PXR/RXR Activation, VEGF Signaling |
hsa-miR-4462 | 0.011 | 3.900 | TargetScan Human | High (predicted) | INPP5A | 0.000 | -1.750 | 1D-myo-inositol Hexakisphosphate Biosynthesis II (Mammalian), D-myo-inositol (1, 3, 4)-trisphosphate Biosynthesis, D-myo-inositol (1, 4, 5)-trisphosphate Degradation, Superpathway of D-myo-inositol (1, 4, 5)-trisphosphate Metabolism, Superpathway of Inositol Phosphate Compounds |
hsa-miR-4462 | 0.011 | 3.900 | TargetScan Human | High (predicted) | IRS1 | 0.007 | -1.490 | 14-3-3-mediated Signaling, 3-phosphoinositide Biosynthesis, Actin Cytoskeleton Signaling, Acute Myeloid Leukemia Signaling, Aldosterone Signaling in Epithelial Cells, AMPK Signaling, Amyotrophic Lateral Sclerosis Signaling, Angiopoietin Signaling, Antiproliferative Role of Somatostatin Receptor 2, Axonal Guidance Signaling, B Cell Receptor Signaling, Breast Cancer Regulation by Stathmin1, Cardiac Hypertrophy Signaling, CCR3 Signaling in Eosinophils, CD28 Signaling in T Helper Cells, CD40 Signaling, Ceramide Signaling, Chronic Myeloid Leukemia Signaling, Clathrin-mediated Endocytosis Signaling, CNTF Signaling, Colorectal Cancer Metastasis Signaling, CREB Signaling in Neurons, CTLA4 Signaling in Cytotoxic T Lymphocytes, CXCR4 Signaling, Dendritic Cell Maturation, Docosahexaenoic Acid (DHA) Signaling, EGF Signaling, EIF2 Signaling, Endometrial Cancer Signaling, Endothelin-1 Signaling, eNOS Signaling, Ephrin A Signaling, ErbB Signaling, ErbB2-ErbB3 Signaling, ErbB4 Signaling, ERK/MAPK Signaling, Erythropoietin Signaling, Estrogen-Dependent Breast Cancer Signaling, FAK Signaling, Fc Epsilon RI Signaling, FcγRIIB Signaling in B Lymphocytes, FGF Signaling, FLT3 Signaling in Hematopoietic Progenitor Cells, fMLP Signaling in Neutrophils, G-Protein Coupled Receptor Signaling, Gap Junction Signaling, GDNF Family Ligand-Receptor Interactions, Germ Cell-Sertoli Cell Junction Signaling, Glioblastoma Multiforme Signaling, Glioma Invasiveness Signaling, Glioma Signaling, Glucocorticoid Receptor Signaling, GM-CSF Signaling, Growth Hormone Signaling, Gα12/13 Signaling, Gαq Signaling, HER-2 Signaling in Breast Cancer, Hereditary Breast Cancer Signaling, HGF Signaling, HIF1α Signaling, HMGB1 Signaling, Human Embryonic Stem Cell Pluripotency, Huntington's Disease Signaling, iCOS-iCOSL Signaling in T Helper Cells, IGF-1 Signaling, IL-12 Signaling and Production in Macrophages, IL-15 Signaling, IL-17 Signaling, IL-17A Signaling in Airway Cells, IL-2 Signaling, IL-3 Signaling, IL-4 Signaling, IL-6 Signaling, IL-8 Signaling, IL-9 Signaling, ILK Signaling, Insulin Receptor Signaling, Integrin Signaling, JAK/Stat Signaling, Leptin Signaling in Obesity, Leukocyte Extravasation Signaling, LPS-stimulated MAPK Signaling, Lymphotoxin β Receptor Signaling, Macropinocytosis Signaling, Melanocyte Development and Pigmentation Signaling, Melanoma Signaling, Molecular Mechanisms of Cancer, Mouse Embryonic Stem Cell Pluripotency, MSP-RON Signaling Pathway, mTOR Signaling, Myc Mediated Apoptosis Signaling, Natural Killer Cell Signaling, Neuropathic Pain Signaling In Dorsal Horn Neurons, Neurotrophin/TRK Signaling, NF-κB Activation by Viruses, NF-κB Signaling, NGF Signaling, Nitric Oxide Signaling in the Cardiovascular System, Non-Small Cell Lung Cancer Signaling, NRF2-mediated Oxidative Stress Response, Ovarian Cancer Signaling, P2Y Purigenic Receptor Signaling Pathway, p53 Signaling, p70S6K Signaling, PAK Signaling, Pancreatic Adenocarcinoma Signaling, Paxillin Signaling, PDGF Signaling, PEDF Signaling, phagosome formation, PI3K Signaling in B Lymphocytes, PKCθ Signaling in T Lymphocytes, PPARα/RXRα Activation, Production of Nitric Oxide and Reactive Oxygen Species in Macrophages, Prolactin Signaling, Prostate Cancer Signaling, Rac Signaling, RANK Signaling in Osteoclasts, Reelin Signaling in Neurons, Regulation of eIF4 and p70S6K Signaling, Regulation of the Epithelial-Mesenchymal Transition Pathway, Relaxin Signaling, Renal Cell Carcinoma Signaling, Renin-Angiotensin Signaling, Role of IL-17A in Arthritis, Role of JAK1 and JAK3 in γc Cytokine Signaling, Role of JAK2 in Hormone-like Cytokine Signaling, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of NANOG in Mammalian Embryonic Stem Cell Pluripotency, Role of NFAT in Cardiac Hypertrophy, Role of NFAT in Regulation of the Immune Response, Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis, Role of p14/p19ARF in Tumor Suppression, Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses, Role of PI3K/AKT Signaling in the Pathogenesis of Influenza, Role of Tissue Factor in Cancer, SAPK/JNK Signaling, Signaling by Rho Family GTPases, Small Cell Lung Cancer Signaling, Sphingosine-1-phosphate Signaling, Superpathway of Inositol Phosphate Compounds, Systemic Lupus Erythematosus Signaling, T Cell Receptor Signaling, Tec Kinase Signaling, Telomerase Signaling, Thrombin Signaling, Thrombopoietin Signaling, TR/RXR Activation, Type II Diabetes Mellitus Signaling, UVA-Induced MAPK Signaling, UVB-Induced MAPK Signaling, VEGF Family Ligand-Receptor Interactions, VEGF Signaling, Virus Entry via Endocytic Pathways, Xenobiotic Metabolism Signaling |
hsa-miR-4462 | 0.011 | 3.900 | TargetScan Human | Moderate (predicted) | MAPRE1 | 0.012 | -3.630 | Remodeling of Epithelial Adherens Junctions |
hsa-miR-4462 | 0.011 | 3.900 | TargetScan Human | Moderate (predicted) | MTMR12 | 0.000 | -2.730 | |
hsa-miR-4462 | 0.011 | 3.900 | TargetScan Human | Moderate (predicted) | MYOM1 | 0.000 | -2.930 | |
hsa-miR-4462 | 0.011 | 3.900 | TargetScan Human | High (predicted) | NECAP2 | 0.000 | -1.660 | |
hsa-miR-4462 | 0.011 | 3.900 | TargetScan Human | Moderate (predicted) | PPP2R2D | 0.003 | -3.490 | Triacylglycerol Biosynthesis |
hsa-miR-4462 | 0.011 | 3.900 | TargetScan Human | Moderate (predicted) | PRRT3 | 0.000 | -1.530 | |
hsa-miR-4462 | 0.011 | 3.900 | TargetScan Human | Moderate (predicted) | PSAP | 0.000 | -1.860 | Lipid Antigen Presentation by CD1 |
hsa-miR-4462 | 0.011 | 3.900 | TargetScan Human | Moderate (predicted) | RAB11FIP3 | 0.000 | -7.870 | |
hsa-miR-4462 | 0.011 | 3.900 | TargetScan Human | High (predicted) | RHEB | 0.014 | -2.570 | mTOR Signaling, PI3K/AKT Signaling |
hsa-miR-4462 | 0.011 | 3.900 | TargetScan Human | Moderate (predicted) | SPIRE1 | 0.015 | -1.720 | |
hsa-miR-4462 | 0.011 | 3.900 | TargetScan Human | Moderate (predicted) | SSH1 | 0.038 | -2.370 | Actin Cytoskeleton Signaling |
hsa-miR-4462 | 0.011 | 3.900 | TargetScan Human | Moderate (predicted) | STX1A | 0.023 | -2.640 | Huntington's Disease Signaling |
hsa-miR-4463 | 0.005 | 5.800 | TargetScan Human | Moderate (predicted) | ADAR | 0.000 | -3.030 | Activation of IRF by Cytosolic Pattern Recognition Receptors |
hsa-miR-4463 | 0.005 | 5.800 | TargetScan Human | High (predicted) | AGO2 | 0.047 | -2.560 | EIF2 Signaling, Regulation of eIF4 and p70S6K Signaling |
hsa-miR-4463 | 0.005 | 5.800 | TargetScan Human | Moderate (predicted) | AHCTF1 | 0.024 | -1.520 | |
hsa-miR-4463 | 0.005 | 5.800 | TargetScan Human | Moderate (predicted) | ASAP2 | 0.000 | -5.940 | |
hsa-miR-4463 | 0.005 | 5.800 | TargetScan Human | Moderate (predicted) | ATP6V1B2 | 0.011 | -2.120 | phagosome maturation |
hsa-miR-4463 | 0.005 | 5.800 | TargetScan Human | Moderate (predicted) | B4GALT1 | 0.000 | -1.790 | |
hsa-miR-4463 | 0.005 | 5.800 | TargetScan Human | Moderate (predicted) | BCR | 0.000 | -2.390 | |
hsa-miR-4463 | 0.005 | 5.800 | TargetScan Human | Moderate (predicted) | CTIF | 0.000 | -2.160 | |
hsa-miR-4463 | 0.005 | 5.800 | TargetScan Human | Moderate (predicted) | DDX41 | 0.000 | -1.490 | |
hsa-miR-4463 | 0.005 | 5.800 | TargetScan Human | Moderate (predicted) | DGKD | 0.000 | -3.610 | Adipogenesis pathway |
hsa-miR-4463 | 0.005 | 5.800 | TargetScan Human | Moderate (predicted) | FSTL1 | 0.001 | -2.680 | |
hsa-miR-4463 | 0.005 | 5.800 | TargetScan Human | Moderate (predicted) | HEATR1 | 0.022 | -3.960 | |
hsa-miR-4463 | 0.005 | 5.800 | TargetScan Human | Moderate (predicted) | HERC6 | 0.055 | -2.310 | |
hsa-miR-4463 | 0.005 | 5.800 | TargetScan Human | Moderate (predicted) | INF2 | 0.004 | -7.710 | |
hsa-miR-4463 | 0.005 | 5.800 | TargetScan Human | Moderate (predicted) | KLF13 | 0.000 | -1.520 | |
hsa-miR-4463 | 0.005 | 5.800 | TargetScan Human | Moderate (predicted) | MAGED2 | 0.000 | -2.720 | |
hsa-miR-4463 | 0.005 | 5.800 | TargetScan Human | Moderate (predicted) | MIEF1 | 0.000 | -1.840 | |
hsa-miR-4463 | 0.005 | 5.800 | TargetScan Human | Moderate (predicted) | N4BP2L1 | 0.018 | -1.720 | |
hsa-miR-4463 | 0.005 | 5.800 | TargetScan Human | Moderate (predicted) | NCOA7 | 0.000 | -2.080 | Aryl Hydrocarbon Receptor Signaling |
hsa-miR-4463 | 0.005 | 5.800 | TargetScan Human | Moderate (predicted) | SEPN1 | 0.003 | -2.715 | |
hsa-miR-4463 | 0.005 | 5.800 | TargetScan Human | Moderate (predicted) | SYNM | 0.012 | -2.420 | |
hsa-miR-4463 | 0.005 | 5.800 | TargetScan Human | Moderate (predicted) | TXNL4B | 0.000 | -2.420 | |
hsa-miR-4463 | 0.005 | 5.800 | TargetScan Human | Moderate (predicted) | TXNRD1 | 0.000 | -2.170 | Antioxidant Action of Vitamin C, NRF2-mediated Oxidative Stress Response, Thioredoxin Pathway, Vitamin-C Transport |
hsa-miR-4463 | 0.005 | 5.800 | TargetScan Human | Moderate (predicted) | UBQLN3 | 0.002 | -1.530 | |
hsa-miR-4463 | 0.005 | 5.800 | TargetScan Human | Moderate (predicted) | VCP | 0.001 | -2.420 | NRF2-mediated Oxidative Stress Response, Unfolded protein response |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | ABHD4 | 0.000 | -2.080 | |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | ADAR | 0.000 | -3.030 | Activation of IRF by Cytosolic Pattern Recognition Receptors |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | High (predicted) | ARF3 | 0.007 | -4.170 | Integrin Signaling |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | ARID3B | 0.000 | -1.480 | |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | ATP6V0A1 | 0.000 | -2.370 | phagosome maturation |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | High (predicted) | BCL2L2 | 0.000 | -2.780 | |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | C11orf21 | 0.000 | -2.570 | |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | C1orf116 | 0.000 | -3.090 | |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | High (predicted) | CD44 | 0.001 | -1.750 | Chondroitin Sulfate Degradation (Metazoa), Dermatan Sulfate Degradation (Metazoa), Glioma Invasiveness Signaling, HIPPO signaling, Leukocyte Extravasation Signaling, Ovarian Cancer Signaling, Rac Signaling, RhoGDI Signaling, Wnt/β-catenin Signaling |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | CIRBP | 0.036 | -1.490 | |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | CLEC16A | 0.000 | -1.950 | |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | CMTM3 | 0.021 | -2.380 | |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | DGKD | 0.000 | -3.610 | Adipogenesis pathway |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | High (predicted) | DIABLO | 0.015 | -1.630 | Apoptosis Signaling, Ceramide Signaling, Death Receptor Signaling, Induction of Apoptosis by HIV1, Lymphotoxin β Receptor Signaling, Molecular Mechanisms of Cancer |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | ELMO2 | 0.000 | -1.600 | CXCR4 Signaling |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | EPN1 | 0.000 | -3.280 | Clathrin-mediated Endocytosis Signaling, Epithelial Adherens Junction Signaling, Germ Cell-Sertoli Cell Junction Signaling, Sertoli Cell-Sertoli Cell Junction Signaling |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | EZR | 0.000 | -1.740 | Actin Cytoskeleton Signaling, Agranulocyte Adhesion and Diapedesis, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, Granulocyte Adhesion and Diapedesis, Leukocyte Extravasation Signaling, Regulation of Cellular Mechanics by Calpain Protease, RhoA Signaling, RhoGDI Signaling, Signaling by Rho Family GTPases |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | High (predicted) | FAM214B | 0.000 | -2.930 | |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | FNTB | 0.049 | -3.080 | Geranylgeranyldiphosphate Biosynthesis, Superpathway of Geranylgeranyldiphosphate Biosynthesis I (via Mevalonate) |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | FSTL1 | 0.001 | -2.680 | |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | High (predicted) | GID8 | 0.000 | -1.560 | |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | High (predicted), Moderate (predicted) | GLG1 | 0.000 | -1.790 | Agranulocyte Adhesion and Diapedesis, Atherosclerosis Signaling, Granulocyte Adhesion and Diapedesis |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | GNAZ | 0.000 | -8.090 | Androgen Signaling, Axonal Guidance Signaling, Cardiac Hypertrophy Signaling, CREB Signaling in Neurons, CXCR4 Signaling, Endothelin-1 Signaling, Ephrin B Signaling, Ephrin Receptor Signaling, G Beta Gamma Signaling, IL-1 Signaling, Molecular Mechanisms of Cancer, Relaxin Signaling, RhoGDI Signaling, Role of NFAT in Regulation of the Immune Response, Signaling by Rho Family GTPases, Synaptic Long Term Depression, Tec Kinase Signaling, Thrombin Signaling |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | HCFC1 | 0.000 | -2.690 | |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | High (predicted) | HDGF | 0.000 | -3.240 | |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | HYAL3 | 0.008 | -1.780 | Chondroitin Sulfate Degradation (Metazoa), Dermatan Sulfate Degradation (Metazoa) |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | KIAA1191 | 0.044 | -2.600 | |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | LPAR5 | 0.006 | -5.010 | eNOS Signaling, GPCR-Mediated Nutrient Sensing in Enteroendocrine Cells, Gα12/13 Signaling, RhoA Signaling |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | MAPKAPK2 | 0.000 | -2.530 | Cardiac Hypertrophy Signaling, CD40 Signaling, FGF Signaling, IL-17 Signaling, IL-6 Signaling, p38 MAPK Signaling, RAR Activation, Role of IL-17A in Arthritis, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | High (predicted) | MOB3C | 0.010 | -6.740 | |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | MYH9 | 0.052 | -7.770 | Actin Cytoskeleton Signaling, Agranulocyte Adhesion and Diapedesis, Calcium Signaling, Cellular Effects of Sildenafil (Viagra), Epithelial Adherens Junction Signaling, Hepatic Fibrosis / Hepatic Stellate Cell Activation, ILK Signaling, Tight Junction Signaling |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | High (predicted) | MYO1C | 0.053 | -1.450 | |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | PGAM1 | 0.002 | -4.110 | Gluconeogenesis I, Glycolysis I, Rapoport-Luebering Glycolytic Shunt |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | PGAM4 | 0.000 | -3.175 | 3-phosphoinositide Biosynthesis, 3-phosphoinositide Degradation, D-myo-inositol (1, 4, 5, 6)-Tetrakisphosphate Biosynthesis, D-myo-inositol (3, 4, 5, 6)-tetrakisphosphate Biosynthesis, D-myo-inositol-5-phosphate Metabolism, Gluconeogenesis I, Glycolysis I, Superpathway of Inositol Phosphate Compounds |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | PLEK | 0.000 | -3.490 | |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | High (predicted) | PNKD | 0.000 | -8.870 | |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | PPP2R2D | 0.003 | -3.490 | Triacylglycerol Biosynthesis |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | RAB1B | 0.000 | -3.170 | |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | RALB | 0.007 | -2.320 | Gαi Signaling, Integrin Signaling, Molecular Mechanisms of Cancer, Phospholipase C Signaling |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | RGS6 | 0.000 | -1.580 | |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | SEPN1 | 0.003 | -2.715 | |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | SRPRA | 0.000 | -1.510 | |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | High (predicted) | STIM1 | 0.000 | -2.840 | |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | STK4 | 0.000 | -5.670 | HIPPO signaling, Non-Small Cell Lung Cancer Signaling |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | TADA3 | 0.053 | -2.670 | |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | High (predicted) | TANGO2 | 0.018 | -3.430 | |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | TBC1D20 | 0.000 | -1.635 | |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | TMEM189 | 0.000 | -1.660 | |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | TPM4 | 0.020 | -3.620 | Calcium Signaling |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | TUBB1 | 0.043 | -2.280 | 14-3-3-mediated Signaling, Axonal Guidance Signaling, Breast Cancer Regulation by Stathmin1, Epithelial Adherens Junction Signaling, Gap Junction Signaling, Germ Cell-Sertoli Cell Junction Signaling, phagosome maturation, Remodeling of Epithelial Adherens Junctions, Sertoli Cell-Sertoli Cell Junction Signaling |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | UBE2G1 | 0.000 | -1.770 | Hypoxia Signaling in the Cardiovascular System, Protein Ubiquitination Pathway |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | High (predicted) | UBE2M | 0.000 | -1.890 | Hypoxia Signaling in the Cardiovascular System, Protein Ubiquitination Pathway |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | VASP | 0.001 | -1.680 | Actin Nucleation by ARP-WASP Complex, Axonal Guidance Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, IL-8 Signaling, Integrin Signaling, Leukocyte Extravasation Signaling, Protein Kinase A Signaling, Tight Junction Signaling |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | WASF2 | 0.003 | -3.850 | Actin Cytoskeleton Signaling, PEDF Signaling, RhoGDI Signaling |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | ZBED1 | 0.031 | -2.780 | |
hsa-miR-4745-5p | 0.006 | 6.800 | TargetScan Human | Moderate (predicted) | ZMIZ2 | 0.025 | -1.570 | |
hsa-miR-4486 | 0.003 | 14.800 | TargetScan Human | Moderate (predicted) | AKAP13 | 0.000 | -1.500 | cAMP-mediated signaling, Cardiac β-adrenergic Signaling, Protein Kinase A Signaling |
hsa-miR-4486 | 0.003 | 14.800 | TargetScan Human | Moderate (predicted) | BCL2L2 | 0.000 | -2.780 | |
hsa-miR-4486 | 0.003 | 14.800 | TargetScan Human | Moderate (predicted) | BCR | 0.000 | -2.390 | |
hsa-miR-4486 | 0.003 | 14.800 | TargetScan Human | Moderate (predicted) | CHSY1 | 0.000 | -1.710 | Chondroitin and Dermatan Biosynthesis, Chondroitin Sulfate Biosynthesis, Chondroitin Sulfate Biosynthesis (Late Stages), Dermatan Sulfate Biosynthesis |
hsa-miR-4486 | 0.003 | 14.800 | TargetScan Human | Moderate (predicted) | CMTM3 | 0.021 | -2.380 | |
hsa-miR-4486 | 0.003 | 14.800 | TargetScan Human | Moderate (predicted) | CRKL | 0.000 | -6.590 | Actin Cytoskeleton Signaling, Axonal Guidance Signaling, Chronic Myeloid Leukemia Signaling, Ephrin Receptor Signaling, ERK/MAPK Signaling, FGF Signaling, HGF Signaling, IL-3 Signaling, Insulin Receptor Signaling, Integrin Signaling, Leukocyte Extravasation Signaling, Neuregulin Signaling, PDGF Signaling, Reelin Signaling in Neurons, Role of PI3K/AKT Signaling in the Pathogenesis of Influenza, SAPK/JNK Signaling |
hsa-miR-4486 | 0.003 | 14.800 | TargetScan Human | Moderate (predicted) | CTDSP1 | 0.000 | -6.090 | |
hsa-miR-4486 | 0.003 | 14.800 | TargetScan Human | Moderate (predicted) | CTNNBIP1 | 0.000 | -1.990 | Adipogenesis pathway |
hsa-miR-4486 | 0.003 | 14.800 | TargetScan Human | Moderate (predicted) | FYN | 0.000 | -3.053 | 3-phosphoinositide Biosynthesis, Axonal Guidance Signaling, Caveolar-mediated Endocytosis Signaling, CD28 Signaling in T Helper Cells, CTLA4 Signaling in Cytotoxic T Lymphocytes, Ephrin A Signaling, Ephrin Receptor Signaling, ERK/MAPK Signaling, FAK Signaling, Fc Epsilon RI Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, G-Protein Coupled Receptor Signaling, Inhibition of Angiogenesis by TSP1, Insulin Receptor Signaling, Integrin Signaling, Molecular Mechanisms of Cancer, Natural Killer Cell Signaling, Phospholipase C Signaling, PI3K Signaling in B Lymphocytes, PKCθ Signaling in T Lymphocytes, Prolactin Signaling, Reelin Signaling in Neurons, Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes, Role of NFAT in Regulation of the Immune Response, Role of Tissue Factor in Cancer, Semaphorin Signaling in Neurons, Superpathway of Inositol Phosphate Compounds, T Cell Receptor Signaling, Tec Kinase Signaling, Virus Entry via Endocytic Pathways |
hsa-miR-4486 | 0.003 | 14.800 | TargetScan Human | Moderate (predicted) | KLHL6 | 0.000 | -1.920 | |
hsa-miR-4486 | 0.003 | 14.800 | TargetScan Human | Moderate (predicted) | LTB | 0.054 | -1.760 | Altered T Cell and B Cell Signaling in Rheumatoid Arthritis, Crosstalk between Dendritic Cells and Natural Killer Cells, Dendritic Cell Maturation, Lymphotoxin β Receptor Signaling, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis |
hsa-miR-4486 | 0.003 | 14.800 | TargetScan Human | High (predicted), Moderate (predicted) | MAPKAPK2 | 0.000 | -2.530 | Cardiac Hypertrophy Signaling, CD40 Signaling, FGF Signaling, IL-17 Signaling, IL-6 Signaling, p38 MAPK Signaling, RAR Activation, Role of IL-17A in Arthritis, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis |
hsa-miR-4486 | 0.003 | 14.800 | TargetScan Human | Moderate (predicted) | MGLL | 0.014 | -4.850 | Triacylglycerol Degradation |
hsa-miR-4486 | 0.003 | 14.800 | TargetScan Human | Moderate (predicted) | NBEAL2 | 0.000 | -2.380 | |
hsa-miR-4486 | 0.003 | 14.800 | TargetScan Human | Moderate (predicted) | PLEK | 0.000 | -3.490 | |
hsa-miR-4486 | 0.003 | 14.800 | TargetScan Human | Moderate (predicted) | PNKD | 0.000 | -8.870 | |
hsa-miR-4486 | 0.003 | 14.800 | TargetScan Human | Moderate (predicted) | RAB11FIP3 | 0.000 | -7.870 | |
hsa-miR-4486 | 0.003 | 14.800 | TargetScan Human | Moderate (predicted) | RBM14 | 0.000 | -1.760 | |
hsa-miR-4486 | 0.003 | 14.800 | TargetScan Human | Moderate (predicted) | SEC14L1 | 0.044 | -3.080 | |
hsa-miR-4486 | 0.003 | 14.800 | TargetScan Human | High (predicted) | SLX4 | 0.012 | -5.420 | |
hsa-miR-4486 | 0.003 | 14.800 | TargetScan Human | Moderate (predicted) | SNX6 | 0.002 | -1.760 | |
hsa-miR-4486 | 0.003 | 14.800 | TargetScan Human | Moderate (predicted) | SRPRA | 0.000 | -1.510 | |
hsa-miR-4486 | 0.003 | 14.800 | TargetScan Human | Moderate (predicted) | SUSD3 | 0.000 | -7.290 | |
hsa-miR-4486 | 0.003 | 14.800 | TargetScan Human | Moderate (predicted) | TADA3 | 0.053 | -2.670 | |
hsa-miR-4486 | 0.003 | 14.800 | TargetScan Human | Moderate (predicted) | TAL1 | 0.000 | -5.160 | |
hsa-miR-4486 | 0.003 | 14.800 | TargetScan Human | Moderate (predicted) | TAPBP | 0.002 | -2.820 | Antigen Presentation Pathway |
hsa-miR-4486 | 0.003 | 14.800 | TargetScan Human | Moderate (predicted) | TBC1D20 | 0.000 | -1.635 | |
hsa-miR-4486 | 0.003 | 14.800 | TargetScan Human | Moderate (predicted) | TNIP1 | 0.007 | -1.560 | Angiopoietin Signaling, NF-κB Signaling, RAR Activation |
hsa-miR-4486 | 0.003 | 14.800 | TargetScan Human | High (predicted) | UBE2O | 0.000 | -3.240 | |
hsa-miR-4486 | 0.003 | 14.800 | TargetScan Human | Moderate (predicted) | UBN1 | 0.000 | -5.410 | |
hsa-miR-4486 | 0.003 | 14.800 | TargetScan Human | Moderate (predicted) | WIPI2 | 0.000 | -1.700 | |
hsa-miR-4486 | 0.003 | 14.800 | TargetScan Human | Moderate (predicted) | ZSWIM7 | 0.000 | -2.590 | |
hsa-miR-4523 | 0.000 | 2.200 | TargetScan Human | Moderate (predicted) | ATP6V1B2 | 0.011 | -2.120 | phagosome maturation |
hsa-miR-4523 | 0.000 | 2.200 | TargetScan Human | Moderate (predicted) | C1orf116 | 0.000 | -3.090 | |
hsa-miR-4523 | 0.000 | 2.200 | TargetScan Human | Moderate (predicted) | CABLES1 | 0.000 | -1.940 | CDK5 Signaling |
hsa-miR-4523 | 0.000 | 2.200 | TargetScan Human | Moderate (predicted) | CBX6 | 0.018 | -2.680 | |
hsa-miR-4523 | 0.000 | 2.200 | TargetScan Human | Moderate (predicted) | CDS2 | 0.007 | -1.900 | CDP-diacylglycerol Biosynthesis I, Phosphatidylglycerol Biosynthesis II (Non-plastidic) |
hsa-miR-4523 | 0.000 | 2.200 | TargetScan Human | Moderate (predicted) | CORO1C | 0.000 | -5.630 | |
hsa-miR-4523 | 0.000 | 2.200 | TargetScan Human | Moderate (predicted) | FAM13B | 0.000 | -1.490 | |
hsa-miR-4523 | 0.000 | 2.200 | TargetScan Human | Moderate (predicted) | FAM65B | 0.011 | -2.360 | |
hsa-miR-4523 | 0.000 | 2.200 | TargetScan Human | Moderate (predicted) | H3F3A/H3F3B | 0.000 | -4.180 | ERK/MAPK Signaling, Estrogen Receptor Signaling, p38 MAPK Signaling, Protein Kinase A Signaling, UVB-Induced MAPK Signaling |
hsa-miR-4523 | 0.000 | 2.200 | TargetScan Human | Moderate (predicted) | JARID2 | 0.000 | -3.110 | Role of Oct4 in Mammalian Embryonic Stem Cell Pluripotency |
hsa-miR-4523 | 0.000 | 2.200 | TargetScan Human | High (predicted) | NEURL1B | 0.006 | -1.480 | |
hsa-miR-4523 | 0.000 | 2.200 | TargetScan Human | Moderate (predicted) | PBX3 | 0.000 | -2.170 | |
hsa-miR-4523 | 0.000 | 2.200 | TargetScan Human | High (predicted) | PGK1 | 0.030 | -2.270 | Gluconeogenesis I, Glycolysis I |
hsa-miR-4523 | 0.000 | 2.200 | TargetScan Human | Moderate (predicted) | TNS3 | 0.000 | -8.510 | 3-phosphoinositide Biosynthesis, 3-phosphoinositide Degradation, D-myo-inositol (1, 4, 5, 6)-Tetrakisphosphate Biosynthesis, D-myo-inositol (3, 4, 5, 6)-tetrakisphosphate Biosynthesis, D-myo-inositol-5-phosphate Metabolism, Superpathway of Inositol Phosphate Compounds |
hsa-miR-4523 | 0.000 | 2.200 | TargetScan Human | Moderate (predicted) | VHL | 0.000 | -2.145 | HIF1α Signaling, Hypoxia Signaling in the Cardiovascular System, Protein Ubiquitination Pathway, Renal Cell Carcinoma Signaling |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | ADAR | 0.000 | -3.030 | Activation of IRF by Cytosolic Pattern Recognition Receptors |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | ADCK3 | 0.000 | -1.710 | p53 Signaling |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | High (predicted) | ARHGEF3 | 0.000 | -1.660 | Breast Cancer Regulation by Stathmin1, Molecular Mechanisms of Cancer, Phospholipase C Signaling, Reelin Signaling in Neurons, RhoGDI Signaling, Signaling by Rho Family GTPases, Thrombin Signaling |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | ARMC7 | 0.000 | -1.860 | |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | ARPP19 | 0.000 | -3.540 | |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | ATXN7L3 | 0.025 | -2.710 | |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | B4GALT1 | 0.000 | -1.790 | |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | C9orf78 | 0.003 | -1.480 | |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | CALM1 (includes others) | 0.000 | -15.670 | 1D-myo-inositol Hexakisphosphate Biosynthesis II (Mammalian), Androgen Signaling, B Cell Receptor Signaling, Breast Cancer Regulation by Stathmin1, Calcium Signaling, Calcium-induced T Lymphocyte Apoptosis, cAMP-mediated signaling, Cardiac Hypertrophy Signaling, CCR3 Signaling in Eosinophils, CCR5 Signaling in Macrophages, CD28 Signaling in T Helper Cells, Cellular Effects of Sildenafil (Viagra), Chemokine Signaling, Corticotropin Releasing Hormone Signaling, CREB Signaling in Neurons, D-myo-inositol (1, 3, 4)-trisphosphate Biosynthesis, Dopamine-DARPP32 Feedback in cAMP Signaling, eNOS Signaling, fMLP Signaling in Neutrophils, Glioma Signaling, Glutamate Receptor Signaling, Gαq Signaling, iCOS-iCOSL Signaling in T Helper Cells, iNOS Signaling, Melatonin Signaling, Nitric Oxide Signaling in the Cardiovascular System, nNOS Signaling in Neurons, nNOS Signaling in Skeletal Muscle Cells, Nur77 Signaling in T Lymphocytes, Phospholipase C Signaling, PI3K Signaling in B Lymphocytes, Protein Kinase A Signaling, RANK Signaling in Osteoclasts, Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of NFAT in Cardiac Hypertrophy, Role of NFAT in Regulation of the Immune Response, Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis, Sperm Motility, Superpathway of D-myo-inositol (1, 4, 5)-trisphosphate Metabolism, Superpathway of Inositol Phosphate Compounds, Synaptic Long Term Potentiation, T Cell Receptor Signaling, α-Adrenergic Signaling |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | CBL | 0.000 | -1.740 | 14-3-3-mediated Signaling, Clathrin-mediated Endocytosis Signaling, Ephrin B Signaling, Erythropoietin Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, FLT3 Signaling in Hematopoietic Progenitor Cells, Insulin Receptor Signaling, Molecular Mechanisms of Cancer, PI3K Signaling in B Lymphocytes, Protein Ubiquitination Pathway, PTEN Signaling, RANK Signaling in Osteoclasts, Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis, Systemic Lupus Erythematosus Signaling, T Cell Receptor Signaling |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | High (predicted) | CDV3 | 0.000 | -1.480 | |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | High (predicted) | CTDSPL | 0.000 | -16.420 | |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | EHD3 | 0.000 | -4.610 | |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | EIF4H | 0.000 | -2.140 | |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | ENDOD1 | 0.000 | -16.800 | |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | ETS1 | 0.000 | -1.570 | B Cell Receptor Signaling, ERK/MAPK Signaling, GM-CSF Signaling, HGF Signaling, Regulation of the Epithelial-Mesenchymal Transition Pathway, Renal Cell Carcinoma Signaling, Telomerase Signaling |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | EZR | 0.000 | -1.740 | Actin Cytoskeleton Signaling, Agranulocyte Adhesion and Diapedesis, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, Granulocyte Adhesion and Diapedesis, Leukocyte Extravasation Signaling, Regulation of Cellular Mechanics by Calpain Protease, RhoA Signaling, RhoGDI Signaling, Signaling by Rho Family GTPases |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | FOPNL | 0.035 | -1.800 | |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | FOXO1 | 0.000 | -1.700 | 14-3-3-mediated Signaling, Adipogenesis pathway, AMPK Signaling, Angiopoietin Signaling, B Cell Receptor Signaling, Cancer Drug Resistance By Drug Efflux, Cell Cycle: G1/S Checkpoint Regulation, Docosahexaenoic Acid (DHA) Signaling, ErbB Signaling, ErbB2-ErbB3 Signaling, FXR/RXR Activation, Glioblastoma Multiforme Signaling, HER-2 Signaling in Breast Cancer, Human Embryonic Stem Cell Pluripotency, IGF-1 Signaling, IL-3 Signaling, Insulin Receptor Signaling, Leptin Signaling in Obesity, Molecular Mechanisms of Cancer, PI3K/AKT Signaling, Prostate Cancer Signaling, PTEN Signaling, PXR/RXR Activation, Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis, VDR/RXR Activation, VEGF Signaling |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | GFOD1 | 0.000 | -2.330 | |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | GID8 | 0.000 | -1.560 | |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | High (predicted) | GUCD1 | 0.000 | -2.490 | |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | HECTD4 | 0.000 | -2.070 | |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | IGF2BP3 | 0.041 | -1.850 | |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | IRS1 | 0.007 | -1.490 | 14-3-3-mediated Signaling, 3-phosphoinositide Biosynthesis, Actin Cytoskeleton Signaling, Acute Myeloid Leukemia Signaling, Aldosterone Signaling in Epithelial Cells, AMPK Signaling, Amyotrophic Lateral Sclerosis Signaling, Angiopoietin Signaling, Antiproliferative Role of Somatostatin Receptor 2, Axonal Guidance Signaling, B Cell Receptor Signaling, Breast Cancer Regulation by Stathmin1, Cardiac Hypertrophy Signaling, CCR3 Signaling in Eosinophils, CD28 Signaling in T Helper Cells, CD40 Signaling, Ceramide Signaling, Chronic Myeloid Leukemia Signaling, Clathrin-mediated Endocytosis Signaling, CNTF Signaling, Colorectal Cancer Metastasis Signaling, CREB Signaling in Neurons, CTLA4 Signaling in Cytotoxic T Lymphocytes, CXCR4 Signaling, Dendritic Cell Maturation, Docosahexaenoic Acid (DHA) Signaling, EGF Signaling, EIF2 Signaling, Endometrial Cancer Signaling, Endothelin-1 Signaling, eNOS Signaling, Ephrin A Signaling, ErbB Signaling, ErbB2-ErbB3 Signaling, ErbB4 Signaling, ERK/MAPK Signaling, Erythropoietin Signaling, Estrogen-Dependent Breast Cancer Signaling, FAK Signaling, Fc Epsilon RI Signaling, FcγRIIB Signaling in B Lymphocytes, FGF Signaling, FLT3 Signaling in Hematopoietic Progenitor Cells, fMLP Signaling in Neutrophils, G-Protein Coupled Receptor Signaling, Gap Junction Signaling, GDNF Family Ligand-Receptor Interactions, Germ Cell-Sertoli Cell Junction Signaling, Glioblastoma Multiforme Signaling, Glioma Invasiveness Signaling, Glioma Signaling, Glucocorticoid Receptor Signaling, GM-CSF Signaling, Growth Hormone Signaling, Gα12/13 Signaling, Gαq Signaling, HER-2 Signaling in Breast Cancer, Hereditary Breast Cancer Signaling, HGF Signaling, HIF1α Signaling, HMGB1 Signaling, Human Embryonic Stem Cell Pluripotency, Huntington's Disease Signaling, iCOS-iCOSL Signaling in T Helper Cells, IGF-1 Signaling, IL-12 Signaling and Production in Macrophages, IL-15 Signaling, IL-17 Signaling, IL-17A Signaling in Airway Cells, IL-2 Signaling, IL-3 Signaling, IL-4 Signaling, IL-6 Signaling, IL-8 Signaling, IL-9 Signaling, ILK Signaling, Insulin Receptor Signaling, Integrin Signaling, JAK/Stat Signaling, Leptin Signaling in Obesity, Leukocyte Extravasation Signaling, LPS-stimulated MAPK Signaling, Lymphotoxin β Receptor Signaling, Macropinocytosis Signaling, Melanocyte Development and Pigmentation Signaling, Melanoma Signaling, Molecular Mechanisms of Cancer, Mouse Embryonic Stem Cell Pluripotency, MSP-RON Signaling Pathway, mTOR Signaling, Myc Mediated Apoptosis Signaling, Natural Killer Cell Signaling, Neuropathic Pain Signaling In Dorsal Horn Neurons, Neurotrophin/TRK Signaling, NF-κB Activation by Viruses, NF-κB Signaling, NGF Signaling, Nitric Oxide Signaling in the Cardiovascular System, Non-Small Cell Lung Cancer Signaling, NRF2-mediated Oxidative Stress Response, Ovarian Cancer Signaling, P2Y Purigenic Receptor Signaling Pathway, p53 Signaling, p70S6K Signaling, PAK Signaling, Pancreatic Adenocarcinoma Signaling, Paxillin Signaling, PDGF Signaling, PEDF Signaling, phagosome formation, PI3K Signaling in B Lymphocytes, PKCθ Signaling in T Lymphocytes, PPARα/RXRα Activation, Production of Nitric Oxide and Reactive Oxygen Species in Macrophages, Prolactin Signaling, Prostate Cancer Signaling, Rac Signaling, RANK Signaling in Osteoclasts, Reelin Signaling in Neurons, Regulation of eIF4 and p70S6K Signaling, Regulation of the Epithelial-Mesenchymal Transition Pathway, Relaxin Signaling, Renal Cell Carcinoma Signaling, Renin-Angiotensin Signaling, Role of IL-17A in Arthritis, Role of JAK1 and JAK3 in γc Cytokine Signaling, Role of JAK2 in Hormone-like Cytokine Signaling, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of NANOG in Mammalian Embryonic Stem Cell Pluripotency, Role of NFAT in Cardiac Hypertrophy, Role of NFAT in Regulation of the Immune Response, Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis, Role of p14/p19ARF in Tumor Suppression, Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses, Role of PI3K/AKT Signaling in the Pathogenesis of Influenza, Role of Tissue Factor in Cancer, SAPK/JNK Signaling, Signaling by Rho Family GTPases, Small Cell Lung Cancer Signaling, Sphingosine-1-phosphate Signaling, Superpathway of Inositol Phosphate Compounds, Systemic Lupus Erythematosus Signaling, T Cell Receptor Signaling, Tec Kinase Signaling, Telomerase Signaling, Thrombin Signaling, Thrombopoietin Signaling, TR/RXR Activation, Type II Diabetes Mellitus Signaling, UVA-Induced MAPK Signaling, UVB-Induced MAPK Signaling, VEGF Family Ligand-Receptor Interactions, VEGF Signaling, Virus Entry via Endocytic Pathways, Xenobiotic Metabolism Signaling |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | ISCA1 | 0.001 | -2.320 | |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | KIF2A | 0.000 | -3.540 | |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | LAPTM4B | 0.000 | -2.845 | |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | LIMS1 | 0.016 | -2.617 | ILK Signaling, Integrin Signaling, PI3K/AKT Signaling |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | LPAR5 | 0.006 | -5.010 | eNOS Signaling, GPCR-Mediated Nutrient Sensing in Enteroendocrine Cells, Gα12/13 Signaling, RhoA Signaling |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | MBP | 0.000 | -12.630 | |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | MICU1 | 0.009 | -2.080 | Calcium Signaling |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | MSRB1 | 0.000 | -1.800 | |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | MTPN | 0.010 | -4.220 | |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | NECAP2 | 0.000 | -1.660 | |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | PACSIN2 | 0.001 | -2.040 | |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | PCTP | 0.000 | -2.100 | |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | PFKFB3 | 0.000 | -3.080 | AMPK Signaling |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | High (predicted) | PSAP | 0.000 | -1.860 | Lipid Antigen Presentation by CD1 |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | PSME4 | 0.001 | -3.180 | Huntington's Disease Signaling, Polyamine Regulation in Colon Cancer |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | RNF14 | 0.016 | -1.530 | |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | SEC16A | 0.003 | -1.470 | 1D-myo-inositol Hexakisphosphate Biosynthesis II (Mammalian), D-myo-inositol (1, 3, 4)-trisphosphate Biosynthesis, D-myo-inositol (1, 4, 5)-trisphosphate Degradation, Superpathway of D-myo-inositol (1, 4, 5)-trisphosphate Metabolism, Superpathway of Inositol Phosphate Compounds |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | SECISBP2 | 0.000 | -2.500 | |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | SET | 0.023 | -2.160 | 3-phosphoinositide Biosynthesis, 3-phosphoinositide Degradation, D-myo-inositol (1, 4, 5, 6)-Tetrakisphosphate Biosynthesis, D-myo-inositol (3, 4, 5, 6)-tetrakisphosphate Biosynthesis, D-myo-inositol-5-phosphate Metabolism, Granzyme A Signaling, Superpathway of Inositol Phosphate Compounds, Transcriptional Regulatory Network in Embryonic Stem Cells |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | SHCBP1 | 0.041 | -1.510 | |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | SLA2 | 0.030 | -1.900 | |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | SLC9A1 | 0.006 | -4.300 | Actin Cytoskeleton Signaling, Aldosterone Signaling in Epithelial Cells, Signaling by Rho Family GTPases |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | STK24 | 0.000 | -7.300 | |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | TAPBP | 0.002 | -2.820 | Antigen Presentation Pathway |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | TBC1D20 | 0.000 | -1.635 | |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | TM2D2 | 0.006 | -2.160 | |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | TMEM50A | 0.000 | -1.800 | |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | TPM3 | 0.038 | -3.010 | Calcium Signaling |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | ULK1 | 0.000 | -4.635 | AMPK Signaling, autophagy, mTOR Signaling |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | High (predicted) | VASH1 | 0.007 | -1.690 | |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | VPS8 | 0.000 | -2.130 | |
hsa-miR-4530 | 0.009 | 5.000 | TargetScan Human | Moderate (predicted) | XK | 0.000 | -3.400 | |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | ADD1 | 0.002 | -2.540 | Gαs Signaling, Protein Kinase A Signaling |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | High (predicted) | ADRBK1 | 0.004 | -2.180 | cAMP-mediated signaling, Cardiac β-adrenergic Signaling, Colorectal Cancer Metastasis Signaling, G-Protein Coupled Receptor Signaling, Gαq Signaling, Sonic Hedgehog Signaling |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | AFAP1 | 0.000 | -4.990 | |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | ARHGEF18 | 0.000 | -2.180 | Breast Cancer Regulation by Stathmin1, Molecular Mechanisms of Cancer, Phospholipase C Signaling, RhoGDI Signaling, Signaling by Rho Family GTPases |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | BCL2L1 | 0.009 | -1.600 | Amyotrophic Lateral Sclerosis Signaling, Apoptosis Signaling, B Cell Receptor Signaling, CD27 Signaling in Lymphocytes, Chronic Myeloid Leukemia Signaling, Colorectal Cancer Metastasis Signaling, Docosahexaenoic Acid (DHA) Signaling, Glucocorticoid Receptor Signaling, GM-CSF Signaling, Huntington's Disease Signaling, IL-15 Signaling, IL-8 Signaling, Induction of Apoptosis by HIV1, JAK/Stat Signaling, Lymphotoxin β Receptor Signaling, Molecular Mechanisms of Cancer, OX40 Signaling Pathway, p53 Signaling, Pancreatic Adenocarcinoma Signaling, PEDF Signaling, PI3K/AKT Signaling, PTEN Signaling, Role of Tissue Factor in Cancer, Small Cell Lung Cancer Signaling, UVA-Induced MAPK Signaling, VEGF Signaling |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | High (predicted) | BCL2L2 | 0.000 | -2.780 | |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | BTBD11 | 0.000 | -6.920 | |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | C15orf39 | 0.016 | -1.560 | |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | C7orf49 | 0.000 | -2.050 | |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | High (predicted) | CBX6 | 0.018 | -2.680 | |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | CIB1 | 0.000 | -1.570 | |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | High (predicted) | CLCN7 | 0.013 | -2.270 | |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | CLEC16A | 0.000 | -1.950 | |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | CS | 0.010 | -1.530 | TCA Cycle II (Eukaryotic) |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | High (predicted) | CSNK1G2 | 0.027 | -4.220 | Dopamine-DARPP32 Feedback in cAMP Signaling, Gap Junction Signaling, Role of NFAT in Regulation of the Immune Response, Role of Wnt/GSK-3β Signaling in the Pathogenesis of Influenza, Wnt/β-catenin Signaling |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | CTDSPL | 0.000 | -16.420 | |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | CTNS | 0.027 | -3.420 | |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | DENND3 | 0.000 | -1.540 | |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | EIF4H | 0.000 | -2.140 | |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | GATA2 | 0.008 | -1.630 | Thrombin Signaling |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | GFOD1 | 0.000 | -2.330 | |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | GLG1 | 0.000 | -1.790 | Agranulocyte Adhesion and Diapedesis, Atherosclerosis Signaling, Granulocyte Adhesion and Diapedesis |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | HCLS1 | 0.001 | -1.740 | |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | INPPL1 | 0.028 | -1.890 | 1D-myo-inositol Hexakisphosphate Biosynthesis II (Mammalian), 3-phosphoinositide Degradation, B Cell Receptor Signaling, D-myo-inositol (1, 3, 4)-trisphosphate Biosynthesis, D-myo-inositol (1, 4, 5)-trisphosphate Degradation, Fc Epsilon RI Signaling, IL-4 Signaling, Insulin Receptor Signaling, Natural Killer Cell Signaling, PDGF Signaling, phagosome formation, PI3K/AKT Signaling, PTEN Signaling, Superpathway of D-myo-inositol (1, 4, 5)-trisphosphate Metabolism, Superpathway of Inositol Phosphate Compounds |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | JUND | 0.000 | -2.380 | Corticotropin Releasing Hormone Signaling, NRF2-mediated Oxidative Stress Response, PCP pathway |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | High (predicted) | LMNA | 0.018 | -3.860 | Apoptosis Signaling, Death Receptor Signaling |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | LRBA | 0.013 | -4.940 | |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | MEF2D | 0.000 | -2.260 | Calcium Signaling, Calcium-induced T Lymphocyte Apoptosis, Cardiac Hypertrophy Signaling, Cholecystokinin/Gastrin-mediated Signaling, Corticotropin Releasing Hormone Signaling, ERK5 Signaling, Gα12/13 Signaling, Nur77 Signaling in T Lymphocytes, p38 MAPK Signaling, Phospholipase C Signaling, Role of NFAT in Cardiac Hypertrophy, Role of NFAT in Regulation of the Immune Response |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | MICU1 | 0.009 | -2.080 | Calcium Signaling |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | MPRIP | 0.000 | -1.630 | Actin Cytoskeleton Signaling, CCR3 Signaling in Eosinophils, Cdc42 Signaling, Cellular Effects of Sildenafil (Viagra), Chemokine Signaling, Integrin Signaling, Phospholipase C Signaling, Regulation of Actin-based Motility by Rho, RhoA Signaling, Thrombin Signaling |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | MTHFR | 0.000 | -1.760 | Folate Transformations I |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | High (predicted) | NBEAL2 | 0.000 | -2.380 | |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | NCOR2 | 0.000 | -1.650 | Aryl Hydrocarbon Receptor Signaling, Estrogen Receptor Signaling, Glucocorticoid Receptor Signaling, Huntington's Disease Signaling, LXR/RXR Activation, PPAR Signaling, PPARα/RXRα Activation, RAR Activation, TR/RXR Activation, VDR/RXR Activation, Xenobiotic Metabolism Signaling |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | NR1H2 | 0.001 | -1.780 | LPS/IL-1 Mediated Inhibition of RXR Function, LXR/RXR Activation |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | PIP5K1C | 0.000 | -2.520 | 3-phosphoinositide Biosynthesis, Actin Cytoskeleton Signaling, Aldosterone Signaling in Epithelial Cells, Clathrin-mediated Endocytosis Signaling, D-myo-inositol (1, 4, 5)-Trisphosphate Biosynthesis, Rac Signaling, Regulation of Actin-based Motility by Rho, RhoA Signaling, RhoGDI Signaling, Signaling by Rho Family GTPases, Superpathway of Inositol Phosphate Compounds |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | PRRT3 | 0.000 | -1.530 | |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | PTP4A3 | 0.001 | -1.870 | |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | High (predicted), Moderate (predicted) | QSOX1 | 0.006 | -1.750 | |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | RASA3 | 0.038 | -2.150 | |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | RNF44 | 0.000 | -1.520 | |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | SEPN1 | 0.003 | -2.715 | |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | SHKBP1 | 0.000 | -1.530 | |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | SLC22A23 | 0.000 | -1.970 | |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | SLC35E1 | 0.000 | -3.270 | |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | High (predicted) | SLC39A3 | 0.000 | -2.730 | |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | SMG7 | 0.000 | -1.740 | |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | SYK | 0.003 | -4.360 | B Cell Receptor Signaling, CD28 Signaling in T Helper Cells, CTLA4 Signaling in Cytotoxic T Lymphocytes, Fc Epsilon RI Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, FcγRIIB Signaling in B Lymphocytes, IL-15 Signaling, IL-2 Signaling, Natural Killer Cell Signaling, p70S6K Signaling, phagosome formation, Phospholipase C Signaling, PI3K Signaling in B Lymphocytes, Role of JAK1 and JAK3 in γc Cytokine Signaling, Role of NFAT in Regulation of the Immune Response, Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | SYT11 | 0.000 | -1.590 | |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | TBC1D13 | 0.000 | -2.330 | |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | High (predicted) | TMEM189 | 0.000 | -1.660 | |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | High (predicted) | TMSB10/TMSB4X | 0.002 | -1.460 | Actin Cytoskeleton Signaling, ILK Signaling |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | TNFRSF14 | 0.028 | -3.390 | Atherosclerosis Signaling, NF-κB Activation by Viruses |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | High (predicted) | TRIM8 | 0.002 | -2.680 | |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | TSC22D4 | 0.000 | -2.190 | |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | High (predicted) | UBE2L3 | 0.000 | -2.790 | Hypoxia Signaling in the Cardiovascular System, Protein Ubiquitination Pathway |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | High (predicted) | UPF1 | 0.016 | -1.490 | |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | VPS37B | 0.000 | -5.390 | phagosome maturation |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | VPS37C | 0.000 | -2.020 | Mechanisms of Viral Exit from Host Cells, phagosome maturation |
hsa-miR-4532 | 0.001 | 24.900 | TargetScan Human | Moderate (predicted) | XYLT2 | 0.000 | -2.470 | Chondroitin Sulfate Biosynthesis, Dermatan Sulfate Biosynthesis, Glycoaminoglycan-protein Linkage Region Biosynthesis, Heparan Sulfate Biosynthesis |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | ABHD4 | 0.000 | -2.080 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | ADD1 | 0.002 | -2.540 | Gαs Signaling, Protein Kinase A Signaling |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | ANKRD28 | 0.001 | -1.900 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | ANO6 | 0.000 | -15.080 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | ANTXR2 | 0.000 | -1.950 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | AP1B1 | 0.000 | -2.400 | Clathrin-mediated Endocytosis Signaling, CTLA4 Signaling in Cytotoxic T Lymphocytes, GABA Receptor Signaling, Lipid Antigen Presentation by CD1, Virus Entry via Endocytic Pathways |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | ARAP1 | 0.000 | -1.620 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | ARF1 | 0.040 | -4.970 | Integrin Signaling, Paxillin Signaling |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | ARF3 | 0.007 | -4.170 | Integrin Signaling |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | ARHGDIA | 0.042 | -1.740 | Regulation of Actin-based Motility by Rho, RhoGDI Signaling |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | ARHGEF18 | 0.000 | -2.180 | Breast Cancer Regulation by Stathmin1, Molecular Mechanisms of Cancer, Phospholipase C Signaling, RhoGDI Signaling, Signaling by Rho Family GTPases |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | ARMC7 | 0.000 | -1.860 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | ARPC4 | 0.015 | -1.570 | Actin Cytoskeleton Signaling, Actin Nucleation by ARP-WASP Complex, Axonal Guidance Signaling, CD28 Signaling in T Helper Cells, Cdc42 Signaling, Clathrin-mediated Endocytosis Signaling, Ephrin Receptor Signaling, Epithelial Adherens Junction Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, fMLP Signaling in Neutrophils, Integrin Signaling, Rac Signaling, Regulation of Actin-based Motility by Rho, Remodeling of Epithelial Adherens Junctions, RhoA Signaling, RhoGDI Signaling, Signaling by Rho Family GTPases |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | ARRB1 | 0.002 | -3.440 | Clathrin-mediated Endocytosis Signaling, Colorectal Cancer Metastasis Signaling, Ovarian Cancer Signaling, Role of Tissue Factor in Cancer |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | ATP2A2 | 0.002 | -1.480 | Calcium Signaling, Calcium Transport I, Calcium-induced T Lymphocyte Apoptosis, Cardiac β-adrenergic Signaling, Dopamine-DARPP32 Feedback in cAMP Signaling, Nitric Oxide Signaling in the Cardiovascular System |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | ATP6V0A1 | 0.000 | -2.370 | phagosome maturation |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | ATXN7L3 | 0.025 | -2.710 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | B4GALT1 | 0.000 | -1.790 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | BCL2L1 | 0.009 | -1.600 | Amyotrophic Lateral Sclerosis Signaling, Apoptosis Signaling, B Cell Receptor Signaling, CD27 Signaling in Lymphocytes, Chronic Myeloid Leukemia Signaling, Colorectal Cancer Metastasis Signaling, Docosahexaenoic Acid (DHA) Signaling, Glucocorticoid Receptor Signaling, GM-CSF Signaling, Huntington's Disease Signaling, IL-15 Signaling, IL-8 Signaling, Induction of Apoptosis by HIV1, JAK/Stat Signaling, Lymphotoxin β Receptor Signaling, Molecular Mechanisms of Cancer, OX40 Signaling Pathway, p53 Signaling, Pancreatic Adenocarcinoma Signaling, PEDF Signaling, PI3K/AKT Signaling, PTEN Signaling, Role of Tissue Factor in Cancer, Small Cell Lung Cancer Signaling, UVA-Induced MAPK Signaling, VEGF Signaling |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | BCL7B | 0.053 | -1.530 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | BCR | 0.000 | -2.390 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | C15orf39 | 0.016 | -1.560 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | CALM1 (includes others) | 0.000 | -15.670 | 1D-myo-inositol Hexakisphosphate Biosynthesis II (Mammalian), Androgen Signaling, B Cell Receptor Signaling, Breast Cancer Regulation by Stathmin1, Calcium Signaling, Calcium-induced T Lymphocyte Apoptosis, cAMP-mediated signaling, Cardiac Hypertrophy Signaling, CCR3 Signaling in Eosinophils, CCR5 Signaling in Macrophages, CD28 Signaling in T Helper Cells, Cellular Effects of Sildenafil (Viagra), Chemokine Signaling, Corticotropin Releasing Hormone Signaling, CREB Signaling in Neurons, D-myo-inositol (1, 3, 4)-trisphosphate Biosynthesis, Dopamine-DARPP32 Feedback in cAMP Signaling, eNOS Signaling, fMLP Signaling in Neutrophils, Glioma Signaling, Glutamate Receptor Signaling, Gαq Signaling, iCOS-iCOSL Signaling in T Helper Cells, iNOS Signaling, Melatonin Signaling, Nitric Oxide Signaling in the Cardiovascular System, nNOS Signaling in Neurons, nNOS Signaling in Skeletal Muscle Cells, Nur77 Signaling in T Lymphocytes, Phospholipase C Signaling, PI3K Signaling in B Lymphocytes, Protein Kinase A Signaling, RANK Signaling in Osteoclasts, Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of NFAT in Cardiac Hypertrophy, Role of NFAT in Regulation of the Immune Response, Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis, Sperm Motility, Superpathway of D-myo-inositol (1, 4, 5)-trisphosphate Metabolism, Superpathway of Inositol Phosphate Compounds, Synaptic Long Term Potentiation, T Cell Receptor Signaling, α-Adrenergic Signaling |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | CBX6 | 0.018 | -2.680 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | CDKN1A | 0.006 | -10.640 | AMPK Signaling, Antiproliferative Role of Somatostatin Receptor 2, Aryl Hydrocarbon Receptor Signaling, ATM Signaling, Bladder Cancer Signaling, Breast Cancer Regulation by Stathmin1, Cell Cycle: G1/S Checkpoint Regulation, Cell Cycle: G2/M DNA Damage Checkpoint Regulation, Chronic Myeloid Leukemia Signaling, Cyclins and Cell Cycle Regulation, Estrogen-mediated S-phase Entry, GADD45 Signaling, Glioblastoma Multiforme Signaling, Glioma Signaling, Glucocorticoid Receptor Signaling, HER-2 Signaling in Breast Cancer, Hereditary Breast Cancer Signaling, HGF Signaling, JAK/Stat Signaling, Melanoma Signaling, Molecular Mechanisms of Cancer, p53 Signaling, Pancreatic Adenocarcinoma Signaling, PI3K/AKT Signaling, Prostate Cancer Signaling, PTEN Signaling, Role of BRCA1 in DNA Damage Response, Role of CHK Proteins in Cell Cycle Checkpoint Control, STAT3 Pathway, Telomerase Signaling, VDR/RXR Activation |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | CDS2 | 0.007 | -1.900 | CDP-diacylglycerol Biosynthesis I, Phosphatidylglycerol Biosynthesis II (Non-plastidic) |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | CHMP1A | 0.026 | -1.940 | Axonal Guidance Signaling |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | CLCN7 | 0.013 | -2.270 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | CLEC2L | 0.011 | -1.450 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | CPNE5 | 0.019 | -4.210 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | CTNNBIP1 | 0.000 | -1.990 | Adipogenesis pathway |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | CTNS | 0.027 | -3.420 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | DCAF12 | 0.000 | -1.920 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | DDA1 | 0.024 | -2.040 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | DGKD | 0.000 | -3.610 | Adipogenesis pathway |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | DLG4 | 0.021 | -2.030 | Glutamate Receptor Signaling, HIPPO signaling, Huntington's Disease Signaling, Neuregulin Signaling, nNOS Signaling in Neurons |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | DNAJA2 | 0.005 | -1.460 | NRF2-mediated Oxidative Stress Response, Unfolded protein response |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | DNAJC8 | 0.000 | -2.150 | Aldosterone Signaling in Epithelial Cells, NRF2-mediated Oxidative Stress Response, Protein Ubiquitination Pathway |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | DSCR3 | 0.000 | -2.070 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | EFHD2 | 0.000 | -2.500 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | EPN1 | 0.000 | -3.280 | Clathrin-mediated Endocytosis Signaling, Epithelial Adherens Junction Signaling, Germ Cell-Sertoli Cell Junction Signaling, Sertoli Cell-Sertoli Cell Junction Signaling |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | FAM120A | 0.000 | -2.420 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | FAM214B | 0.000 | -2.930 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | FNBP1 | 0.000 | -1.530 | Actin Nucleation by ARP-WASP Complex, Cardiac Hypertrophy Signaling, Cholecystokinin/Gastrin-mediated Signaling, Colorectal Cancer Metastasis Signaling, CXCR4 Signaling, Germ Cell-Sertoli Cell Junction Signaling, Glioblastoma Multiforme Signaling, Glioma Invasiveness Signaling, Gαq Signaling, HMGB1 Signaling, IL-8 Signaling, ILK Signaling, Integrin Signaling, Molecular Mechanisms of Cancer, mTOR Signaling, phagosome formation, Phospholipase C Signaling, Production of Nitric Oxide and Reactive Oxygen Species in Macrophages, Regulation of Actin-based Motility by Rho, RhoGDI Signaling, Semaphorin Signaling in Neurons, Signaling by Rho Family GTPases, Sphingosine-1-phosphate Signaling, Tec Kinase Signaling, Thrombin Signaling |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | GNAZ | 0.000 | -8.090 | Androgen Signaling, Axonal Guidance Signaling, Cardiac Hypertrophy Signaling, CREB Signaling in Neurons, CXCR4 Signaling, Endothelin-1 Signaling, Ephrin B Signaling, Ephrin Receptor Signaling, G Beta Gamma Signaling, IL-1 Signaling, Molecular Mechanisms of Cancer, Relaxin Signaling, RhoGDI Signaling, Role of NFAT in Regulation of the Immune Response, Signaling by Rho Family GTPases, Synaptic Long Term Depression, Tec Kinase Signaling, Thrombin Signaling |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | GP6 | 0.009 | -1.890 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | GTDC1 | 0.000 | -1.570 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | GUCD1 | 0.000 | -2.490 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | HCFC1 | 0.000 | -2.690 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | HCLS1 | 0.001 | -1.740 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | HDGF | 0.000 | -3.240 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | HLA-DRA | 0.000 | -1.685 | Allograft Rejection Signaling, Altered T Cell and B Cell Signaling in Rheumatoid Arthritis, Antigen Presentation Pathway, Autoimmune Thyroid Disease Signaling, B Cell Development, Calcium-induced T Lymphocyte Apoptosis, CD28 Signaling in T Helper Cells, Cdc42 Signaling, Communication between Innate and Adaptive Immune Cells, Crosstalk between Dendritic Cells and Natural Killer Cells, Dendritic Cell Maturation, Graft-versus-Host Disease Signaling, iCOS-iCOSL Signaling in T Helper Cells, IL-4 Signaling, Nur77 Signaling in T Lymphocytes, OX40 Signaling Pathway, phagosome maturation, PKCθ Signaling in T Lymphocytes, Role of NFAT in Regulation of the Immune Response, T Helper Cell Differentiation, Type I Diabetes Mellitus Signaling |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | IP6K1 | 0.000 | -1.647 | Inositol Pyrophosphates Biosynthesis, Superpathway of Inositol Phosphate Compounds |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | ITIH5 | 0.000 | -1.600 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | LMNA | 0.018 | -3.860 | Apoptosis Signaling, Death Receptor Signaling |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | MAP1A | 0.000 | -5.290 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | MAPK8IP3 | 0.000 | -1.500 | Reelin Signaling in Neurons, SAPK/JNK Signaling |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | MAPKAPK2 | 0.000 | -2.530 | Cardiac Hypertrophy Signaling, CD40 Signaling, FGF Signaling, IL-17 Signaling, IL-6 Signaling, p38 MAPK Signaling, RAR Activation, Role of IL-17A in Arthritis, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | MAPRE2 | 0.050 | -2.680 | Remodeling of Epithelial Adherens Junctions |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | MEF2D | 0.000 | -2.260 | Calcium Signaling, Calcium-induced T Lymphocyte Apoptosis, Cardiac Hypertrophy Signaling, Cholecystokinin/Gastrin-mediated Signaling, Corticotropin Releasing Hormone Signaling, ERK5 Signaling, Gα12/13 Signaling, Nur77 Signaling in T Lymphocytes, p38 MAPK Signaling, Phospholipase C Signaling, Role of NFAT in Cardiac Hypertrophy, Role of NFAT in Regulation of the Immune Response |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | MICU1 | 0.009 | -2.080 | Calcium Signaling |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | MID1IP1 | 0.000 | -1.540 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | MLEC | 0.000 | -1.745 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | MSRB1 | 0.000 | -1.800 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | MTMR14 | 0.000 | -1.580 | 3-phosphoinositide Degradation |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | NCOA1 | 0.000 | -2.820 | Androgen Signaling, Estrogen Receptor Signaling, Glucocorticoid Receptor Signaling, HIF1α Signaling, IL-12 Signaling and Production in Macrophages, LPS/IL-1 Mediated Inhibition of RXR Function, PPAR Signaling, PXR/RXR Activation, RAR Activation, Role of Wnt/GSK-3β Signaling in the Pathogenesis of Influenza, TR/RXR Activation, VDR/RXR Activation, Xenobiotic Metabolism Signaling |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | NCOA7 | 0.000 | -2.080 | Aryl Hydrocarbon Receptor Signaling |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | NEURL1B | 0.006 | -1.480 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | NKIRAS2 | 0.014 | -2.140 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | NPRL3 | 0.001 | -2.140 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | ORMDL3 | 0.019 | -3.370 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | PCSK7 | 0.009 | -1.660 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | PFKFB3 | 0.000 | -3.080 | AMPK Signaling |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | PIP5K1C | 0.000 | -2.520 | 3-phosphoinositide Biosynthesis, Actin Cytoskeleton Signaling, Aldosterone Signaling in Epithelial Cells, Clathrin-mediated Endocytosis Signaling, D-myo-inositol (1, 4, 5)-Trisphosphate Biosynthesis, Rac Signaling, Regulation of Actin-based Motility by Rho, RhoA Signaling, RhoGDI Signaling, Signaling by Rho Family GTPases, Superpathway of Inositol Phosphate Compounds |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | POLR1D | 0.029 | -2.260 | Assembly of RNA Polymerase I Complex |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | PROSER2 | 0.000 | -2.530 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | PRRT3 | 0.000 | -1.530 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | PSMF1 | 0.008 | -1.690 | Huntington's Disease Signaling, Polyamine Regulation in Colon Cancer |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | PTGIR | 0.038 | -2.020 | cAMP-mediated signaling, Eicosanoid Signaling, G-Protein Coupled Receptor Signaling, Gαs Signaling |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | PTPRF | 0.000 | -4.400 | 3-phosphoinositide Biosynthesis, 3-phosphoinositide Degradation, D-myo-inositol (1, 4, 5, 6)-Tetrakisphosphate Biosynthesis, D-myo-inositol (3, 4, 5, 6)-tetrakisphosphate Biosynthesis, D-myo-inositol-5-phosphate Metabolism, Insulin Receptor Signaling, Protein Kinase A Signaling, Superpathway of Inositol Phosphate Compounds |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | PUM2 | 0.000 | -1.620 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | QSOX1 | 0.006 | -1.750 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | RAB1B | 0.000 | -3.170 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | RALBP1 | 0.010 | -1.900 | Molecular Mechanisms of Cancer, Pancreatic Adenocarcinoma Signaling |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | RBM4 | 0.000 | -1.500 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | RCC2 | 0.000 | -4.220 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | RCOR3 | 0.005 | -1.950 | Huntington's Disease Signaling |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | RGS6 | 0.000 | -1.580 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | SCAND1 | 0.024 | -1.630 | PPAR Signaling, RAR Activation, Xenobiotic Metabolism Signaling |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | SELP | 0.001 | -5.730 | Agranulocyte Adhesion and Diapedesis, Atherosclerosis Signaling, Granulocyte Adhesion and Diapedesis |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | SEPN1 | 0.003 | -2.715 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | SERF2 | 0.005 | -1.630 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | SH3PXD2A | 0.000 | -3.860 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | SLC35D2 | 0.000 | -3.490 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | SLC35D3 | 0.000 | -1.980 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | SLC39A3 | 0.000 | -2.730 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | SLC9A1 | 0.006 | -4.300 | Actin Cytoskeleton Signaling, Aldosterone Signaling in Epithelial Cells, Signaling by Rho Family GTPases |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | SLX4 | 0.012 | -5.420 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | SMAP2 | 0.005 | -3.070 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | SPHK1 | 0.007 | -4.360 | Ceramide Signaling, Human Embryonic Stem Cell Pluripotency, PDGF Signaling, Sphingosine-1-phosphate Signaling |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | SRC | 0.000 | -7.470 | 14-3-3-mediated Signaling, Agrin Interactions at Neuromuscular Junction, AMPK Signaling, Androgen Signaling, Antiproliferative Role of Somatostatin Receptor 2, Aryl Hydrocarbon Receptor Signaling, cAMP-mediated signaling, Caveolar-mediated Endocytosis Signaling, Cdc42 Signaling, Chemokine Signaling, Cholecystokinin/Gastrin-mediated Signaling, Clathrin-mediated Endocytosis Signaling, Colorectal Cancer Metastasis Signaling, CXCR4 Signaling, EGF Signaling, Endothelin-1 Signaling, Ephrin Receptor Signaling, Epithelial Adherens Junction Signaling, ERK/MAPK Signaling, ERK5 Signaling, Erythropoietin Signaling, Estrogen Receptor Signaling, Estrogen-Dependent Breast Cancer Signaling, FAK Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, G Beta Gamma Signaling, G-Protein Coupled Receptor Signaling, Gap Junction Signaling, Germ Cell-Sertoli Cell Junction Signaling, Glioblastoma Multiforme Signaling, GNRH Signaling, Gα12/13 Signaling, Gαi Signaling, Gαs Signaling, IL-8 Signaling, Integrin Signaling, Leukocyte Extravasation Signaling, Macropinocytosis Signaling, Melanocyte Development and Pigmentation Signaling, Molecular Mechanisms of Cancer, Neuregulin Signaling, Neuropathic Pain Signaling In Dorsal Horn Neurons, Ovarian Cancer Signaling, p70S6K Signaling, Paxillin Signaling, PDGF Signaling, Phospholipase C Signaling, RANK Signaling in Osteoclasts, RAR Activation, Reelin Signaling in Neurons, Regulation of Cellular Mechanics by Calpain Protease, Remodeling of Epithelial Adherens Junctions, RhoGDI Signaling, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of NFAT in Cardiac Hypertrophy, Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis, Role of Tissue Factor in Cancer, Sertoli Cell-Sertoli Cell Junction Signaling, STAT3 Pathway, Tec Kinase Signaling, Thrombin Signaling, UVC-Induced MAPK Signaling, VEGF Signaling, Virus Entry via Endocytic Pathways, Wnt/β-catenin Signaling |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | SRF | 0.000 | -1.770 | Cardiac Hypertrophy Signaling, Cholecystokinin/Gastrin-mediated Signaling, EGF Signaling, ERK/MAPK Signaling, Growth Hormone Signaling, IGF-1 Signaling, IL-6 Signaling, LPS-stimulated MAPK Signaling, p38 MAPK Signaling, PDGF Signaling, PEDF Signaling |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | SRGN | 0.025 | -1.700 | Tumoricidal Function of Hepatic Natural Killer Cells |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | STARD8 | 0.000 | -2.730 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | STIM1 | 0.000 | -2.840 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | STK24 | 0.000 | -7.300 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | STX1A | 0.023 | -2.640 | Huntington's Disease Signaling |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | SYTL4 | 0.009 | -3.290 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | TBC1D20 | 0.000 | -1.635 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | TMCC2 | 0.000 | -3.300 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | TMEM189 | 0.000 | -1.660 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | TNFSF4 | 0.001 | -6.110 | OX40 Signaling Pathway |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | TNS1 | 0.000 | -2.530 | FAK Signaling |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | TNS3 | 0.000 | -8.510 | 3-phosphoinositide Biosynthesis, 3-phosphoinositide Degradation, D-myo-inositol (1, 4, 5, 6)-Tetrakisphosphate Biosynthesis, D-myo-inositol (3, 4, 5, 6)-tetrakisphosphate Biosynthesis, D-myo-inositol-5-phosphate Metabolism, Superpathway of Inositol Phosphate Compounds |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | TPM3 | 0.038 | -3.010 | Calcium Signaling |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | TPM4 | 0.020 | -3.620 | Calcium Signaling |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | TPP1 | 0.013 | -5.000 | Telomerase Signaling |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | TTC7B | 0.000 | -1.550 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | TTYH3 | 0.000 | -2.680 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | TXNL4B | 0.000 | -2.420 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | UBA1 | 0.003 | -3.120 | Protein Ubiquitination Pathway |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | UBE2M | 0.000 | -1.890 | Hypoxia Signaling in the Cardiovascular System, Protein Ubiquitination Pathway |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | UQCRH | 0.021 | -1.450 | Mitochondrial Dysfunction, Oxidative Phosphorylation |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | VASP | 0.001 | -1.680 | Actin Nucleation by ARP-WASP Complex, Axonal Guidance Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, IL-8 Signaling, Integrin Signaling, Leukocyte Extravasation Signaling, Protein Kinase A Signaling, Tight Junction Signaling |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | WNK1 | 0.000 | -1.760 | ERK5 Signaling |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | High (predicted) | ZMIZ2 | 0.025 | -1.570 | |
hsa-miR-4651 | 0.010 | 5.700 | TargetScan Human | Moderate (predicted) | ZZEF1 | 0.000 | -2.950 | |
hsa-miR-4674 | 0.003 | 10.200 | TargetScan Human | Moderate (predicted) | AKT1 | 0.003 | -1.870 | 14-3-3-mediated Signaling, Acute Myeloid Leukemia Signaling, Acute Phase Response Signaling, Adipogenesis pathway, AMPK Signaling, Amyloid Processing, Angiopoietin Signaling, Axonal Guidance Signaling, B Cell Receptor Signaling, Cancer Drug Resistance By Drug Efflux, Cardiac Hypertrophy Signaling, CD28 Signaling in T Helper Cells, Ceramide Signaling, Chronic Myeloid Leukemia Signaling, CNTF Signaling, Colorectal Cancer Metastasis Signaling, CREB Signaling in Neurons, CTLA4 Signaling in Cytotoxic T Lymphocytes, CXCR4 Signaling, Dendritic Cell Maturation, DNA damage-induced 14-3-3σ Signaling, Docosahexaenoic Acid (DHA) Signaling, EGF Signaling, EIF2 Signaling, Endometrial Cancer Signaling, eNOS Signaling, Ephrin Receptor Signaling, Epithelial Adherens Junction Signaling, ErbB Signaling, ErbB2-ErbB3 Signaling, ErbB4 Signaling, ERK5 Signaling, Erythropoietin Signaling, Estrogen-Dependent Breast Cancer Signaling, FAK Signaling, Fc Epsilon RI Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, FcγRIIB Signaling in B Lymphocytes, FGF Signaling, FLT3 Signaling in Hematopoietic Progenitor Cells, FXR/RXR Activation, G Beta Gamma Signaling, G-Protein Coupled Receptor Signaling, Gap Junction Signaling, Germ Cell-Sertoli Cell Junction Signaling, Glioblastoma Multiforme Signaling, Glioma Signaling, Glucocorticoid Receptor Signaling, GM-CSF Signaling, Gα12/13 Signaling, Gαq Signaling, HER-2 Signaling in Breast Cancer, Hereditary Breast Cancer Signaling, HGF Signaling, HIF1α Signaling, HMGB1 Signaling, Human Embryonic Stem Cell Pluripotency, Huntington's Disease Signaling, Hypoxia Signaling in the Cardiovascular System, iCOS-iCOSL Signaling in T Helper Cells, IGF-1 Signaling, IL-12 Signaling and Production in Macrophages, IL-15 Signaling, IL-17 Signaling, IL-17A Signaling in Airway Cells, IL-2 Signaling, IL-22 Signaling, IL-3 Signaling, IL-4 Signaling, IL-6 Signaling, IL-8 Signaling, ILK Signaling, Inhibition of Angiogenesis by TSP1, Insulin Receptor Signaling, Integrin Signaling, JAK/Stat Signaling, Leptin Signaling in Obesity, Lymphotoxin β Receptor Signaling, Melanoma Signaling, Molecular Mechanisms of Cancer, Mouse Embryonic Stem Cell Pluripotency, mTOR Signaling, Myc Mediated Apoptosis Signaling, Natural Killer Cell Signaling, Neuregulin Signaling, Neurotrophin/TRK Signaling, NF-κB Activation by Viruses, NF-κB Signaling, NGF Signaling, Nitric Oxide Signaling in the Cardiovascular System, Non-Small Cell Lung Cancer Signaling, NRF2-mediated Oxidative Stress Response, Ovarian Cancer Signaling, P2Y Purigenic Receptor Signaling Pathway, p53 Signaling, p70S6K Signaling, Pancreatic Adenocarcinoma Signaling, PEDF Signaling, PI3K Signaling in B Lymphocytes, PI3K/AKT Signaling, Production of Nitric Oxide and Reactive Oxygen Species in Macrophages, Prostate Cancer Signaling, PTEN Signaling, PXR/RXR Activation, RANK Signaling in Osteoclasts, RAR Activation, Reelin Signaling in Neurons, Regulation of eIF4 and p70S6K Signaling, Regulation of the Epithelial-Mesenchymal Transition Pathway, Relaxin Signaling, Renal Cell Carcinoma Signaling, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of MAPK Signaling in the Pathogenesis of Influenza, Role of NANOG in Mammalian Embryonic Stem Cell Pluripotency, Role of NFAT in Cardiac Hypertrophy, Role of NFAT in Regulation of the Immune Response, Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis, Role of PI3K/AKT Signaling in the Pathogenesis of Influenza, Role of PKR in Interferon Induction and Antiviral Response, Role of Tissue Factor in Cancer, Sertoli Cell-Sertoli Cell Junction Signaling, Small Cell Lung Cancer Signaling, Sphingosine-1-phosphate Signaling, Systemic Lupus Erythematosus Signaling, Telomerase Signaling, Thrombin Signaling, Tight Junction Signaling, TR/RXR Activation, TREM1 Signaling, Type II Diabetes Mellitus Signaling, UVB-Induced MAPK Signaling, VEGF Family Ligand-Receptor Interactions, VEGF Signaling, Wnt/β-catenin Signaling |
hsa-miR-4674 | 0.003 | 10.200 | TargetScan Human | Moderate (predicted) | AP1B1 | 0.000 | -2.400 | Clathrin-mediated Endocytosis Signaling, CTLA4 Signaling in Cytotoxic T Lymphocytes, GABA Receptor Signaling, Lipid Antigen Presentation by CD1, Virus Entry via Endocytic Pathways |
hsa-miR-4674 | 0.003 | 10.200 | TargetScan Human | Moderate (predicted) | ARID3B | 0.000 | -1.480 | |
hsa-miR-4674 | 0.003 | 10.200 | TargetScan Human | Moderate (predicted) | BCL2L2 | 0.000 | -2.780 | |
hsa-miR-4674 | 0.003 | 10.200 | TargetScan Human | High (predicted), Moderate (predicted) | BTN3A2 | 0.003 | -2.840 | |
hsa-miR-4674 | 0.003 | 10.200 | TargetScan Human | Moderate (predicted) | C6orf106 | 0.000 | -1.760 | |
hsa-miR-4674 | 0.003 | 10.200 | TargetScan Human | Moderate (predicted) | CABLES1 | 0.000 | -1.940 | CDK5 Signaling |
hsa-miR-4674 | 0.003 | 10.200 | TargetScan Human | Moderate (predicted) | CDC42SE2 | 0.003 | -5.970 | |
hsa-miR-4674 | 0.003 | 10.200 | TargetScan Human | Moderate (predicted) | CHMP6 | 0.047 | -4.410 | Mechanisms of Viral Exit from Host Cells |
hsa-miR-4674 | 0.003 | 10.200 | TargetScan Human | Moderate (predicted) | CMTM3 | 0.021 | -2.380 | |
hsa-miR-4674 | 0.003 | 10.200 | TargetScan Human | High (predicted) | CNPY3 | 0.044 | -1.510 | |
hsa-miR-4674 | 0.003 | 10.200 | TargetScan Human | Moderate (predicted) | FAM172A | 0.031 | -2.420 | |
hsa-miR-4674 | 0.003 | 10.200 | TargetScan Human | Moderate (predicted) | FAM65B | 0.011 | -2.360 | |
hsa-miR-4674 | 0.003 | 10.200 | TargetScan Human | Moderate (predicted) | GDE1 | 0.018 | -2.620 | |
hsa-miR-4674 | 0.003 | 10.200 | TargetScan Human | Moderate (predicted) | GP6 | 0.009 | -1.890 | |
hsa-miR-4674 | 0.003 | 10.200 | TargetScan Human | Moderate (predicted) | HCFC1 | 0.000 | -2.690 | |
hsa-miR-4674 | 0.003 | 10.200 | TargetScan Human | Moderate (predicted) | KIF3C | 0.001 | -2.030 | |
hsa-miR-4674 | 0.003 | 10.200 | TargetScan Human | Moderate (predicted) | LAMC1 | 0.000 | -2.320 | Agrin Interactions at Neuromuscular Junction, CDK5 Signaling |
hsa-miR-4674 | 0.003 | 10.200 | TargetScan Human | Moderate (predicted) | LTA | 0.011 | -2.140 | Activation of IRF by Cytosolic Pattern Recognition Receptors, Altered T Cell and B Cell Signaling in Rheumatoid Arthritis, CD40 Signaling, Crosstalk between Dendritic Cells and Natural Killer Cells, Dendritic Cell Maturation, Hepatic Cholestasis, HMGB1 Signaling, Lymphotoxin β Receptor Signaling, NF-κB Signaling, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses, TNFR2 Signaling, Type I Diabetes Mellitus Signaling |
hsa-miR-4674 | 0.003 | 10.200 | TargetScan Human | High (predicted) | MAP1A | 0.000 | -5.290 | |
hsa-miR-4674 | 0.003 | 10.200 | TargetScan Human | High (predicted) | MBP | 0.000 | -12.630 | |
hsa-miR-4674 | 0.003 | 10.200 | TargetScan Human | Moderate (predicted) | MTMR12 | 0.000 | -2.730 | |
hsa-miR-4674 | 0.003 | 10.200 | TargetScan Human | Moderate (predicted) | NCOA1 | 0.000 | -2.820 | Androgen Signaling, Estrogen Receptor Signaling, Glucocorticoid Receptor Signaling, HIF1α Signaling, IL-12 Signaling and Production in Macrophages, LPS/IL-1 Mediated Inhibition of RXR Function, PPAR Signaling, PXR/RXR Activation, RAR Activation, Role of Wnt/GSK-3β Signaling in the Pathogenesis of Influenza, TR/RXR Activation, VDR/RXR Activation, Xenobiotic Metabolism Signaling |
hsa-miR-4674 | 0.003 | 10.200 | TargetScan Human | Moderate (predicted) | RALB | 0.007 | -2.320 | Gαi Signaling, Integrin Signaling, Molecular Mechanisms of Cancer, Phospholipase C Signaling |
hsa-miR-4674 | 0.003 | 10.200 | TargetScan Human | Moderate (predicted) | REPS2 | 0.015 | -1.855 | |
hsa-miR-4674 | 0.003 | 10.200 | TargetScan Human | Moderate (predicted) | SH3KBP1 | 0.001 | -1.720 | Clathrin-mediated Endocytosis Signaling |
hsa-miR-4674 | 0.003 | 10.200 | TargetScan Human | Moderate (predicted) | SHCBP1 | 0.041 | -1.510 | |
hsa-miR-4674 | 0.003 | 10.200 | TargetScan Human | Moderate (predicted) | SLX4 | 0.012 | -5.420 | |
hsa-miR-4674 | 0.003 | 10.200 | TargetScan Human | Moderate (predicted) | TANGO2 | 0.018 | -3.430 | |
hsa-miR-4674 | 0.003 | 10.200 | TargetScan Human | High (predicted) | TXNL4B | 0.000 | -2.420 | |
hsa-miR-4674 | 0.003 | 10.200 | TargetScan Human | Moderate (predicted) | VPS9D1 | 0.002 | -1.640 | Mitochondrial Dysfunction, Oxidative Phosphorylation |
hsa-miR-4674 | 0.003 | 10.200 | TargetScan Human | Moderate (predicted) | WBP1L | 0.000 | -2.250 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | ADRBK1 | 0.004 | -2.180 | cAMP-mediated signaling, Cardiac β-adrenergic Signaling, Colorectal Cancer Metastasis Signaling, G-Protein Coupled Receptor Signaling, Gαq Signaling, Sonic Hedgehog Signaling |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | AP1M2 | 0.039 | -1.490 | CTLA4 Signaling in Cytotoxic T Lymphocytes |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | ARHGAP1 | 0.003 | -1.490 | Leukocyte Extravasation Signaling, RhoA Signaling, RhoGDI Signaling, Semaphorin Signaling in Neurons |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | ARHGEF18 | 0.000 | -2.180 | Breast Cancer Regulation by Stathmin1, Molecular Mechanisms of Cancer, Phospholipase C Signaling, RhoGDI Signaling, Signaling by Rho Family GTPases |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | High (predicted) | ARID3B | 0.000 | -1.480 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | ARMC7 | 0.000 | -1.860 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | ASAP2 | 0.000 | -5.940 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | ATG9A | 0.000 | -1.785 | autophagy |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | High (predicted) | C11orf21 | 0.000 | -2.570 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | C6orf106 | 0.000 | -1.760 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | CABLES1 | 0.000 | -1.940 | CDK5 Signaling |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | CASP3 | 0.000 | -7.420 | Amyotrophic Lateral Sclerosis Signaling, Apoptosis Signaling, CD27 Signaling in Lymphocytes, Colorectal Cancer Metastasis Signaling, Cytotoxic T Lymphocyte-mediated Apoptosis of Target Cells, Death Receptor Signaling, Docosahexaenoic Acid (DHA) Signaling, Endoplasmic Reticulum Stress Pathway, Endothelin-1 Signaling, eNOS Signaling, Granzyme B Signaling, Huntington's Disease Signaling, ILK Signaling, Induction of Apoptosis by HIV1, Inhibition of Angiogenesis by TSP1, Lymphotoxin β Receptor Signaling, Mitochondrial Dysfunction, Molecular Mechanisms of Cancer, Myc Mediated Apoptosis Signaling, Nur77 Signaling in T Lymphocytes, PAK Signaling, Parkinson's Signaling, PTEN Signaling, Retinoic acid Mediated Apoptosis Signaling, Role of MAPK Signaling in the Pathogenesis of Influenza, Role of PKR in Interferon Induction and Antiviral Response, Role of Tissue Factor in Cancer, Sphingosine-1-phosphate Signaling, TNFR1 Signaling, Tumoricidal Function of Hepatic Natural Killer Cells, TWEAK Signaling, Type I Diabetes Mellitus Signaling, UVA-Induced MAPK Signaling |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | CBX6 | 0.018 | -2.680 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | CDR2L | 0.000 | -3.870 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | CHD4 | 0.020 | -2.770 | DNA Methylation and Transcriptional Repression Signaling |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | CHMP1B | 0.055 | -1.830 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | CLEC16A | 0.000 | -1.950 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | High (predicted) | CLIP2 | 0.000 | -4.440 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | CTDSPL | 0.000 | -16.420 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | High (predicted) | DNAJA2 | 0.005 | -1.460 | NRF2-mediated Oxidative Stress Response, Unfolded protein response |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | DSTN | 0.037 | -1.470 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | FNBP1 | 0.000 | -1.530 | Actin Nucleation by ARP-WASP Complex, Cardiac Hypertrophy Signaling, Cholecystokinin/Gastrin-mediated Signaling, Colorectal Cancer Metastasis Signaling, CXCR4 Signaling, Germ Cell-Sertoli Cell Junction Signaling, Glioblastoma Multiforme Signaling, Glioma Invasiveness Signaling, Gαq Signaling, HMGB1 Signaling, IL-8 Signaling, ILK Signaling, Integrin Signaling, Molecular Mechanisms of Cancer, mTOR Signaling, phagosome formation, Phospholipase C Signaling, Production of Nitric Oxide and Reactive Oxygen Species in Macrophages, Regulation of Actin-based Motility by Rho, RhoGDI Signaling, Semaphorin Signaling in Neurons, Signaling by Rho Family GTPases, Sphingosine-1-phosphate Signaling, Tec Kinase Signaling, Thrombin Signaling |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | FNBP1L | 0.004 | -2.010 | Cdc42 Signaling |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | FNTB | 0.049 | -3.080 | Geranylgeranyldiphosphate Biosynthesis, Superpathway of Geranylgeranyldiphosphate Biosynthesis I (via Mevalonate) |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | GATA2 | 0.008 | -1.630 | Thrombin Signaling |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | High (predicted) | GLG1 | 0.000 | -1.790 | Agranulocyte Adhesion and Diapedesis, Atherosclerosis Signaling, Granulocyte Adhesion and Diapedesis |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | GUCD1 | 0.000 | -2.490 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | ITIH5 | 0.000 | -1.600 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | KATNB1 | 0.029 | -1.990 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | LPIN2 | 0.000 | -1.500 | Triacylglycerol Biosynthesis |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | MAN2A2 | 0.000 | -2.330 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | MAPK8IP3 | 0.000 | -1.500 | Reelin Signaling in Neurons, SAPK/JNK Signaling |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | MGLL | 0.014 | -4.850 | Triacylglycerol Degradation |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | MPRIP | 0.000 | -1.630 | Actin Cytoskeleton Signaling, CCR3 Signaling in Eosinophils, Cdc42 Signaling, Cellular Effects of Sildenafil (Viagra), Chemokine Signaling, Integrin Signaling, Phospholipase C Signaling, Regulation of Actin-based Motility by Rho, RhoA Signaling, Thrombin Signaling |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | MTCH1 | 0.000 | -1.530 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | High (predicted) | MYO1C | 0.053 | -1.450 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | P2RX1 | 0.034 | -3.990 | Gustation Pathway |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | PGK1 | 0.030 | -2.270 | Gluconeogenesis I, Glycolysis I |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | PIP5K1C | 0.000 | -2.520 | 3-phosphoinositide Biosynthesis, Actin Cytoskeleton Signaling, Aldosterone Signaling in Epithelial Cells, Clathrin-mediated Endocytosis Signaling, D-myo-inositol (1, 4, 5)-Trisphosphate Biosynthesis, Rac Signaling, Regulation of Actin-based Motility by Rho, RhoA Signaling, RhoGDI Signaling, Signaling by Rho Family GTPases, Superpathway of Inositol Phosphate Compounds |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | High (predicted) | PLEK | 0.000 | -3.490 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | PRKCA | 0.000 | -2.250 | 14-3-3-mediated Signaling, Aldosterone Signaling in Epithelial Cells, Androgen Signaling, Apoptosis Signaling, Axonal Guidance Signaling, Breast Cancer Regulation by Stathmin1, Calcium-induced T Lymphocyte Apoptosis, Caveolar-mediated Endocytosis Signaling, CCR3 Signaling in Eosinophils, CCR5 Signaling in Macrophages, Chemokine Signaling, Cholecystokinin/Gastrin-mediated Signaling, Corticotropin Releasing Hormone Signaling, CREB Signaling in Neurons, CXCR4 Signaling, Dopamine-DARPP32 Feedback in cAMP Signaling, EGF Signaling, Endothelin-1 Signaling, eNOS Signaling, ErbB Signaling, ErbB4 Signaling, ERK/MAPK Signaling, Erythropoietin Signaling, Factors Promoting Cardiogenesis in Vertebrates, Fc Epsilon RI Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, FGF Signaling, fMLP Signaling in Neutrophils, G Beta Gamma Signaling, G-Protein Coupled Receptor Signaling, Gap Junction Signaling, Glioma Signaling, GNRH Signaling, GPCR-Mediated Nutrient Sensing in Enteroendocrine Cells, Growth Hormone Signaling, Gαq Signaling, Hepatic Cholestasis, HER-2 Signaling in Breast Cancer, HGF Signaling, Huntington's Disease Signaling, IL-12 Signaling and Production in Macrophages, IL-3 Signaling, IL-8 Signaling, Leukocyte Extravasation Signaling, LPS-stimulated MAPK Signaling, Macropinocytosis Signaling, Mechanisms of Viral Exit from Host Cells, Melatonin Signaling, Molecular Mechanisms of Cancer, mTOR Signaling, Natural Killer Cell Signaling, Neuregulin Signaling, Neuropathic Pain Signaling In Dorsal Horn Neurons, NF-κB Activation by Viruses, Nitric Oxide Signaling in the Cardiovascular System, nNOS Signaling in Neurons, Non-Small Cell Lung Cancer Signaling, NRF2-mediated Oxidative Stress Response, P2Y Purigenic Receptor Signaling Pathway, p70S6K Signaling, PDGF Signaling, phagosome formation, Phospholipase C Signaling, PPARα/RXRα Activation, Production of Nitric Oxide and Reactive Oxygen Species in Macrophages, Prolactin Signaling, Protein Kinase A Signaling, RAR Activation, Renin-Angiotensin Signaling, RhoGDI Signaling, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of MAPK Signaling in the Pathogenesis of Influenza, Role of NFAT in Cardiac Hypertrophy, Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses, Role of Tissue Factor in Cancer, Sperm Motility, Synaptic Long Term Depression, Synaptic Long Term Potentiation, Tec Kinase Signaling, Thrombin Signaling, Thrombopoietin Signaling, Type II Diabetes Mellitus Signaling, UVA-Induced MAPK Signaling, UVB-Induced MAPK Signaling, UVC-Induced MAPK Signaling, VDR/RXR Activation, VEGF Family Ligand-Receptor Interactions, VEGF Signaling, Virus Entry via Endocytic Pathways, Wnt/Ca+ pathway, Xenobiotic Metabolism Signaling, α-Adrenergic Signaling |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | PTK2 | 0.000 | -5.750 | Actin Cytoskeleton Signaling, Agrin Interactions at Neuromuscular Junction, Angiopoietin Signaling, Axonal Guidance Signaling, B Cell Receptor Signaling, Chemokine Signaling, Cholecystokinin/Gastrin-mediated Signaling, CXCR4 Signaling, Ephrin A Signaling, Ephrin B Signaling, Ephrin Receptor Signaling, ERK/MAPK Signaling, FAK Signaling, Germ Cell-Sertoli Cell Junction Signaling, Glioma Invasiveness Signaling, GNRH Signaling, Gα12/13 Signaling, HGF Signaling, IGF-1 Signaling, IL-15 Production, IL-15 Signaling, IL-8 Signaling, ILK Signaling, Integrin Signaling, Leukocyte Extravasation Signaling, Molecular Mechanisms of Cancer, PAK Signaling, Paxillin Signaling, Protein Kinase A Signaling, PTEN Signaling, Rac Signaling, Regulation of Cellular Mechanics by Calpain Protease, Renin-Angiotensin Signaling, RhoA Signaling, Semaphorin Signaling in Neurons, Signaling by Rho Family GTPases, Small Cell Lung Cancer Signaling, Sperm Motility, Sphingosine-1-phosphate Signaling, Tec Kinase Signaling, Thrombin Signaling, VEGF Signaling |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | High (predicted) | PTPRF | 0.000 | -4.400 | 3-phosphoinositide Biosynthesis, 3-phosphoinositide Degradation, D-myo-inositol (1, 4, 5, 6)-Tetrakisphosphate Biosynthesis, D-myo-inositol (3, 4, 5, 6)-tetrakisphosphate Biosynthesis, D-myo-inositol-5-phosphate Metabolism, Insulin Receptor Signaling, Protein Kinase A Signaling, Superpathway of Inositol Phosphate Compounds |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | RAB6B | 0.027 | -2.390 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | RAF1 | 0.000 | -1.530 | 14-3-3-mediated Signaling, Actin Cytoskeleton Signaling, Acute Myeloid Leukemia Signaling, Acute Phase Response Signaling, Aldosterone Signaling in Epithelial Cells, Apoptosis Signaling, Axonal Guidance Signaling, B Cell Receptor Signaling, Bladder Cancer Signaling, BMP signaling pathway, Breast Cancer Regulation by Stathmin1, cAMP-mediated signaling, Cancer Drug Resistance By Drug Efflux, Cardiac Hypertrophy Signaling, CCR3 Signaling in Eosinophils, Cdc42 Signaling, CDK5 Signaling, Ceramide Signaling, Chemokine Signaling, Cholecystokinin/Gastrin-mediated Signaling, Chronic Myeloid Leukemia Signaling, CNTF Signaling, Corticotropin Releasing Hormone Signaling, CREB Signaling in Neurons, CXCR4 Signaling, Cyclins and Cell Cycle Regulation, EGF Signaling, EIF2 Signaling, Endometrial Cancer Signaling, Endothelin-1 Signaling, Ephrin Receptor Signaling, ErbB Signaling, ErbB2-ErbB3 Signaling, ErbB4 Signaling, ERK/MAPK Signaling, Erythropoietin Signaling, Estrogen Receptor Signaling, FAK Signaling, Fc Epsilon RI Signaling, FGF Signaling, FLT3 Signaling in Hematopoietic Progenitor Cells, fMLP Signaling in Neutrophils, G Beta Gamma Signaling, G-Protein Coupled Receptor Signaling, Gap Junction Signaling, GDNF Family Ligand-Receptor Interactions, Glioblastoma Multiforme Signaling, Glioma Signaling, Glucocorticoid Receptor Signaling, GM-CSF Signaling, GNRH Signaling, Gα12/13 Signaling, Gαi Signaling, Gαq Signaling, HGF Signaling, IGF-1 Signaling, IL-15 Signaling, IL-2 Signaling, IL-3 Signaling, IL-6 Signaling, IL-8 Signaling, Insulin Receptor Signaling, Integrin Signaling, JAK/Stat Signaling, LPS-stimulated MAPK Signaling, Melanocyte Development and Pigmentation Signaling, Melanoma Signaling, Melatonin Signaling, Molecular Mechanisms of Cancer, Mouse Embryonic Stem Cell Pluripotency, Natural Killer Cell Signaling, Neuregulin Signaling, Neurotrophin/TRK Signaling, NF-κB Activation by Viruses, NF-κB Signaling, NGF Signaling, Non-Small Cell Lung Cancer Signaling, NRF2-mediated Oxidative Stress Response, Oncostatin M Signaling, Ovarian Cancer Signaling, P2Y Purigenic Receptor Signaling Pathway, p70S6K Signaling, PAK Signaling, Pancreatic Adenocarcinoma Signaling, PDGF Signaling, PEDF Signaling, Phospholipase C Signaling, PI3K Signaling in B Lymphocytes, PI3K/AKT Signaling, PPAR Signaling, PPARα/RXRα Activation, Prolactin Signaling, Prostate Cancer Signaling, Protein Kinase A Signaling, PTEN Signaling, Rac Signaling, RANK Signaling in Osteoclasts, Regulation of eIF4 and p70S6K Signaling, Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes, Regulation of the Epithelial-Mesenchymal Transition Pathway, Renal Cell Carcinoma Signaling, Renin-Angiotensin Signaling, Role of IL-17F in Allergic Inflammatory Airway Diseases, Role of JAK1, JAK2 and TYK2 in Interferon Signaling, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of MAPK Signaling in the Pathogenesis of Influenza, Role of NANOG in Mammalian Embryonic Stem Cell Pluripotency, Role of NFAT in Cardiac Hypertrophy, Role of NFAT in Regulation of the Immune Response, Sertoli Cell-Sertoli Cell Junction Signaling, Signaling by Rho Family GTPases, STAT3 Pathway, Synaptic Long Term Depression, Synaptic Long Term Potentiation, T Cell Receptor Signaling, Telomerase Signaling, TGF-β Signaling, Thrombin Signaling, Thrombopoietin Signaling, UVC-Induced MAPK Signaling, VEGF Family Ligand-Receptor Interactions, VEGF Signaling, Xenobiotic Metabolism Signaling, α-Adrenergic Signaling |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | RGS6 | 0.000 | -1.580 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | RNF115 | 0.000 | -2.040 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | SEPN1 | 0.003 | -2.715 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | SERF2 | 0.005 | -1.630 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | High (predicted), Moderate (predicted) | SLCO3A1 | 0.001 | -1.480 | Hepatic Cholestasis |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | High (predicted) | SLX4 | 0.012 | -5.420 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | SPIRE1 | 0.015 | -1.720 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | SRC | 0.000 | -7.470 | 14-3-3-mediated Signaling, Agrin Interactions at Neuromuscular Junction, AMPK Signaling, Androgen Signaling, Antiproliferative Role of Somatostatin Receptor 2, Aryl Hydrocarbon Receptor Signaling, cAMP-mediated signaling, Caveolar-mediated Endocytosis Signaling, Cdc42 Signaling, Chemokine Signaling, Cholecystokinin/Gastrin-mediated Signaling, Clathrin-mediated Endocytosis Signaling, Colorectal Cancer Metastasis Signaling, CXCR4 Signaling, EGF Signaling, Endothelin-1 Signaling, Ephrin Receptor Signaling, Epithelial Adherens Junction Signaling, ERK/MAPK Signaling, ERK5 Signaling, Erythropoietin Signaling, Estrogen Receptor Signaling, Estrogen-Dependent Breast Cancer Signaling, FAK Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, G Beta Gamma Signaling, G-Protein Coupled Receptor Signaling, Gap Junction Signaling, Germ Cell-Sertoli Cell Junction Signaling, Glioblastoma Multiforme Signaling, GNRH Signaling, Gα12/13 Signaling, Gαi Signaling, Gαs Signaling, IL-8 Signaling, Integrin Signaling, Leukocyte Extravasation Signaling, Macropinocytosis Signaling, Melanocyte Development and Pigmentation Signaling, Molecular Mechanisms of Cancer, Neuregulin Signaling, Neuropathic Pain Signaling In Dorsal Horn Neurons, Ovarian Cancer Signaling, p70S6K Signaling, Paxillin Signaling, PDGF Signaling, Phospholipase C Signaling, RANK Signaling in Osteoclasts, RAR Activation, Reelin Signaling in Neurons, Regulation of Cellular Mechanics by Calpain Protease, Remodeling of Epithelial Adherens Junctions, RhoGDI Signaling, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of NFAT in Cardiac Hypertrophy, Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis, Role of Tissue Factor in Cancer, Sertoli Cell-Sertoli Cell Junction Signaling, STAT3 Pathway, Tec Kinase Signaling, Thrombin Signaling, UVC-Induced MAPK Signaling, VEGF Signaling, Virus Entry via Endocytic Pathways, Wnt/β-catenin Signaling |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | STARD8 | 0.000 | -2.730 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | High (predicted) | STK40 | 0.000 | -1.530 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | STX1A | 0.023 | -2.640 | Huntington's Disease Signaling |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | SYTL4 | 0.009 | -3.290 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | TACC1 | 0.000 | -5.110 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | High (predicted) | TAL1 | 0.000 | -5.160 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | TGOLN2 | 0.000 | -2.570 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | High (predicted) | TMEM189 | 0.000 | -1.660 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | TMEM50A | 0.000 | -1.800 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | TRIM8 | 0.002 | -2.680 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | High (predicted) | TSPAN18 | 0.000 | -4.570 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | UBE2L3 | 0.000 | -2.790 | Hypoxia Signaling in the Cardiovascular System, Protein Ubiquitination Pathway |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | UCP2 | 0.049 | -4.070 | Mitochondrial Dysfunction, TR/RXR Activation |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | VASH1 | 0.007 | -1.690 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | WASF2 | 0.003 | -3.850 | Actin Cytoskeleton Signaling, PEDF Signaling, RhoGDI Signaling |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | WBP1L | 0.000 | -2.250 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | XK | 0.000 | -3.400 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | Moderate (predicted) | ZBED1 | 0.031 | -2.780 | |
hsa-miR-4741 | 0.005 | 8.800 | TargetScan Human | High (predicted) | ZMIZ2 | 0.025 | -1.570 | |
hsa-miR-4689 | 0.014 | 6.500 | TargetScan Human | Moderate (predicted) | ABCC4 | 0.013 | -7.280 | LPS/IL-1 Mediated Inhibition of RXR Function, NRF2-mediated Oxidative Stress Response |
hsa-miR-4689 | 0.014 | 6.500 | TargetScan Human | Moderate (predicted) | AKAP13 | 0.000 | -1.500 | cAMP-mediated signaling, Cardiac β-adrenergic Signaling, Protein Kinase A Signaling |
hsa-miR-4689 | 0.014 | 6.500 | TargetScan Human | Moderate (predicted) | ARHGEF12 | 0.000 | -2.160 | Actin Cytoskeleton Signaling, Axonal Guidance Signaling, Breast Cancer Regulation by Stathmin1, Molecular Mechanisms of Cancer, Phospholipase C Signaling, Reelin Signaling in Neurons, RhoA Signaling, RhoGDI Signaling, Semaphorin Signaling in Neurons, Signaling by Rho Family GTPases, Thrombin Signaling |
hsa-miR-4689 | 0.014 | 6.500 | TargetScan Human | Moderate (predicted) | BICD2 | 0.027 | -7.190 | |
hsa-miR-4689 | 0.014 | 6.500 | TargetScan Human | High (predicted), Moderate (predicted) | BTN3A2 | 0.003 | -2.840 | |
hsa-miR-4689 | 0.014 | 6.500 | TargetScan Human | Moderate (predicted) | C1orf198 | 0.001 | -7.420 | |
hsa-miR-4689 | 0.014 | 6.500 | TargetScan Human | Moderate (predicted) | CABLES1 | 0.000 | -1.940 | CDK5 Signaling |
hsa-miR-4689 | 0.014 | 6.500 | TargetScan Human | Moderate (predicted) | CDKN1A | 0.006 | -10.640 | AMPK Signaling, Antiproliferative Role of Somatostatin Receptor 2, Aryl Hydrocarbon Receptor Signaling, ATM Signaling, Bladder Cancer Signaling, Breast Cancer Regulation by Stathmin1, Cell Cycle: G1/S Checkpoint Regulation, Cell Cycle: G2/M DNA Damage Checkpoint Regulation, Chronic Myeloid Leukemia Signaling, Cyclins and Cell Cycle Regulation, Estrogen-mediated S-phase Entry, GADD45 Signaling, Glioblastoma Multiforme Signaling, Glioma Signaling, Glucocorticoid Receptor Signaling, HER-2 Signaling in Breast Cancer, Hereditary Breast Cancer Signaling, HGF Signaling, JAK/Stat Signaling, Melanoma Signaling, Molecular Mechanisms of Cancer, p53 Signaling, Pancreatic Adenocarcinoma Signaling, PI3K/AKT Signaling, Prostate Cancer Signaling, PTEN Signaling, Role of BRCA1 in DNA Damage Response, Role of CHK Proteins in Cell Cycle Checkpoint Control, STAT3 Pathway, Telomerase Signaling, VDR/RXR Activation |
hsa-miR-4689 | 0.014 | 6.500 | TargetScan Human | Moderate (predicted) | CHMP4B | 0.000 | -1.700 | Mechanisms of Viral Exit from Host Cells |
hsa-miR-4689 | 0.014 | 6.500 | TargetScan Human | Moderate (predicted) | CPNE5 | 0.019 | -4.210 | |
hsa-miR-4689 | 0.014 | 6.500 | TargetScan Human | Moderate (predicted) | DNM3 | 0.000 | -4.980 | Clathrin-mediated Endocytosis Signaling, GNRH Signaling, Huntington's Disease Signaling, Remodeling of Epithelial Adherens Junctions |
hsa-miR-4689 | 0.014 | 6.500 | TargetScan Human | Moderate (predicted) | EFTUD2 | 0.000 | -2.990 | Systemic Lupus Erythematosus Signaling |
hsa-miR-4689 | 0.014 | 6.500 | TargetScan Human | Moderate (predicted) | ENDOD1 | 0.000 | -16.800 | |
hsa-miR-4689 | 0.014 | 6.500 | TargetScan Human | Moderate (predicted) | FAM110A | 0.007 | -3.840 | |
hsa-miR-4689 | 0.014 | 6.500 | TargetScan Human | Moderate (predicted) | FAM172A | 0.031 | -2.420 | |
hsa-miR-4689 | 0.014 | 6.500 | TargetScan Human | Moderate (predicted) | HSBP1 | 0.001 | -3.640 | |
hsa-miR-4689 | 0.014 | 6.500 | TargetScan Human | Moderate (predicted) | MAP1A | 0.000 | -5.290 | |
hsa-miR-4689 | 0.014 | 6.500 | TargetScan Human | Moderate (predicted) | MAPK8IP3 | 0.000 | -1.500 | Reelin Signaling in Neurons, SAPK/JNK Signaling |
hsa-miR-4689 | 0.014 | 6.500 | TargetScan Human | Moderate (predicted) | MBP | 0.000 | -12.630 | |
hsa-miR-4689 | 0.014 | 6.500 | TargetScan Human | Moderate (predicted) | MPRIP | 0.000 | -1.630 | Actin Cytoskeleton Signaling, CCR3 Signaling in Eosinophils, Cdc42 Signaling, Cellular Effects of Sildenafil (Viagra), Chemokine Signaling, Integrin Signaling, Phospholipase C Signaling, Regulation of Actin-based Motility by Rho, RhoA Signaling, Thrombin Signaling |
hsa-miR-4689 | 0.014 | 6.500 | TargetScan Human | Moderate (predicted) | QSOX1 | 0.006 | -1.750 | |
hsa-miR-4689 | 0.014 | 6.500 | TargetScan Human | Moderate (predicted) | SLC2A3 | 0.002 | -9.910 | Antioxidant Action of Vitamin C, HIF1α Signaling, Vitamin-C Transport |
hsa-miR-4689 | 0.014 | 6.500 | TargetScan Human | Moderate (predicted) | TMEM50A | 0.000 | -1.800 | |
hsa-miR-4689 | 0.014 | 6.500 | TargetScan Human | High (predicted) | TNFRSF14 | 0.028 | -3.390 | Atherosclerosis Signaling, NF-κB Activation by Viruses |
hsa-miR-4689 | 0.014 | 6.500 | TargetScan Human | Moderate (predicted) | TNS1 | 0.000 | -2.530 | FAK Signaling |
hsa-miR-4689 | 0.014 | 6.500 | TargetScan Human | Moderate (predicted) | TPM3 | 0.038 | -3.010 | Calcium Signaling |
hsa-miR-4689 | 0.014 | 6.500 | TargetScan Human | Moderate (predicted) | TPP1 | 0.013 | -5.000 | Telomerase Signaling |
hsa-miR-4689 | 0.014 | 6.500 | TargetScan Human | Moderate (predicted) | UBE3B | 0.000 | -2.480 | Protein Ubiquitination Pathway |
hsa-miR-4689 | 0.014 | 6.500 | TargetScan Human | Moderate (predicted) | YWHAZ | 0.000 | -6.410 | 14-3-3-mediated Signaling, Cell Cycle: G2/M DNA Damage Checkpoint Regulation, ERK/MAPK Signaling, ERK5 Signaling, HIPPO signaling, IGF-1 Signaling, Myc Mediated Apoptosis Signaling, p70S6K Signaling, PI3K/AKT Signaling, Protein Kinase A Signaling |
hsa-miR-4689 | 0.014 | 6.500 | TargetScan Human | Moderate (predicted) | ZBED1 | 0.031 | -2.780 | |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | AKAP13 | 0.000 | -1.500 | cAMP-mediated signaling, Cardiac β-adrenergic Signaling, Protein Kinase A Signaling |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | AP1B1 | 0.000 | -2.400 | Clathrin-mediated Endocytosis Signaling, CTLA4 Signaling in Cytotoxic T Lymphocytes, GABA Receptor Signaling, Lipid Antigen Presentation by CD1, Virus Entry via Endocytic Pathways |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | ARHGAP1 | 0.003 | -1.490 | Leukocyte Extravasation Signaling, RhoA Signaling, RhoGDI Signaling, Semaphorin Signaling in Neurons |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | ARPC4 | 0.015 | -1.570 | Actin Cytoskeleton Signaling, Actin Nucleation by ARP-WASP Complex, Axonal Guidance Signaling, CD28 Signaling in T Helper Cells, Cdc42 Signaling, Clathrin-mediated Endocytosis Signaling, Ephrin Receptor Signaling, Epithelial Adherens Junction Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, fMLP Signaling in Neutrophils, Integrin Signaling, Rac Signaling, Regulation of Actin-based Motility by Rho, Remodeling of Epithelial Adherens Junctions, RhoA Signaling, RhoGDI Signaling, Signaling by Rho Family GTPases |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | ARPC5 | 0.000 | -9.370 | Actin Cytoskeleton Signaling, Actin Nucleation by ARP-WASP Complex, Axonal Guidance Signaling, CD28 Signaling in T Helper Cells, Cdc42 Signaling, Clathrin-mediated Endocytosis Signaling, Corticotropin Releasing Hormone Signaling, Ephrin Receptor Signaling, Epithelial Adherens Junction Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, fMLP Signaling in Neutrophils, Integrin Signaling, Rac Signaling, Regulation of Actin-based Motility by Rho, Remodeling of Epithelial Adherens Junctions, RhoA Signaling, RhoGDI Signaling, Signaling by Rho Family GTPases |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | BNIP3L | 0.002 | -1.965 | |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | BTN3A2 | 0.003 | -2.840 | |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | C1orf198 | 0.001 | -7.420 | |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | CDKN1A | 0.006 | -10.640 | AMPK Signaling, Antiproliferative Role of Somatostatin Receptor 2, Aryl Hydrocarbon Receptor Signaling, ATM Signaling, Bladder Cancer Signaling, Breast Cancer Regulation by Stathmin1, Cell Cycle: G1/S Checkpoint Regulation, Cell Cycle: G2/M DNA Damage Checkpoint Regulation, Chronic Myeloid Leukemia Signaling, Cyclins and Cell Cycle Regulation, Estrogen-mediated S-phase Entry, GADD45 Signaling, Glioblastoma Multiforme Signaling, Glioma Signaling, Glucocorticoid Receptor Signaling, HER-2 Signaling in Breast Cancer, Hereditary Breast Cancer Signaling, HGF Signaling, JAK/Stat Signaling, Melanoma Signaling, Molecular Mechanisms of Cancer, p53 Signaling, Pancreatic Adenocarcinoma Signaling, PI3K/AKT Signaling, Prostate Cancer Signaling, PTEN Signaling, Role of BRCA1 in DNA Damage Response, Role of CHK Proteins in Cell Cycle Checkpoint Control, STAT3 Pathway, Telomerase Signaling, VDR/RXR Activation |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | CRKL | 0.000 | -6.590 | Actin Cytoskeleton Signaling, Axonal Guidance Signaling, Chronic Myeloid Leukemia Signaling, Ephrin Receptor Signaling, ERK/MAPK Signaling, FGF Signaling, HGF Signaling, IL-3 Signaling, Insulin Receptor Signaling, Integrin Signaling, Leukocyte Extravasation Signaling, Neuregulin Signaling, PDGF Signaling, Reelin Signaling in Neurons, Role of PI3K/AKT Signaling in the Pathogenesis of Influenza, SAPK/JNK Signaling |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | CS | 0.010 | -1.530 | TCA Cycle II (Eukaryotic) |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | CTDSP1 | 0.000 | -6.090 | |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | DGKD | 0.000 | -3.610 | Adipogenesis pathway |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | EFTUD2 | 0.000 | -2.990 | Systemic Lupus Erythematosus Signaling |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | ENKUR | 0.000 | -2.140 | |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | F11R | 0.002 | -2.480 | Leukocyte Extravasation Signaling, Sertoli Cell-Sertoli Cell Junction Signaling, Tight Junction Signaling |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | FAM214B | 0.000 | -2.930 | |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | High (predicted) | FBXW11 | 0.009 | -1.700 | |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | FNBP1 | 0.000 | -1.530 | Actin Nucleation by ARP-WASP Complex, Cardiac Hypertrophy Signaling, Cholecystokinin/Gastrin-mediated Signaling, Colorectal Cancer Metastasis Signaling, CXCR4 Signaling, Germ Cell-Sertoli Cell Junction Signaling, Glioblastoma Multiforme Signaling, Glioma Invasiveness Signaling, Gαq Signaling, HMGB1 Signaling, IL-8 Signaling, ILK Signaling, Integrin Signaling, Molecular Mechanisms of Cancer, mTOR Signaling, phagosome formation, Phospholipase C Signaling, Production of Nitric Oxide and Reactive Oxygen Species in Macrophages, Regulation of Actin-based Motility by Rho, RhoGDI Signaling, Semaphorin Signaling in Neurons, Signaling by Rho Family GTPases, Sphingosine-1-phosphate Signaling, Tec Kinase Signaling, Thrombin Signaling |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | FOXO1 | 0.000 | -1.700 | 14-3-3-mediated Signaling, Adipogenesis pathway, AMPK Signaling, Angiopoietin Signaling, B Cell Receptor Signaling, Cancer Drug Resistance By Drug Efflux, Cell Cycle: G1/S Checkpoint Regulation, Docosahexaenoic Acid (DHA) Signaling, ErbB Signaling, ErbB2-ErbB3 Signaling, FXR/RXR Activation, Glioblastoma Multiforme Signaling, HER-2 Signaling in Breast Cancer, Human Embryonic Stem Cell Pluripotency, IGF-1 Signaling, IL-3 Signaling, Insulin Receptor Signaling, Leptin Signaling in Obesity, Molecular Mechanisms of Cancer, PI3K/AKT Signaling, Prostate Cancer Signaling, PTEN Signaling, PXR/RXR Activation, Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis, VDR/RXR Activation, VEGF Signaling |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | FRMD8 | 0.007 | -4.010 | |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | GATA2 | 0.008 | -1.630 | Thrombin Signaling |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | High (predicted) | GLG1 | 0.000 | -1.790 | Agranulocyte Adhesion and Diapedesis, Atherosclerosis Signaling, Granulocyte Adhesion and Diapedesis |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | GNAZ | 0.000 | -8.090 | Androgen Signaling, Axonal Guidance Signaling, Cardiac Hypertrophy Signaling, CREB Signaling in Neurons, CXCR4 Signaling, Endothelin-1 Signaling, Ephrin B Signaling, Ephrin Receptor Signaling, G Beta Gamma Signaling, IL-1 Signaling, Molecular Mechanisms of Cancer, Relaxin Signaling, RhoGDI Signaling, Role of NFAT in Regulation of the Immune Response, Signaling by Rho Family GTPases, Synaptic Long Term Depression, Tec Kinase Signaling, Thrombin Signaling |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | HECTD4 | 0.000 | -2.070 | |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | HNRNPUL1 | 0.000 | -2.250 | |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | High (predicted) | ITGB3 | 0.007 | -6.420 | Agrin Interactions at Neuromuscular Junction, Caveolar-mediated Endocytosis Signaling, Clathrin-mediated Endocytosis Signaling, Glioma Invasiveness Signaling, Granulocyte Adhesion and Diapedesis, HER-2 Signaling in Breast Cancer, IL-8 Signaling, ILK Signaling, Integrin Signaling, Leukocyte Extravasation Signaling, Macropinocytosis Signaling, NF-κB Activation by Viruses, P2Y Purigenic Receptor Signaling Pathway, Paxillin Signaling, Reelin Signaling in Neurons, Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis, Role of Tissue Factor in Cancer, Virus Entry via Endocytic Pathways |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | JAM3 | 0.004 | -11.080 | Agranulocyte Adhesion and Diapedesis, Granulocyte Adhesion and Diapedesis, Leukocyte Extravasation Signaling, Sertoli Cell-Sertoli Cell Junction Signaling, Tight Junction Signaling |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | KIF3C | 0.001 | -2.030 | |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | LASP1 | 0.000 | -5.070 | IL-8 Signaling |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | LDLRAP1 | 0.000 | -6.690 | Clathrin-mediated Endocytosis Signaling |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | MAP2K1 | 0.013 | -1.500 | 14-3-3-mediated Signaling, 4-1BB Signaling in T Lymphocytes, Actin Cytoskeleton Signaling, Acute Myeloid Leukemia Signaling, Acute Phase Response Signaling, Aldosterone Signaling in Epithelial Cells, Antiproliferative Role of Somatostatin Receptor 2, Apoptosis Signaling, Axonal Guidance Signaling, B Cell Receptor Signaling, Bladder Cancer Signaling, BMP signaling pathway, Breast Cancer Regulation by Stathmin1, cAMP-mediated signaling, Cancer Drug Resistance By Drug Efflux, Cardiac Hypertrophy Signaling, CCR3 Signaling in Eosinophils, CD27 Signaling in Lymphocytes, CD28 Signaling in T Helper Cells, CD40 Signaling, CDK5 Signaling, Ceramide Signaling, Chemokine Signaling, Cholecystokinin/Gastrin-mediated Signaling, Chronic Myeloid Leukemia Signaling, CNTF Signaling, Colorectal Cancer Metastasis Signaling, Corticotropin Releasing Hormone Signaling, CREB Signaling in Neurons, CXCR4 Signaling, EGF Signaling, EIF2 Signaling, Endometrial Cancer Signaling, Ephrin Receptor Signaling, ErbB Signaling, ErbB2-ErbB3 Signaling, ErbB4 Signaling, ERK/MAPK Signaling, Erythropoietin Signaling, Estrogen Receptor Signaling, FAK Signaling, Fc Epsilon RI Signaling, FGF Signaling, FLT3 Signaling in Hematopoietic Progenitor Cells, fMLP Signaling in Neutrophils, G-Protein Coupled Receptor Signaling, Gap Junction Signaling, GDNF Family Ligand-Receptor Interactions, Germ Cell-Sertoli Cell Junction Signaling, Glioblastoma Multiforme Signaling, Glioma Signaling, Glucocorticoid Receptor Signaling, GM-CSF Signaling, GNRH Signaling, Gα12/13 Signaling, Gαq Signaling, Gαs Signaling, HGF Signaling, HMGB1 Signaling, IGF-1 Signaling, IL-12 Signaling and Production in Macrophages, IL-15 Signaling, IL-17 Signaling, IL-17A Signaling in Airway Cells, IL-2 Signaling, IL-3 Signaling, IL-6 Signaling, IL-8 Signaling, Insulin Receptor Signaling, Integrin Signaling, JAK/Stat Signaling, Leptin Signaling in Obesity, LPS-stimulated MAPK Signaling, Melanocyte Development and Pigmentation Signaling, Melanoma Signaling, Melatonin Signaling, Molecular Mechanisms of Cancer, Mouse Embryonic Stem Cell Pluripotency, Natural Killer Cell Signaling, Neuregulin Signaling, Neurotrophin/TRK Signaling, NGF Signaling, Nitric Oxide Signaling in the Cardiovascular System, Non-Small Cell Lung Cancer Signaling, NRF2-mediated Oxidative Stress Response, Oncostatin M Signaling, Ovarian Cancer Signaling, P2Y Purigenic Receptor Signaling Pathway, p70S6K Signaling, PAK Signaling, Pancreatic Adenocarcinoma Signaling, PDGF Signaling, Phospholipase C Signaling, PI3K Signaling in B Lymphocytes, PI3K/AKT Signaling, PPAR Signaling, PPARα/RXRα Activation, Production of Nitric Oxide and Reactive Oxygen Species in Macrophages, Prolactin Signaling, Prostate Cancer Signaling, Protein Kinase A Signaling, PTEN Signaling, Pyridoxal 5'-phosphate Salvage Pathway, Rac Signaling, RANK Signaling in Osteoclasts, RAR Activation, Regulation of eIF4 and p70S6K Signaling, Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes, Regulation of the Epithelial-Mesenchymal Transition Pathway, Relaxin Signaling, Renal Cell Carcinoma Signaling, Renin-Angiotensin Signaling, Role of IL-17A in Arthritis, Role of IL-17F in Allergic Inflammatory Airway Diseases, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of MAPK Signaling in the Pathogenesis of Influenza, Role of NANOG in Mammalian Embryonic Stem Cell Pluripotency, Role of NFAT in Cardiac Hypertrophy, Role of NFAT in Regulation of the Immune Response, Role of PI3K/AKT Signaling in the Pathogenesis of Influenza, Salvage Pathways of Pyrimidine Ribonucleotides, Sertoli Cell-Sertoli Cell Junction Signaling, Signaling by Rho Family GTPases, STAT3 Pathway, Synaptic Long Term Depression, Synaptic Long Term Potentiation, T Cell Receptor Signaling, Telomerase Signaling, TGF-β Signaling, Thrombin Signaling, Thrombopoietin Signaling, Thyroid Cancer Signaling, UVB-Induced MAPK Signaling, UVC-Induced MAPK Signaling, VEGF Family Ligand-Receptor Interactions, VEGF Signaling, Xenobiotic Metabolism Signaling, α-Adrenergic Signaling |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | High (predicted) | MAPK8IP3 | 0.000 | -1.500 | Reelin Signaling in Neurons, SAPK/JNK Signaling |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | MAPKAPK2 | 0.000 | -2.530 | Cardiac Hypertrophy Signaling, CD40 Signaling, FGF Signaling, IL-17 Signaling, IL-6 Signaling, p38 MAPK Signaling, RAR Activation, Role of IL-17A in Arthritis, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | MPST | 0.008 | -1.950 | L-cysteine Degradation III, Thiosulfate Disproportionation III (Rhodanese) |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | NCOA7 | 0.000 | -2.080 | Aryl Hydrocarbon Receptor Signaling |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | High (predicted) | NLRX1 | 0.000 | -1.690 | |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | OXTR | 0.023 | -1.910 | |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | High (predicted) | PFKFB3 | 0.000 | -3.080 | AMPK Signaling |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | PPP6R3 | 0.000 | -1.530 | |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | PRRT3 | 0.000 | -1.530 | |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | PTGIR | 0.038 | -2.020 | cAMP-mediated signaling, Eicosanoid Signaling, G-Protein Coupled Receptor Signaling, Gαs Signaling |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | PTPRF | 0.000 | -4.400 | 3-phosphoinositide Biosynthesis, 3-phosphoinositide Degradation, D-myo-inositol (1, 4, 5, 6)-Tetrakisphosphate Biosynthesis, D-myo-inositol (3, 4, 5, 6)-tetrakisphosphate Biosynthesis, D-myo-inositol-5-phosphate Metabolism, Insulin Receptor Signaling, Protein Kinase A Signaling, Superpathway of Inositol Phosphate Compounds |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | High (predicted) | RAB11FIP3 | 0.000 | -7.870 | |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | High (predicted) | RAC1 | 0.000 | -4.510 | Actin Cytoskeleton Signaling, Actin Nucleation by ARP-WASP Complex, Agrin Interactions at Neuromuscular Junction, Amyotrophic Lateral Sclerosis Signaling, Axonal Guidance Signaling, B Cell Receptor Signaling, Breast Cancer Regulation by Stathmin1, CCR3 Signaling in Eosinophils, CD28 Signaling in T Helper Cells, Clathrin-mediated Endocytosis Signaling, Colorectal Cancer Metastasis Signaling, CXCR4 Signaling, Ephrin A Signaling, Ephrin B Signaling, Ephrin Receptor Signaling, Epithelial Adherens Junction Signaling, ERK/MAPK Signaling, FAK Signaling, Fc Epsilon RI Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, FGF Signaling, fMLP Signaling in Neutrophils, GDNF Family Ligand-Receptor Interactions, Germ Cell-Sertoli Cell Junction Signaling, Glioblastoma Multiforme Signaling, Glucocorticoid Receptor Signaling, GNRH Signaling, HGF Signaling, HMGB1 Signaling, iCOS-iCOSL Signaling in T Helper Cells, IL-3 Signaling, IL-8 Signaling, Integrin Signaling, Leukocyte Extravasation Signaling, LPS-stimulated MAPK Signaling, Macropinocytosis Signaling, Molecular Mechanisms of Cancer, mTOR Signaling, Natural Killer Cell Signaling, Netrin Signaling, NGF Signaling, PAK Signaling, Pancreatic Adenocarcinoma Signaling, Paxillin Signaling, PCP pathway, PEDF Signaling, Phospholipase C Signaling, PI3K Signaling in B Lymphocytes, PKCθ Signaling in T Lymphocytes, Production of Nitric Oxide and Reactive Oxygen Species in Macrophages, PTEN Signaling, Rac Signaling, RAR Activation, Regulation of Actin-based Motility by Rho, Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes, Renal Cell Carcinoma Signaling, Renin-Angiotensin Signaling, RhoGDI Signaling, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of p14/p19ARF in Tumor Suppression, Role of Tissue Factor in Cancer, SAPK/JNK Signaling, Semaphorin Signaling in Neurons, Sertoli Cell-Sertoli Cell Junction Signaling, Signaling by Rho Family GTPases, Sphingosine-1-phosphate Signaling, STAT3 Pathway, T Cell Receptor Signaling, Tight Junction Signaling, Virus Entry via Endocytic Pathways |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | RBM4 | 0.000 | -1.500 | |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | RCOR3 | 0.005 | -1.950 | Huntington's Disease Signaling |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | RGS6 | 0.000 | -1.580 | |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | High (predicted) | RIOK3 | 0.000 | -9.390 | |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | SHC1 | 0.005 | -2.460 | Actin Cytoskeleton Signaling, Acute Phase Response Signaling, Androgen Signaling, Axonal Guidance Signaling, B Cell Receptor Signaling, Breast Cancer Regulation by Stathmin1, Cholecystokinin/Gastrin-mediated Signaling, CREB Signaling in Neurons, EGF Signaling, EIF2 Signaling, Endothelin-1 Signaling, Ephrin Receptor Signaling, ErbB Signaling, ErbB2-ErbB3 Signaling, ErbB4 Signaling, ERK/MAPK Signaling, Erythropoietin Signaling, Estrogen Receptor Signaling, FcγRIIB Signaling in B Lymphocytes, FLT3 Signaling in Hematopoietic Progenitor Cells, G Beta Gamma Signaling, G-Protein Coupled Receptor Signaling, GDNF Family Ligand-Receptor Interactions, Glioblastoma Multiforme Signaling, Glioma Signaling, Glucocorticoid Receptor Signaling, GM-CSF Signaling, Gαi Signaling, Huntington's Disease Signaling, iCOS-iCOSL Signaling in T Helper Cells, IGF-1 Signaling, IL-15 Signaling, IL-2 Signaling, IL-3 Signaling, IL-4 Signaling, IL-6 Signaling, Insulin Receptor Signaling, Integrin Signaling, JAK/Stat Signaling, Melanocyte Development and Pigmentation Signaling, Molecular Mechanisms of Cancer, Myc Mediated Apoptosis Signaling, Natural Killer Cell Signaling, Neuregulin Signaling, Neurotrophin/TRK Signaling, NGF Signaling, Oncostatin M Signaling, p70S6K Signaling, PAK Signaling, PDGF Signaling, Phospholipase C Signaling, PI3K/AKT Signaling, PPAR Signaling, PPARα/RXRα Activation, Prolactin Signaling, PTEN Signaling, Regulation of eIF4 and p70S6K Signaling, Renin-Angiotensin Signaling, Role of JAK1 and JAK3 in γc Cytokine Signaling, Role of JAK2 in Hormone-like Cytokine Signaling, Role of NANOG in Mammalian Embryonic Stem Cell Pluripotency, Role of NFAT in Cardiac Hypertrophy, SAPK/JNK Signaling, Telomerase Signaling, Thrombin Signaling, Thrombopoietin Signaling, Thyroid Cancer Signaling, VEGF Family Ligand-Receptor Interactions, VEGF Signaling |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | SLA2 | 0.030 | -1.900 | |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | SLC44A1 | 0.021 | -4.650 | |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | High (predicted) | STX11 | 0.042 | -4.430 | |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | STX16 | 0.000 | -3.840 | Huntington's Disease Signaling, phagosome maturation, Tight Junction Signaling |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | High (predicted) | TACC1 | 0.000 | -5.110 | |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | TGFBR2 | 0.000 | -2.090 | Antiproliferative Role of TOB in T Cell Signaling, Cardiac Hypertrophy Signaling, Chronic Myeloid Leukemia Signaling, Colorectal Cancer Metastasis Signaling, Epithelial Adherens Junction Signaling, Factors Promoting Cardiogenesis in Vertebrates, Germ Cell-Sertoli Cell Junction Signaling, Glucocorticoid Receptor Signaling, Hepatic Fibrosis / Hepatic Stellate Cell Activation, Human Embryonic Stem Cell Pluripotency, Inhibition of Angiogenesis by TSP1, Molecular Mechanisms of Cancer, NF-κB Signaling, p38 MAPK Signaling, Pancreatic Adenocarcinoma Signaling, PPARα/RXRα Activation, Protein Kinase A Signaling, PTEN Signaling, Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes, Regulation of the Epithelial-Mesenchymal Transition Pathway, Role of NFAT in Cardiac Hypertrophy, STAT3 Pathway, T Helper Cell Differentiation, TGF-β Signaling, Tight Junction Signaling, Wnt/β-catenin Signaling |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | TMCC2 | 0.000 | -3.300 | |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | TMEM63A | 0.007 | -2.130 | |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | TPM3 | 0.038 | -3.010 | Calcium Signaling |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | UBALD2 | 0.001 | -1.490 | |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | VHL | 0.000 | -2.145 | HIF1α Signaling, Hypoxia Signaling in the Cardiovascular System, Protein Ubiquitination Pathway, Renal Cell Carcinoma Signaling |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | High (predicted) | WASF2 | 0.003 | -3.850 | Actin Cytoskeleton Signaling, PEDF Signaling, RhoGDI Signaling |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | Moderate (predicted) | WIPI1 | 0.000 | -3.840 | autophagy |
hsa-miR-4695-5p | 0.003 | 6.300 | TargetScan Human | High (predicted) | ZFP91 | 0.000 | -1.790 | |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | Moderate (predicted) | ADORA2A | 0.040 | -3.270 | cAMP-mediated signaling, G-Protein Coupled Receptor Signaling, Gαs Signaling |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | Moderate (predicted) | ANK1 | 0.000 | -2.780 | Rac Signaling |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | Moderate (predicted) | ARHGEF18 | 0.000 | -2.180 | Breast Cancer Regulation by Stathmin1, Molecular Mechanisms of Cancer, Phospholipase C Signaling, RhoGDI Signaling, Signaling by Rho Family GTPases |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | Moderate (predicted) | BRD3 | 0.047 | -5.970 | |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | High (predicted) | BTBD11 | 0.000 | -6.920 | |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | Moderate (predicted) | CBX6 | 0.018 | -2.680 | |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | High (predicted) | CEBPB | 0.042 | -1.970 | Acute Phase Response Signaling, Adipogenesis pathway, Glucocorticoid Receptor Signaling, IL-12 Signaling and Production in Macrophages, IL-17 Signaling, IL-17A Signaling in Fibroblasts, IL-6 Signaling, JAK/Stat Signaling, Prolactin Signaling, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Type II Diabetes Mellitus Signaling, Unfolded protein response, VDR/RXR Activation |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | Moderate (predicted) | CLCN7 | 0.013 | -2.270 | |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | Moderate (predicted) | CLDN15 | 0.002 | -1.860 | Agranulocyte Adhesion and Diapedesis, Granulocyte Adhesion and Diapedesis, Leukocyte Extravasation Signaling, Sertoli Cell-Sertoli Cell Junction Signaling, Tight Junction Signaling |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | Moderate (predicted) | CLIP2 | 0.000 | -4.440 | |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | High (predicted) | CTIF | 0.000 | -2.160 | |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | Moderate (predicted) | FURIN | 0.007 | -3.340 | Mitochondrial Dysfunction, Notch Signaling |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | Moderate (predicted) | GTF3C5 | 0.003 | -1.470 | Assembly of RNA Polymerase III Complex |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | Moderate (predicted) | HECTD4 | 0.000 | -2.070 | |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | Moderate (predicted) | INF2 | 0.004 | -7.710 | |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | Moderate (predicted) | ITIH5 | 0.000 | -1.600 | |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | Moderate (predicted) | JARID2 | 0.000 | -3.110 | Role of Oct4 in Mammalian Embryonic Stem Cell Pluripotency |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | Moderate (predicted) | JUND | 0.000 | -2.380 | Corticotropin Releasing Hormone Signaling, NRF2-mediated Oxidative Stress Response, PCP pathway |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | Moderate (predicted) | KIAA0513 | 0.000 | -7.100 | |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | Moderate (predicted) | KLF13 | 0.000 | -1.520 | |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | Moderate (predicted) | LPIN2 | 0.000 | -1.500 | Triacylglycerol Biosynthesis |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | Moderate (predicted) | MAP2K2 | 0.000 | -1.590 | 14-3-3-mediated Signaling, 4-1BB Signaling in T Lymphocytes, Actin Cytoskeleton Signaling, Acute Myeloid Leukemia Signaling, Acute Phase Response Signaling, Aldosterone Signaling in Epithelial Cells, Antiproliferative Role of Somatostatin Receptor 2, Apoptosis Signaling, Axonal Guidance Signaling, B Cell Receptor Signaling, Bladder Cancer Signaling, BMP signaling pathway, Breast Cancer Regulation by Stathmin1, cAMP-mediated signaling, Cancer Drug Resistance By Drug Efflux, Cardiac Hypertrophy Signaling, CCR3 Signaling in Eosinophils, CD27 Signaling in Lymphocytes, CD28 Signaling in T Helper Cells, CD40 Signaling, CDK5 Signaling, Chemokine Signaling, Cholecystokinin/Gastrin-mediated Signaling, Chronic Myeloid Leukemia Signaling, CNTF Signaling, Colorectal Cancer Metastasis Signaling, Corticotropin Releasing Hormone Signaling, CREB Signaling in Neurons, CXCR4 Signaling, EIF2 Signaling, Endometrial Cancer Signaling, Ephrin Receptor Signaling, ErbB Signaling, ErbB2-ErbB3 Signaling, ErbB4 Signaling, ERK/MAPK Signaling, Erythropoietin Signaling, Estrogen Receptor Signaling, FAK Signaling, Fc Epsilon RI Signaling, FLT3 Signaling in Hematopoietic Progenitor Cells, fMLP Signaling in Neutrophils, G-Protein Coupled Receptor Signaling, Gap Junction Signaling, GDNF Family Ligand-Receptor Interactions, Germ Cell-Sertoli Cell Junction Signaling, Glioblastoma Multiforme Signaling, Glioma Signaling, Glucocorticoid Receptor Signaling, GM-CSF Signaling, GNRH Signaling, Gα12/13 Signaling, Gαq Signaling, Gαs Signaling, HGF Signaling, HMGB1 Signaling, IGF-1 Signaling, IL-12 Signaling and Production in Macrophages, IL-15 Signaling, IL-17 Signaling, IL-17A Signaling in Airway Cells, IL-2 Signaling, IL-3 Signaling, IL-6 Signaling, IL-8 Signaling, Insulin Receptor Signaling, Integrin Signaling, JAK/Stat Signaling, Leptin Signaling in Obesity, Leukocyte Extravasation Signaling, LPS-stimulated MAPK Signaling, Melanocyte Development and Pigmentation Signaling, Melanoma Signaling, Melatonin Signaling, Molecular Mechanisms of Cancer, Mouse Embryonic Stem Cell Pluripotency, Natural Killer Cell Signaling, Neuregulin Signaling, Neurotrophin/TRK Signaling, NGF Signaling, Nitric Oxide Signaling in the Cardiovascular System, Non-Small Cell Lung Cancer Signaling, NRF2-mediated Oxidative Stress Response, Oncostatin M Signaling, Ovarian Cancer Signaling, P2Y Purigenic Receptor Signaling Pathway, p70S6K Signaling, PAK Signaling, Pancreatic Adenocarcinoma Signaling, PDGF Signaling, Phospholipase C Signaling, PI3K Signaling in B Lymphocytes, PI3K/AKT Signaling, PPAR Signaling, PPARα/RXRα Activation, Prolactin Signaling, Prostate Cancer Signaling, Protein Kinase A Signaling, PTEN Signaling, Pyridoxal 5'-phosphate Salvage Pathway, Rac Signaling, RANK Signaling in Osteoclasts, Regulation of eIF4 and p70S6K Signaling, Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes, Regulation of the Epithelial-Mesenchymal Transition Pathway, Renal Cell Carcinoma Signaling, Renin-Angiotensin Signaling, Role of IL-17A in Arthritis, Role of IL-17F in Allergic Inflammatory Airway Diseases, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of MAPK Signaling in the Pathogenesis of Influenza, Role of NANOG in Mammalian Embryonic Stem Cell Pluripotency, Role of NFAT in Cardiac Hypertrophy, Role of NFAT in Regulation of the Immune Response, Role of PI3K/AKT Signaling in the Pathogenesis of Influenza, Salvage Pathways of Pyrimidine Ribonucleotides, Sertoli Cell-Sertoli Cell Junction Signaling, Signaling by Rho Family GTPases, STAT3 Pathway, Synaptic Long Term Depression, Synaptic Long Term Potentiation, T Cell Receptor Signaling, Telomerase Signaling, TGF-β Signaling, Thrombin Signaling, Thrombopoietin Signaling, Thyroid Cancer Signaling, UVC-Induced MAPK Signaling, VEGF Family Ligand-Receptor Interactions, VEGF Signaling, Xenobiotic Metabolism Signaling, α-Adrenergic Signaling |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | Moderate (predicted) | MBP | 0.000 | -12.630 | |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | High (predicted) | MLEC | 0.000 | -1.745 | |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | Moderate (predicted) | MOB3C | 0.010 | -6.740 | |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | High (predicted) | NAP1L4 | 0.000 | -4.430 | |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | High (predicted) | NCOR2 | 0.000 | -1.650 | Aryl Hydrocarbon Receptor Signaling, Estrogen Receptor Signaling, Glucocorticoid Receptor Signaling, Huntington's Disease Signaling, LXR/RXR Activation, PPAR Signaling, PPARα/RXRα Activation, RAR Activation, TR/RXR Activation, VDR/RXR Activation, Xenobiotic Metabolism Signaling |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | Moderate (predicted) | NDST1 | 0.000 | -3.200 | Chondroitin Sulfate Biosynthesis, Chondroitin Sulfate Biosynthesis (Late Stages), Dermatan Sulfate Biosynthesis, Dermatan Sulfate Biosynthesis (Late Stages), Heparan Sulfate Biosynthesis, Heparan Sulfate Biosynthesis (Late Stages), LPS/IL-1 Mediated Inhibition of RXR Function, Triacylglycerol Degradation, Xenobiotic Metabolism Signaling |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | Moderate (predicted) | PPP3R1 | 0.000 | -3.920 | Axonal Guidance Signaling, B Cell Receptor Signaling, Calcium Signaling, Calcium-induced T Lymphocyte Apoptosis, cAMP-mediated signaling, Cardiac Hypertrophy Signaling, CD28 Signaling in T Helper Cells, Clathrin-mediated Endocytosis Signaling, Dopamine-DARPP32 Feedback in cAMP Signaling, fMLP Signaling in Neutrophils, Gap Junction Signaling, Glucocorticoid Receptor Signaling, GM-CSF Signaling, Gαq Signaling, iCOS-iCOSL Signaling in T Helper Cells, IL-3 Signaling, Netrin Signaling, nNOS Signaling in Neurons, Nur77 Signaling in T Lymphocytes, Phospholipase C Signaling, PI3K Signaling in B Lymphocytes, PKCθ Signaling in T Lymphocytes, Protein Kinase A Signaling, RANK Signaling in Osteoclasts, Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of NFAT in Cardiac Hypertrophy, Role of NFAT in Regulation of the Immune Response, Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis, Synaptic Long Term Potentiation, T Cell Receptor Signaling |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | Moderate (predicted) | RBM38 | 0.000 | -5.310 | |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | Moderate (predicted) | SLC39A3 | 0.000 | -2.730 | |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | Moderate (predicted) | SNN | 0.000 | -13.920 | |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | Moderate (predicted) | SRC | 0.000 | -7.470 | 14-3-3-mediated Signaling, Agrin Interactions at Neuromuscular Junction, AMPK Signaling, Androgen Signaling, Antiproliferative Role of Somatostatin Receptor 2, Aryl Hydrocarbon Receptor Signaling, cAMP-mediated signaling, Caveolar-mediated Endocytosis Signaling, Cdc42 Signaling, Chemokine Signaling, Cholecystokinin/Gastrin-mediated Signaling, Clathrin-mediated Endocytosis Signaling, Colorectal Cancer Metastasis Signaling, CXCR4 Signaling, EGF Signaling, Endothelin-1 Signaling, Ephrin Receptor Signaling, Epithelial Adherens Junction Signaling, ERK/MAPK Signaling, ERK5 Signaling, Erythropoietin Signaling, Estrogen Receptor Signaling, Estrogen-Dependent Breast Cancer Signaling, FAK Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, G Beta Gamma Signaling, G-Protein Coupled Receptor Signaling, Gap Junction Signaling, Germ Cell-Sertoli Cell Junction Signaling, Glioblastoma Multiforme Signaling, GNRH Signaling, Gα12/13 Signaling, Gαi Signaling, Gαs Signaling, IL-8 Signaling, Integrin Signaling, Leukocyte Extravasation Signaling, Macropinocytosis Signaling, Melanocyte Development and Pigmentation Signaling, Molecular Mechanisms of Cancer, Neuregulin Signaling, Neuropathic Pain Signaling In Dorsal Horn Neurons, Ovarian Cancer Signaling, p70S6K Signaling, Paxillin Signaling, PDGF Signaling, Phospholipase C Signaling, RANK Signaling in Osteoclasts, RAR Activation, Reelin Signaling in Neurons, Regulation of Cellular Mechanics by Calpain Protease, Remodeling of Epithelial Adherens Junctions, RhoGDI Signaling, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of NFAT in Cardiac Hypertrophy, Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis, Role of Tissue Factor in Cancer, Sertoli Cell-Sertoli Cell Junction Signaling, STAT3 Pathway, Tec Kinase Signaling, Thrombin Signaling, UVC-Induced MAPK Signaling, VEGF Signaling, Virus Entry via Endocytic Pathways, Wnt/β-catenin Signaling |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | Moderate (predicted) | SRF | 0.000 | -1.770 | Cardiac Hypertrophy Signaling, Cholecystokinin/Gastrin-mediated Signaling, EGF Signaling, ERK/MAPK Signaling, Growth Hormone Signaling, IGF-1 Signaling, IL-6 Signaling, LPS-stimulated MAPK Signaling, p38 MAPK Signaling, PDGF Signaling, PEDF Signaling |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | Moderate (predicted) | STK24 | 0.000 | -7.300 | |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | Moderate (predicted) | STX16 | 0.000 | -3.840 | Huntington's Disease Signaling, phagosome maturation, Tight Junction Signaling |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | High (predicted) | STX1A | 0.023 | -2.640 | Huntington's Disease Signaling |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | Moderate (predicted) | TNK2 | 0.001 | -3.200 | Cdc42 Signaling, Integrin Signaling |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | Moderate (predicted) | TNS3 | 0.000 | -8.510 | 3-phosphoinositide Biosynthesis, 3-phosphoinositide Degradation, D-myo-inositol (1, 4, 5, 6)-Tetrakisphosphate Biosynthesis, D-myo-inositol (3, 4, 5, 6)-tetrakisphosphate Biosynthesis, D-myo-inositol-5-phosphate Metabolism, Superpathway of Inositol Phosphate Compounds |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | Moderate (predicted) | TSPAN18 | 0.000 | -4.570 | |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | High (predicted) | UBALD2 | 0.001 | -1.490 | |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | Moderate (predicted) | WIPI2 | 0.000 | -1.700 | |
hsa-miR-4707-5p | 0.006 | 7.000 | TargetScan Human | High (predicted) | ZBED1 | 0.031 | -2.780 | |
hsa-miR-4734 | 0.009 | 6.900 | TargetScan Human | Moderate (predicted) | AKT1 | 0.003 | -1.870 | 14-3-3-mediated Signaling, Acute Myeloid Leukemia Signaling, Acute Phase Response Signaling, Adipogenesis pathway, AMPK Signaling, Amyloid Processing, Angiopoietin Signaling, Axonal Guidance Signaling, B Cell Receptor Signaling, Cancer Drug Resistance By Drug Efflux, Cardiac Hypertrophy Signaling, CD28 Signaling in T Helper Cells, Ceramide Signaling, Chronic Myeloid Leukemia Signaling, CNTF Signaling, Colorectal Cancer Metastasis Signaling, CREB Signaling in Neurons, CTLA4 Signaling in Cytotoxic T Lymphocytes, CXCR4 Signaling, Dendritic Cell Maturation, DNA damage-induced 14-3-3σ Signaling, Docosahexaenoic Acid (DHA) Signaling, EGF Signaling, EIF2 Signaling, Endometrial Cancer Signaling, eNOS Signaling, Ephrin Receptor Signaling, Epithelial Adherens Junction Signaling, ErbB Signaling, ErbB2-ErbB3 Signaling, ErbB4 Signaling, ERK5 Signaling, Erythropoietin Signaling, Estrogen-Dependent Breast Cancer Signaling, FAK Signaling, Fc Epsilon RI Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, FcγRIIB Signaling in B Lymphocytes, FGF Signaling, FLT3 Signaling in Hematopoietic Progenitor Cells, FXR/RXR Activation, G Beta Gamma Signaling, G-Protein Coupled Receptor Signaling, Gap Junction Signaling, Germ Cell-Sertoli Cell Junction Signaling, Glioblastoma Multiforme Signaling, Glioma Signaling, Glucocorticoid Receptor Signaling, GM-CSF Signaling, Gα12/13 Signaling, Gαq Signaling, HER-2 Signaling in Breast Cancer, Hereditary Breast Cancer Signaling, HGF Signaling, HIF1α Signaling, HMGB1 Signaling, Human Embryonic Stem Cell Pluripotency, Huntington's Disease Signaling, Hypoxia Signaling in the Cardiovascular System, iCOS-iCOSL Signaling in T Helper Cells, IGF-1 Signaling, IL-12 Signaling and Production in Macrophages, IL-15 Signaling, IL-17 Signaling, IL-17A Signaling in Airway Cells, IL-2 Signaling, IL-22 Signaling, IL-3 Signaling, IL-4 Signaling, IL-6 Signaling, IL-8 Signaling, ILK Signaling, Inhibition of Angiogenesis by TSP1, Insulin Receptor Signaling, Integrin Signaling, JAK/Stat Signaling, Leptin Signaling in Obesity, Lymphotoxin β Receptor Signaling, Melanoma Signaling, Molecular Mechanisms of Cancer, Mouse Embryonic Stem Cell Pluripotency, mTOR Signaling, Myc Mediated Apoptosis Signaling, Natural Killer Cell Signaling, Neuregulin Signaling, Neurotrophin/TRK Signaling, NF-κB Activation by Viruses, NF-κB Signaling, NGF Signaling, Nitric Oxide Signaling in the Cardiovascular System, Non-Small Cell Lung Cancer Signaling, NRF2-mediated Oxidative Stress Response, Ovarian Cancer Signaling, P2Y Purigenic Receptor Signaling Pathway, p53 Signaling, p70S6K Signaling, Pancreatic Adenocarcinoma Signaling, PEDF Signaling, PI3K Signaling in B Lymphocytes, PI3K/AKT Signaling, Production of Nitric Oxide and Reactive Oxygen Species in Macrophages, Prostate Cancer Signaling, PTEN Signaling, PXR/RXR Activation, RANK Signaling in Osteoclasts, RAR Activation, Reelin Signaling in Neurons, Regulation of eIF4 and p70S6K Signaling, Regulation of the Epithelial-Mesenchymal Transition Pathway, Relaxin Signaling, Renal Cell Carcinoma Signaling, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of MAPK Signaling in the Pathogenesis of Influenza, Role of NANOG in Mammalian Embryonic Stem Cell Pluripotency, Role of NFAT in Cardiac Hypertrophy, Role of NFAT in Regulation of the Immune Response, Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis, Role of PI3K/AKT Signaling in the Pathogenesis of Influenza, Role of PKR in Interferon Induction and Antiviral Response, Role of Tissue Factor in Cancer, Sertoli Cell-Sertoli Cell Junction Signaling, Small Cell Lung Cancer Signaling, Sphingosine-1-phosphate Signaling, Systemic Lupus Erythematosus Signaling, Telomerase Signaling, Thrombin Signaling, Tight Junction Signaling, TR/RXR Activation, TREM1 Signaling, Type II Diabetes Mellitus Signaling, UVB-Induced MAPK Signaling, VEGF Family Ligand-Receptor Interactions, VEGF Signaling, Wnt/β-catenin Signaling |
hsa-miR-4734 | 0.009 | 6.900 | TargetScan Human | Moderate (predicted) | ATG9A | 0.000 | -1.785 | autophagy |
hsa-miR-4734 | 0.009 | 6.900 | TargetScan Human | High (predicted) | BCR | 0.000 | -2.390 | |
hsa-miR-4734 | 0.009 | 6.900 | TargetScan Human | Moderate (predicted) | CCNJL | 0.000 | -1.610 | |
hsa-miR-4734 | 0.009 | 6.900 | TargetScan Human | Moderate (predicted) | DGKD | 0.000 | -3.610 | Adipogenesis pathway |
hsa-miR-4734 | 0.009 | 6.900 | TargetScan Human | Moderate (predicted) | DIMT1 | 0.016 | -3.270 | |
hsa-miR-4734 | 0.009 | 6.900 | TargetScan Human | Moderate (predicted) | EZR | 0.000 | -1.740 | Actin Cytoskeleton Signaling, Agranulocyte Adhesion and Diapedesis, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, Granulocyte Adhesion and Diapedesis, Leukocyte Extravasation Signaling, Regulation of Cellular Mechanics by Calpain Protease, RhoA Signaling, RhoGDI Signaling, Signaling by Rho Family GTPases |
hsa-miR-4734 | 0.009 | 6.900 | TargetScan Human | Moderate (predicted) | INSIG1 | 0.000 | -4.310 | Unfolded protein response |
hsa-miR-4734 | 0.009 | 6.900 | TargetScan Human | Moderate (predicted) | MAPK8IP3 | 0.000 | -1.500 | Reelin Signaling in Neurons, SAPK/JNK Signaling |
hsa-miR-4734 | 0.009 | 6.900 | TargetScan Human | Moderate (predicted) | MIEF1 | 0.000 | -1.840 | |
hsa-miR-4734 | 0.009 | 6.900 | TargetScan Human | Moderate (predicted) | MYH9 | 0.052 | -7.770 | Actin Cytoskeleton Signaling, Agranulocyte Adhesion and Diapedesis, Calcium Signaling, Cellular Effects of Sildenafil (Viagra), Epithelial Adherens Junction Signaling, Hepatic Fibrosis / Hepatic Stellate Cell Activation, ILK Signaling, Tight Junction Signaling |
hsa-miR-4734 | 0.009 | 6.900 | TargetScan Human | Moderate (predicted) | ORAI3 | 0.000 | -1.540 | |
hsa-miR-4734 | 0.009 | 6.900 | TargetScan Human | Moderate (predicted) | PACSIN2 | 0.001 | -2.040 | |
hsa-miR-4734 | 0.009 | 6.900 | TargetScan Human | High (predicted) | PDGFA | 0.001 | -4.260 | Actin Cytoskeleton Signaling, Atherosclerosis Signaling, Axonal Guidance Signaling, Clathrin-mediated Endocytosis Signaling, Ephrin Receptor Signaling, Glioblastoma Multiforme Signaling, Glioma Signaling, Hepatic Fibrosis / Hepatic Stellate Cell Activation, Human Embryonic Stem Cell Pluripotency, Macropinocytosis Signaling, PAK Signaling, PDGF Signaling, PPAR Signaling, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Sphingosine-1-phosphate Signaling, VDR/RXR Activation |
hsa-miR-4734 | 0.009 | 6.900 | TargetScan Human | Moderate (predicted) | PRKCA | 0.000 | -2.250 | 14-3-3-mediated Signaling, Aldosterone Signaling in Epithelial Cells, Androgen Signaling, Apoptosis Signaling, Axonal Guidance Signaling, Breast Cancer Regulation by Stathmin1, Calcium-induced T Lymphocyte Apoptosis, Caveolar-mediated Endocytosis Signaling, CCR3 Signaling in Eosinophils, CCR5 Signaling in Macrophages, Chemokine Signaling, Cholecystokinin/Gastrin-mediated Signaling, Corticotropin Releasing Hormone Signaling, CREB Signaling in Neurons, CXCR4 Signaling, Dopamine-DARPP32 Feedback in cAMP Signaling, EGF Signaling, Endothelin-1 Signaling, eNOS Signaling, ErbB Signaling, ErbB4 Signaling, ERK/MAPK Signaling, Erythropoietin Signaling, Factors Promoting Cardiogenesis in Vertebrates, Fc Epsilon RI Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, FGF Signaling, fMLP Signaling in Neutrophils, G Beta Gamma Signaling, G-Protein Coupled Receptor Signaling, Gap Junction Signaling, Glioma Signaling, GNRH Signaling, GPCR-Mediated Nutrient Sensing in Enteroendocrine Cells, Growth Hormone Signaling, Gαq Signaling, Hepatic Cholestasis, HER-2 Signaling in Breast Cancer, HGF Signaling, Huntington's Disease Signaling, IL-12 Signaling and Production in Macrophages, IL-3 Signaling, IL-8 Signaling, Leukocyte Extravasation Signaling, LPS-stimulated MAPK Signaling, Macropinocytosis Signaling, Mechanisms of Viral Exit from Host Cells, Melatonin Signaling, Molecular Mechanisms of Cancer, mTOR Signaling, Natural Killer Cell Signaling, Neuregulin Signaling, Neuropathic Pain Signaling In Dorsal Horn Neurons, NF-κB Activation by Viruses, Nitric Oxide Signaling in the Cardiovascular System, nNOS Signaling in Neurons, Non-Small Cell Lung Cancer Signaling, NRF2-mediated Oxidative Stress Response, P2Y Purigenic Receptor Signaling Pathway, p70S6K Signaling, PDGF Signaling, phagosome formation, Phospholipase C Signaling, PPARα/RXRα Activation, Production of Nitric Oxide and Reactive Oxygen Species in Macrophages, Prolactin Signaling, Protein Kinase A Signaling, RAR Activation, Renin-Angiotensin Signaling, RhoGDI Signaling, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of MAPK Signaling in the Pathogenesis of Influenza, Role of NFAT in Cardiac Hypertrophy, Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses, Role of Tissue Factor in Cancer, Sperm Motility, Synaptic Long Term Depression, Synaptic Long Term Potentiation, Tec Kinase Signaling, Thrombin Signaling, Thrombopoietin Signaling, Type II Diabetes Mellitus Signaling, UVA-Induced MAPK Signaling, UVB-Induced MAPK Signaling, UVC-Induced MAPK Signaling, VDR/RXR Activation, VEGF Family Ligand-Receptor Interactions, VEGF Signaling, Virus Entry via Endocytic Pathways, Wnt/Ca+ pathway, Xenobiotic Metabolism Signaling, α-Adrenergic Signaling |
hsa-miR-4734 | 0.009 | 6.900 | TargetScan Human | High (predicted) | PTPN1 | 0.000 | -2.900 | 3-phosphoinositide Biosynthesis, 3-phosphoinositide Degradation, Caveolar-mediated Endocytosis Signaling, D-myo-inositol (1, 4, 5, 6)-Tetrakisphosphate Biosynthesis, D-myo-inositol (3, 4, 5, 6)-tetrakisphosphate Biosynthesis, D-myo-inositol-5-phosphate Metabolism, Insulin Receptor Signaling, JAK/Stat Signaling, Protein Kinase A Signaling, Role of JAK2 in Hormone-like Cytokine Signaling, Superpathway of Inositol Phosphate Compounds |
hsa-miR-4734 | 0.009 | 6.900 | TargetScan Human | Moderate (predicted) | RCC2 | 0.000 | -4.220 | |
hsa-miR-4734 | 0.009 | 6.900 | TargetScan Human | High (predicted) | STX16 | 0.000 | -3.840 | Huntington's Disease Signaling, phagosome maturation, Tight Junction Signaling |
hsa-miR-4734 | 0.009 | 6.900 | TargetScan Human | Moderate (predicted) | TAPBP | 0.002 | -2.820 | Antigen Presentation Pathway |
hsa-miR-4734 | 0.009 | 6.900 | TargetScan Human | Moderate (predicted) | TMEM63A | 0.007 | -2.130 | |
hsa-miR-4734 | 0.009 | 6.900 | TargetScan Human | Moderate (predicted) | UBE2O | 0.000 | -3.240 | |
hsa-miR-4734 | 0.009 | 6.900 | TargetScan Human | Moderate (predicted) | ZBED1 | 0.031 | -2.780 | |
hsa-miR-4734 | 0.009 | 6.900 | TargetScan Human | High (predicted) | ZZEF1 | 0.000 | -2.950 | |
hsa-miR-509-3-5p | 0.001 | -2.300 | TargetScan Human | Moderate (predicted) | FAM13A | 0.000 | 1.570 | |
hsa-miR-510 | 0.006 | -2.200 | TargetScan Human | Moderate (predicted) | FEZ1 | 0.002 | 1.740 | |
hsa-miR-510 | 0.006 | -2.200 | TargetScan Human | Moderate (predicted) | POLR2J2/POLR2J3 | 0.000 | 1.450 | Androgen Signaling, Assembly of RNA Polymerase II Complex, CREB Signaling in Neurons, Estrogen Receptor Signaling, Glucocorticoid Receptor Signaling, Hereditary Breast Cancer Signaling, Huntington's Disease Signaling, Nucleotide Excision Repair Pathway |
hsa-miR-510 | 0.006 | -2.200 | TargetScan Human | High (predicted) | TERF1 | 0.000 | 1.580 | Telomerase Signaling, Telomere Extension by Telomerase |
hsa-miR-510 | 0.006 | -2.200 | TargetScan Human | High (predicted) | THOC2 | 0.003 | 1.770 | |
hsa-miR-542-3p | 0.022 | -2.400 | TargetScan Human | Moderate (predicted) | HGD | 0.000 | 1.490 | Tyrosine Degradation I |
hsa-miR-548aa | 0.000 | -2.600 | TargetScan Human | Moderate (predicted) | CSNK2A1 | 0.008 | 2.650 | Amyloid Processing, Clathrin-mediated Endocytosis Signaling, EGF Signaling, IGF-1 Signaling, IL-2 Signaling, IL-6 Signaling, NF-κB Signaling, PDGF Signaling, PTEN Signaling, RAR Activation, VDR/RXR Activation, Wnt/β-catenin Signaling |
hsa-miR-548aa | 0.000 | -2.600 | TargetScan Human | Moderate (predicted) | LCLAT1 | 0.000 | 2.280 | CDP-diacylglycerol Biosynthesis I, Phosphatidylglycerol Biosynthesis II (Non-plastidic), Triacylglycerol Biosynthesis |
hsa-miR-548aa | 0.000 | -2.600 | TargetScan Human | Moderate (predicted) | NAA35 | 0.000 | 2.010 | |
hsa-miR-548aa | 0.000 | -2.600 | TargetScan Human | Moderate (predicted) | TERF1 | 0.000 | 1.580 | Telomerase Signaling, Telomere Extension by Telomerase |
hsa-miR-548aa | 0.000 | -2.600 | TargetScan Human | Moderate (predicted) | TRIO | 0.019 | 1.550 | Actin Cytoskeleton Signaling, NGF Signaling |
hsa-miR-548aa | 0.000 | -2.600 | TargetScan Human | Moderate (predicted) | ZFAND1 | 0.000 | 1.490 | |
hsa-miR-548ac | 0.001 | -3.100 | TargetScan Human | Moderate (predicted) | LRRCC1 | 0.000 | 1.790 | |
hsa-miR-548a-3p | 0.000 | -2.600 | TargetScan Human | Moderate (predicted) | CCDC53 | 0.000 | 1.880 | |
hsa-miR-548a-3p | 0.000 | -2.600 | TargetScan Human | Moderate (predicted) | NEMF | 0.000 | 2.250 | |
hsa-miR-602 | 0.003 | 10.300 | TargetScan Human | Moderate (predicted) | ADD1 | 0.002 | -2.540 | Gαs Signaling, Protein Kinase A Signaling |
hsa-miR-602 | 0.003 | 10.300 | TargetScan Human | Moderate (predicted) | ADGRE5 | 0.000 | -4.100 | |
hsa-miR-602 | 0.003 | 10.300 | TargetScan Human | High (predicted) | AGO2 | 0.047 | -2.560 | EIF2 Signaling, Regulation of eIF4 and p70S6K Signaling |
hsa-miR-602 | 0.003 | 10.300 | TargetScan Human | Moderate (predicted) | AKAP13 | 0.000 | -1.500 | cAMP-mediated signaling, Cardiac β-adrenergic Signaling, Protein Kinase A Signaling |
hsa-miR-602 | 0.003 | 10.300 | TargetScan Human | High (predicted) | AXIN1 | 0.000 | -2.470 | Basal Cell Carcinoma Signaling, Colorectal Cancer Metastasis Signaling, Endometrial Cancer Signaling, Ephrin B Signaling, Ephrin Receptor Signaling, Factors Promoting Cardiogenesis in Vertebrates, Germ Cell-Sertoli Cell Junction Signaling, Glioblastoma Multiforme Signaling, Human Embryonic Stem Cell Pluripotency, Molecular Mechanisms of Cancer, Mouse Embryonic Stem Cell Pluripotency, Ovarian Cancer Signaling, Regulation of the Epithelial-Mesenchymal Transition Pathway, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of NANOG in Mammalian Embryonic Stem Cell Pluripotency, Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis, Role of Wnt/GSK-3β Signaling in the Pathogenesis of Influenza, Sertoli Cell-Sertoli Cell Junction Signaling, Wnt/Ca+ pathway, Wnt/β-catenin Signaling |
hsa-miR-602 | 0.003 | 10.300 | TargetScan Human | Moderate (predicted) | CALM1 (includes others) | 0.000 | -15.670 | 1D-myo-inositol Hexakisphosphate Biosynthesis II (Mammalian), Androgen Signaling, B Cell Receptor Signaling, Breast Cancer Regulation by Stathmin1, Calcium Signaling, Calcium-induced T Lymphocyte Apoptosis, cAMP-mediated signaling, Cardiac Hypertrophy Signaling, CCR3 Signaling in Eosinophils, CCR5 Signaling in Macrophages, CD28 Signaling in T Helper Cells, Cellular Effects of Sildenafil (Viagra), Chemokine Signaling, Corticotropin Releasing Hormone Signaling, CREB Signaling in Neurons, D-myo-inositol (1, 3, 4)-trisphosphate Biosynthesis, Dopamine-DARPP32 Feedback in cAMP Signaling, eNOS Signaling, fMLP Signaling in Neutrophils, Glioma Signaling, Glutamate Receptor Signaling, Gαq Signaling, iCOS-iCOSL Signaling in T Helper Cells, iNOS Signaling, Melatonin Signaling, Nitric Oxide Signaling in the Cardiovascular System, nNOS Signaling in Neurons, nNOS Signaling in Skeletal Muscle Cells, Nur77 Signaling in T Lymphocytes, Phospholipase C Signaling, PI3K Signaling in B Lymphocytes, Protein Kinase A Signaling, RANK Signaling in Osteoclasts, Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of NFAT in Cardiac Hypertrophy, Role of NFAT in Regulation of the Immune Response, Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis, Sperm Motility, Superpathway of D-myo-inositol (1, 4, 5)-trisphosphate Metabolism, Superpathway of Inositol Phosphate Compounds, Synaptic Long Term Potentiation, T Cell Receptor Signaling, α-Adrenergic Signaling |
hsa-miR-602 | 0.003 | 10.300 | TargetScan Human | Moderate (predicted) | CDKN1A | 0.006 | -10.640 | AMPK Signaling, Antiproliferative Role of Somatostatin Receptor 2, Aryl Hydrocarbon Receptor Signaling, ATM Signaling, Bladder Cancer Signaling, Breast Cancer Regulation by Stathmin1, Cell Cycle: G1/S Checkpoint Regulation, Cell Cycle: G2/M DNA Damage Checkpoint Regulation, Chronic Myeloid Leukemia Signaling, Cyclins and Cell Cycle Regulation, Estrogen-mediated S-phase Entry, GADD45 Signaling, Glioblastoma Multiforme Signaling, Glioma Signaling, Glucocorticoid Receptor Signaling, HER-2 Signaling in Breast Cancer, Hereditary Breast Cancer Signaling, HGF Signaling, JAK/Stat Signaling, Melanoma Signaling, Molecular Mechanisms of Cancer, p53 Signaling, Pancreatic Adenocarcinoma Signaling, PI3K/AKT Signaling, Prostate Cancer Signaling, PTEN Signaling, Role of BRCA1 in DNA Damage Response, Role of CHK Proteins in Cell Cycle Checkpoint Control, STAT3 Pathway, Telomerase Signaling, VDR/RXR Activation |
hsa-miR-602 | 0.003 | 10.300 | TargetScan Human | Moderate (predicted) | CLCN7 | 0.013 | -2.270 | |
hsa-miR-602 | 0.003 | 10.300 | TargetScan Human | High (predicted) | CSK | 0.000 | -7.130 | Actin Cytoskeleton Signaling, B Cell Receptor Signaling, CD28 Signaling in T Helper Cells, FAK Signaling, Gαq Signaling, iCOS-iCOSL Signaling in T Helper Cells, Paxillin Signaling, RAR Activation, T Cell Receptor Signaling |
hsa-miR-602 | 0.003 | 10.300 | TargetScan Human | Moderate (predicted) | CTDSP1 | 0.000 | -6.090 | |
hsa-miR-602 | 0.003 | 10.300 | TargetScan Human | Moderate (predicted) | CTNNBIP1 | 0.000 | -1.990 | Adipogenesis pathway |
hsa-miR-602 | 0.003 | 10.300 | TargetScan Human | Moderate (predicted) | FAM13B | 0.000 | -1.490 | |
hsa-miR-602 | 0.003 | 10.300 | TargetScan Human | High (predicted) | FAM20B | 0.000 | -4.060 | Pyridoxal 5'-phosphate Salvage Pathway, Salvage Pathways of Pyrimidine Ribonucleotides |
hsa-miR-602 | 0.003 | 10.300 | TargetScan Human | Moderate (predicted) | GLG1 | 0.000 | -1.790 | Agranulocyte Adhesion and Diapedesis, Atherosclerosis Signaling, Granulocyte Adhesion and Diapedesis |
hsa-miR-602 | 0.003 | 10.300 | TargetScan Human | Moderate (predicted) | LAMC1 | 0.000 | -2.320 | Agrin Interactions at Neuromuscular Junction, CDK5 Signaling |
hsa-miR-602 | 0.003 | 10.300 | TargetScan Human | High (predicted) | LPIN2 | 0.000 | -1.500 | Triacylglycerol Biosynthesis |
hsa-miR-602 | 0.003 | 10.300 | TargetScan Human | High (predicted) | ORMDL3 | 0.019 | -3.370 | |
hsa-miR-602 | 0.003 | 10.300 | TargetScan Human | High (predicted) | PIP4K2A | 0.000 | -9.600 | 3-phosphoinositide Biosynthesis, Actin Cytoskeleton Signaling, Aldosterone Signaling in Epithelial Cells, D-myo-inositol (1, 4, 5)-Trisphosphate Biosynthesis, D-myo-inositol-5-phosphate Metabolism, Rac Signaling, Regulation of Actin-based Motility by Rho, RhoA Signaling, RhoGDI Signaling, Signaling by Rho Family GTPases, Superpathway of Inositol Phosphate Compounds |
hsa-miR-602 | 0.003 | 10.300 | TargetScan Human | Moderate (predicted) | PSAP | 0.000 | -1.860 | Lipid Antigen Presentation by CD1 |
hsa-miR-602 | 0.003 | 10.300 | TargetScan Human | Moderate (predicted) | SCAND1 | 0.024 | -1.630 | PPAR Signaling, RAR Activation, Xenobiotic Metabolism Signaling |
hsa-miR-602 | 0.003 | 10.300 | TargetScan Human | Moderate (predicted) | SH3KBP1 | 0.001 | -1.720 | Clathrin-mediated Endocytosis Signaling |
hsa-miR-602 | 0.003 | 10.300 | TargetScan Human | Moderate (predicted) | SLC22A23 | 0.000 | -1.970 | |
hsa-miR-602 | 0.003 | 10.300 | TargetScan Human | High (predicted) | SPIRE1 | 0.015 | -1.720 | |
hsa-miR-602 | 0.003 | 10.300 | TargetScan Human | High (predicted) | TAL1 | 0.000 | -5.160 | |
hsa-miR-602 | 0.003 | 10.300 | TargetScan Human | Moderate (predicted) | TNS1 | 0.000 | -2.530 | FAK Signaling |
hsa-miR-602 | 0.003 | 10.300 | TargetScan Human | Moderate (predicted) | TSC22D4 | 0.000 | -2.190 | |
hsa-miR-602 | 0.003 | 10.300 | TargetScan Human | Moderate (predicted) | UBAC1 | 0.000 | -2.090 | |
hsa-miR-602 | 0.003 | 10.300 | TargetScan Human | Moderate (predicted) | WIPI1 | 0.000 | -3.840 | autophagy |
hsa-miR-635 | 0.014 | -2.400 | TargetScan Human | Moderate (predicted) | AKAP7 | 0.000 | 2.860 | cAMP-mediated signaling, Cardiac β-adrenergic Signaling, Protein Kinase A Signaling |
hsa-miR-635 | 0.014 | -2.400 | TargetScan Human | High (predicted) | COL8A2 | 0.041 | 2.880 | Hepatic Fibrosis / Hepatic Stellate Cell Activation |
hsa-miR-642b | 0.001 | 6.000 | TargetScan Human | Moderate (predicted) | ADAR | 0.000 | -3.030 | Activation of IRF by Cytosolic Pattern Recognition Receptors |
hsa-miR-642b | 0.001 | 6.000 | TargetScan Human | Moderate (predicted) | C2orf88 | 0.004 | -2.530 | |
hsa-miR-642b | 0.001 | 6.000 | TargetScan Human | Moderate (predicted) | C5orf15 | 0.008 | -1.470 | |
hsa-miR-642b | 0.001 | 6.000 | TargetScan Human | High (predicted) | CBL | 0.000 | -1.740 | 14-3-3-mediated Signaling, Clathrin-mediated Endocytosis Signaling, Ephrin B Signaling, Erythropoietin Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, FLT3 Signaling in Hematopoietic Progenitor Cells, Insulin Receptor Signaling, Molecular Mechanisms of Cancer, PI3K Signaling in B Lymphocytes, Protein Ubiquitination Pathway, PTEN Signaling, RANK Signaling in Osteoclasts, Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis, Systemic Lupus Erythematosus Signaling, T Cell Receptor Signaling |
hsa-miR-642b | 0.001 | 6.000 | TargetScan Human | Moderate (predicted) | CCPG1 | 0.006 | -2.870 | |
hsa-miR-642b | 0.001 | 6.000 | TargetScan Human | Moderate (predicted) | CELF2 | 0.000 | -1.560 | |
hsa-miR-642b | 0.001 | 6.000 | TargetScan Human | Moderate (predicted) | FNBP1L | 0.004 | -2.010 | Cdc42 Signaling |
hsa-miR-642b | 0.001 | 6.000 | TargetScan Human | Moderate (predicted) | GFOD1 | 0.000 | -2.330 | |
hsa-miR-642b | 0.001 | 6.000 | TargetScan Human | Moderate (predicted) | KIAA0513 | 0.000 | -7.100 | |
hsa-miR-642b | 0.001 | 6.000 | TargetScan Human | Moderate (predicted) | MID1IP1 | 0.000 | -1.540 | |
hsa-miR-642b | 0.001 | 6.000 | TargetScan Human | Moderate (predicted) | MTCH1 | 0.000 | -1.530 | |
hsa-miR-642b | 0.001 | 6.000 | TargetScan Human | High (predicted) | NCOA7 | 0.000 | -2.080 | Aryl Hydrocarbon Receptor Signaling |
hsa-miR-642b | 0.001 | 6.000 | TargetScan Human | Moderate (predicted) | PKP4 | 0.000 | -2.120 | |
hsa-miR-642b | 0.001 | 6.000 | TargetScan Human | Moderate (predicted) | POLR1D | 0.029 | -2.260 | Assembly of RNA Polymerase I Complex |
hsa-miR-642b | 0.001 | 6.000 | TargetScan Human | Moderate (predicted) | RHCE/RHD | 0.003 | -1.450 | |
hsa-miR-642b | 0.001 | 6.000 | TargetScan Human | Moderate (predicted) | SSBP2 | 0.047 | -2.010 | |
hsa-miR-642b | 0.001 | 6.000 | TargetScan Human | Moderate (predicted) | STK24 | 0.000 | -7.300 | |
hsa-miR-642b | 0.001 | 6.000 | TargetScan Human | Moderate (predicted) | STX11 | 0.042 | -4.430 | |
hsa-miR-642b | 0.001 | 6.000 | TargetScan Human | Moderate (predicted) | SYK | 0.003 | -4.360 | B Cell Receptor Signaling, CD28 Signaling in T Helper Cells, CTLA4 Signaling in Cytotoxic T Lymphocytes, Fc Epsilon RI Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, FcγRIIB Signaling in B Lymphocytes, IL-15 Signaling, IL-2 Signaling, Natural Killer Cell Signaling, p70S6K Signaling, phagosome formation, Phospholipase C Signaling, PI3K Signaling in B Lymphocytes, Role of JAK1 and JAK3 in γc Cytokine Signaling, Role of NFAT in Regulation of the Immune Response, Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses |
hsa-miR-642b | 0.001 | 6.000 | TargetScan Human | High (predicted) | SYT11 | 0.000 | -1.590 | |
hsa-miR-642b | 0.001 | 6.000 | TargetScan Human | High (predicted) | TMEM50A | 0.000 | -1.800 | |
hsa-miR-642b | 0.001 | 6.000 | TargetScan Human | High (predicted) | VPS26B | 0.047 | -1.840 | |
hsa-miR-642b | 0.001 | 6.000 | TargetScan Human | Moderate (predicted) | WIPI2 | 0.000 | -1.700 | |
hsa-miR-642b | 0.001 | 6.000 | TargetScan Human | Moderate (predicted) | WWC3 | 0.000 | -2.030 | |
hsa-miR-943 | 0.001 | 2.500 | TargetScan Human | Moderate (predicted) | ABCC4 | 0.013 | -7.280 | LPS/IL-1 Mediated Inhibition of RXR Function, NRF2-mediated Oxidative Stress Response |
hsa-miR-943 | 0.001 | 2.500 | TargetScan Human | Moderate (predicted) | CALM1 (includes others) | 0.000 | -15.670 | 1D-myo-inositol Hexakisphosphate Biosynthesis II (Mammalian), Androgen Signaling, B Cell Receptor Signaling, Breast Cancer Regulation by Stathmin1, Calcium Signaling, Calcium-induced T Lymphocyte Apoptosis, cAMP-mediated signaling, Cardiac Hypertrophy Signaling, CCR3 Signaling in Eosinophils, CCR5 Signaling in Macrophages, CD28 Signaling in T Helper Cells, Cellular Effects of Sildenafil (Viagra), Chemokine Signaling, Corticotropin Releasing Hormone Signaling, CREB Signaling in Neurons, D-myo-inositol (1, 3, 4)-trisphosphate Biosynthesis, Dopamine-DARPP32 Feedback in cAMP Signaling, eNOS Signaling, fMLP Signaling in Neutrophils, Glioma Signaling, Glutamate Receptor Signaling, Gαq Signaling, iCOS-iCOSL Signaling in T Helper Cells, iNOS Signaling, Melatonin Signaling, Nitric Oxide Signaling in the Cardiovascular System, nNOS Signaling in Neurons, nNOS Signaling in Skeletal Muscle Cells, Nur77 Signaling in T Lymphocytes, Phospholipase C Signaling, PI3K Signaling in B Lymphocytes, Protein Kinase A Signaling, RANK Signaling in Osteoclasts, Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of NFAT in Cardiac Hypertrophy, Role of NFAT in Regulation of the Immune Response, Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis, Sperm Motility, Superpathway of D-myo-inositol (1, 4, 5)-trisphosphate Metabolism, Superpathway of Inositol Phosphate Compounds, Synaptic Long Term Potentiation, T Cell Receptor Signaling, α-Adrenergic Signaling |
hsa-miR-943 | 0.001 | 2.500 | TargetScan Human | Moderate (predicted) | CCR6 | 0.024 | -1.560 | |
hsa-miR-943 | 0.001 | 2.500 | TargetScan Human | High (predicted) | CD44 | 0.001 | -1.750 | Chondroitin Sulfate Degradation (Metazoa), Dermatan Sulfate Degradation (Metazoa), Glioma Invasiveness Signaling, HIPPO signaling, Leukocyte Extravasation Signaling, Ovarian Cancer Signaling, Rac Signaling, RhoGDI Signaling, Wnt/β-catenin Signaling |
hsa-miR-943 | 0.001 | 2.500 | TargetScan Human | Moderate (predicted) | EGF | 0.000 | -2.220 | Actin Cytoskeleton Signaling, Axonal Guidance Signaling, Bladder Cancer Signaling, Caveolar-mediated Endocytosis Signaling, Clathrin-mediated Endocytosis Signaling, Colorectal Cancer Metastasis Signaling, EGF Signaling, Ephrin Receptor Signaling, Epithelial Adherens Junction Signaling, ErbB Signaling, ERK5 Signaling, FAK Signaling, Gap Junction Signaling, Glioblastoma Multiforme Signaling, Glioma Signaling, GNRH Signaling, Hepatic Fibrosis / Hepatic Stellate Cell Activation, HER-2 Signaling in Breast Cancer, Huntington's Disease Signaling, IL-8 Signaling, Macropinocytosis Signaling, Neuregulin Signaling, NF-κB Signaling, Non-Small Cell Lung Cancer Signaling, Ovarian Cancer Signaling, Pancreatic Adenocarcinoma Signaling, Regulation of Cellular Mechanics by Calpain Protease, Regulation of the Epithelial-Mesenchymal Transition Pathway, Telomerase Signaling, Thrombin Signaling |
hsa-miR-943 | 0.001 | 2.500 | TargetScan Human | Moderate (predicted) | HYAL3 | 0.008 | -1.780 | Chondroitin Sulfate Degradation (Metazoa), Dermatan Sulfate Degradation (Metazoa) |
hsa-miR-943 | 0.001 | 2.500 | TargetScan Human | Moderate (predicted) | JARID2 | 0.000 | -3.110 | Role of Oct4 in Mammalian Embryonic Stem Cell Pluripotency |
hsa-miR-943 | 0.001 | 2.500 | TargetScan Human | Moderate (predicted) | MBNL1 | 0.000 | -12.940 | |
hsa-miR-943 | 0.001 | 2.500 | TargetScan Human | Moderate (predicted) | MBP | 0.000 | -12.630 | |
hsa-miR-943 | 0.001 | 2.500 | TargetScan Human | Moderate (predicted) | NUMB | 0.019 | -1.850 | Clathrin-mediated Endocytosis Signaling, Notch Signaling |
hsa-miR-943 | 0.001 | 2.500 | TargetScan Human | Moderate (predicted) | PRKCQ | 0.000 | -2.290 | 14-3-3-mediated Signaling, Aldosterone Signaling in Epithelial Cells, Androgen Signaling, Apoptosis Signaling, Axonal Guidance Signaling, B Cell Receptor Signaling, Breast Cancer Regulation by Stathmin1, Calcium-induced T Lymphocyte Apoptosis, CCR3 Signaling in Eosinophils, CCR5 Signaling in Macrophages, CD28 Signaling in T Helper Cells, Cholecystokinin/Gastrin-mediated Signaling, Corticotropin Releasing Hormone Signaling, CREB Signaling in Neurons, CXCR4 Signaling, Dopamine-DARPP32 Feedback in cAMP Signaling, Endothelin-1 Signaling, eNOS Signaling, ErbB Signaling, ErbB4 Signaling, Erythropoietin Signaling, Factors Promoting Cardiogenesis in Vertebrates, Fc Epsilon RI Signaling, Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes, fMLP Signaling in Neutrophils, G Beta Gamma Signaling, Gap Junction Signaling, Glioma Signaling, GNRH Signaling, GPCR-Mediated Nutrient Sensing in Enteroendocrine Cells, Growth Hormone Signaling, Gαq Signaling, Hepatic Cholestasis, HER-2 Signaling in Breast Cancer, HGF Signaling, Huntington's Disease Signaling, iCOS-iCOSL Signaling in T Helper Cells, IL-12 Signaling and Production in Macrophages, IL-3 Signaling, IL-8 Signaling, Leukocyte Extravasation Signaling, LPS-stimulated MAPK Signaling, Macropinocytosis Signaling, Mechanisms of Viral Exit from Host Cells, Melatonin Signaling, Molecular Mechanisms of Cancer, mTOR Signaling, Natural Killer Cell Signaling, Neuregulin Signaling, Neuropathic Pain Signaling In Dorsal Horn Neurons, NF-κB Activation by Viruses, NF-κB Signaling, Nitric Oxide Signaling in the Cardiovascular System, nNOS Signaling in Neurons, NRF2-mediated Oxidative Stress Response, P2Y Purigenic Receptor Signaling Pathway, p70S6K Signaling, phagosome formation, Phospholipase C Signaling, PKCθ Signaling in T Lymphocytes, Production of Nitric Oxide and Reactive Oxygen Species in Macrophages, Prolactin Signaling, Protein Kinase A Signaling, Pyridoxal 5'-phosphate Salvage Pathway, RAR Activation, Renin-Angiotensin Signaling, Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis, Role of NFAT in Cardiac Hypertrophy, Role of NFAT in Regulation of the Immune Response, Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses, Salvage Pathways of Pyrimidine Ribonucleotides, Sperm Motility, Synaptic Long Term Depression, Synaptic Long Term Potentiation, T Cell Receptor Signaling, Tec Kinase Signaling, Thrombin Signaling, Thrombopoietin Signaling, Type II Diabetes Mellitus Signaling, UVB-Induced MAPK Signaling, UVC-Induced MAPK Signaling, VDR/RXR Activation, VEGF Family Ligand-Receptor Interactions, Virus Entry via Endocytic Pathways, Xenobiotic Metabolism Signaling, α-Adrenergic Signaling |
hsa-miR-943 | 0.001 | 2.500 | TargetScan Human | Moderate (predicted) | PRTFDC1 | 0.000 | -1.830 | |
hsa-miR-943 | 0.001 | 2.500 | TargetScan Human | Moderate (predicted) | SHCBP1 | 0.041 | -1.510 | |
hsa-miR-943 | 0.001 | 2.500 | TargetScan Human | Moderate (predicted) | SLC35E1 | 0.000 | -3.270 | |
hsa-miR-943 | 0.001 | 2.500 | TargetScan Human | Moderate (predicted) | VGLL4 | 0.001 | -7.360 |